data_2kgs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kgs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 122.598 1.189 . . . . 0.0 113.924 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.43 163.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 129.728 3.211 . . . . 0.0 114.058 167.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.8 138.72 45.77 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.679 1.591 . . . . 0.0 112.331 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.62 148.47 24.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.42 1.488 . . . . 0.0 110.507 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.6 p -151.38 159.51 44.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.195 1.474 . . . . 0.0 113.387 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.81 141.67 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.337 1.855 . . . . 0.0 108.781 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.6 p -143.36 146.66 33.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.573 0.749 . . . . 0.0 112.461 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -112.93 149.0 33.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.647 1.579 . . . . 0.0 111.833 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.5 m -136.3 58.2 1.75 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.336 2.254 . . . . 0.0 111.222 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.06 -86.92 1.18 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.572 1.082 . . . . 0.0 113.434 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -120.56 30.12 7.09 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.26 1.824 . . . . 0.0 112.245 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -142.34 137.76 30.75 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.184 2.193 . . . . 0.0 108.226 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.96 142.5 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.439 1.096 . . . . 0.0 111.282 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -127.35 130.46 49.49 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.923 1.289 . . . . 0.0 111.165 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.67 122.0 41.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.755 2.022 . . . . 0.0 110.524 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.3 mm -134.06 132.12 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.911 1.684 . . . . 0.0 109.722 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.19 -159.71 32.9 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.025 -1.672 . . . . 0.0 116.294 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -158.37 145.1 17.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.94 2.496 . . . . 0.0 110.116 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -152.44 169.97 8.76 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.523 1.129 . . . . 0.0 113.002 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.79 -29.11 35.91 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.818 3.012 . . . . 0.0 113.664 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -152.76 162.87 40.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.36 1.552 . . . . 0.0 113.005 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.56 -27.34 69.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.425 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.08 70.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.434 0.694 . . . . 0.0 112.209 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -39.27 70.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.525 0.678 . . . . 0.0 111.864 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.9 -40.75 96.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.974 2.11 . . . . 0.0 112.385 170.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.48 -34.53 78.49 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.024 1.33 . . . . 0.0 112.366 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.27 80.0 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.233 -0.917 . . . . 0.0 112.436 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -65.26 -42.34 93.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.737 0.815 . . . . 0.0 111.288 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.6 ptp -74.82 -27.85 60.46 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -68.47 -40.0 81.17 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.41 -34.15 76.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.089 0.956 . . . . 0.0 112.795 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.66 -28.66 26.26 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -64.45 -28.93 70.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.864 1.266 . . . . 0.0 112.363 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -28.38 28.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.796 2.141 . . . . 0.0 115.393 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 tp -137.76 16.55 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.551 1.14 . . . . 0.0 113.274 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tt -58.59 137.13 57.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 111.403 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.46 147.17 32.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.738 1.615 . . . . 0.0 111.377 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.51 104.53 0.65 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.704 2.936 . . . . 0.0 112.283 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.58 -11.15 7.12 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.499 2.0 . . . . 0.0 113.727 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -69.32 113.08 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 118.358 1.079 . . . . 0.0 110.499 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -72.14 154.05 41.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.445 1.498 . . . . 0.0 112.371 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 t -137.09 131.02 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.285 1.434 . . . . 0.0 109.767 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.4 mt -129.55 141.84 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.186 1.794 . . . . 0.0 109.309 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.76 138.19 44.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.936 1.294 . . . . 0.0 113.043 -171.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.2 17.69 2.43 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.586 1.955 . . . . 0.0 112.672 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.39 124.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.946 -1.096 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -84.31 167.2 16.79 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.839 2.456 . . . . 0.0 113.102 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -133.11 125.04 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.193 1.397 . . . . 0.0 111.342 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -153.96 127.19 4.21 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.545 1.938 . . . . 0.0 110.742 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.34 -7.38 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.618 2.212 . . . . 0.0 114.723 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 p -70.3 -11.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.683 1.129 . . . . 0.0 113.742 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.89 147.34 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.323 1.849 . . . . 0.0 111.373 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -142.86 152.48 42.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.278 1.831 . . . . 0.0 110.687 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -145.32 177.9 8.48 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -175.79 0.26 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.02 2.528 . . . . 0.0 110.603 164.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -134.78 107.45 7.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.703 1.201 . . . . 0.0 111.743 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -69.01 -1.82 8.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 m -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 171.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.6 m -85.62 -12.09 52.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.179 1.792 . . . . 0.0 113.926 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -88.97 0.85 56.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.975 1.71 . . . . 0.0 114.125 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -45.54 -47.57 36.98 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 120.998 -1.063 . . . . 0.0 113.378 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.4 -22.76 38.86 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.364 2.043 . . . . 0.0 114.127 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -44.98 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.292 0.951 . . . . 0.0 110.474 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.73 -32.15 69.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.9 m -57.89 -42.01 83.74 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.084 0.856 . . . . 0.0 111.488 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.84 66.1 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.4 p -116.61 6.13 13.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.589 1.955 . . . . 0.0 116.165 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.2 t -52.28 -42.17 85.34 Favored Pre-proline 0 N--CA 1.482 1.172 0 O-C-N 120.185 -1.572 . . . . 0.0 113.58 167.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.86 12.49 1.95 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.672 2.248 . . . . 0.0 114.353 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 mt -113.96 97.74 45.81 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.264 1.826 . . . . 0.0 109.956 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.98 -23.48 21.79 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.906 2.404 . . . . 0.0 114.885 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.13 6.72 43.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.363 1.865 . . . . 0.0 113.653 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -52.42 152.1 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.959 1.304 . . . . 0.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.15 163.31 35.91 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.872 1.225 . . . . 0.0 111.769 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -140.75 149.6 42.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.269 1.028 . . . . 0.0 109.355 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 153.3 48.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.702 1.601 . . . . 0.0 110.868 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -143.52 133.73 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.101 1.36 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.12 146.09 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 112.484 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 51.36 -71.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 129.304 3.041 . . . . 0.0 117.997 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -144.95 21.0 1.61 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.37 1.868 . . . . 0.0 113.694 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -136.53 140.97 43.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.772 1.629 . . . . 0.0 111.139 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.23 131.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.829 2.052 . . . . 0.0 107.977 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.3 m -122.56 132.17 54.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.972 1.309 . . . . 0.0 110.128 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.64 123.77 36.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.312 1.445 . . . . 0.0 109.169 -173.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.0 t -135.23 152.34 51.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.687 1.195 . . . . 0.0 112.129 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 159.42 -178.41 35.56 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.78 -1.2 . . . . 0.0 114.046 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.3 p -120.7 84.65 2.26 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.598 2.359 . . . . 0.0 111.869 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.6 149.7 81.29 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.79 -30.36 27.34 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.558 2.838 . . . . 0.0 113.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t -152.21 164.5 37.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.64 1.176 . . . . 0.0 112.092 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -61.52 -21.61 64.39 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.616 1.166 . . . . 0.0 113.845 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -64.85 -40.28 94.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.222 1.009 . . . . 0.0 111.38 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -65.91 -39.95 91.03 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.015 -0.428 . . . . 0.0 111.958 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.74 -42.83 94.02 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.002 0.819 . . . . 0.0 112.585 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.78 -41.26 87.98 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 112.713 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.54 81.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.525 0.73 . . . . 0.0 112.424 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.33 -38.39 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.075 0.852 . . . . 0.0 110.553 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -61.45 -45.16 95.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.192 0.597 . . . . 0.0 111.293 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -61.94 -42.9 99.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.469 0.708 . . . . 0.0 112.204 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.03 92.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.663 0.385 . . . . 0.0 111.373 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.56 78.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.22 0.608 . . . . 0.0 112.371 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.8 m -67.85 -38.62 83.37 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.703 0.801 . . . . 0.0 111.734 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -35.95 74.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.66 -36.91 50.92 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.145 0.978 . . . . 0.0 112.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -135.74 64.27 56.24 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.615 1.566 . . . . 0.0 113.307 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.16 -3.92 14.5 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.449 2.766 . . . . 0.0 114.316 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.28 20.09 6.85 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.678 1.991 . . . . 0.0 113.062 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.3 mtt -135.7 163.5 30.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.775 1.63 . . . . 0.0 110.805 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -70.79 143.07 51.28 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.608 -0.683 . . . . 0.0 109.643 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 pt -137.41 86.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.72 1.608 . . . . 0.0 111.694 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.8 t -82.56 92.55 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.201 1.4 . . . . 0.0 110.687 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.76 68.92 4.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.599 1.56 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -68.03 -5.68 18.65 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.24 1.816 . . . . 0.0 114.542 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -42.21 137.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.832 2.053 . . . . 0.0 111.701 171.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 124.884 1.274 . . . . 0.0 110.955 172.601 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 CA--C 1.551 1.003 0 CA-C-O 122.048 0.928 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 m -41.23 164.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.872 3.269 . . . . 0.0 115.251 168.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.73 139.89 52.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.712 1.605 . . . . 0.0 112.381 166.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 tt -159.92 154.76 24.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.338 1.455 . . . . 0.0 111.784 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -139.42 150.31 45.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.556 1.942 . . . . 0.0 111.705 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -142.43 138.76 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.819 1.648 . . . . 0.0 108.885 171.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -145.88 142.73 29.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -107.0 148.99 28.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.125 1.77 . . . . 0.0 112.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.7 t -141.09 99.19 3.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.713 1.605 . . . . 0.0 110.943 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.77 -96.8 0.1 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.311 1.91 . . . . 0.0 113.619 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -120.58 34.95 5.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.15 1.78 . . . . 0.0 112.234 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -141.39 137.35 32.22 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.861 2.065 . . . . 0.0 108.89 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.83 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.256 1.022 . . . . 0.0 111.541 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.3 m -125.97 129.43 49.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.515 1.126 . . . . 0.0 111.165 -171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.31 126.93 55.93 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.508 1.923 . . . . 0.0 110.1 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.1 mt -139.61 127.43 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.075 1.35 . . . . 0.0 109.257 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.48 -155.89 26.43 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.618 -1.301 . . . . 0.0 115.242 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.22 150.32 25.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.345 1.858 . . . . 0.0 112.289 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -152.34 170.12 8.52 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.323 1.849 . . . . 0.0 112.309 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.62 -31.8 32.3 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.382 3.388 . . . . 0.0 113.805 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.55 164.76 38.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 123.255 1.502 . . . . 0.0 112.813 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -60.57 -32.0 71.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.769 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 112.149 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -37.86 67.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.157 0.583 . . . . 0.0 111.992 172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -67.53 -34.81 77.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.69 1.196 . . . . 0.0 112.838 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.26 74.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.406 1.082 . . . . 0.0 111.632 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.32 80.71 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.623 -0.673 . . . . 0.0 112.809 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.66 -42.77 98.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.816 0.847 . . . . 0.0 111.458 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 28.8 ptm -73.39 -30.93 63.6 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.763 -0.586 . . . . 0.0 112.34 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.9 m -66.65 -40.34 88.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.086 0.954 . . . . 0.0 111.158 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.29 -31.91 72.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.313 1.045 . . . . 0.0 113.121 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.6 -25.34 21.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.58 -32.23 70.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.876 1.27 . . . . 0.0 112.246 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.14 -27.85 57.91 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.747 1.641 . . . . 0.0 115.117 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 14.41 6.08 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.502 1.521 . . . . 0.0 112.552 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.2 129.02 38.44 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.122 0.969 . . . . 0.0 111.383 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.83 41.42 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.555 1.542 . . . . 0.0 111.505 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.48 104.15 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.353 2.702 . . . . 0.0 112.97 -172.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.87 -9.09 9.83 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.78 2.133 . . . . 0.0 113.678 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.9 t -71.28 110.44 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 118.312 1.056 . . . . 0.0 111.799 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.23 156.42 39.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.381 1.873 . . . . 0.0 112.363 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.75 134.72 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.146 1.379 . . . . 0.0 109.623 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.84 140.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.253 1.821 . . . . 0.0 108.765 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.04 131.57 49.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.104 1.362 . . . . 0.0 112.163 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -140.35 24.95 2.27 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.279 2.231 . . . . 0.0 112.058 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.3 mp -82.49 129.83 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.766 1.226 . . . . 0.0 111.022 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -92.84 169.63 10.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.178 1.391 . . . . 0.0 113.46 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.89 119.49 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.751 1.621 . . . . 0.0 110.694 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.25 126.24 5.07 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.596 2.358 . . . . 0.0 110.034 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.7 -4.2 14.19 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.321 2.681 . . . . 0.0 114.473 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.6 t -71.0 -13.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.398 1.879 . . . . 0.0 112.732 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.64 153.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.926 2.09 . . . . 0.0 110.555 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -146.71 143.84 29.01 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.32 1.848 . . . . 0.0 108.424 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 m -128.16 171.17 12.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.137 1.335 . . . . 0.0 114.476 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.61 176.01 4.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.131 1.772 . . . . 0.0 109.697 165.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -118.38 102.68 9.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.946 0.898 . . . . 0.0 112.295 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -69.77 -2.98 13.51 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.8 m -54.61 -33.89 61.15 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.901 -1.125 . . . . 0.0 112.492 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.6 m -96.32 1.8 52.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 113.676 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -91.44 -5.71 53.91 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.891 1.676 . . . . 0.0 113.455 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -45.91 -48.22 40.88 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.04 1.336 . . . . 0.0 113.006 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.56 -24.78 41.58 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.9 1.733 . . . . 0.0 113.862 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.35 -44.0 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.223 0.92 . . . . 0.0 110.407 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.23 -35.55 78.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.211 0.604 . . . . 0.0 112.214 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.9 m -59.71 -42.61 93.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.838 0.855 . . . . 0.0 111.554 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.23 -17.52 64.79 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 m -104.62 1.94 30.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.314 2.246 . . . . 0.0 114.884 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.31 -44.53 93.69 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-O 117.388 -1.291 . . . . 0.0 114.161 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.81 14.37 2.35 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.725 2.283 . . . . 0.0 114.193 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.3 93.78 23.84 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 109.761 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.53 -21.06 26.37 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.844 3.029 . . . . 0.0 116.657 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -107.4 13.0 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.079 1.752 . . . . 0.0 113.067 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.06 148.13 8.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 113.116 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.9 161.76 33.06 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 124.624 1.107 . . . . 0.0 111.58 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 tp -134.09 146.55 50.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.494 1.118 . . . . 0.0 109.114 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -135.73 151.6 50.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.986 0.915 . . . . 0.0 110.748 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -143.19 132.25 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.884 1.274 . . . . 0.0 109.05 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.23 155.08 28.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 167.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 41.39 -86.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.156 2.583 . . . . 0.0 114.991 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -140.64 29.54 1.93 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.907 1.23 . . . . 0.0 112.564 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.0 m -137.86 142.08 40.72 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.871 2.068 . . . . 0.0 110.67 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.64 142.91 31.27 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 125.527 1.531 . . . . 0.0 111.378 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 m -125.58 139.78 53.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.701 1.6 . . . . 0.0 110.163 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 mp -132.64 130.81 40.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.952 1.301 . . . . 0.0 110.405 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 27.4 m -138.05 151.08 47.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.654 1.182 . . . . 0.0 110.931 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.49 -174.4 39.71 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 120.542 -1.349 . . . . 0.0 115.883 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.2 p -128.11 80.07 1.94 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.879 2.472 . . . . 0.0 111.816 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.46 83.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -170.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.03 -29.12 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 113.976 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.2 t -150.25 155.9 40.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.622 1.969 . . . . 0.0 110.575 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.3 p -56.67 -24.7 50.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.326 1.45 . . . . 0.0 113.303 168.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.44 -45.92 92.25 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.317 . . . . 0.0 111.724 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.189 0.595 . . . . 0.0 112.172 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -63.25 -42.19 99.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.134 0.879 . . . . 0.0 112.444 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.18 -39.7 86.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.863 0.865 . . . . 0.0 112.153 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.44 93.77 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.977 -0.452 . . . . 0.0 112.162 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 72.9 t -67.91 -42.05 85.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 122.779 0.432 . . . . 0.0 111.094 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.711 0.687 . . . . 0.0 111.882 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -68.96 -39.82 79.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.053 0.941 . . . . 0.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.82 -43.18 99.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.572 0.349 . . . . 0.0 111.385 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.015 0.526 . . . . 0.0 112.195 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.4 m -64.97 -38.82 92.22 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.716 -0.615 . . . . 0.0 111.971 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.0 m -67.58 -36.09 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.401 0.68 . . . . 0.0 112.763 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 51.6 m -74.37 -38.2 63.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.354 1.062 . . . . 0.0 112.245 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.35 62.69 64.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.621 1.568 . . . . 0.0 113.536 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.0 -14.16 34.99 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.436 2.757 . . . . 0.0 114.1 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -95.16 5.88 50.58 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.208 1.803 . . . . 0.0 113.195 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.3 mtt -128.62 152.43 48.36 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.634 1.573 . . . . 0.0 111.824 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.92 146.64 45.96 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.216 0.606 . . . . 0.0 110.071 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.0 143.08 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.551 1.14 . . . . 0.0 109.693 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.59 93.38 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.783 1.233 . . . . 0.0 109.982 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -80.76 130.82 35.28 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.286 0.565 . . . . 0.0 111.488 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.92 3.89 3.78 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.731 2.412 . . . . 0.0 111.956 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.32 139.59 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.137 1.375 . . . . 0.0 109.748 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 111.356 173.57 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -42.54 165.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.936 2.894 . . . . 0.0 113.571 165.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.04 151.92 39.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 114.958 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mp -146.0 157.12 43.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 111.449 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 t -148.6 127.24 12.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.899 1.68 . . . . 0.0 110.0 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.0 139.42 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.686 1.594 . . . . 0.0 108.694 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -143.87 145.13 32.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.996 0.918 . . . . 0.0 112.522 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -109.81 149.11 30.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.649 1.579 . . . . 0.0 111.769 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -135.81 58.47 1.75 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.101 2.16 . . . . 0.0 111.443 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.75 -88.62 1.24 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.628 1.108 . . . . 0.0 113.231 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -119.46 30.41 7.11 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.703 1.601 . . . . 0.0 112.465 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -140.76 137.6 33.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.37 2.268 . . . . 0.0 108.021 167.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.1 142.31 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 0.0 111.312 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.2 m -127.85 128.8 45.86 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.645 1.178 . . . . 0.0 110.436 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.69 120.39 36.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.889 1.675 . . . . 0.0 109.266 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mm -119.14 144.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.375 1.87 . . . . 0.0 107.55 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.99 -153.87 23.0 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -162.22 143.64 10.68 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.204 2.201 . . . . 0.0 111.321 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -156.79 171.76 7.01 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.065 1.346 . . . . 0.0 113.004 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.18 -29.44 14.41 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.316 3.344 . . . . 0.0 113.645 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -156.34 166.48 33.3 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 123.392 1.568 . . . . 0.0 114.11 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.11 -32.16 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.721 1.608 . . . . 0.0 112.709 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.98 72.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.419 0.687 . . . . 0.0 111.903 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.44 67.54 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -39.38 94.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.218 1.407 . . . . 0.0 111.849 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.78 87.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 112.357 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.13 82.26 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.554 -0.716 . . . . 0.0 112.443 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.49 -39.79 81.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.157 0.983 . . . . 0.0 111.564 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -72.23 -33.58 67.67 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.226 -0.922 . . . . 0.0 112.341 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.6 m -63.5 -41.75 98.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.563 0.745 . . . . 0.0 111.149 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.82 78.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.144 0.978 . . . . 0.0 113.343 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.14 -43.52 61.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 111.836 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.65 -25.86 68.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 112.715 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.1 17.46 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.58 2.038 . . . . 0.0 114.409 172.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 7.24 3.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.479 1.112 . . . . 0.0 113.753 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.49 125.63 22.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.174 0.99 . . . . 0.0 110.815 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.4 148.97 40.15 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.022 1.329 . . . . 0.0 111.436 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.04 102.2 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.63 2.887 . . . . 0.0 112.443 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.86 -10.3 7.08 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.741 2.115 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.93 110.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.416 1.108 . . . . 0.0 110.734 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.49 152.48 45.33 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.515 1.526 . . . . 0.0 112.24 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.91 138.33 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.923 1.289 . . . . 0.0 111.993 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 87.1 mt -133.33 140.17 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.186 1.794 . . . . 0.0 108.781 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.31 134.31 41.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.26 1.424 . . . . 0.0 112.568 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -141.61 26.72 1.91 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.427 1.891 . . . . 0.0 113.16 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.76 130.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.596 -1.315 . . . . 0.0 111.154 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -82.4 160.66 22.72 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.028 1.731 . . . . 0.0 112.257 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.93 121.54 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 111.169 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.19 129.22 4.66 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.804 1.641 . . . . 0.0 110.656 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.07 -6.44 19.11 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.378 2.719 . . . . 0.0 114.823 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.84 -10.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.937 1.695 . . . . 0.0 112.603 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.1 144.49 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 128.595 2.758 . . . . 0.0 109.95 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -143.5 155.11 44.25 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.97 2.108 . . . . 0.0 109.548 -170.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -139.5 178.86 6.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.86 169.98 14.65 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.568 1.947 . . . . 0.0 110.177 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.26 158.93 15.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 112.52 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.26 2.32 11.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.559 1.544 . . . . 0.0 112.211 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 m -53.63 -32.39 51.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.163 1.385 . . . . 0.0 112.78 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.6 m -105.24 7.61 33.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.526 1.93 . . . . 0.0 113.674 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.61 56.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.482 1.513 . . . . 0.0 113.655 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -46.82 -48.81 50.42 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.71 1.204 . . . . 0.0 112.738 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 -24.87 38.73 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.888 1.725 . . . . 0.0 113.96 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.9 t -64.88 -45.29 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.329 0.968 . . . . 0.0 110.371 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -71.07 -31.3 67.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.744 0.818 . . . . 0.0 112.789 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.2 m -63.11 -42.58 99.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.907 0.776 . . . . 0.0 111.391 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.29 65.88 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.1 p -102.49 7.12 40.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.196 1.799 . . . . 0.0 115.364 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.7 t -48.62 -44.62 67.87 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.478 -1.389 . . . . 0.0 114.499 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.46 13.62 2.37 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.558 2.172 . . . . 0.0 114.226 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -113.95 92.8 27.03 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.146 1.779 . . . . 0.0 110.445 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.79 -22.78 23.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.454 2.769 . . . . 0.0 115.428 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -100.54 9.34 42.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.353 1.861 . . . . 0.0 113.342 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -52.56 149.31 6.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.023 0.916 . . . . 0.0 112.38 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 164.44 35.52 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.468 1.032 . . . . 0.0 111.772 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.53 146.84 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.68 1.192 . . . . 0.0 109.796 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -138.24 143.03 39.92 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.907 0.883 . . . . 0.0 110.002 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.76 131.96 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.904 0.882 . . . . 0.0 109.46 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.11 156.22 26.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 167.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 46.8 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 129.706 3.202 . . . . 0.0 117.813 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.89 22.98 1.1 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.468 2.307 . . . . 0.0 112.835 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.4 m -143.55 143.82 31.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.942 1.697 . . . . 0.0 112.148 -170.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.8 141.79 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 126.333 1.853 . . . . 0.0 110.53 167.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.3 m -131.17 137.57 49.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.884 1.674 . . . . 0.0 109.62 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.61 127.9 34.01 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.177 1.391 . . . . 0.0 109.23 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 91.1 m -130.69 152.18 50.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.644 1.577 . . . . 0.0 110.229 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.13 -174.66 39.45 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.753 -1.217 . . . . 0.0 114.385 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.5 p -128.17 74.91 1.58 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.105 2.162 . . . . 0.0 112.082 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.79 154.31 93.71 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 -26.36 19.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.624 2.883 . . . . 0.0 114.077 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.3 t -147.99 156.89 43.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.737 2.015 . . . . 0.0 110.423 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.3 p -54.0 -31.13 50.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.781 2.033 . . . . 0.0 112.577 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.32 -41.92 80.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 112.064 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.85 -43.35 96.42 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.098 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.91 -35.99 81.26 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.5 1.045 . . . . 0.0 112.272 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.25 -41.92 89.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.356 0.662 . . . . 0.0 112.449 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.48 91.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.735 0.814 . . . . 0.0 112.528 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.87 -42.9 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.375 0.534 . . . . 0.0 110.483 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -62.94 -41.5 99.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.88 1.272 . . . . 0.0 112.437 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -69.96 -37.65 75.86 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.215 1.006 . . . . 0.0 111.198 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.82 99.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.885 0.474 . . . . 0.0 111.385 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.46 88.16 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.58 0.627 . . . . 0.0 112.195 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.8 m -63.64 -39.91 95.53 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.745 -0.597 . . . . 0.0 112.049 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.2 m -67.63 -35.17 78.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 29.7 m -76.58 -38.62 54.6 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.051 0.94 . . . . 0.0 112.428 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -133.28 59.15 39.46 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.089 1.356 . . . . 0.0 113.428 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 -15.05 40.56 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.486 2.791 . . . . 0.0 113.85 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -92.16 0.81 57.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.839 1.655 . . . . 0.0 113.592 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 64.6 mtt -130.59 162.06 30.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.72 . . . . 0.0 112.307 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -70.72 147.34 49.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.16 131.15 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.45 1.5 . . . . 0.0 109.284 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.5 t -126.34 92.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 110.729 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.96 66.57 3.63 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.208 2.203 . . . . 0.0 113.723 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -67.24 -6.46 18.36 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.995 1.718 . . . . 0.0 114.573 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.81 142.1 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.33 1.852 . . . . 0.0 111.272 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 125.569 1.548 . . . . 0.0 110.594 171.588 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 121.553 0.692 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -43.5 157.04 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.536 2.734 . . . . 0.0 114.916 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.6 154.13 28.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.143 1.777 . . . . 0.0 113.628 166.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tp -154.73 152.02 29.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.821 1.648 . . . . 0.0 111.438 -171.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -149.99 131.38 14.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.209 1.404 . . . . 0.0 110.608 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 64.9 mt -135.71 142.86 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.375 1.47 . . . . 0.0 108.524 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.4 p -142.23 150.25 40.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.11 142.72 49.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.626 1.97 . . . . 0.0 110.255 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -141.37 66.19 1.37 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.745 . . . . 0.0 112.242 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.73 -81.18 1.27 Allowed Glycine 0 N--CA 1.477 1.37 0 O-C-N 121.223 -0.923 . . . . 0.0 114.708 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.98 32.71 5.05 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.388 173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.72 141.91 30.7 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.089 2.156 . . . . 0.0 108.967 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.68 142.82 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 111.211 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.6 m -130.2 125.24 34.45 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.982 1.313 . . . . 0.0 110.829 -171.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.71 128.48 55.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.032 1.733 . . . . 0.0 110.015 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.94 144.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.1 1.76 . . . . 0.0 108.443 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.29 -156.54 28.19 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.533 -1.354 . . . . 0.0 116.219 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -164.0 128.71 2.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.215 1.806 . . . . 0.0 112.29 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -143.51 168.02 14.03 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.707 1.603 . . . . 0.0 113.134 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -67.32 -31.81 34.27 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.095 3.197 . . . . 0.0 113.31 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.28 166.85 32.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 123.473 1.606 . . . . 0.0 113.573 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -60.82 -29.86 69.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.418 1.887 . . . . 0.0 113.489 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.27 -29.87 68.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.776 1.23 . . . . 0.0 112.199 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.72 83.16 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.63 -0.669 . . . . 0.0 111.204 173.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.129 1.372 . . . . 0.0 111.785 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.86 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.467 0.707 . . . . 0.0 112.581 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.61 76.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.29 -42.42 93.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.907 1.283 . . . . 0.0 111.543 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.7 ptm -73.11 -32.1 64.74 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.655 -0.653 . . . . 0.0 111.997 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -64.55 -38.55 91.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 111.056 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.25 -35.33 76.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.814 0.845 . . . . 0.0 112.968 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.92 -23.38 22.72 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.63 -29.62 68.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.909 1.284 . . . . 0.0 112.229 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.24 -27.14 52.0 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.813 1.673 . . . . 0.0 115.267 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 12.65 5.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.622 1.569 . . . . 0.0 112.459 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.42 125.46 23.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.729 0.811 . . . . 0.0 110.979 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.58 148.56 46.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.97 1.308 . . . . 0.0 111.079 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.31 102.49 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.496 2.798 . . . . 0.0 112.738 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.48 -8.96 8.28 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.684 2.088 . . . . 0.0 113.713 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.61 114.19 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.506 1.153 . . . . 0.0 111.006 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -69.99 153.63 42.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.783 1.633 . . . . 0.0 112.322 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.45 132.36 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.709 1.204 . . . . 0.0 110.006 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.0 148.59 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.998 1.719 . . . . 0.0 110.396 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.03 130.3 31.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.932 1.693 . . . . 0.0 111.823 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -140.75 28.92 1.93 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.603 2.361 . . . . 0.0 111.127 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.55 119.29 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.632 1.173 . . . . 0.0 109.927 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -73.85 165.51 24.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.388 1.875 . . . . 0.0 112.221 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.6 t -132.39 123.73 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.091 1.356 . . . . 0.0 111.021 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.62 120.78 2.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.468 1.907 . . . . 0.0 110.529 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.68 -6.39 18.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.655 2.237 . . . . 0.0 115.0 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.23 -12.9 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.007 0.923 . . . . 0.0 112.206 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.08 149.01 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.709 1.603 . . . . 0.0 110.52 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -145.21 145.74 31.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.288 1.835 . . . . 0.0 109.153 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -133.42 -179.61 5.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.457 ' H ' ' CD1' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -68.01 -176.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 130.162 3.385 . . . . 0.0 110.866 170.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -123.95 95.11 4.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 112.795 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -73.18 2.31 7.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.9 m -56.46 -36.0 68.56 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.627 -1.296 . . . . 0.0 112.183 172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.8 m -89.5 -2.51 58.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.808 1.643 . . . . 0.0 113.762 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.52 -6.68 52.91 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.511 1.124 . . . . 0.0 113.294 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.72 -48.63 76.49 Favored Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 120.767 -1.208 . . . . 0.0 113.49 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.44 -28.43 32.48 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.584 2.189 . . . . 0.0 114.026 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.26 -46.23 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 0.855 . . . . 0.0 110.753 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.34 -30.57 63.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.578 0.751 . . . . 0.0 112.336 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.6 m -61.17 -44.54 97.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 111.305 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.65 -17.63 64.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 92.2 p -107.75 7.02 28.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 115.286 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -52.42 -47.4 93.31 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 167.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.07 12.46 1.23 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.807 2.338 . . . . 0.0 114.279 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.9 mt -110.59 96.55 28.36 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.746 2.019 . . . . 0.0 109.131 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 -19.54 28.36 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.978 2.452 . . . . 0.0 114.594 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -109.26 11.07 25.56 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.806 2.042 . . . . 0.0 113.843 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.92 155.04 1.91 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.899 1.28 . . . . 0.0 112.983 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.54 164.27 36.15 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.328 0.96 . . . . 0.0 112.196 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.08 145.45 49.37 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.517 1.127 . . . . 0.0 109.317 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -141.32 134.74 29.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.73 0.812 . . . . 0.0 109.924 173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.73 136.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.111 0.564 . . . . 0.0 109.997 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.98 150.45 25.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.787 0.435 . . . . 0.0 112.144 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 39.35 -101.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.569 1.948 . . . . 0.0 112.97 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -117.91 21.31 12.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.489 1.515 . . . . 0.0 112.99 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.2 m -135.61 137.23 41.7 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.086 1.754 . . . . 0.0 112.379 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.4 141.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 126.142 1.777 . . . . 0.0 111.682 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 88.0 m -131.42 136.98 48.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.933 1.693 . . . . 0.0 110.218 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -130.04 133.12 46.52 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.003 1.721 . . . . 0.0 109.471 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 31.7 m -138.88 148.32 43.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.915 1.286 . . . . 0.0 110.753 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.21 -172.0 37.36 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.523 -1.361 . . . . 0.0 114.885 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -121.41 89.02 3.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.531 2.732 . . . . 0.0 111.998 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.02 53.94 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 120.695 -1.253 . . . . 0.0 113.73 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.27 -26.63 41.69 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.82 3.013 . . . . 0.0 114.226 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.5 t -147.94 157.04 43.32 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.55 1.94 . . . . 0.0 110.063 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 p -59.58 -20.87 58.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.094 0.958 . . . . 0.0 112.907 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.25 -47.55 83.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.756 1.223 . . . . 0.0 111.775 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -58.37 -42.2 86.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.187 0.595 . . . . 0.0 111.867 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -45.26 94.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.839 0.745 . . . . 0.0 112.203 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -66.21 -39.29 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.267 1.027 . . . . 0.0 111.983 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.75 89.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.703 0.801 . . . . 0.0 112.694 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.96 -38.64 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.702 -0.624 . . . . 0.0 110.914 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.668 0.787 . . . . 0.0 111.716 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -63.6 -40.09 96.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.584 0.754 . . . . 0.0 111.848 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.89 97.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.813 0.445 . . . . 0.0 111.376 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.64 -37.64 88.11 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.675 -0.64 . . . . 0.0 112.119 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.6 m -63.27 -41.29 99.01 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.623 -0.673 . . . . 0.0 111.751 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -65.82 -35.94 82.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.4 -36.91 52.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.077 0.951 . . . . 0.0 112.685 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -133.39 61.13 52.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.411 1.484 . . . . 0.0 113.635 -172.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.26 -9.58 25.65 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.687 2.925 . . . . 0.0 114.338 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -114.47 9.72 16.8 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.63 1.972 . . . . 0.0 113.601 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.6 mtm -126.17 161.13 28.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.437 1.895 . . . . 0.0 111.247 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -71.2 146.49 49.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.833 0.853 . . . . 0.0 110.036 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.6 pt -130.71 143.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.115 0.966 . . . . 0.0 111.381 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.0 t -135.68 121.87 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.596 1.158 . . . . 0.0 110.483 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -112.27 70.43 0.71 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.43 1.892 . . . . 0.0 111.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.1 -5.61 42.67 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.545 1.538 . . . . 0.0 114.336 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 68.8 mt -51.28 140.16 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.087 1.755 . . . . 0.0 111.257 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.727 1.611 . . . . 0.0 110.63 172.155 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.699 0.761 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -39.44 154.39 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 129.896 3.278 . . . . 0.0 117.179 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.12 135.42 39.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.676 1.591 . . . . 0.0 111.105 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.09 146.82 23.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.091 1.356 . . . . 0.0 110.817 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -142.75 142.96 32.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.084 1.753 . . . . 0.0 110.809 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -142.6 136.66 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.989 1.316 . . . . 0.0 109.445 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -138.86 145.76 40.38 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.937 0.895 . . . . 0.0 112.02 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -108.53 150.49 27.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.011 1.324 . . . . 0.0 112.84 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.0 m -137.78 59.77 1.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.694 2.398 . . . . 0.0 111.99 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.03 -92.84 1.05 Allowed Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.018 1.294 . . . . 0.0 112.856 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -113.08 29.85 7.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.814 1.645 . . . . 0.0 112.327 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.32 140.49 30.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.466 2.307 . . . . 0.0 108.44 170.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.01 144.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.696 1.198 . . . . 0.0 111.131 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.7 m -129.56 128.13 42.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.384 1.074 . . . . 0.0 111.607 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.14 126.93 55.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.787 2.035 . . . . 0.0 110.525 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.5 mt -138.16 125.66 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.32 1.448 . . . . 0.0 109.137 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.65 -156.75 25.64 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 120.859 -1.151 . . . . 0.0 115.144 -171.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -159.45 146.27 16.69 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.882 2.073 . . . . 0.0 111.355 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -151.86 170.2 8.3 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.965 1.706 . . . . 0.0 111.586 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.31 -31.83 42.75 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.265 3.31 . . . . 0.0 113.537 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.47 165.65 35.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.617 1.675 . . . . 0.0 113.123 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.79 -25.77 68.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.728 2.011 . . . . 0.0 113.958 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.19 63.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.96 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -37.65 67.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.196 0.598 . . . . 0.0 111.836 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -26.54 60.52 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 172.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.5 75.65 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.439 -0.788 . . . . 0.0 112.301 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.0 85.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.914 -1.116 . . . . 0.0 112.282 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.76 -42.57 99.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -30.95 62.45 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.496 -0.752 . . . . 0.0 112.434 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.4 m -65.1 -38.44 90.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.81 1.244 . . . . 0.0 111.308 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.82 72.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.799 1.24 . . . . 0.0 113.182 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.29 -25.23 20.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.46 -30.99 70.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.978 1.311 . . . . 0.0 112.37 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.72 -27.15 55.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.601 1.572 . . . . 0.0 115.254 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 10.4 6.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.793 1.637 . . . . 0.0 112.453 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.59 130.45 46.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.451 1.101 . . . . 0.0 111.372 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.2 147.27 39.98 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.245 1.418 . . . . 0.0 111.108 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.88 102.92 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.593 2.862 . . . . 0.0 112.562 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.04 -10.28 7.43 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.838 2.161 . . . . 0.0 113.793 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.92 115.33 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.339 1.069 . . . . 0.0 110.896 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -73.81 155.02 39.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.009 1.724 . . . . 0.0 112.563 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -135.44 132.92 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.847 1.259 . . . . 0.0 109.851 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.2 mt -126.45 138.36 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.406 1.882 . . . . 0.0 108.855 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.63 132.43 37.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.745 1.218 . . . . 0.0 112.824 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -136.75 18.82 3.06 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.428 2.291 . . . . 0.0 112.315 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.82 132.89 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.689 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -94.49 169.82 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.65 1.58 . . . . 0.0 113.248 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.54 118.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.777 1.631 . . . . 0.0 110.774 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -149.3 123.06 4.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.107 2.163 . . . . 0.0 110.419 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.58 -5.06 15.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.023 2.482 . . . . 0.0 114.544 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.24 -13.28 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.209 1.804 . . . . 0.0 112.468 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.72 149.42 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.091 2.157 . . . . 0.0 109.71 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.38 152.58 48.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.038 2.135 . . . . 0.0 106.495 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.0 m -132.74 175.46 9.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.264 1.393 . . . . 0.0 114.256 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.98 158.18 33.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.692 1.597 . . . . 0.0 109.583 166.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.4 148.12 28.4 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.015 165.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.33 0.26 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.713 1.205 . . . . 0.0 113.052 171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -55.28 -37.86 67.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.205 1.002 . . . . 0.0 111.798 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -92.04 3.08 56.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.066 1.747 . . . . 0.0 113.848 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.72 -3.79 51.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.775 1.63 . . . . 0.0 113.687 172.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.07 -49.16 30.8 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.464 1.105 . . . . 0.0 112.39 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.59 -24.83 55.34 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.75 1.633 . . . . 0.0 113.692 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.6 t -66.2 -46.1 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.131 0.878 . . . . 0.0 110.687 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -73.87 -30.07 62.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.485 0.714 . . . . 0.0 112.57 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.8 m -66.77 -39.73 87.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.074 0.95 . . . . 0.0 111.541 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.17 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.8 p -101.13 7.88 43.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.364 1.866 . . . . 0.0 115.191 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.4 t -47.52 -44.97 56.7 Favored Pre-proline 0 N--CA 1.485 1.312 0 O-C-N 120.391 -1.443 . . . . 0.0 114.554 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.8 13.97 2.18 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.447 2.098 . . . . 0.0 114.089 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.39 91.97 35.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.171 1.788 . . . . 0.0 110.583 -171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.07 -17.8 31.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.864 3.042 . . . . 0.0 115.879 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.97 16.08 16.16 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.743 2.417 . . . . 0.0 112.519 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -53.94 153.7 4.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.474 1.109 . . . . 0.0 112.74 168.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.17 161.28 33.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.135 1.35 . . . . 0.0 111.672 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tp -131.45 146.3 52.19 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.037 1.335 . . . . 0.0 109.235 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.75 147.62 42.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.126 0.97 . . . . 0.0 110.822 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.78 133.02 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.666 1.186 . . . . 0.0 109.744 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.24 152.8 24.66 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 167.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 42.15 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.585 3.154 . . . . 0.0 117.253 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -141.86 20.54 2.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.602 1.961 . . . . 0.0 113.022 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.6 m -138.3 140.97 39.81 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.029 1.332 . . . . 0.0 112.555 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.55 131.96 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.418 1.887 . . . . 0.0 111.084 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.6 m -123.94 137.74 54.58 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.679 1.592 . . . . 0.0 110.058 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.65 126.57 29.41 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.616 1.166 . . . . 0.0 110.663 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 98.8 m -132.07 150.86 52.05 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.344 1.457 . . . . 0.0 110.455 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.38 -175.13 39.68 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.79 -1.194 . . . . 0.0 114.183 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.0 p -130.13 81.02 1.99 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.208 1.803 . . . . 0.0 112.071 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.9 153.24 95.63 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.231 1.412 . . . . 0.0 114.293 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.99 -34.63 37.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.093 2.529 . . . . 0.0 113.168 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.7 m -144.47 156.02 43.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.65 1.98 . . . . 0.0 110.644 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 p -62.55 -22.86 66.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.222 1.009 . . . . 0.0 113.633 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -63.95 -42.87 97.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.617 1.167 . . . . 0.0 111.462 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -62.97 -40.9 99.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.451 0.569 . . . . 0.0 111.782 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.6 -46.82 87.82 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.474 0.579 . . . . 0.0 112.214 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.76 -37.66 85.05 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.371 0.668 . . . . 0.0 111.944 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.02 89.33 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.624 0.769 . . . . 0.0 112.573 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.03 -42.63 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.737 0.699 . . . . 0.0 110.655 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -42.07 99.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 112.316 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -72.65 -32.76 66.11 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.91 -47.2 78.6 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.22 93.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 t -72.38 -30.09 64.36 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.635 -0.666 . . . . 0.0 112.168 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.3 m -70.06 -38.98 75.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.138 0.975 . . . . 0.0 112.591 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 39.4 m -71.59 -39.33 70.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.684 1.194 . . . . 0.0 112.311 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -129.85 60.5 52.19 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.448 1.499 . . . . 0.0 113.732 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.39 -14.94 34.61 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.435 2.757 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.46 -1.85 58.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.7 1.6 . . . . 0.0 113.892 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -126.12 160.03 31.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 112.071 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -70.49 151.1 45.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.956 0.902 . . . . 0.0 110.406 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.87 135.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.027 0.931 . . . . 0.0 111.526 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 37.0 t -130.59 87.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.408 1.483 . . . . 0.0 109.825 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -72.97 130.89 41.37 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.902 . . . . 0.0 110.93 171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -137.0 0.15 2.35 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.494 2.318 . . . . 0.0 111.929 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.15 142.7 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.259 1.823 . . . . 0.0 110.073 171.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 125.821 1.648 . . . . 0.0 110.557 172.383 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 121.857 0.837 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -37.38 161.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.353 3.061 . . . . 0.0 114.867 167.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.39 146.5 47.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.855 1.662 . . . . 0.0 114.077 167.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 tt -157.15 155.82 31.64 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.823 1.249 . . . . 0.0 112.195 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 t -139.26 140.01 37.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.93 2.092 . . . . 0.0 110.284 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.25 133.9 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.283 1.433 . . . . 0.0 108.864 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 t -143.29 142.25 31.28 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.251 0.62 . . . . 0.0 112.196 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.34 148.47 28.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.305 1.442 . . . . 0.0 110.897 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -143.7 66.04 1.3 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.541 1.536 . . . . 0.0 112.526 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -90.07 1.46 Allowed Glycine 0 N--CA 1.472 1.07 0 C-N-CA 124.308 0.956 . . . . 0.0 113.106 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -122.22 35.94 4.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.985 1.714 . . . . 0.0 111.729 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.4 m -145.0 145.73 31.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.93 2.492 . . . . 0.0 108.183 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 p -134.75 144.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.814 1.246 . . . . 0.0 110.987 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.4 m -128.78 132.78 47.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.422 1.089 . . . . 0.0 111.739 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 117.8 29.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.566 2.346 . . . . 0.0 109.637 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.37 120.33 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.604 1.162 . . . . 0.0 109.053 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.02 -154.02 17.18 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -170.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -153.27 145.92 24.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.515 2.326 . . . . 0.0 112.651 -170.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -155.94 171.43 7.32 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.641 1.576 . . . . 0.0 112.85 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.47 -30.61 23.35 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.327 3.351 . . . . 0.0 113.705 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -155.49 166.74 32.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.287 1.518 . . . . 0.0 113.16 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.62 -28.91 70.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.927 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.06 75.01 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.63 -37.73 67.93 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.365 0.666 . . . . 0.0 112.427 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -60.11 -45.88 91.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.631 1.172 . . . . 0.0 111.314 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.77 77.88 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.986 1.314 . . . . 0.0 111.956 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.48 92.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.14 -39.66 86.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 111.227 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 78.1 mmm -65.94 -41.55 91.18 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.548 0.739 . . . . 0.0 111.639 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.8 m -61.72 -40.48 95.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.343 1.057 . . . . 0.0 110.857 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.96 -31.44 72.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.686 1.194 . . . . 0.0 113.606 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -93.33 -22.39 18.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.7 -30.46 61.56 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.666 1.587 . . . . 0.0 112.367 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.83 -28.28 52.24 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.686 1.612 . . . . 0.0 114.986 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 9.54 6.44 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.81 1.644 . . . . 0.0 112.768 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.3 129.99 44.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.297 1.039 . . . . 0.0 111.109 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.51 149.11 40.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.201 1.401 . . . . 0.0 111.388 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.9 102.8 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.575 2.85 . . . . 0.0 112.582 -174.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -10.38 7.34 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.795 2.14 . . . . 0.0 113.662 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.34 114.78 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 118.358 1.079 . . . . 0.0 110.889 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -71.25 157.16 38.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.982 1.713 . . . . 0.0 112.734 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.97 140.21 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.557 1.143 . . . . 0.0 112.441 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.18 139.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.745 2.018 . . . . 0.0 108.391 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.31 134.81 34.75 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.87 29.88 1.87 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.179 2.592 . . . . 0.0 111.347 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.25 123.66 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.482 -1.386 . . . . 0.0 110.746 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -90.3 162.75 15.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.931 1.292 . . . . 0.0 112.551 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.7 117.98 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.046 1.339 . . . . 0.0 110.941 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.98 117.14 4.18 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.75 2.02 . . . . 0.0 109.878 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 -5.77 17.8 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.964 2.443 . . . . 0.0 114.953 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.66 -1.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.406 1.482 . . . . 0.0 113.527 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.35 142.48 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 128.899 2.879 . . . . 0.0 109.143 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -136.73 154.78 50.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.522 2.329 . . . . 0.0 108.802 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -136.05 177.28 7.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.746 1.157 . . . . 0.0 114.052 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.26 156.99 38.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.161 . . . . 0.0 108.271 167.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.42 152.93 37.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.847 -0.533 . . . . 0.0 111.311 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -122.72 3.07 9.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.463 1.505 . . . . 0.0 111.75 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.2 m -53.5 -37.54 62.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.526 1.13 . . . . 0.0 111.876 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.4 m -96.63 6.1 49.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 113.653 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.66 -6.28 59.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.159 1.384 . . . . 0.0 113.269 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.79 -50.12 44.92 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.026 1.33 . . . . 0.0 112.648 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.51 -24.28 56.63 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 113.738 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.97 -46.97 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.453 1.024 . . . . 0.0 110.649 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -74.32 -28.88 61.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 112.587 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 m -70.25 -41.17 73.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.809 1.244 . . . . 0.0 111.694 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.25 -28.64 68.88 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.312 -0.868 . . . . 0.0 112.649 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.7 p -90.52 0.1 57.46 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -45.6 -46.71 37.14 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 120.779 1.627 . . . . 0.0 115.159 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.51 13.67 1.34 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.727 2.285 . . . . 0.0 114.154 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.12 83.76 12.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.592 1.957 . . . . 0.0 110.188 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.09 -15.86 50.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.452 2.768 . . . . 0.0 115.075 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.89 1.93 27.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.778 2.431 . . . . 0.0 114.34 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -60.07 155.28 17.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.053 -1.029 . . . . 0.0 113.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.36 169.36 37.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.874 1.702 . . . . 0.0 112.995 167.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.19 147.79 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.433 1.893 . . . . 0.0 109.387 177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -136.91 140.26 42.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 109.904 168.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.41 134.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.999 0.92 . . . . 0.0 109.782 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.66 157.67 27.53 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.677 0.791 . . . . 0.0 112.701 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 44.59 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.837 2.455 . . . . 0.0 114.082 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -144.16 33.8 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 119.77 1.168 . . . . 0.0 112.463 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.8 m -133.27 139.14 46.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.75 2.02 . . . . 0.0 111.109 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.35 128.09 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.158 1.783 . . . . 0.0 111.401 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 84.9 m -122.77 134.65 54.42 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.886 1.674 . . . . 0.0 110.03 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.21 124.72 31.2 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.784 1.234 . . . . 0.0 110.174 -171.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.5 m -137.07 123.3 20.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.986 1.314 . . . . 0.0 110.947 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.47 48.28 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.948 1.261 . . . . 0.0 112.926 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.5 p -125.08 81.21 1.94 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 0.0 112.35 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.66 153.96 92.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.2 -31.05 30.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.2 2.6 . . . . 0.0 113.536 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 p -149.27 166.58 28.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.858 1.263 . . . . 0.0 112.804 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.5 p -64.05 -25.06 67.95 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 113.604 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -66.3 -42.16 88.72 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.482 -0.762 . . . . 0.0 111.09 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.32 -41.37 98.9 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.475 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -66.57 -40.54 89.01 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.631 1.105 . . . . 0.0 111.888 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.83 -43.99 97.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.647 1.179 . . . . 0.0 112.382 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.91 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.499 0.72 . . . . 0.0 112.185 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.57 -43.3 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 118.132 0.424 . . . . 0.0 111.243 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -70.02 -36.18 74.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.806 0.73 . . . . 0.0 112.663 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.29 -39.99 81.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.247 1.019 . . . . 0.0 111.571 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.87 95.82 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.08 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.46 87.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.139 0.575 . . . . 0.0 112.395 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.5 m -66.45 -38.1 86.61 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.716 -0.615 . . . . 0.0 111.594 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.8 t -65.27 -38.54 90.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.671 0.788 . . . . 0.0 112.616 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.0 m -73.31 -39.35 65.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.22 1.008 . . . . 0.0 112.764 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -131.96 61.41 57.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.549 1.54 . . . . 0.0 113.815 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.02 -10.95 26.82 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.664 2.909 . . . . 0.0 114.731 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -104.96 -0.93 26.43 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.082 1.753 . . . . 0.0 113.73 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -108.57 160.3 16.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.914 2.086 . . . . 0.0 111.711 -172.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -73.47 147.25 44.3 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.694 -0.628 . . . . 0.0 109.908 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.6 tt -135.04 142.17 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.7 0.8 . . . . 0.0 112.274 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.62 91.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.692 1.597 . . . . 0.0 110.194 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -83.18 74.07 10.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.298 1.839 . . . . 0.0 111.413 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -72.76 -11.54 60.65 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.989 1.315 . . . . 0.0 113.459 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.2 pt -52.04 144.21 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 127.106 2.162 . . . . 0.0 114.531 172.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.936 2.094 . . . . 0.0 111.088 178.811 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 CA--C 1.552 1.029 0 CA-C-O 122.054 0.93 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 t -35.91 162.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 131.114 3.766 . . . . 0.0 114.809 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 150.16 50.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.605 1.562 . . . . 0.0 114.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 tt -160.53 156.73 26.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 111.526 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.3 p -145.22 158.32 43.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 112.653 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -141.67 142.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 108.01 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -139.18 142.69 37.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.321 0.648 . . . . 0.0 111.936 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -112.9 148.28 35.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.777 1.631 . . . . 0.0 111.376 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -134.19 56.64 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.427 2.291 . . . . 0.0 110.438 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.3 -98.82 0.67 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 126.039 1.781 . . . . 0.0 112.365 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -96.38 18.4 14.0 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.406 1.482 . . . . 0.0 113.013 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -137.51 131.87 32.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.818 1.647 . . . . 0.0 108.81 167.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.26 137.8 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.545 1.138 . . . . 0.0 111.253 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -122.66 136.96 55.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.5 1.12 . . . . 0.0 112.6 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.86 121.98 39.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.944 2.098 . . . . 0.0 109.085 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 mt -135.27 133.04 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.02 1.328 . . . . 0.0 108.173 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.96 -146.88 12.28 Favored Glycine 0 N--CA 1.465 0.624 0 O-C-N 120.338 -1.476 . . . . 0.0 115.941 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -153.16 150.77 29.4 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.094 2.557 . . . . 0.0 111.842 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -157.7 170.07 9.56 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 126.026 1.73 . . . . 0.0 110.39 166.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -71.72 -29.96 15.1 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.392 3.395 . . . . 0.0 113.696 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -159.15 166.92 30.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.384 1.564 . . . . 0.0 113.554 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.56 -32.98 70.85 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.676 1.59 . . . . 0.0 112.836 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.97 73.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.818 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.6 60.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.452 0.701 . . . . 0.0 112.339 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.28 -42.03 96.63 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 111.817 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.35 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.684 1.194 . . . . 0.0 111.552 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.04 93.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.8 -39.6 80.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.677 0.791 . . . . 0.0 111.369 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm -65.14 -41.12 95.08 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.741 -0.599 . . . . 0.0 111.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.3 m -62.95 -39.8 95.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 0.0 110.897 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.45 75.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.965 0.906 . . . . 0.0 113.386 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.88 -24.1 21.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -73.04 -29.66 63.16 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.521 1.529 . . . . 0.0 112.337 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.05 52.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.817 1.675 . . . . 0.0 115.077 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 11.1 5.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.456 1.503 . . . . 0.0 112.76 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.75 135.46 56.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.225 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.42 150.27 37.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.814 1.646 . . . . 0.0 111.337 -176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.14 106.28 0.79 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.554 2.836 . . . . 0.0 112.523 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.84 -10.83 10.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.508 2.004 . . . . 0.0 113.75 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.48 118.27 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.345 1.058 . . . . 0.0 110.858 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -75.57 151.1 37.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 112.376 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -136.76 132.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.259 1.424 . . . . 0.0 109.454 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.7 mt -126.62 139.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.736 1.614 . . . . 0.0 109.451 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -132.57 128.16 36.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.43 1.492 . . . . 0.0 111.832 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -136.63 19.97 3.1 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.264 2.225 . . . . 0.0 112.147 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.1 mt -70.87 134.21 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 112.322 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -80.68 160.33 25.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.978 2.111 . . . . 0.0 112.721 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.5 t -131.62 119.16 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.161 1.384 . . . . 0.0 110.95 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.47 110.94 2.41 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.577 1.551 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.71 -6.07 16.98 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.987 2.458 . . . . 0.0 114.812 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.14 -16.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.938 0.895 . . . . 0.0 112.266 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 m -122.59 139.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.583 2.353 . . . . 0.0 110.203 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -128.37 155.54 44.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.273 1.829 . . . . 0.0 109.068 -170.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -139.08 179.79 6.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.09 176.22 2.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.451 1.9 . . . . 0.0 111.922 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -128.93 98.71 5.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 111.054 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.18 9.16 3.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.875 1.27 . . . . 0.0 113.022 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 67.4 m -51.93 -25.09 7.39 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.787 -1.195 . . . . 0.0 113.57 167.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 m -106.94 3.28 25.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.021 2.128 . . . . 0.0 113.818 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.09 -6.11 59.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.373 1.469 . . . . 0.0 113.657 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.21 -48.75 79.23 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.644 1.178 . . . . 0.0 113.2 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -23.6 44.27 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.792 1.661 . . . . 0.0 113.474 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.41 -46.34 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.925 0.784 . . . . 0.0 110.413 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -67.7 -35.47 78.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.999 0.52 . . . . 0.0 111.997 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.0 m -60.69 -44.52 96.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.074 0.949 . . . . 0.0 111.478 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.77 -26.56 67.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.268 0.627 . . . . 0.0 112.636 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.2 m -90.44 0.14 57.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.949 2.1 . . . . 0.0 115.576 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -52.89 -49.27 87.88 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-N 120.423 1.465 . . . . 0.0 114.001 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -84.26 18.39 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.009 2.473 . . . . 0.0 113.465 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mt -110.06 80.43 1.81 Allowed Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 127.014 2.126 . . . . 0.0 107.856 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.88 -21.39 50.48 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.035 2.49 . . . . 0.0 114.557 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -94.57 6.16 49.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.62 1.968 . . . . 0.0 113.509 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -54.81 153.77 5.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.731 1.213 . . . . 0.0 113.844 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.04 164.87 38.01 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.595 1.569 . . . . 0.0 110.768 167.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.46 164.16 30.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.693 -0.886 . . . . 0.0 112.976 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -138.02 152.52 48.94 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.458 1.503 . . . . 0.0 110.374 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 t -144.77 130.24 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.179 1.392 . . . . 0.0 108.682 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 143.75 20.68 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.083 -0.386 . . . . 0.0 112.014 167.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 42.39 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.124 2.17 . . . . 0.0 114.623 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -122.12 17.0 10.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.504 1.922 . . . . 0.0 113.364 -171.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 61.1 m -138.8 144.45 39.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.272 1.829 . . . . 0.0 112.485 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.66 132.56 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.229 2.212 . . . . 0.0 109.481 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 m -122.26 136.94 54.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 110.25 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mp -136.07 127.64 28.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.319 1.047 . . . . 0.0 110.093 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.0 m -136.14 151.85 50.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.616 1.566 . . . . 0.0 110.489 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.17 -176.41 42.09 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.261 -1.524 . . . . 0.0 113.907 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.2 m -132.78 112.71 12.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.928 1.291 . . . . 0.0 110.005 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.83 159.6 29.11 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.72 2.008 . . . . 0.0 113.67 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.47 -33.24 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.455 2.77 . . . . 0.0 113.143 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 55.2 m -144.68 155.41 43.57 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.491 1.916 . . . . 0.0 111.072 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 p -57.7 -27.6 63.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 113.088 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.42 -42.29 98.73 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.988 1.315 . . . . 0.0 111.624 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -62.56 -43.19 99.43 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.949 0.5 . . . . 0.0 111.912 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -62.72 -42.13 99.5 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.4 -41.19 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.263 1.425 . . . . 0.0 112.036 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.32 89.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.418 0.687 . . . . 0.0 112.054 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.41 -41.03 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 118.298 0.499 . . . . 0.0 111.115 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.14 -42.89 99.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.442 0.697 . . . . 0.0 111.967 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -66.17 -40.43 90.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.355 1.062 . . . . 0.0 111.569 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.36 97.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.002 0.521 . . . . 0.0 111.393 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.42 90.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.066 0.546 . . . . 0.0 111.974 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.0 m -63.43 -40.17 96.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.497 -0.752 . . . . 0.0 111.849 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.2 m -66.37 -35.81 81.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 35.7 m -77.52 -34.59 53.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.03 0.932 . . . . 0.0 112.668 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -126.87 59.64 36.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 0.0 113.553 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.85 -3.65 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.329 2.686 . . . . 0.0 114.834 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.84 20.22 4.6 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.708 2.003 . . . . 0.0 112.606 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.1 ttt -141.99 149.55 40.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.851 1.66 . . . . 0.0 109.976 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -70.42 141.34 52.13 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.146 -0.971 . . . . 0.0 111.142 -171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.65 138.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.545 1.538 . . . . 0.0 110.338 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.86 79.3 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.515 1.926 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -75.34 130.87 39.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.251 -0.906 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.36 5.35 3.76 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.389 2.276 . . . . 0.0 112.173 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 27.6 mt -56.6 143.45 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.835 1.654 . . . . 0.0 110.72 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 125.898 1.679 . . . . 0.0 111.44 176.59 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 122.004 0.907 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 t -36.92 158.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.0 2.92 . . . . 0.0 115.126 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.1 147.7 43.04 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.096 1.758 . . . . 0.0 114.285 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -155.99 153.54 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.976 1.71 . . . . 0.0 111.6 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -137.61 147.68 45.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.367 1.867 . . . . 0.0 111.158 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.46 138.47 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.344 1.857 . . . . 0.0 108.792 169.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 t -147.92 139.56 23.82 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.452 -0.78 . . . . 0.0 112.067 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -109.97 148.07 32.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.4 m -134.93 60.09 1.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.631 2.372 . . . . 0.0 110.948 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.36 -91.71 1.37 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.807 1.194 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -116.74 27.71 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.876 1.67 . . . . 0.0 112.8 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -140.29 131.7 26.84 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.264 1.826 . . . . 0.0 108.61 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.6 138.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 111.226 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -119.41 143.99 47.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.323 1.049 . . . . 0.0 112.252 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.51 110.76 14.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.671 2.388 . . . . 0.0 108.924 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.0 120.32 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.266 1.426 . . . . 0.0 108.679 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.77 -152.88 21.25 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.184 -0.947 . . . . 0.0 114.223 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.78 160.15 43.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.032 2.133 . . . . 0.0 111.895 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -157.06 171.63 7.2 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 126.225 1.81 . . . . 0.0 112.227 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -65.32 -31.46 52.68 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.547 2.831 . . . . 0.0 114.09 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -157.23 168.6 26.93 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.126 1.441 . . . . 0.0 114.002 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.28 -29.06 70.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.568 1.547 . . . . 0.0 113.182 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.71 70.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.725 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.96 65.42 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -61.17 -40.96 95.83 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.172 -0.955 . . . . 0.0 111.817 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.2 78.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.144 0.978 . . . . 0.0 111.323 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.8 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.15 -46.14 82.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.721 0.691 . . . . 0.0 111.53 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.4 mmm -65.13 -39.88 93.68 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.671 0.788 . . . . 0.0 111.167 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.0 m -63.03 -41.5 99.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.062 0.945 . . . . 0.0 110.658 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.21 -29.28 68.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -92.37 -23.99 19.04 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.67 -32.09 73.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.695 1.598 . . . . 0.0 112.246 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.68 -29.4 49.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.841 1.686 . . . . 0.0 115.139 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.52 15.3 4.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.23 1.412 . . . . 0.0 112.524 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.82 127.21 31.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.68 0.792 . . . . 0.0 111.202 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.97 149.12 38.3 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.874 1.27 . . . . 0.0 111.155 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.29 103.7 0.81 Allowed 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.625 2.883 . . . . 0.0 112.602 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.64 -8.31 10.15 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.421 1.962 . . . . 0.0 113.596 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.88 112.1 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.425 1.113 . . . . 0.0 110.595 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.55 149.29 48.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.209 1.404 . . . . 0.0 111.728 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.4 t -135.51 127.72 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.007 1.323 . . . . 0.0 109.385 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.28 103.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.118 1.367 . . . . 0.0 109.036 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -85.22 123.4 30.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.271 1.028 . . . . 0.0 111.098 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.54 20.41 3.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.896 2.479 . . . . 0.0 111.03 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.27 122.85 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.154 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -80.9 168.73 18.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.204 1.802 . . . . 0.0 112.519 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.99 125.91 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 111.525 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.12 112.28 3.07 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.82 1.648 . . . . 0.0 110.305 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.62 -4.92 15.59 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.59 2.86 . . . . 0.0 114.607 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.05 -1.87 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.491 1.516 . . . . 0.0 113.477 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.77 154.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 128.257 2.623 . . . . 0.0 108.935 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.031 1.332 . . . . 0.0 108.116 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 m -141.71 171.25 14.32 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 178.5 7.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.013 2.125 . . . . 0.0 109.752 165.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.65 168.42 11.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.578 1.551 . . . . 0.0 113.769 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.37 13.78 8.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.131 2.172 . . . . 0.0 112.138 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -56.93 -30.4 63.96 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.697 -1.252 . . . . 0.0 113.384 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -102.86 1.65 34.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 0.0 113.663 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.73 -5.72 58.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.73 1.212 . . . . 0.0 113.787 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -48.78 -50.4 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 O-C-N 121.035 -1.04 . . . . 0.0 113.226 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 -24.55 41.21 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.495 2.13 . . . . 0.0 114.113 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.84 -45.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.569 1.077 . . . . 0.0 110.497 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.42 -33.53 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.223 0.609 . . . . 0.0 112.496 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.8 m -61.05 -43.12 99.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.126 0.875 . . . . 0.0 111.352 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.55 66.08 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.992 0.917 . . . . 0.0 113.448 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -106.45 7.68 31.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.573 1.949 . . . . 0.0 115.236 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.11 -44.97 88.59 Favored Pre-proline 0 N--CA 1.482 1.136 0 O-C-N 120.457 -1.402 . . . . 0.0 113.758 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.81 15.44 1.47 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.826 2.351 . . . . 0.0 113.942 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -119.41 91.6 44.52 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 126.181 1.792 . . . . 0.0 110.63 -171.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.38 -20.88 31.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.963 2.442 . . . . 0.0 114.821 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.62 1.83 46.71 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.353 1.861 . . . . 0.0 113.819 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.3 149.7 9.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.667 1.187 . . . . 0.0 113.606 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.86 162.91 34.43 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.205 1.384 . . . . 0.0 111.772 167.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.5 tt -141.5 145.04 34.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.953 1.301 . . . . 0.0 108.949 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -140.28 149.75 43.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.981 1.312 . . . . 0.0 111.578 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.71 136.41 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.006 1.322 . . . . 0.0 110.82 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.55 152.84 18.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.536 1.134 . . . . 0.0 111.579 166.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 49.06 -69.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 129.798 3.239 . . . . 0.0 117.424 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.24 15.31 0.91 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.811 2.444 . . . . 0.0 113.658 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -139.66 155.9 47.13 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.136 -1.602 . . . . 0.0 114.276 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.33 110.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.603 1.961 . . . . 0.0 110.438 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.5 m -94.91 138.85 32.12 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.184 1.394 . . . . 0.0 110.708 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.09 124.72 35.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.641 1.576 . . . . 0.0 109.037 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.3 m -129.63 145.12 51.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.893 1.677 . . . . 0.0 110.447 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.7 -172.09 42.41 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 120.764 -1.21 . . . . 0.0 113.93 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -124.74 71.52 1.17 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.298 2.239 . . . . 0.0 112.908 -171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.2 149.27 97.17 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.1 -27.07 30.03 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.652 2.901 . . . . 0.0 114.15 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.2 t -148.38 156.87 43.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.465 1.906 . . . . 0.0 110.276 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 62.0 p -58.82 -20.93 54.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.086 0.954 . . . . 0.0 113.205 167.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.91 -47.33 81.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.81 1.244 . . . . 0.0 111.747 170.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -60.2 -40.1 88.85 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.268 0.627 . . . . 0.0 112.032 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.52 -46.27 90.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 0.0 112.256 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.91 -41.67 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.468 0.707 . . . . 0.0 112.092 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.91 95.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 112.407 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.72 -41.78 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.051 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.12 -45.22 93.02 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 111.872 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -69.13 -36.42 77.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.405 0.682 . . . . 0.0 111.351 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.33 86.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.047 0.539 . . . . 0.0 112.062 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.72 94.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.789 0.722 . . . . 0.0 111.907 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 85.7 m -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.688 -0.633 . . . . 0.0 111.933 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 73.7 m -66.68 -35.56 80.44 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.4 m -75.96 -36.92 59.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 112.728 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.01 59.5 45.59 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.305 1.442 . . . . 0.0 113.013 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.64 -5.16 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.175 . . . . 0.0 115.603 -171.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.5 14.79 8.22 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.141 1.777 . . . . 0.0 112.997 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.1 mtm -133.3 164.76 26.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.617 1.967 . . . . 0.0 110.207 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -76.96 152.75 35.13 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.348 -0.845 . . . . 0.0 111.741 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.99 136.93 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.099 1.36 . . . . 0.0 109.418 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.1 t -126.1 89.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.985 1.314 . . . . 0.0 109.618 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -74.95 65.57 1.44 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.674 2.39 . . . . 0.0 112.337 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -71.12 5.46 2.1 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.347 2.259 . . . . 0.0 114.387 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.1 mm -50.96 143.7 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.416 1.886 . . . . 0.0 111.301 171.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 125.879 1.672 . . . . 0.0 110.268 168.085 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 122.191 0.996 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.17 157.35 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 129.89 3.276 . . . . 0.0 114.981 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 tt -95.28 129.86 42.25 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.601 1.561 . . . . 0.0 110.777 167.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.79 140.98 19.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.235 1.014 . . . . 0.0 109.182 -175.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -146.49 160.44 42.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 123.209 1.48 . . . . 0.0 113.371 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 tt -144.64 144.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.067 1.347 . . . . 0.0 109.715 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 t -142.58 141.16 31.94 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.011 0.524 . . . . 0.0 111.899 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -108.4 148.66 29.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.462 1.505 . . . . 0.0 112.141 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.3 m -137.18 60.29 1.65 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.037 2.135 . . . . 0.0 111.509 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.28 -89.06 1.38 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.545 1.069 . . . . 0.0 113.135 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -121.22 29.75 7.15 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.063 1.745 . . . . 0.0 112.099 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 96.6 m -141.02 136.29 31.95 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.998 2.119 . . . . 0.0 108.113 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.32 143.0 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.338 1.055 . . . . 0.0 111.418 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.0 m -126.78 126.11 42.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.216 1.006 . . . . 0.0 111.507 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.84 129.97 49.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.16 2.184 . . . . 0.0 110.379 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.26 144.07 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.077 1.351 . . . . 0.0 109.122 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 152.51 -147.77 17.86 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 119.964 -1.71 . . . . 0.0 115.466 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -154.41 143.56 21.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.326 2.65 . . . . 0.0 110.923 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -152.51 170.72 7.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.775 1.23 . . . . 0.0 112.426 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.71 -29.32 10.75 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.808 3.005 . . . . 0.0 114.287 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -159.57 172.08 18.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.356 1.55 . . . . 0.0 114.836 -171.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.41 -34.22 73.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.277 1.831 . . . . 0.0 112.985 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.66 71.16 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.074 0.55 . . . . 0.0 111.547 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.74 75.76 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.974 0.509 . . . . 0.0 112.274 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -63.19 -41.88 99.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.582 0.753 . . . . 0.0 111.804 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.62 84.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.388 0.675 . . . . 0.0 112.451 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.89 76.26 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.653 -0.654 . . . . 0.0 112.713 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.2 -40.58 90.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.652 1.181 . . . . 0.0 111.321 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -73.82 -32.46 63.71 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.746 -0.596 . . . . 0.0 112.109 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -65.48 -39.22 91.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.027 0.931 . . . . 0.0 110.98 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.15 79.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.978 0.911 . . . . 0.0 113.119 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.9 -24.83 24.7 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.92 -28.24 67.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.676 1.59 . . . . 0.0 112.203 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -53.7 -28.16 37.46 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.792 2.139 . . . . 0.0 115.388 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.32 15.15 3.48 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 113.598 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -55.9 127.38 30.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.93 0.892 . . . . 0.0 111.267 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.39 149.26 44.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.157 1.383 . . . . 0.0 111.176 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.87 102.76 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.529 2.819 . . . . 0.0 112.665 -174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.4 -8.7 8.36 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.742 2.115 . . . . 0.0 113.852 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.57 113.83 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.477 1.139 . . . . 0.0 111.055 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -73.68 153.14 40.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.906 1.682 . . . . 0.0 112.267 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.63 133.64 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.706 1.203 . . . . 0.0 109.846 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.0 mt -128.66 141.27 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.266 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -130.06 128.49 42.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.887 1.275 . . . . 0.0 112.766 -171.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.8 17.96 3.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.339 2.256 . . . . 0.0 112.73 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.81 130.77 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.811 1.244 . . . . 0.0 110.954 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -86.6 164.11 17.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.922 1.689 . . . . 0.0 112.373 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.85 120.79 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.118 1.367 . . . . 0.0 111.657 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.07 130.46 5.27 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.346 1.859 . . . . 0.0 110.156 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.27 -4.68 15.42 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.775 2.983 . . . . 0.0 114.691 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -15.14 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 126.002 1.721 . . . . 0.0 112.58 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.98 145.43 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 128.022 2.529 . . . . 0.0 110.491 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -141.68 150.85 42.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.282 1.833 . . . . 0.0 109.013 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -126.21 168.22 14.37 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.45 ' H ' ' CD1' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -69.69 155.45 40.49 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.814 2.846 . . . . 0.0 108.586 167.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.35 88.19 7.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.379 1.072 . . . . 0.0 113.373 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -61.58 -8.65 4.62 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.717 -1.24 . . . . 0.0 113.55 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 m -49.17 -29.5 5.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.085 1.754 . . . . 0.0 112.506 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 m -108.97 2.33 21.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.63 2.372 . . . . 0.0 113.488 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.42 -2.96 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.852 1.661 . . . . 0.0 113.647 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.45 -47.66 83.17 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.761 1.224 . . . . 0.0 113.187 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.51 -27.01 46.71 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.807 1.671 . . . . 0.0 113.632 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.93 -45.32 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.948 0.795 . . . . 0.0 110.775 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -74.49 -30.11 61.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.152 0.581 . . . . 0.0 112.398 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -62.42 -44.2 97.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.481 1.112 . . . . 0.0 111.408 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.79 -17.0 64.66 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -112.95 3.06 16.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.523 1.929 . . . . 0.0 115.542 -177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 91.3 t -53.62 -40.37 80.02 Favored Pre-proline 0 N--CA 1.481 1.096 0 O-C-N 120.132 -1.605 . . . . 0.0 113.858 167.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.41 14.25 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.68 2.254 . . . . 0.0 114.065 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.1 mt -120.69 84.34 37.09 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.964 2.106 . . . . 0.0 109.308 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.45 -17.79 58.36 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.44 2.76 . . . . 0.0 115.297 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -105.77 5.54 30.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.423 2.289 . . . . 0.0 113.913 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -56.53 152.28 12.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.252 1.025 . . . . 0.0 113.251 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.57 35.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.654 1.597 . . . . 0.0 112.356 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.62 150.35 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.296 1.438 . . . . 0.0 109.584 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -139.21 142.3 37.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.479 1.112 . . . . 0.0 109.089 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.6 t -143.45 128.45 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.713 1.205 . . . . 0.0 109.063 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.45 155.03 29.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 36.54 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.058 2.543 . . . . 0.0 114.971 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.1 15.32 8.46 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.841 2.056 . . . . 0.0 113.171 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -139.43 145.1 38.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.616 1.566 . . . . 0.0 112.609 -171.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.25 141.09 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.429 1.892 . . . . 0.0 110.257 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.3 m -132.49 135.08 45.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 109.6 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.85 125.36 33.42 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.192 1.397 . . . . 0.0 109.564 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.9 m -134.86 131.21 37.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.888 1.275 . . . . 0.0 110.244 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.99 -174.47 45.32 Favored Glycine 0 CA--C 1.538 1.473 0 O-C-N 120.879 -1.138 . . . . 0.0 112.882 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -126.88 80.51 1.95 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.954 1.702 . . . . 0.0 113.726 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.74 153.87 90.01 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.763 1.625 . . . . 0.0 114.751 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -25.54 16.04 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 114.634 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.8 t -153.29 157.53 40.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.33 1.852 . . . . 0.0 110.71 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 p -59.64 -24.08 63.56 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.289 1.036 . . . . 0.0 113.41 169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.65 -44.07 87.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.546 1.138 . . . . 0.0 111.32 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -61.95 -39.68 92.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.232 0.613 . . . . 0.0 111.992 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -60.54 -43.34 97.31 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.183 0.901 . . . . 0.0 112.716 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.39 -43.51 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.368 0.667 . . . . 0.0 112.11 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.65 84.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.75 0.82 . . . . 0.0 112.195 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.3 -39.62 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.408 0.549 . . . . 0.0 110.836 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -64.33 -43.61 94.08 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.678 0.672 . . . . 0.0 111.737 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -67.59 -37.15 82.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.956 0.903 . . . . 0.0 112.136 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.84 83.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.809 0.444 . . . . 0.0 110.869 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.44 -37.56 87.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.931 0.492 . . . . 0.0 112.044 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.4 m -68.84 -36.64 78.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.652 0.781 . . . . 0.0 111.734 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 t -68.05 -38.69 82.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.185 0.994 . . . . 0.0 112.376 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 41.9 m -72.86 -40.02 66.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.093 0.957 . . . . 0.0 112.339 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -129.77 61.1 56.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.411 1.484 . . . . 0.0 113.906 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.63 -13.14 32.23 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.221 2.614 . . . . 0.0 113.154 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -98.9 3.17 47.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.818 2.047 . . . . 0.0 113.483 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -133.86 164.32 27.52 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.344 1.857 . . . . 0.0 111.691 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -76.65 150.78 36.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.529 0.732 . . . . 0.0 110.808 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.54 133.51 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.271 1.429 . . . . 0.0 109.92 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.75 84.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.891 1.676 . . . . 0.0 109.486 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.18 70.34 3.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.622 1.569 . . . . 0.0 111.48 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -68.3 -9.61 48.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.799 2.04 . . . . 0.0 114.251 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.4 pt -58.12 156.09 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.268 1.427 . . . . 0.0 112.861 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 . . . . . 0 C--N 1.33 -0.254 0 C-N-CA 124.782 1.233 . . . . 0.0 110.968 168.619 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.887 0.851 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.96 151.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.544 2.738 . . . . 0.0 114.199 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.58 129.03 54.58 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.378 1.871 . . . . 0.0 111.643 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -154.06 154.93 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.565 1.146 . . . . 0.0 112.447 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -138.03 145.99 42.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.985 2.114 . . . . 0.0 110.787 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 tt -140.24 139.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.25 1.42 . . . . 0.0 109.153 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 t -146.8 143.49 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -105.02 148.12 27.09 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.657 1.583 . . . . 0.0 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.3 m -135.17 63.58 1.61 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.484 2.314 . . . . 0.0 111.407 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 -88.71 1.26 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.745 1.164 . . . . 0.0 113.058 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -122.53 34.15 5.23 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.063 1.745 . . . . 0.0 111.871 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.7 m -143.68 140.7 30.18 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.563 2.345 . . . . 0.0 108.239 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.24 143.97 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.381 1.073 . . . . 0.0 111.316 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.5 m -127.11 130.44 49.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.352 1.061 . . . . 0.0 111.562 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 122.75 47.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.21 2.204 . . . . 0.0 110.123 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.87 116.75 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.575 1.15 . . . . 0.0 109.313 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.77 -161.02 32.25 Favored Glycine 0 CA--C 1.525 0.719 0 O-C-N 120.502 -1.374 . . . . 0.0 114.727 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.14 142.21 24.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.073 2.149 . . . . 0.0 111.331 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -152.44 169.77 9.07 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.285 1.434 . . . . 0.0 112.749 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.26 -25.51 11.4 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.845 3.03 . . . . 0.0 114.179 174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -155.54 164.22 38.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.688 1.595 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -66.36 -26.35 67.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.615 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -29.94 69.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.457 0.703 . . . . 0.0 112.005 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.24 75.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.325 0.65 . . . . 0.0 112.606 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.9 -42.3 99.74 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.629 1.172 . . . . 0.0 111.371 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.74 82.71 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.745 0.818 . . . . 0.0 111.767 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.22 91.74 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.35 -39.4 89.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 111.754 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.21 -38.68 82.19 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.325 -0.86 . . . . 0.0 112.097 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -63.32 -40.94 98.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.442 1.097 . . . . 0.0 110.981 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -33.74 76.23 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.254 1.021 . . . . 0.0 112.978 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.52 -26.8 24.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.29 -27.73 66.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.806 1.642 . . . . 0.0 112.355 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.75 -29.26 25.5 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.918 2.199 . . . . 0.0 115.306 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.1 16.76 2.81 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.343 1.057 . . . . 0.0 113.523 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -56.28 133.39 52.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.86 0.864 . . . . 0.0 111.477 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.06 34.0 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.291 1.436 . . . . 0.0 111.216 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 103.21 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.578 2.852 . . . . 0.0 112.393 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.6 -9.94 6.82 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.607 2.051 . . . . 0.0 113.783 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.83 112.91 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 118.553 1.177 . . . . 0.0 110.795 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.98 158.46 36.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.866 1.667 . . . . 0.0 112.592 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -136.62 133.2 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.104 1.361 . . . . 0.0 109.807 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.8 139.48 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.191 1.797 . . . . 0.0 108.971 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -127.59 126.13 41.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 113.16 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -137.35 23.53 2.97 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.761 2.424 . . . . 0.0 111.684 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.6 144.98 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 120.768 -1.207 . . . . 0.0 111.22 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -116.2 161.66 18.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.17 1.788 . . . . 0.0 111.903 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -131.3 120.72 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.358 1.463 . . . . 0.0 111.765 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.42 129.75 4.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.608 1.963 . . . . 0.0 110.167 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.49 -3.23 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.085 3.19 . . . . 0.0 115.039 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.5 t -66.13 -19.25 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.714 2.006 . . . . 0.0 112.505 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.26 139.67 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 127.485 2.314 . . . . 0.0 109.824 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -144.98 146.83 32.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.429 1.892 . . . . 0.0 108.982 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.08 -179.82 6.0 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.68 174.64 1.31 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.682 2.393 . . . . 0.0 110.816 166.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.66 155.89 17.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.795 1.238 . . . . 0.0 112.056 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.75 0.26 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.122 1.369 . . . . 0.0 113.264 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.4 m -56.74 -40.11 75.14 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.105 -0.997 . . . . 0.0 111.699 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.1 m -83.28 -7.33 59.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.589 1.556 . . . . 0.0 114.167 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.84 -1.65 54.58 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.815 1.646 . . . . 0.0 114.32 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -45.58 -47.92 37.22 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.391 1.076 . . . . 0.0 113.132 169.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -24.22 54.63 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.125 1.884 . . . . 0.0 113.94 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.9 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.193 0.906 . . . . 0.0 110.813 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.94 -37.89 76.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.748 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.4 m -58.42 -41.35 84.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.64 -12.16 61.01 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 m -117.21 -5.46 11.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.622 1.969 . . . . 0.0 115.839 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.69 -40.82 80.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-N 121.867 2.121 . . . . 0.0 115.739 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.42 -8.32 23.08 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 CA-C-N 122.688 1.996 . . . . 0.0 114.373 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.3 119.21 73.62 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.351 1.46 . . . . 0.0 110.934 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.87 -24.61 9.81 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.78 2.32 . . . . 0.0 115.39 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -113.47 8.5 17.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.402 1.881 . . . . 0.0 114.001 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -56.44 148.1 20.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.745 0.818 . . . . 0.0 112.934 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.32 166.72 39.01 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.532 1.063 . . . . 0.0 112.414 171.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.56 150.93 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.174 1.389 . . . . 0.0 110.3 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.57 145.51 47.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.365 1.066 . . . . 0.0 110.256 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.55 129.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.882 1.273 . . . . 0.0 108.672 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -159.61 158.92 32.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.329 0.652 . . . . 0.0 112.364 170.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 43.82 -89.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.556 2.342 . . . . 0.0 114.194 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.93 24.86 3.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.769 2.028 . . . . 0.0 111.727 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 20.2 m -135.74 142.3 44.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.803 1.641 . . . . 0.0 112.327 -171.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.14 129.32 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.544 1.938 . . . . 0.0 110.547 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 m -125.64 137.28 53.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.385 1.474 . . . . 0.0 110.666 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.2 125.53 31.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.354 1.462 . . . . 0.0 109.877 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 m -132.78 152.9 51.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.745 1.618 . . . . 0.0 110.416 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.05 -167.02 37.22 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 120.741 -1.224 . . . . 0.0 114.568 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 p -136.03 70.62 1.42 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.733 2.013 . . . . 0.0 112.861 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.19 153.14 95.47 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.6 1.56 . . . . 0.0 114.94 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.94 -27.87 20.29 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.608 2.872 . . . . 0.0 114.323 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.2 t -151.55 156.68 41.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.046 1.739 . . . . 0.0 111.139 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.1 m -58.33 -21.4 49.33 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.488 1.115 . . . . 0.0 113.409 167.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.44 -46.77 87.02 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.216 1.006 . . . . 0.0 111.614 170.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -59.77 -42.19 92.75 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.173 0.589 . . . . 0.0 111.791 170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -62.18 -44.59 96.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.835 0.743 . . . . 0.0 112.685 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.72 -42.15 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 111.82 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.63 -40.93 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.14 0.576 . . . . 0.0 111.059 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -64.87 -41.5 95.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.292 1.037 . . . . 0.0 111.846 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -69.23 -34.84 75.45 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.561 1.144 . . . . 0.0 112.521 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.94 83.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 117.929 0.331 . . . . 0.0 111.199 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.76 92.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.99 0.916 . . . . 0.0 112.513 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 t -74.4 -28.24 61.0 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.723 -0.611 . . . . 0.0 112.158 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -39.42 71.7 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.857 0.863 . . . . 0.0 112.81 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.1 t -79.58 -31.68 41.86 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -128.91 60.51 50.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.355 1.462 . . . . 0.0 114.029 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.58 -14.6 30.51 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.352 2.702 . . . . 0.0 114.859 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -95.72 -8.55 34.24 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.241 1.016 . . . . 0.0 113.453 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 98.7 mtp -106.43 160.77 15.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 112.507 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -67.35 142.85 56.65 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.466 0.706 . . . . 0.0 109.484 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.63 127.35 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 110.243 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.54 97.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.496 1.118 . . . . 0.0 110.767 -171.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -75.72 123.04 24.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.309 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -129.14 5.68 5.33 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.825 2.45 . . . . 0.0 111.6 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.0 mt -61.99 142.05 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.901 1.68 . . . . 0.0 110.529 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 127.276 2.231 . . . . 0.0 110.261 178.4 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 42.11 54.73 4.05 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.772 2.029 . . . . 0.0 115.088 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 t -151.17 168.3 25.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.091 1.357 . . . . 0.0 112.575 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 150.26 31.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.994 1.718 . . . . 0.0 110.98 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.56 174.62 10.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.207 2.203 . . . . 0.0 110.789 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -139.05 45.94 1.97 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.894 1.278 . . . . 0.0 112.753 -171.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.52 169.07 1.87 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.21 1.804 . . . . 0.0 113.924 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.43 163.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 129.728 3.211 . . . . 0.0 114.058 167.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.8 138.72 45.77 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.679 1.591 . . . . 0.0 112.331 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.62 148.47 24.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.42 1.488 . . . . 0.0 110.507 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.6 p -151.38 159.51 44.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.195 1.474 . . . . 0.0 113.387 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.81 141.67 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.337 1.855 . . . . 0.0 108.781 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.6 p -143.36 146.66 33.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.573 0.749 . . . . 0.0 112.461 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -112.93 149.0 33.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.647 1.579 . . . . 0.0 111.833 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.5 m -136.3 58.2 1.75 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.336 2.254 . . . . 0.0 111.222 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.06 -86.92 1.18 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.572 1.082 . . . . 0.0 113.434 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -120.56 30.12 7.09 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.26 1.824 . . . . 0.0 112.245 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -142.34 137.76 30.75 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.184 2.193 . . . . 0.0 108.226 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.96 142.5 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.439 1.096 . . . . 0.0 111.282 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -127.35 130.46 49.49 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.923 1.289 . . . . 0.0 111.165 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.67 122.0 41.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.755 2.022 . . . . 0.0 110.524 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.3 mm -134.06 132.12 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.911 1.684 . . . . 0.0 109.722 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.19 -159.71 32.9 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.025 -1.672 . . . . 0.0 116.294 -172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -158.37 145.1 17.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.94 2.496 . . . . 0.0 110.116 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -152.44 169.97 8.76 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.523 1.129 . . . . 0.0 113.002 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.79 -29.11 35.91 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.818 3.012 . . . . 0.0 113.664 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -152.76 162.87 40.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.36 1.552 . . . . 0.0 113.005 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.56 -27.34 69.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.425 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.08 70.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.434 0.694 . . . . 0.0 112.209 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -39.27 70.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.525 0.678 . . . . 0.0 111.864 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.9 -40.75 96.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.974 2.11 . . . . 0.0 112.385 170.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.48 -34.53 78.49 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.024 1.33 . . . . 0.0 112.366 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.27 80.0 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.233 -0.917 . . . . 0.0 112.436 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -65.26 -42.34 93.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.737 0.815 . . . . 0.0 111.288 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.6 ptp -74.82 -27.85 60.46 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -68.47 -40.0 81.17 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.41 -34.15 76.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.089 0.956 . . . . 0.0 112.795 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.66 -28.66 26.26 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -64.45 -28.93 70.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.864 1.266 . . . . 0.0 112.363 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -28.38 28.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.796 2.141 . . . . 0.0 115.393 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 tp -137.76 16.55 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.551 1.14 . . . . 0.0 113.274 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tt -58.59 137.13 57.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 111.403 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.46 147.17 32.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.738 1.615 . . . . 0.0 111.377 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.51 104.53 0.65 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.704 2.936 . . . . 0.0 112.283 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.58 -11.15 7.12 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.499 2.0 . . . . 0.0 113.727 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -69.32 113.08 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 118.358 1.079 . . . . 0.0 110.499 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -72.14 154.05 41.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.445 1.498 . . . . 0.0 112.371 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 t -137.09 131.02 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.285 1.434 . . . . 0.0 109.767 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.4 mt -129.55 141.84 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.186 1.794 . . . . 0.0 109.309 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.76 138.19 44.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.936 1.294 . . . . 0.0 113.043 -171.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.2 17.69 2.43 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.586 1.955 . . . . 0.0 112.672 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.39 124.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.946 -1.096 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -84.31 167.2 16.79 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.839 2.456 . . . . 0.0 113.102 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -133.11 125.04 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.193 1.397 . . . . 0.0 111.342 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -153.96 127.19 4.21 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.545 1.938 . . . . 0.0 110.742 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.34 -7.38 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.618 2.212 . . . . 0.0 114.723 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 p -70.3 -11.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.683 1.129 . . . . 0.0 113.742 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.89 147.34 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.323 1.849 . . . . 0.0 111.373 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -142.86 152.48 42.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.278 1.831 . . . . 0.0 110.687 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -145.32 177.9 8.48 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -175.79 0.26 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.02 2.528 . . . . 0.0 110.603 164.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -134.78 107.45 7.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.703 1.201 . . . . 0.0 111.743 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -69.01 -1.82 8.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 m -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 171.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.6 m -85.62 -12.09 52.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.179 1.792 . . . . 0.0 113.926 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -88.97 0.85 56.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.975 1.71 . . . . 0.0 114.125 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -45.54 -47.57 36.98 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 120.998 -1.063 . . . . 0.0 113.378 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.4 -22.76 38.86 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.364 2.043 . . . . 0.0 114.127 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -44.98 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.292 0.951 . . . . 0.0 110.474 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.73 -32.15 69.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.9 m -57.89 -42.01 83.74 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.084 0.856 . . . . 0.0 111.488 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.84 66.1 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.4 p -116.61 6.13 13.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.589 1.955 . . . . 0.0 116.165 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.2 t -52.28 -42.17 85.34 Favored Pre-proline 0 N--CA 1.482 1.172 0 O-C-N 120.185 -1.572 . . . . 0.0 113.58 167.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.86 12.49 1.95 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.672 2.248 . . . . 0.0 114.353 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 mt -113.96 97.74 45.81 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.264 1.826 . . . . 0.0 109.956 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.98 -23.48 21.79 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.906 2.404 . . . . 0.0 114.885 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.13 6.72 43.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.363 1.865 . . . . 0.0 113.653 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -52.42 152.1 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.959 1.304 . . . . 0.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.15 163.31 35.91 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.872 1.225 . . . . 0.0 111.769 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -140.75 149.6 42.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.269 1.028 . . . . 0.0 109.355 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 153.3 48.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.702 1.601 . . . . 0.0 110.868 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -143.52 133.73 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.101 1.36 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.12 146.09 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 112.484 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 51.36 -71.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 129.304 3.041 . . . . 0.0 117.997 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -144.95 21.0 1.61 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.37 1.868 . . . . 0.0 113.694 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -136.53 140.97 43.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.772 1.629 . . . . 0.0 111.139 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.23 131.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.829 2.052 . . . . 0.0 107.977 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.3 m -122.56 132.17 54.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.972 1.309 . . . . 0.0 110.128 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.64 123.77 36.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.312 1.445 . . . . 0.0 109.169 -173.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.0 t -135.23 152.34 51.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.687 1.195 . . . . 0.0 112.129 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 159.42 -178.41 35.56 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.78 -1.2 . . . . 0.0 114.046 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.3 p -120.7 84.65 2.26 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.598 2.359 . . . . 0.0 111.869 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.6 149.7 81.29 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.79 -30.36 27.34 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.558 2.838 . . . . 0.0 113.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t -152.21 164.5 37.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.64 1.176 . . . . 0.0 112.092 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -61.52 -21.61 64.39 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.616 1.166 . . . . 0.0 113.845 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -64.85 -40.28 94.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.222 1.009 . . . . 0.0 111.38 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -65.91 -39.95 91.03 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.015 -0.428 . . . . 0.0 111.958 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.74 -42.83 94.02 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.002 0.819 . . . . 0.0 112.585 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.78 -41.26 87.98 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 112.713 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.54 81.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.525 0.73 . . . . 0.0 112.424 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.33 -38.39 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.075 0.852 . . . . 0.0 110.553 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -61.45 -45.16 95.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.192 0.597 . . . . 0.0 111.293 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -61.94 -42.9 99.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.469 0.708 . . . . 0.0 112.204 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.03 92.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.663 0.385 . . . . 0.0 111.373 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.56 78.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.22 0.608 . . . . 0.0 112.371 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.8 m -67.85 -38.62 83.37 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.703 0.801 . . . . 0.0 111.734 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -35.95 74.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.66 -36.91 50.92 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.145 0.978 . . . . 0.0 112.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -135.74 64.27 56.24 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.615 1.566 . . . . 0.0 113.307 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.16 -3.92 14.5 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.449 2.766 . . . . 0.0 114.316 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.28 20.09 6.85 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.678 1.991 . . . . 0.0 113.062 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.3 mtt -135.7 163.5 30.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.775 1.63 . . . . 0.0 110.805 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -70.79 143.07 51.28 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.608 -0.683 . . . . 0.0 109.643 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 pt -137.41 86.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.72 1.608 . . . . 0.0 111.694 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.8 t -82.56 92.55 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.201 1.4 . . . . 0.0 110.687 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.76 68.92 4.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.599 1.56 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -68.03 -5.68 18.65 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.24 1.816 . . . . 0.0 114.542 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -42.21 137.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.832 2.053 . . . . 0.0 111.701 171.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.6 161.58 33.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.884 1.274 . . . . 0.0 110.955 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.97 135.98 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.93 0.492 . . . . 0.0 109.712 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 53.7 m -55.07 135.9 48.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 112.694 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -167.69 31.22 0.18 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.228 0.918 . . . . 0.0 114.507 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -146.57 118.58 8.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.023 1.329 . . . . 0.0 110.857 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -155.74 57.77 1.64 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 112.327 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.94 154.15 73.55 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.294 2.662 . . . . 0.0 113.114 -174.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 95.47 0.86 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.144 3.229 . . . . 0.0 111.856 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.18 54.77 0.13 Allowed Glycine 0 CA--C 1.538 1.527 0 CA-C-O 118.484 -1.175 . . . . 0.0 114.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.53 156.16 67.24 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.18 2.587 . . . . 0.0 112.704 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.75 170.82 19.49 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.948 3.099 . . . . 0.0 112.716 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.014 2.526 . . . . 0.0 114.658 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.92 166.99 27.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.357 1.463 . . . . 0.0 111.979 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.0 m -133.78 142.56 47.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.034 1.733 . . . . 0.0 111.039 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.42 39.66 0.74 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 0.0 112.768 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.8 tp -74.86 121.32 21.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.889 1.276 . . . . 0.0 110.862 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 p -73.1 108.91 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.461 1.104 . . . . 0.0 113.659 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.53 177.51 4.82 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.914 2.086 . . . . 0.0 110.812 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 m -41.23 164.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.872 3.269 . . . . 0.0 115.251 168.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.73 139.89 52.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.712 1.605 . . . . 0.0 112.381 166.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 tt -159.92 154.76 24.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.338 1.455 . . . . 0.0 111.784 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -139.42 150.31 45.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.556 1.942 . . . . 0.0 111.705 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -142.43 138.76 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.819 1.648 . . . . 0.0 108.885 171.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -145.88 142.73 29.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -107.0 148.99 28.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.125 1.77 . . . . 0.0 112.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.7 t -141.09 99.19 3.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.713 1.605 . . . . 0.0 110.943 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.77 -96.8 0.1 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.311 1.91 . . . . 0.0 113.619 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -120.58 34.95 5.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.15 1.78 . . . . 0.0 112.234 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -141.39 137.35 32.22 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.861 2.065 . . . . 0.0 108.89 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.83 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.256 1.022 . . . . 0.0 111.541 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.3 m -125.97 129.43 49.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.515 1.126 . . . . 0.0 111.165 -171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.31 126.93 55.93 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.508 1.923 . . . . 0.0 110.1 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.1 mt -139.61 127.43 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.075 1.35 . . . . 0.0 109.257 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.48 -155.89 26.43 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.618 -1.301 . . . . 0.0 115.242 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.22 150.32 25.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.345 1.858 . . . . 0.0 112.289 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -152.34 170.12 8.52 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.323 1.849 . . . . 0.0 112.309 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.62 -31.8 32.3 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.382 3.388 . . . . 0.0 113.805 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.55 164.76 38.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 123.255 1.502 . . . . 0.0 112.813 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -60.57 -32.0 71.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.769 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 112.149 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -37.86 67.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.157 0.583 . . . . 0.0 111.992 172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -67.53 -34.81 77.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.69 1.196 . . . . 0.0 112.838 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.26 74.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.406 1.082 . . . . 0.0 111.632 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.32 80.71 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.623 -0.673 . . . . 0.0 112.809 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.66 -42.77 98.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.816 0.847 . . . . 0.0 111.458 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 28.8 ptm -73.39 -30.93 63.6 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.763 -0.586 . . . . 0.0 112.34 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.9 m -66.65 -40.34 88.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.086 0.954 . . . . 0.0 111.158 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.29 -31.91 72.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.313 1.045 . . . . 0.0 113.121 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.6 -25.34 21.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.58 -32.23 70.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.876 1.27 . . . . 0.0 112.246 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.14 -27.85 57.91 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.747 1.641 . . . . 0.0 115.117 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 14.41 6.08 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.502 1.521 . . . . 0.0 112.552 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.2 129.02 38.44 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.122 0.969 . . . . 0.0 111.383 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.83 41.42 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.555 1.542 . . . . 0.0 111.505 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.48 104.15 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.353 2.702 . . . . 0.0 112.97 -172.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.87 -9.09 9.83 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.78 2.133 . . . . 0.0 113.678 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.9 t -71.28 110.44 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 118.312 1.056 . . . . 0.0 111.799 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.23 156.42 39.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.381 1.873 . . . . 0.0 112.363 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.75 134.72 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.146 1.379 . . . . 0.0 109.623 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.84 140.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.253 1.821 . . . . 0.0 108.765 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.04 131.57 49.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.104 1.362 . . . . 0.0 112.163 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -140.35 24.95 2.27 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.279 2.231 . . . . 0.0 112.058 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.3 mp -82.49 129.83 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.766 1.226 . . . . 0.0 111.022 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -92.84 169.63 10.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.178 1.391 . . . . 0.0 113.46 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.89 119.49 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.751 1.621 . . . . 0.0 110.694 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.25 126.24 5.07 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.596 2.358 . . . . 0.0 110.034 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.7 -4.2 14.19 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.321 2.681 . . . . 0.0 114.473 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.6 t -71.0 -13.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.398 1.879 . . . . 0.0 112.732 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.64 153.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.926 2.09 . . . . 0.0 110.555 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -146.71 143.84 29.01 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.32 1.848 . . . . 0.0 108.424 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 m -128.16 171.17 12.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.137 1.335 . . . . 0.0 114.476 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.61 176.01 4.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.131 1.772 . . . . 0.0 109.697 165.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -118.38 102.68 9.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.946 0.898 . . . . 0.0 112.295 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -69.77 -2.98 13.51 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.8 m -54.61 -33.89 61.15 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.901 -1.125 . . . . 0.0 112.492 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.6 m -96.32 1.8 52.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 113.676 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -91.44 -5.71 53.91 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.891 1.676 . . . . 0.0 113.455 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -45.91 -48.22 40.88 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.04 1.336 . . . . 0.0 113.006 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.56 -24.78 41.58 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.9 1.733 . . . . 0.0 113.862 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.35 -44.0 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.223 0.92 . . . . 0.0 110.407 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.23 -35.55 78.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.211 0.604 . . . . 0.0 112.214 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.9 m -59.71 -42.61 93.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.838 0.855 . . . . 0.0 111.554 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.23 -17.52 64.79 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 m -104.62 1.94 30.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.314 2.246 . . . . 0.0 114.884 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.31 -44.53 93.69 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-O 117.388 -1.291 . . . . 0.0 114.161 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.81 14.37 2.35 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.725 2.283 . . . . 0.0 114.193 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.3 93.78 23.84 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 109.761 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.53 -21.06 26.37 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.844 3.029 . . . . 0.0 116.657 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -107.4 13.0 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.079 1.752 . . . . 0.0 113.067 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.06 148.13 8.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 113.116 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.9 161.76 33.06 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 124.624 1.107 . . . . 0.0 111.58 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 tp -134.09 146.55 50.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.494 1.118 . . . . 0.0 109.114 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -135.73 151.6 50.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.986 0.915 . . . . 0.0 110.748 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -143.19 132.25 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.884 1.274 . . . . 0.0 109.05 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.23 155.08 28.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 167.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 41.39 -86.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.156 2.583 . . . . 0.0 114.991 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -140.64 29.54 1.93 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.907 1.23 . . . . 0.0 112.564 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.0 m -137.86 142.08 40.72 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.871 2.068 . . . . 0.0 110.67 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.64 142.91 31.27 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 125.527 1.531 . . . . 0.0 111.378 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 m -125.58 139.78 53.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.701 1.6 . . . . 0.0 110.163 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 mp -132.64 130.81 40.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.952 1.301 . . . . 0.0 110.405 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 27.4 m -138.05 151.08 47.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.654 1.182 . . . . 0.0 110.931 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.49 -174.4 39.71 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 120.542 -1.349 . . . . 0.0 115.883 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.2 p -128.11 80.07 1.94 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.879 2.472 . . . . 0.0 111.816 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.46 83.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -170.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.03 -29.12 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 113.976 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.2 t -150.25 155.9 40.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.622 1.969 . . . . 0.0 110.575 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.3 p -56.67 -24.7 50.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.326 1.45 . . . . 0.0 113.303 168.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.44 -45.92 92.25 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.317 . . . . 0.0 111.724 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.189 0.595 . . . . 0.0 112.172 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -63.25 -42.19 99.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.134 0.879 . . . . 0.0 112.444 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.18 -39.7 86.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.863 0.865 . . . . 0.0 112.153 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.44 93.77 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.977 -0.452 . . . . 0.0 112.162 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 72.9 t -67.91 -42.05 85.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 122.779 0.432 . . . . 0.0 111.094 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.711 0.687 . . . . 0.0 111.882 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -68.96 -39.82 79.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.053 0.941 . . . . 0.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.82 -43.18 99.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.572 0.349 . . . . 0.0 111.385 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.015 0.526 . . . . 0.0 112.195 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.4 m -64.97 -38.82 92.22 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.716 -0.615 . . . . 0.0 111.971 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.0 m -67.58 -36.09 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.401 0.68 . . . . 0.0 112.763 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 51.6 m -74.37 -38.2 63.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.354 1.062 . . . . 0.0 112.245 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.35 62.69 64.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.621 1.568 . . . . 0.0 113.536 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.0 -14.16 34.99 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.436 2.757 . . . . 0.0 114.1 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -95.16 5.88 50.58 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.208 1.803 . . . . 0.0 113.195 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.3 mtt -128.62 152.43 48.36 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.634 1.573 . . . . 0.0 111.824 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.92 146.64 45.96 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.216 0.606 . . . . 0.0 110.071 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.0 143.08 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.551 1.14 . . . . 0.0 109.693 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.59 93.38 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.783 1.233 . . . . 0.0 109.982 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -80.76 130.82 35.28 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.286 0.565 . . . . 0.0 111.488 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.92 3.89 3.78 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.731 2.412 . . . . 0.0 111.956 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.32 139.59 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.137 1.375 . . . . 0.0 109.748 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -122.04 166.12 14.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 111.356 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.7 t -79.42 137.08 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.1 t -63.19 168.4 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.224 1.41 . . . . 0.0 113.188 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -155.43 -31.01 0.03 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.419 1.009 . . . . 0.0 115.078 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -150.34 119.18 6.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.798 1.239 . . . . 0.0 110.109 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -157.75 154.75 25.56 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.83 1.652 . . . . 0.0 111.472 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.5 162.56 42.01 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.313 2.675 . . . . 0.0 112.089 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.44 155.53 69.65 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.044 2.496 . . . . 0.0 112.343 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -96.34 177.7 33.73 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.554 1.073 . . . . 0.0 114.642 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 159.19 54.6 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.052 3.168 . . . . 0.0 112.192 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.23 114.87 3.76 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.542 2.828 . . . . 0.0 111.406 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.285 1.834 . . . . 0.0 111.934 -179.066 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.77 58.2 2.75 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.231 1.412 . . . . 0.0 113.002 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.3 m -63.13 155.46 27.94 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 113.667 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 48.36 42.74 18.64 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.207 1.803 . . . . 0.0 114.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.99 168.66 9.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.776 1.63 . . . . 0.0 113.218 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 t -140.54 102.74 4.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.047 0.939 . . . . 0.0 112.297 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -118.83 174.8 6.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.099 2.559 . . . . 0.0 111.806 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -42.54 165.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.936 2.894 . . . . 0.0 113.571 165.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.04 151.92 39.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 114.958 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mp -146.0 157.12 43.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 111.449 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 t -148.6 127.24 12.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.899 1.68 . . . . 0.0 110.0 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.0 139.42 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.686 1.594 . . . . 0.0 108.694 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -143.87 145.13 32.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.996 0.918 . . . . 0.0 112.522 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -109.81 149.11 30.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.649 1.579 . . . . 0.0 111.769 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -135.81 58.47 1.75 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.101 2.16 . . . . 0.0 111.443 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.75 -88.62 1.24 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.628 1.108 . . . . 0.0 113.231 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -119.46 30.41 7.11 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.703 1.601 . . . . 0.0 112.465 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -140.76 137.6 33.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.37 2.268 . . . . 0.0 108.021 167.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.1 142.31 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 0.0 111.312 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.2 m -127.85 128.8 45.86 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.645 1.178 . . . . 0.0 110.436 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.69 120.39 36.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.889 1.675 . . . . 0.0 109.266 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mm -119.14 144.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.375 1.87 . . . . 0.0 107.55 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.99 -153.87 23.0 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -162.22 143.64 10.68 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.204 2.201 . . . . 0.0 111.321 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -156.79 171.76 7.01 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.065 1.346 . . . . 0.0 113.004 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.18 -29.44 14.41 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.316 3.344 . . . . 0.0 113.645 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -156.34 166.48 33.3 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 123.392 1.568 . . . . 0.0 114.11 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.11 -32.16 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.721 1.608 . . . . 0.0 112.709 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.98 72.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.419 0.687 . . . . 0.0 111.903 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.44 67.54 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -39.38 94.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.218 1.407 . . . . 0.0 111.849 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.78 87.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 112.357 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.13 82.26 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.554 -0.716 . . . . 0.0 112.443 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.49 -39.79 81.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.157 0.983 . . . . 0.0 111.564 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -72.23 -33.58 67.67 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.226 -0.922 . . . . 0.0 112.341 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.6 m -63.5 -41.75 98.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.563 0.745 . . . . 0.0 111.149 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.82 78.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.144 0.978 . . . . 0.0 113.343 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.14 -43.52 61.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 111.836 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.65 -25.86 68.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 112.715 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.1 17.46 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.58 2.038 . . . . 0.0 114.409 172.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 7.24 3.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.479 1.112 . . . . 0.0 113.753 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.49 125.63 22.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.174 0.99 . . . . 0.0 110.815 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.4 148.97 40.15 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.022 1.329 . . . . 0.0 111.436 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.04 102.2 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.63 2.887 . . . . 0.0 112.443 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.86 -10.3 7.08 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.741 2.115 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.93 110.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.416 1.108 . . . . 0.0 110.734 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.49 152.48 45.33 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.515 1.526 . . . . 0.0 112.24 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.91 138.33 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.923 1.289 . . . . 0.0 111.993 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 87.1 mt -133.33 140.17 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.186 1.794 . . . . 0.0 108.781 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.31 134.31 41.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.26 1.424 . . . . 0.0 112.568 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -141.61 26.72 1.91 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.427 1.891 . . . . 0.0 113.16 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.76 130.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.596 -1.315 . . . . 0.0 111.154 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -82.4 160.66 22.72 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.028 1.731 . . . . 0.0 112.257 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.93 121.54 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 111.169 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.19 129.22 4.66 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.804 1.641 . . . . 0.0 110.656 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.07 -6.44 19.11 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.378 2.719 . . . . 0.0 114.823 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.84 -10.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.937 1.695 . . . . 0.0 112.603 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.1 144.49 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 128.595 2.758 . . . . 0.0 109.95 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -143.5 155.11 44.25 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.97 2.108 . . . . 0.0 109.548 -170.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -139.5 178.86 6.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.86 169.98 14.65 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.568 1.947 . . . . 0.0 110.177 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.26 158.93 15.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 112.52 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.26 2.32 11.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.559 1.544 . . . . 0.0 112.211 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 m -53.63 -32.39 51.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.163 1.385 . . . . 0.0 112.78 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.6 m -105.24 7.61 33.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.526 1.93 . . . . 0.0 113.674 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.61 56.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.482 1.513 . . . . 0.0 113.655 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -46.82 -48.81 50.42 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.71 1.204 . . . . 0.0 112.738 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 -24.87 38.73 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.888 1.725 . . . . 0.0 113.96 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.9 t -64.88 -45.29 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.329 0.968 . . . . 0.0 110.371 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -71.07 -31.3 67.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.744 0.818 . . . . 0.0 112.789 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.2 m -63.11 -42.58 99.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.907 0.776 . . . . 0.0 111.391 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.29 65.88 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.1 p -102.49 7.12 40.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.196 1.799 . . . . 0.0 115.364 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.7 t -48.62 -44.62 67.87 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.478 -1.389 . . . . 0.0 114.499 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.46 13.62 2.37 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.558 2.172 . . . . 0.0 114.226 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -113.95 92.8 27.03 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.146 1.779 . . . . 0.0 110.445 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.79 -22.78 23.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.454 2.769 . . . . 0.0 115.428 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -100.54 9.34 42.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.353 1.861 . . . . 0.0 113.342 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -52.56 149.31 6.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.023 0.916 . . . . 0.0 112.38 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 164.44 35.52 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.468 1.032 . . . . 0.0 111.772 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.53 146.84 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.68 1.192 . . . . 0.0 109.796 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -138.24 143.03 39.92 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.907 0.883 . . . . 0.0 110.002 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.76 131.96 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.904 0.882 . . . . 0.0 109.46 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.11 156.22 26.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 167.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 46.8 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 129.706 3.202 . . . . 0.0 117.813 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.89 22.98 1.1 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.468 2.307 . . . . 0.0 112.835 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.4 m -143.55 143.82 31.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.942 1.697 . . . . 0.0 112.148 -170.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.8 141.79 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 126.333 1.853 . . . . 0.0 110.53 167.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.3 m -131.17 137.57 49.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.884 1.674 . . . . 0.0 109.62 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.61 127.9 34.01 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.177 1.391 . . . . 0.0 109.23 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 91.1 m -130.69 152.18 50.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.644 1.577 . . . . 0.0 110.229 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.13 -174.66 39.45 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.753 -1.217 . . . . 0.0 114.385 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.5 p -128.17 74.91 1.58 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.105 2.162 . . . . 0.0 112.082 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.79 154.31 93.71 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 -26.36 19.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.624 2.883 . . . . 0.0 114.077 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.3 t -147.99 156.89 43.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.737 2.015 . . . . 0.0 110.423 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.3 p -54.0 -31.13 50.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.781 2.033 . . . . 0.0 112.577 168.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.32 -41.92 80.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 112.064 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.85 -43.35 96.42 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.098 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.91 -35.99 81.26 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.5 1.045 . . . . 0.0 112.272 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.25 -41.92 89.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.356 0.662 . . . . 0.0 112.449 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.48 91.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.735 0.814 . . . . 0.0 112.528 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.87 -42.9 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.375 0.534 . . . . 0.0 110.483 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -62.94 -41.5 99.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.88 1.272 . . . . 0.0 112.437 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -69.96 -37.65 75.86 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.215 1.006 . . . . 0.0 111.198 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.82 99.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.885 0.474 . . . . 0.0 111.385 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.46 88.16 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.58 0.627 . . . . 0.0 112.195 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.8 m -63.64 -39.91 95.53 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.745 -0.597 . . . . 0.0 112.049 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.2 m -67.63 -35.17 78.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 29.7 m -76.58 -38.62 54.6 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.051 0.94 . . . . 0.0 112.428 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -133.28 59.15 39.46 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.089 1.356 . . . . 0.0 113.428 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 -15.05 40.56 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.486 2.791 . . . . 0.0 113.85 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -92.16 0.81 57.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.839 1.655 . . . . 0.0 113.592 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 64.6 mtt -130.59 162.06 30.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.72 . . . . 0.0 112.307 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -70.72 147.34 49.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.16 131.15 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.45 1.5 . . . . 0.0 109.284 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.5 t -126.34 92.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 110.729 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.96 66.57 3.63 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.208 2.203 . . . . 0.0 113.723 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -67.24 -6.46 18.36 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.995 1.718 . . . . 0.0 114.573 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.81 142.1 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.33 1.852 . . . . 0.0 111.272 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -129.38 173.16 10.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.569 1.548 . . . . 0.0 110.594 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.45 143.59 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.582 0.753 . . . . 0.0 109.203 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 10.7 t -58.09 154.04 13.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.694 1.198 . . . . 0.0 113.353 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -169.66 38.87 0.2 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.587 1.089 . . . . 0.0 113.518 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -140.08 -162.32 1.33 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.769 1.627 . . . . 0.0 110.494 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.37 148.96 40.66 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.174 1.39 . . . . 0.0 113.513 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 160.6 48.99 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.467 2.778 . . . . 0.0 113.057 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.42 170.9 16.25 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.85 3.033 . . . . 0.0 112.782 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -164.73 -178.6 38.22 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.893 1.235 . . . . 0.0 113.545 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.86 158.54 57.46 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.763 2.975 . . . . 0.0 112.929 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.16 127.82 16.52 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.677 2.918 . . . . 0.0 111.059 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.312 1.845 . . . . 0.0 113.335 176.104 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.82 170.27 18.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.511 1.525 . . . . 0.0 111.864 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -117.29 165.37 13.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.577 1.551 . . . . 0.0 112.917 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.87 44.84 1.18 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.341 1.456 . . . . 0.0 111.855 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 109.68 1.55 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.519 1.528 . . . . 0.0 113.052 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 p -68.18 117.98 10.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.572 1.149 . . . . 0.0 111.311 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -146.18 174.06 11.66 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.252 2.621 . . . . 0.0 109.89 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -43.5 157.04 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.536 2.734 . . . . 0.0 114.916 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.6 154.13 28.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.143 1.777 . . . . 0.0 113.628 166.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tp -154.73 152.02 29.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.821 1.648 . . . . 0.0 111.438 -171.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -149.99 131.38 14.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.209 1.404 . . . . 0.0 110.608 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 64.9 mt -135.71 142.86 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.375 1.47 . . . . 0.0 108.524 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.4 p -142.23 150.25 40.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.11 142.72 49.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.626 1.97 . . . . 0.0 110.255 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -141.37 66.19 1.37 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.745 . . . . 0.0 112.242 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.73 -81.18 1.27 Allowed Glycine 0 N--CA 1.477 1.37 0 O-C-N 121.223 -0.923 . . . . 0.0 114.708 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.98 32.71 5.05 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.388 173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.72 141.91 30.7 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.089 2.156 . . . . 0.0 108.967 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.68 142.82 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 111.211 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.6 m -130.2 125.24 34.45 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.982 1.313 . . . . 0.0 110.829 -171.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.71 128.48 55.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.032 1.733 . . . . 0.0 110.015 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.94 144.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.1 1.76 . . . . 0.0 108.443 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.29 -156.54 28.19 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.533 -1.354 . . . . 0.0 116.219 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -164.0 128.71 2.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.215 1.806 . . . . 0.0 112.29 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -143.51 168.02 14.03 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.707 1.603 . . . . 0.0 113.134 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -67.32 -31.81 34.27 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.095 3.197 . . . . 0.0 113.31 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.28 166.85 32.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 123.473 1.606 . . . . 0.0 113.573 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -60.82 -29.86 69.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.418 1.887 . . . . 0.0 113.489 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.27 -29.87 68.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.776 1.23 . . . . 0.0 112.199 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.72 83.16 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.63 -0.669 . . . . 0.0 111.204 173.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.129 1.372 . . . . 0.0 111.785 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.86 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.467 0.707 . . . . 0.0 112.581 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.61 76.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.29 -42.42 93.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.907 1.283 . . . . 0.0 111.543 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.7 ptm -73.11 -32.1 64.74 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.655 -0.653 . . . . 0.0 111.997 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -64.55 -38.55 91.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 111.056 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.25 -35.33 76.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.814 0.845 . . . . 0.0 112.968 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.92 -23.38 22.72 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.63 -29.62 68.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.909 1.284 . . . . 0.0 112.229 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.24 -27.14 52.0 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.813 1.673 . . . . 0.0 115.267 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 12.65 5.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.622 1.569 . . . . 0.0 112.459 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.42 125.46 23.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.729 0.811 . . . . 0.0 110.979 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.58 148.56 46.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.97 1.308 . . . . 0.0 111.079 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.31 102.49 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.496 2.798 . . . . 0.0 112.738 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.48 -8.96 8.28 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.684 2.088 . . . . 0.0 113.713 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.61 114.19 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.506 1.153 . . . . 0.0 111.006 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -69.99 153.63 42.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.783 1.633 . . . . 0.0 112.322 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.45 132.36 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.709 1.204 . . . . 0.0 110.006 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.0 148.59 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.998 1.719 . . . . 0.0 110.396 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.03 130.3 31.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.932 1.693 . . . . 0.0 111.823 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -140.75 28.92 1.93 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.603 2.361 . . . . 0.0 111.127 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.55 119.29 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.632 1.173 . . . . 0.0 109.927 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -73.85 165.51 24.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.388 1.875 . . . . 0.0 112.221 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.6 t -132.39 123.73 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.091 1.356 . . . . 0.0 111.021 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.62 120.78 2.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.468 1.907 . . . . 0.0 110.529 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.68 -6.39 18.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.655 2.237 . . . . 0.0 115.0 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.23 -12.9 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.007 0.923 . . . . 0.0 112.206 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.08 149.01 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.709 1.603 . . . . 0.0 110.52 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -145.21 145.74 31.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.288 1.835 . . . . 0.0 109.153 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -133.42 -179.61 5.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.457 ' H ' ' CD1' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -68.01 -176.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 130.162 3.385 . . . . 0.0 110.866 170.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -123.95 95.11 4.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 112.795 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -73.18 2.31 7.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.9 m -56.46 -36.0 68.56 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.627 -1.296 . . . . 0.0 112.183 172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.8 m -89.5 -2.51 58.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.808 1.643 . . . . 0.0 113.762 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.52 -6.68 52.91 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.511 1.124 . . . . 0.0 113.294 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.72 -48.63 76.49 Favored Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 120.767 -1.208 . . . . 0.0 113.49 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.44 -28.43 32.48 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.584 2.189 . . . . 0.0 114.026 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.26 -46.23 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 0.855 . . . . 0.0 110.753 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.34 -30.57 63.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.578 0.751 . . . . 0.0 112.336 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.6 m -61.17 -44.54 97.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 111.305 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.65 -17.63 64.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 92.2 p -107.75 7.02 28.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 115.286 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -52.42 -47.4 93.31 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 167.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.07 12.46 1.23 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.807 2.338 . . . . 0.0 114.279 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.9 mt -110.59 96.55 28.36 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.746 2.019 . . . . 0.0 109.131 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 -19.54 28.36 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.978 2.452 . . . . 0.0 114.594 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -109.26 11.07 25.56 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.806 2.042 . . . . 0.0 113.843 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.92 155.04 1.91 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.899 1.28 . . . . 0.0 112.983 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.54 164.27 36.15 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.328 0.96 . . . . 0.0 112.196 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.08 145.45 49.37 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.517 1.127 . . . . 0.0 109.317 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -141.32 134.74 29.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.73 0.812 . . . . 0.0 109.924 173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.73 136.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.111 0.564 . . . . 0.0 109.997 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.98 150.45 25.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.787 0.435 . . . . 0.0 112.144 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 39.35 -101.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.569 1.948 . . . . 0.0 112.97 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -117.91 21.31 12.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.489 1.515 . . . . 0.0 112.99 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.2 m -135.61 137.23 41.7 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.086 1.754 . . . . 0.0 112.379 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.4 141.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 126.142 1.777 . . . . 0.0 111.682 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 88.0 m -131.42 136.98 48.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.933 1.693 . . . . 0.0 110.218 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -130.04 133.12 46.52 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.003 1.721 . . . . 0.0 109.471 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 31.7 m -138.88 148.32 43.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.915 1.286 . . . . 0.0 110.753 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.21 -172.0 37.36 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.523 -1.361 . . . . 0.0 114.885 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -121.41 89.02 3.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.531 2.732 . . . . 0.0 111.998 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.02 53.94 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 120.695 -1.253 . . . . 0.0 113.73 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.27 -26.63 41.69 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.82 3.013 . . . . 0.0 114.226 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.5 t -147.94 157.04 43.32 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.55 1.94 . . . . 0.0 110.063 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 p -59.58 -20.87 58.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.094 0.958 . . . . 0.0 112.907 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.25 -47.55 83.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.756 1.223 . . . . 0.0 111.775 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -58.37 -42.2 86.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.187 0.595 . . . . 0.0 111.867 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -45.26 94.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.839 0.745 . . . . 0.0 112.203 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -66.21 -39.29 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.267 1.027 . . . . 0.0 111.983 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.75 89.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.703 0.801 . . . . 0.0 112.694 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.96 -38.64 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.702 -0.624 . . . . 0.0 110.914 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.668 0.787 . . . . 0.0 111.716 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -63.6 -40.09 96.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.584 0.754 . . . . 0.0 111.848 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.89 97.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.813 0.445 . . . . 0.0 111.376 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.64 -37.64 88.11 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.675 -0.64 . . . . 0.0 112.119 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.6 m -63.27 -41.29 99.01 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.623 -0.673 . . . . 0.0 111.751 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -65.82 -35.94 82.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.4 -36.91 52.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.077 0.951 . . . . 0.0 112.685 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -133.39 61.13 52.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.411 1.484 . . . . 0.0 113.635 -172.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.26 -9.58 25.65 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.687 2.925 . . . . 0.0 114.338 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -114.47 9.72 16.8 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.63 1.972 . . . . 0.0 113.601 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.6 mtm -126.17 161.13 28.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.437 1.895 . . . . 0.0 111.247 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -71.2 146.49 49.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.833 0.853 . . . . 0.0 110.036 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.6 pt -130.71 143.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.115 0.966 . . . . 0.0 111.381 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.0 t -135.68 121.87 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.596 1.158 . . . . 0.0 110.483 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -112.27 70.43 0.71 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.43 1.892 . . . . 0.0 111.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.1 -5.61 42.67 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.545 1.538 . . . . 0.0 114.336 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 68.8 mt -51.28 140.16 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.087 1.755 . . . . 0.0 111.257 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -134.76 175.06 9.9 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.727 1.611 . . . . 0.0 110.63 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.7 t -77.78 141.11 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 111.183 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.0 m -54.25 149.25 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.048 . . . . 0.0 113.474 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.07 31.96 6.86 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.243 1.877 . . . . 0.0 113.896 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 53.28 48.94 20.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.549 1.94 . . . . 0.0 113.663 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -134.5 61.73 50.81 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.492 1.917 . . . . 0.0 113.006 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -68.06 162.44 39.99 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 123.538 2.825 . . . . 0.0 112.739 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -67.68 161.74 42.38 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.357 2.705 . . . . 0.0 112.996 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -176.05 -178.14 45.62 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.828 1.204 . . . . 0.0 113.686 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.68 159.23 54.26 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.751 2.967 . . . . 0.0 112.993 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.8 170.85 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.972 3.115 . . . . 0.0 112.654 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.916 1.686 . . . . 0.0 113.329 175.193 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.18 163.34 17.92 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.347 1.059 . . . . 0.0 113.327 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.2 t -151.38 150.99 31.12 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 111.039 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.87 53.71 0.77 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.186 1.794 . . . . 0.0 113.636 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.42 96.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.913 1.685 . . . . 0.0 111.197 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 t -58.73 119.29 6.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.25 1.82 . . . . 0.0 112.333 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pp -128.72 172.78 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.111 2.165 . . . . 0.0 111.708 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -39.44 154.39 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 129.896 3.278 . . . . 0.0 117.179 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.12 135.42 39.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.676 1.591 . . . . 0.0 111.105 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.09 146.82 23.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.091 1.356 . . . . 0.0 110.817 -175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -142.75 142.96 32.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.084 1.753 . . . . 0.0 110.809 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -142.6 136.66 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.989 1.316 . . . . 0.0 109.445 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -138.86 145.76 40.38 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.937 0.895 . . . . 0.0 112.02 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -108.53 150.49 27.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.011 1.324 . . . . 0.0 112.84 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.0 m -137.78 59.77 1.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.694 2.398 . . . . 0.0 111.99 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.03 -92.84 1.05 Allowed Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.018 1.294 . . . . 0.0 112.856 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -113.08 29.85 7.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.814 1.645 . . . . 0.0 112.327 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.32 140.49 30.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.466 2.307 . . . . 0.0 108.44 170.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.01 144.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.696 1.198 . . . . 0.0 111.131 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.7 m -129.56 128.13 42.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.384 1.074 . . . . 0.0 111.607 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.14 126.93 55.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.787 2.035 . . . . 0.0 110.525 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.5 mt -138.16 125.66 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.32 1.448 . . . . 0.0 109.137 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.65 -156.75 25.64 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 120.859 -1.151 . . . . 0.0 115.144 -171.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -159.45 146.27 16.69 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.882 2.073 . . . . 0.0 111.355 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -151.86 170.2 8.3 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.965 1.706 . . . . 0.0 111.586 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.31 -31.83 42.75 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.265 3.31 . . . . 0.0 113.537 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.47 165.65 35.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.617 1.675 . . . . 0.0 113.123 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.79 -25.77 68.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.728 2.011 . . . . 0.0 113.958 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.19 63.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.96 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -37.65 67.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.196 0.598 . . . . 0.0 111.836 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -26.54 60.52 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 172.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.5 75.65 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.439 -0.788 . . . . 0.0 112.301 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.0 85.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.914 -1.116 . . . . 0.0 112.282 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.76 -42.57 99.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -30.95 62.45 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.496 -0.752 . . . . 0.0 112.434 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.4 m -65.1 -38.44 90.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.81 1.244 . . . . 0.0 111.308 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.82 72.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.799 1.24 . . . . 0.0 113.182 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.29 -25.23 20.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.46 -30.99 70.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.978 1.311 . . . . 0.0 112.37 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.72 -27.15 55.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.601 1.572 . . . . 0.0 115.254 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 10.4 6.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.793 1.637 . . . . 0.0 112.453 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.59 130.45 46.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.451 1.101 . . . . 0.0 111.372 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.2 147.27 39.98 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.245 1.418 . . . . 0.0 111.108 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.88 102.92 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.593 2.862 . . . . 0.0 112.562 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.04 -10.28 7.43 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.838 2.161 . . . . 0.0 113.793 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.92 115.33 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.339 1.069 . . . . 0.0 110.896 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -73.81 155.02 39.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.009 1.724 . . . . 0.0 112.563 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -135.44 132.92 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.847 1.259 . . . . 0.0 109.851 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.2 mt -126.45 138.36 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.406 1.882 . . . . 0.0 108.855 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.63 132.43 37.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.745 1.218 . . . . 0.0 112.824 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -136.75 18.82 3.06 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.428 2.291 . . . . 0.0 112.315 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.82 132.89 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.689 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -94.49 169.82 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.65 1.58 . . . . 0.0 113.248 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.54 118.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.777 1.631 . . . . 0.0 110.774 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -149.3 123.06 4.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.107 2.163 . . . . 0.0 110.419 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.58 -5.06 15.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.023 2.482 . . . . 0.0 114.544 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.24 -13.28 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.209 1.804 . . . . 0.0 112.468 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.72 149.42 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.091 2.157 . . . . 0.0 109.71 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.38 152.58 48.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.038 2.135 . . . . 0.0 106.495 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.0 m -132.74 175.46 9.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.264 1.393 . . . . 0.0 114.256 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.98 158.18 33.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.692 1.597 . . . . 0.0 109.583 166.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.4 148.12 28.4 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.015 165.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.33 0.26 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.713 1.205 . . . . 0.0 113.052 171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -55.28 -37.86 67.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.205 1.002 . . . . 0.0 111.798 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -92.04 3.08 56.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.066 1.747 . . . . 0.0 113.848 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.72 -3.79 51.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.775 1.63 . . . . 0.0 113.687 172.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.07 -49.16 30.8 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.464 1.105 . . . . 0.0 112.39 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.59 -24.83 55.34 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.75 1.633 . . . . 0.0 113.692 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.6 t -66.2 -46.1 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.131 0.878 . . . . 0.0 110.687 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -73.87 -30.07 62.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.485 0.714 . . . . 0.0 112.57 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.8 m -66.77 -39.73 87.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.074 0.95 . . . . 0.0 111.541 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.17 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.8 p -101.13 7.88 43.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.364 1.866 . . . . 0.0 115.191 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.4 t -47.52 -44.97 56.7 Favored Pre-proline 0 N--CA 1.485 1.312 0 O-C-N 120.391 -1.443 . . . . 0.0 114.554 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.8 13.97 2.18 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.447 2.098 . . . . 0.0 114.089 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.39 91.97 35.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.171 1.788 . . . . 0.0 110.583 -171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.07 -17.8 31.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.864 3.042 . . . . 0.0 115.879 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.97 16.08 16.16 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.743 2.417 . . . . 0.0 112.519 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -53.94 153.7 4.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.474 1.109 . . . . 0.0 112.74 168.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.17 161.28 33.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.135 1.35 . . . . 0.0 111.672 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tp -131.45 146.3 52.19 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.037 1.335 . . . . 0.0 109.235 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.75 147.62 42.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.126 0.97 . . . . 0.0 110.822 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.78 133.02 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.666 1.186 . . . . 0.0 109.744 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.24 152.8 24.66 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 167.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 42.15 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.585 3.154 . . . . 0.0 117.253 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -141.86 20.54 2.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.602 1.961 . . . . 0.0 113.022 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.6 m -138.3 140.97 39.81 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.029 1.332 . . . . 0.0 112.555 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.55 131.96 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.418 1.887 . . . . 0.0 111.084 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.6 m -123.94 137.74 54.58 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.679 1.592 . . . . 0.0 110.058 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.65 126.57 29.41 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.616 1.166 . . . . 0.0 110.663 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 98.8 m -132.07 150.86 52.05 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.344 1.457 . . . . 0.0 110.455 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.38 -175.13 39.68 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.79 -1.194 . . . . 0.0 114.183 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.0 p -130.13 81.02 1.99 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.208 1.803 . . . . 0.0 112.071 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.9 153.24 95.63 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.231 1.412 . . . . 0.0 114.293 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.99 -34.63 37.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.093 2.529 . . . . 0.0 113.168 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.7 m -144.47 156.02 43.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.65 1.98 . . . . 0.0 110.644 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 p -62.55 -22.86 66.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.222 1.009 . . . . 0.0 113.633 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -63.95 -42.87 97.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.617 1.167 . . . . 0.0 111.462 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -62.97 -40.9 99.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.451 0.569 . . . . 0.0 111.782 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.6 -46.82 87.82 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.474 0.579 . . . . 0.0 112.214 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.76 -37.66 85.05 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.371 0.668 . . . . 0.0 111.944 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.02 89.33 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.624 0.769 . . . . 0.0 112.573 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.03 -42.63 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.737 0.699 . . . . 0.0 110.655 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -42.07 99.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 112.316 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -72.65 -32.76 66.11 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.91 -47.2 78.6 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.22 93.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 t -72.38 -30.09 64.36 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.635 -0.666 . . . . 0.0 112.168 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.3 m -70.06 -38.98 75.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.138 0.975 . . . . 0.0 112.591 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 39.4 m -71.59 -39.33 70.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.684 1.194 . . . . 0.0 112.311 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -129.85 60.5 52.19 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.448 1.499 . . . . 0.0 113.732 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.39 -14.94 34.61 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.435 2.757 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.46 -1.85 58.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.7 1.6 . . . . 0.0 113.892 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -126.12 160.03 31.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 112.071 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -70.49 151.1 45.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.956 0.902 . . . . 0.0 110.406 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.87 135.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.027 0.931 . . . . 0.0 111.526 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 37.0 t -130.59 87.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.408 1.483 . . . . 0.0 109.825 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -72.97 130.89 41.37 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.902 . . . . 0.0 110.93 171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -137.0 0.15 2.35 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.494 2.318 . . . . 0.0 111.929 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.15 142.7 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.259 1.823 . . . . 0.0 110.073 171.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.67 173.55 8.92 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.821 1.648 . . . . 0.0 110.557 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.87 141.12 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.454 -0.779 . . . . 0.0 109.767 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.6 t -63.04 165.83 6.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 113.925 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 161.11 -3.8 0.08 OUTLIER Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.843 1.211 . . . . 0.0 115.494 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -152.36 160.4 43.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.671 1.989 . . . . 0.0 109.014 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 50.93 64.57 7.98 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.78 2.032 . . . . 0.0 114.53 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.14 161.04 31.67 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 123.464 2.776 . . . . 0.0 112.539 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.76 146.87 89.24 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.288 2.659 . . . . 0.0 113.375 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.73 -50.86 27.97 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 117.996 -1.447 . . . . 0.0 116.25 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.31 150.09 46.42 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 CA-C-N 120.898 2.349 . . . . 0.0 113.017 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 172.78 15.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.072 3.182 . . . . 0.0 112.831 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.293 0 C-N-CA 127.989 2.516 . . . . 0.0 114.63 178.701 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 CA-C-O 121.165 0.314 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.41 16.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.084 1.754 . . . . 0.0 111.202 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -131.28 159.57 37.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.223 1.409 . . . . 0.0 113.673 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.59 39.46 1.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.094 1.358 . . . . 0.0 112.718 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.09 131.85 35.24 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.445 1.498 . . . . 0.0 110.273 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -68.87 103.45 1.8 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.073 1.349 . . . . 0.0 113.315 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.07 176.08 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.742 2.017 . . . . 0.0 110.099 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -37.38 161.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.353 3.061 . . . . 0.0 114.867 167.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.39 146.5 47.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.855 1.662 . . . . 0.0 114.077 167.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 tt -157.15 155.82 31.64 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.823 1.249 . . . . 0.0 112.195 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 t -139.26 140.01 37.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.93 2.092 . . . . 0.0 110.284 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.25 133.9 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.283 1.433 . . . . 0.0 108.864 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 t -143.29 142.25 31.28 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.251 0.62 . . . . 0.0 112.196 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.34 148.47 28.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.305 1.442 . . . . 0.0 110.897 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -143.7 66.04 1.3 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.541 1.536 . . . . 0.0 112.526 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -90.07 1.46 Allowed Glycine 0 N--CA 1.472 1.07 0 C-N-CA 124.308 0.956 . . . . 0.0 113.106 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -122.22 35.94 4.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.985 1.714 . . . . 0.0 111.729 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.4 m -145.0 145.73 31.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.93 2.492 . . . . 0.0 108.183 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 p -134.75 144.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.814 1.246 . . . . 0.0 110.987 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.4 m -128.78 132.78 47.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.422 1.089 . . . . 0.0 111.739 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 117.8 29.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.566 2.346 . . . . 0.0 109.637 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.37 120.33 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.604 1.162 . . . . 0.0 109.053 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.02 -154.02 17.18 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -170.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -153.27 145.92 24.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.515 2.326 . . . . 0.0 112.651 -170.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -155.94 171.43 7.32 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.641 1.576 . . . . 0.0 112.85 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.47 -30.61 23.35 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.327 3.351 . . . . 0.0 113.705 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -155.49 166.74 32.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.287 1.518 . . . . 0.0 113.16 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.62 -28.91 70.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.927 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.06 75.01 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.63 -37.73 67.93 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.365 0.666 . . . . 0.0 112.427 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -60.11 -45.88 91.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.631 1.172 . . . . 0.0 111.314 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.77 77.88 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.986 1.314 . . . . 0.0 111.956 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.48 92.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.14 -39.66 86.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 111.227 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 78.1 mmm -65.94 -41.55 91.18 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.548 0.739 . . . . 0.0 111.639 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.8 m -61.72 -40.48 95.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.343 1.057 . . . . 0.0 110.857 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.96 -31.44 72.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.686 1.194 . . . . 0.0 113.606 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -93.33 -22.39 18.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.7 -30.46 61.56 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.666 1.587 . . . . 0.0 112.367 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.83 -28.28 52.24 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.686 1.612 . . . . 0.0 114.986 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 9.54 6.44 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.81 1.644 . . . . 0.0 112.768 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.3 129.99 44.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.297 1.039 . . . . 0.0 111.109 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.51 149.11 40.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.201 1.401 . . . . 0.0 111.388 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.9 102.8 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.575 2.85 . . . . 0.0 112.582 -174.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -10.38 7.34 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.795 2.14 . . . . 0.0 113.662 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.34 114.78 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 118.358 1.079 . . . . 0.0 110.889 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -71.25 157.16 38.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.982 1.713 . . . . 0.0 112.734 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.97 140.21 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.557 1.143 . . . . 0.0 112.441 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.18 139.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.745 2.018 . . . . 0.0 108.391 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.31 134.81 34.75 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.87 29.88 1.87 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.179 2.592 . . . . 0.0 111.347 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.25 123.66 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.482 -1.386 . . . . 0.0 110.746 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -90.3 162.75 15.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.931 1.292 . . . . 0.0 112.551 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.7 117.98 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.046 1.339 . . . . 0.0 110.941 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.98 117.14 4.18 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.75 2.02 . . . . 0.0 109.878 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 -5.77 17.8 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.964 2.443 . . . . 0.0 114.953 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.66 -1.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.406 1.482 . . . . 0.0 113.527 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.35 142.48 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 128.899 2.879 . . . . 0.0 109.143 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -136.73 154.78 50.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.522 2.329 . . . . 0.0 108.802 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -136.05 177.28 7.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.746 1.157 . . . . 0.0 114.052 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.26 156.99 38.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.161 . . . . 0.0 108.271 167.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.42 152.93 37.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.847 -0.533 . . . . 0.0 111.311 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -122.72 3.07 9.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.463 1.505 . . . . 0.0 111.75 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.2 m -53.5 -37.54 62.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.526 1.13 . . . . 0.0 111.876 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.4 m -96.63 6.1 49.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 113.653 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.66 -6.28 59.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.159 1.384 . . . . 0.0 113.269 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.79 -50.12 44.92 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.026 1.33 . . . . 0.0 112.648 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.51 -24.28 56.63 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 113.738 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.97 -46.97 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.453 1.024 . . . . 0.0 110.649 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -74.32 -28.88 61.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 112.587 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 m -70.25 -41.17 73.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.809 1.244 . . . . 0.0 111.694 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.25 -28.64 68.88 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.312 -0.868 . . . . 0.0 112.649 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.7 p -90.52 0.1 57.46 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -45.6 -46.71 37.14 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 120.779 1.627 . . . . 0.0 115.159 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.51 13.67 1.34 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.727 2.285 . . . . 0.0 114.154 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.12 83.76 12.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.592 1.957 . . . . 0.0 110.188 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.09 -15.86 50.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.452 2.768 . . . . 0.0 115.075 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.89 1.93 27.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.778 2.431 . . . . 0.0 114.34 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -60.07 155.28 17.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.053 -1.029 . . . . 0.0 113.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.36 169.36 37.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.874 1.702 . . . . 0.0 112.995 167.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.19 147.79 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.433 1.893 . . . . 0.0 109.387 177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -136.91 140.26 42.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 109.904 168.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.41 134.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.999 0.92 . . . . 0.0 109.782 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.66 157.67 27.53 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.677 0.791 . . . . 0.0 112.701 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 44.59 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.837 2.455 . . . . 0.0 114.082 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -144.16 33.8 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 119.77 1.168 . . . . 0.0 112.463 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.8 m -133.27 139.14 46.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.75 2.02 . . . . 0.0 111.109 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.35 128.09 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.158 1.783 . . . . 0.0 111.401 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 84.9 m -122.77 134.65 54.42 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.886 1.674 . . . . 0.0 110.03 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.21 124.72 31.2 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.784 1.234 . . . . 0.0 110.174 -171.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.5 m -137.07 123.3 20.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.986 1.314 . . . . 0.0 110.947 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.47 48.28 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.948 1.261 . . . . 0.0 112.926 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.5 p -125.08 81.21 1.94 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 0.0 112.35 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.66 153.96 92.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.2 -31.05 30.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.2 2.6 . . . . 0.0 113.536 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 p -149.27 166.58 28.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.858 1.263 . . . . 0.0 112.804 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.5 p -64.05 -25.06 67.95 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 113.604 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -66.3 -42.16 88.72 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.482 -0.762 . . . . 0.0 111.09 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.32 -41.37 98.9 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.475 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -66.57 -40.54 89.01 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.631 1.105 . . . . 0.0 111.888 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.83 -43.99 97.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.647 1.179 . . . . 0.0 112.382 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.91 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.499 0.72 . . . . 0.0 112.185 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.57 -43.3 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 118.132 0.424 . . . . 0.0 111.243 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -70.02 -36.18 74.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.806 0.73 . . . . 0.0 112.663 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.29 -39.99 81.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.247 1.019 . . . . 0.0 111.571 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.87 95.82 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.08 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.46 87.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.139 0.575 . . . . 0.0 112.395 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.5 m -66.45 -38.1 86.61 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.716 -0.615 . . . . 0.0 111.594 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.8 t -65.27 -38.54 90.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.671 0.788 . . . . 0.0 112.616 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.0 m -73.31 -39.35 65.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.22 1.008 . . . . 0.0 112.764 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -131.96 61.41 57.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.549 1.54 . . . . 0.0 113.815 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.02 -10.95 26.82 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.664 2.909 . . . . 0.0 114.731 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -104.96 -0.93 26.43 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.082 1.753 . . . . 0.0 113.73 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -108.57 160.3 16.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.914 2.086 . . . . 0.0 111.711 -172.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -73.47 147.25 44.3 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.694 -0.628 . . . . 0.0 109.908 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.6 tt -135.04 142.17 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.7 0.8 . . . . 0.0 112.274 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.62 91.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.692 1.597 . . . . 0.0 110.194 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -83.18 74.07 10.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.298 1.839 . . . . 0.0 111.413 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -72.76 -11.54 60.65 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.989 1.315 . . . . 0.0 113.459 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.2 pt -52.04 144.21 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 127.106 2.162 . . . . 0.0 114.531 172.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.35 170.28 16.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.936 2.094 . . . . 0.0 111.088 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.52 142.73 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 170.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.6 t -59.61 160.95 6.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.973 1.309 . . . . 0.0 113.13 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.1 -7.6 0.09 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.364 0.983 . . . . 0.0 115.379 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -142.87 140.0 31.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.406 1.882 . . . . 0.0 108.519 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 42.72 53.63 8.96 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.895 1.678 . . . . 0.0 114.592 -171.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -68.21 160.72 47.63 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.542 2.828 . . . . 0.0 112.61 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.88 162.73 41.02 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.362 2.708 . . . . 0.0 113.487 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.79 -176.5 49.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 125.102 1.334 . . . . 0.0 114.473 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.58 163.62 37.43 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.96 3.106 . . . . 0.0 112.781 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.75 62.17 7.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.984 3.789 . . . . 0.0 112.931 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.322 0 C-N-CA 127.005 2.122 . . . . 0.0 113.476 177.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.503 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.15 171.51 17.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.374 1.47 . . . . 0.0 112.076 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.4 p -132.71 166.55 21.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.897 2.079 . . . . 0.0 112.057 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 46.12 43.78 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.483 1.513 . . . . 0.0 113.228 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.07 115.0 1.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.827 2.051 . . . . 0.0 114.028 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 p -81.31 109.61 15.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.479 1.512 . . . . 0.0 112.709 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -134.52 171.19 14.66 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.701 2.8 . . . . 0.0 109.173 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 t -35.91 162.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 131.114 3.766 . . . . 0.0 114.809 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 150.16 50.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.605 1.562 . . . . 0.0 114.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 tt -160.53 156.73 26.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 111.526 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.3 p -145.22 158.32 43.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 112.653 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -141.67 142.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 108.01 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -139.18 142.69 37.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.321 0.648 . . . . 0.0 111.936 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -112.9 148.28 35.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.777 1.631 . . . . 0.0 111.376 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -134.19 56.64 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.427 2.291 . . . . 0.0 110.438 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.3 -98.82 0.67 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 126.039 1.781 . . . . 0.0 112.365 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -96.38 18.4 14.0 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.406 1.482 . . . . 0.0 113.013 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -137.51 131.87 32.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.818 1.647 . . . . 0.0 108.81 167.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.26 137.8 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.545 1.138 . . . . 0.0 111.253 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -122.66 136.96 55.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.5 1.12 . . . . 0.0 112.6 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.86 121.98 39.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.944 2.098 . . . . 0.0 109.085 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 mt -135.27 133.04 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.02 1.328 . . . . 0.0 108.173 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.96 -146.88 12.28 Favored Glycine 0 N--CA 1.465 0.624 0 O-C-N 120.338 -1.476 . . . . 0.0 115.941 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -153.16 150.77 29.4 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.094 2.557 . . . . 0.0 111.842 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -157.7 170.07 9.56 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 126.026 1.73 . . . . 0.0 110.39 166.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -71.72 -29.96 15.1 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.392 3.395 . . . . 0.0 113.696 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -159.15 166.92 30.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.384 1.564 . . . . 0.0 113.554 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.56 -32.98 70.85 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.676 1.59 . . . . 0.0 112.836 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.97 73.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.818 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.6 60.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.452 0.701 . . . . 0.0 112.339 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.28 -42.03 96.63 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 111.817 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.35 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.684 1.194 . . . . 0.0 111.552 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.04 93.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.8 -39.6 80.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.677 0.791 . . . . 0.0 111.369 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm -65.14 -41.12 95.08 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.741 -0.599 . . . . 0.0 111.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.3 m -62.95 -39.8 95.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 0.0 110.897 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.45 75.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.965 0.906 . . . . 0.0 113.386 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.88 -24.1 21.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -73.04 -29.66 63.16 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.521 1.529 . . . . 0.0 112.337 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.05 52.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.817 1.675 . . . . 0.0 115.077 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 11.1 5.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.456 1.503 . . . . 0.0 112.76 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.75 135.46 56.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.225 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.42 150.27 37.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.814 1.646 . . . . 0.0 111.337 -176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.14 106.28 0.79 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.554 2.836 . . . . 0.0 112.523 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.84 -10.83 10.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.508 2.004 . . . . 0.0 113.75 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.48 118.27 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.345 1.058 . . . . 0.0 110.858 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -75.57 151.1 37.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 112.376 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -136.76 132.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.259 1.424 . . . . 0.0 109.454 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.7 mt -126.62 139.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.736 1.614 . . . . 0.0 109.451 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -132.57 128.16 36.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.43 1.492 . . . . 0.0 111.832 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -136.63 19.97 3.1 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.264 2.225 . . . . 0.0 112.147 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.1 mt -70.87 134.21 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 112.322 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -80.68 160.33 25.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.978 2.111 . . . . 0.0 112.721 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.5 t -131.62 119.16 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.161 1.384 . . . . 0.0 110.95 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.47 110.94 2.41 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.577 1.551 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.71 -6.07 16.98 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.987 2.458 . . . . 0.0 114.812 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.14 -16.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.938 0.895 . . . . 0.0 112.266 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 m -122.59 139.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.583 2.353 . . . . 0.0 110.203 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -128.37 155.54 44.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.273 1.829 . . . . 0.0 109.068 -170.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -139.08 179.79 6.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.09 176.22 2.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.451 1.9 . . . . 0.0 111.922 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -128.93 98.71 5.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 111.054 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.18 9.16 3.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.875 1.27 . . . . 0.0 113.022 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 67.4 m -51.93 -25.09 7.39 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.787 -1.195 . . . . 0.0 113.57 167.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 m -106.94 3.28 25.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.021 2.128 . . . . 0.0 113.818 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.09 -6.11 59.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.373 1.469 . . . . 0.0 113.657 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.21 -48.75 79.23 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.644 1.178 . . . . 0.0 113.2 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -23.6 44.27 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.792 1.661 . . . . 0.0 113.474 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.41 -46.34 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.925 0.784 . . . . 0.0 110.413 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -67.7 -35.47 78.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.999 0.52 . . . . 0.0 111.997 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.0 m -60.69 -44.52 96.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.074 0.949 . . . . 0.0 111.478 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.77 -26.56 67.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.268 0.627 . . . . 0.0 112.636 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.2 m -90.44 0.14 57.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.949 2.1 . . . . 0.0 115.576 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -52.89 -49.27 87.88 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-N 120.423 1.465 . . . . 0.0 114.001 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -84.26 18.39 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.009 2.473 . . . . 0.0 113.465 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mt -110.06 80.43 1.81 Allowed Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 127.014 2.126 . . . . 0.0 107.856 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.88 -21.39 50.48 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.035 2.49 . . . . 0.0 114.557 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -94.57 6.16 49.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.62 1.968 . . . . 0.0 113.509 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -54.81 153.77 5.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.731 1.213 . . . . 0.0 113.844 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.04 164.87 38.01 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.595 1.569 . . . . 0.0 110.768 167.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.46 164.16 30.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.693 -0.886 . . . . 0.0 112.976 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -138.02 152.52 48.94 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.458 1.503 . . . . 0.0 110.374 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 t -144.77 130.24 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.179 1.392 . . . . 0.0 108.682 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 143.75 20.68 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.083 -0.386 . . . . 0.0 112.014 167.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 42.39 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.124 2.17 . . . . 0.0 114.623 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -122.12 17.0 10.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.504 1.922 . . . . 0.0 113.364 -171.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 61.1 m -138.8 144.45 39.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.272 1.829 . . . . 0.0 112.485 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.66 132.56 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.229 2.212 . . . . 0.0 109.481 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 m -122.26 136.94 54.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 110.25 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mp -136.07 127.64 28.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.319 1.047 . . . . 0.0 110.093 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.0 m -136.14 151.85 50.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.616 1.566 . . . . 0.0 110.489 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.17 -176.41 42.09 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.261 -1.524 . . . . 0.0 113.907 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.2 m -132.78 112.71 12.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.928 1.291 . . . . 0.0 110.005 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.83 159.6 29.11 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.72 2.008 . . . . 0.0 113.67 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.47 -33.24 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.455 2.77 . . . . 0.0 113.143 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 55.2 m -144.68 155.41 43.57 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.491 1.916 . . . . 0.0 111.072 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 p -57.7 -27.6 63.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 113.088 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.42 -42.29 98.73 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.988 1.315 . . . . 0.0 111.624 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -62.56 -43.19 99.43 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.949 0.5 . . . . 0.0 111.912 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -62.72 -42.13 99.5 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.4 -41.19 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.263 1.425 . . . . 0.0 112.036 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.32 89.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.418 0.687 . . . . 0.0 112.054 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.41 -41.03 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 118.298 0.499 . . . . 0.0 111.115 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.14 -42.89 99.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.442 0.697 . . . . 0.0 111.967 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -66.17 -40.43 90.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.355 1.062 . . . . 0.0 111.569 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.36 97.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.002 0.521 . . . . 0.0 111.393 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.42 90.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.066 0.546 . . . . 0.0 111.974 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.0 m -63.43 -40.17 96.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.497 -0.752 . . . . 0.0 111.849 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.2 m -66.37 -35.81 81.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 35.7 m -77.52 -34.59 53.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.03 0.932 . . . . 0.0 112.668 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -126.87 59.64 36.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 0.0 113.553 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.85 -3.65 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.329 2.686 . . . . 0.0 114.834 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.84 20.22 4.6 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.708 2.003 . . . . 0.0 112.606 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.1 ttt -141.99 149.55 40.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.851 1.66 . . . . 0.0 109.976 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -70.42 141.34 52.13 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.146 -0.971 . . . . 0.0 111.142 -171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.65 138.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.545 1.538 . . . . 0.0 110.338 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.86 79.3 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.515 1.926 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -75.34 130.87 39.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.251 -0.906 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.36 5.35 3.76 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.389 2.276 . . . . 0.0 112.173 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 27.6 mt -56.6 143.45 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.835 1.654 . . . . 0.0 110.72 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -126.37 174.29 8.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.898 1.679 . . . . 0.0 111.44 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.09 142.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.539 1.136 . . . . 0.0 109.665 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 13.6 t -58.91 146.46 37.63 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.985 0.914 . . . . 0.0 113.429 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -153.64 12.77 0.57 Allowed Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.311 1.434 . . . . 0.0 114.4 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -145.5 21.03 1.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.729 1.612 . . . . 0.0 112.145 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.58 154.48 0.11 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 128.834 2.854 . . . . 0.0 114.574 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.41 163.79 35.18 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 122.971 2.447 . . . . 0.0 112.226 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.11 160.63 37.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.291 2.661 . . . . 0.0 112.702 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.63 64.49 0.55 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.88 1.229 . . . . 0.0 113.758 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.57 159.0 46.87 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.398 2.732 . . . . 0.0 112.299 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.55 165.9 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.486 2.791 . . . . 0.0 112.618 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.974 2.109 . . . . 0.0 112.068 -178.63 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.18 158.69 44.22 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.031 1.332 . . . . 0.0 111.831 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.9 t -157.98 177.24 11.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.524 1.53 . . . . 0.0 111.377 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.64 125.55 14.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.769 1.628 . . . . 0.0 109.849 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.76 169.03 18.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.661 1.584 . . . . 0.0 112.087 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -145.95 67.05 1.2 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.135 1.374 . . . . 0.0 112.191 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -82.62 167.34 18.37 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.902 1.681 . . . . 0.0 111.999 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 t -36.92 158.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.0 2.92 . . . . 0.0 115.126 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.1 147.7 43.04 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.096 1.758 . . . . 0.0 114.285 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -155.99 153.54 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.976 1.71 . . . . 0.0 111.6 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -137.61 147.68 45.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.367 1.867 . . . . 0.0 111.158 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.46 138.47 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.344 1.857 . . . . 0.0 108.792 169.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 t -147.92 139.56 23.82 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.452 -0.78 . . . . 0.0 112.067 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -109.97 148.07 32.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.4 m -134.93 60.09 1.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.631 2.372 . . . . 0.0 110.948 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.36 -91.71 1.37 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.807 1.194 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -116.74 27.71 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.876 1.67 . . . . 0.0 112.8 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -140.29 131.7 26.84 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.264 1.826 . . . . 0.0 108.61 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.6 138.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 111.226 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -119.41 143.99 47.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.323 1.049 . . . . 0.0 112.252 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.51 110.76 14.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.671 2.388 . . . . 0.0 108.924 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.0 120.32 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.266 1.426 . . . . 0.0 108.679 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.77 -152.88 21.25 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.184 -0.947 . . . . 0.0 114.223 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.78 160.15 43.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.032 2.133 . . . . 0.0 111.895 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -157.06 171.63 7.2 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 126.225 1.81 . . . . 0.0 112.227 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -65.32 -31.46 52.68 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.547 2.831 . . . . 0.0 114.09 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -157.23 168.6 26.93 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.126 1.441 . . . . 0.0 114.002 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.28 -29.06 70.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.568 1.547 . . . . 0.0 113.182 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.71 70.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.725 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.96 65.42 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -61.17 -40.96 95.83 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.172 -0.955 . . . . 0.0 111.817 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.2 78.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.144 0.978 . . . . 0.0 111.323 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.8 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.15 -46.14 82.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.721 0.691 . . . . 0.0 111.53 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.4 mmm -65.13 -39.88 93.68 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.671 0.788 . . . . 0.0 111.167 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.0 m -63.03 -41.5 99.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.062 0.945 . . . . 0.0 110.658 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.21 -29.28 68.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -92.37 -23.99 19.04 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.67 -32.09 73.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.695 1.598 . . . . 0.0 112.246 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.68 -29.4 49.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.841 1.686 . . . . 0.0 115.139 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.52 15.3 4.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.23 1.412 . . . . 0.0 112.524 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.82 127.21 31.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.68 0.792 . . . . 0.0 111.202 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.97 149.12 38.3 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.874 1.27 . . . . 0.0 111.155 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.29 103.7 0.81 Allowed 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.625 2.883 . . . . 0.0 112.602 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.64 -8.31 10.15 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.421 1.962 . . . . 0.0 113.596 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.88 112.1 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.425 1.113 . . . . 0.0 110.595 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.55 149.29 48.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.209 1.404 . . . . 0.0 111.728 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.4 t -135.51 127.72 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.007 1.323 . . . . 0.0 109.385 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.28 103.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.118 1.367 . . . . 0.0 109.036 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -85.22 123.4 30.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.271 1.028 . . . . 0.0 111.098 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.54 20.41 3.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.896 2.479 . . . . 0.0 111.03 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.27 122.85 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.154 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -80.9 168.73 18.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.204 1.802 . . . . 0.0 112.519 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.99 125.91 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 111.525 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.12 112.28 3.07 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.82 1.648 . . . . 0.0 110.305 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.62 -4.92 15.59 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.59 2.86 . . . . 0.0 114.607 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.05 -1.87 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.491 1.516 . . . . 0.0 113.477 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.77 154.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 128.257 2.623 . . . . 0.0 108.935 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.031 1.332 . . . . 0.0 108.116 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 m -141.71 171.25 14.32 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 178.5 7.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.013 2.125 . . . . 0.0 109.752 165.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.65 168.42 11.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.578 1.551 . . . . 0.0 113.769 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.37 13.78 8.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.131 2.172 . . . . 0.0 112.138 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -56.93 -30.4 63.96 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.697 -1.252 . . . . 0.0 113.384 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -102.86 1.65 34.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 0.0 113.663 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.73 -5.72 58.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.73 1.212 . . . . 0.0 113.787 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -48.78 -50.4 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 O-C-N 121.035 -1.04 . . . . 0.0 113.226 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 -24.55 41.21 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.495 2.13 . . . . 0.0 114.113 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.84 -45.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.569 1.077 . . . . 0.0 110.497 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.42 -33.53 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.223 0.609 . . . . 0.0 112.496 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.8 m -61.05 -43.12 99.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.126 0.875 . . . . 0.0 111.352 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.55 66.08 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.992 0.917 . . . . 0.0 113.448 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -106.45 7.68 31.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.573 1.949 . . . . 0.0 115.236 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.11 -44.97 88.59 Favored Pre-proline 0 N--CA 1.482 1.136 0 O-C-N 120.457 -1.402 . . . . 0.0 113.758 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.81 15.44 1.47 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.826 2.351 . . . . 0.0 113.942 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.6 mt -119.41 91.6 44.52 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 126.181 1.792 . . . . 0.0 110.63 -171.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.38 -20.88 31.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.963 2.442 . . . . 0.0 114.821 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.62 1.83 46.71 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.353 1.861 . . . . 0.0 113.819 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.3 149.7 9.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.667 1.187 . . . . 0.0 113.606 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.86 162.91 34.43 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.205 1.384 . . . . 0.0 111.772 167.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.5 tt -141.5 145.04 34.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.953 1.301 . . . . 0.0 108.949 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -140.28 149.75 43.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.981 1.312 . . . . 0.0 111.578 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.71 136.41 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.006 1.322 . . . . 0.0 110.82 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.55 152.84 18.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.536 1.134 . . . . 0.0 111.579 166.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 49.06 -69.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 129.798 3.239 . . . . 0.0 117.424 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.24 15.31 0.91 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.811 2.444 . . . . 0.0 113.658 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -139.66 155.9 47.13 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.136 -1.602 . . . . 0.0 114.276 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.33 110.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.603 1.961 . . . . 0.0 110.438 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.5 m -94.91 138.85 32.12 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.184 1.394 . . . . 0.0 110.708 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.09 124.72 35.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.641 1.576 . . . . 0.0 109.037 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.3 m -129.63 145.12 51.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.893 1.677 . . . . 0.0 110.447 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.7 -172.09 42.41 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 120.764 -1.21 . . . . 0.0 113.93 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -124.74 71.52 1.17 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.298 2.239 . . . . 0.0 112.908 -171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.2 149.27 97.17 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.1 -27.07 30.03 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.652 2.901 . . . . 0.0 114.15 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.2 t -148.38 156.87 43.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.465 1.906 . . . . 0.0 110.276 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 62.0 p -58.82 -20.93 54.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.086 0.954 . . . . 0.0 113.205 167.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.91 -47.33 81.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.81 1.244 . . . . 0.0 111.747 170.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -60.2 -40.1 88.85 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.268 0.627 . . . . 0.0 112.032 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.52 -46.27 90.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 0.0 112.256 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.91 -41.67 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.468 0.707 . . . . 0.0 112.092 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.91 95.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 112.407 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.72 -41.78 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.051 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.12 -45.22 93.02 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 111.872 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -69.13 -36.42 77.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.405 0.682 . . . . 0.0 111.351 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.33 86.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.047 0.539 . . . . 0.0 112.062 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.72 94.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.789 0.722 . . . . 0.0 111.907 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 85.7 m -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.688 -0.633 . . . . 0.0 111.933 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 73.7 m -66.68 -35.56 80.44 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.4 m -75.96 -36.92 59.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 112.728 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.01 59.5 45.59 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.305 1.442 . . . . 0.0 113.013 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.64 -5.16 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.175 . . . . 0.0 115.603 -171.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.5 14.79 8.22 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.141 1.777 . . . . 0.0 112.997 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.1 mtm -133.3 164.76 26.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.617 1.967 . . . . 0.0 110.207 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -76.96 152.75 35.13 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.348 -0.845 . . . . 0.0 111.741 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.99 136.93 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.099 1.36 . . . . 0.0 109.418 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.1 t -126.1 89.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.985 1.314 . . . . 0.0 109.618 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -74.95 65.57 1.44 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.674 2.39 . . . . 0.0 112.337 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -71.12 5.46 2.1 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.347 2.259 . . . . 0.0 114.387 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.1 mm -50.96 143.7 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.416 1.886 . . . . 0.0 111.301 171.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -128.56 173.33 10.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.879 1.672 . . . . 0.0 110.268 168.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.9 t -87.26 144.12 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.882 0.873 . . . . 0.0 109.455 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 13.5 t -55.18 149.89 11.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.443 1.497 . . . . 0.0 113.996 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -177.62 42.76 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.464 1.506 . . . . 0.0 112.45 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -137.63 122.89 19.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.617 1.567 . . . . 0.0 110.499 -171.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.79 154.22 86.13 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.818 1.247 . . . . 0.0 113.107 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.63 160.57 47.5 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 123.155 2.57 . . . . 0.0 111.915 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.04 143.45 72.18 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.021 2.481 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 173.09 60.14 0.05 OUTLIER Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.566 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.15 157.75 58.17 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.424 2.749 . . . . 0.0 113.033 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.9 170.53 19.47 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.836 3.024 . . . . 0.0 112.61 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.613 1.965 . . . . 0.0 111.929 -179.93 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.65 166.64 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 127.284 2.233 . . . . 0.0 115.528 -172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 m -74.3 120.95 20.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.618 1.167 . . . . 0.0 111.09 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.18 58.2 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.726 0.811 . . . . 0.0 112.45 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.49 136.67 22.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.982 1.313 . . . . 0.0 109.977 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 t -86.66 116.5 24.81 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 112.549 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.92 171.91 7.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.479 2.312 . . . . 0.0 110.603 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.17 157.35 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 129.89 3.276 . . . . 0.0 114.981 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 tt -95.28 129.86 42.25 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.601 1.561 . . . . 0.0 110.777 167.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.79 140.98 19.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.235 1.014 . . . . 0.0 109.182 -175.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.3 p -146.49 160.44 42.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 123.209 1.48 . . . . 0.0 113.371 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 tt -144.64 144.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.067 1.347 . . . . 0.0 109.715 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 t -142.58 141.16 31.94 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.011 0.524 . . . . 0.0 111.899 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -108.4 148.66 29.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.462 1.505 . . . . 0.0 112.141 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.3 m -137.18 60.29 1.65 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.037 2.135 . . . . 0.0 111.509 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.28 -89.06 1.38 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.545 1.069 . . . . 0.0 113.135 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -121.22 29.75 7.15 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.063 1.745 . . . . 0.0 112.099 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 96.6 m -141.02 136.29 31.95 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.998 2.119 . . . . 0.0 108.113 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.32 143.0 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.338 1.055 . . . . 0.0 111.418 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.0 m -126.78 126.11 42.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.216 1.006 . . . . 0.0 111.507 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.84 129.97 49.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.16 2.184 . . . . 0.0 110.379 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.26 144.07 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.077 1.351 . . . . 0.0 109.122 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 152.51 -147.77 17.86 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 119.964 -1.71 . . . . 0.0 115.466 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -154.41 143.56 21.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.326 2.65 . . . . 0.0 110.923 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -152.51 170.72 7.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.775 1.23 . . . . 0.0 112.426 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.71 -29.32 10.75 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.808 3.005 . . . . 0.0 114.287 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -159.57 172.08 18.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.356 1.55 . . . . 0.0 114.836 -171.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.41 -34.22 73.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.277 1.831 . . . . 0.0 112.985 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.66 71.16 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.074 0.55 . . . . 0.0 111.547 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.74 75.76 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.974 0.509 . . . . 0.0 112.274 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -63.19 -41.88 99.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.582 0.753 . . . . 0.0 111.804 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.62 84.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.388 0.675 . . . . 0.0 112.451 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.89 76.26 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.653 -0.654 . . . . 0.0 112.713 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.2 -40.58 90.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.652 1.181 . . . . 0.0 111.321 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -73.82 -32.46 63.71 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.746 -0.596 . . . . 0.0 112.109 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -65.48 -39.22 91.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.027 0.931 . . . . 0.0 110.98 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.15 79.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.978 0.911 . . . . 0.0 113.119 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.9 -24.83 24.7 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.92 -28.24 67.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.676 1.59 . . . . 0.0 112.203 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -53.7 -28.16 37.46 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.792 2.139 . . . . 0.0 115.388 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.32 15.15 3.48 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 113.598 174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -55.9 127.38 30.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.93 0.892 . . . . 0.0 111.267 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.39 149.26 44.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.157 1.383 . . . . 0.0 111.176 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.87 102.76 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.529 2.819 . . . . 0.0 112.665 -174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.4 -8.7 8.36 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.742 2.115 . . . . 0.0 113.852 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.57 113.83 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.477 1.139 . . . . 0.0 111.055 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -73.68 153.14 40.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.906 1.682 . . . . 0.0 112.267 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.63 133.64 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.706 1.203 . . . . 0.0 109.846 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.0 mt -128.66 141.27 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.266 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -130.06 128.49 42.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.887 1.275 . . . . 0.0 112.766 -171.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.8 17.96 3.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.339 2.256 . . . . 0.0 112.73 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.81 130.77 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.811 1.244 . . . . 0.0 110.954 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -86.6 164.11 17.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.922 1.689 . . . . 0.0 112.373 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.85 120.79 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.118 1.367 . . . . 0.0 111.657 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.07 130.46 5.27 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.346 1.859 . . . . 0.0 110.156 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.27 -4.68 15.42 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.775 2.983 . . . . 0.0 114.691 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -15.14 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 126.002 1.721 . . . . 0.0 112.58 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.98 145.43 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 128.022 2.529 . . . . 0.0 110.491 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -141.68 150.85 42.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.282 1.833 . . . . 0.0 109.013 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -126.21 168.22 14.37 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.45 ' H ' ' CD1' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -69.69 155.45 40.49 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.814 2.846 . . . . 0.0 108.586 167.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.35 88.19 7.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.379 1.072 . . . . 0.0 113.373 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -61.58 -8.65 4.62 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.717 -1.24 . . . . 0.0 113.55 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 m -49.17 -29.5 5.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.085 1.754 . . . . 0.0 112.506 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 m -108.97 2.33 21.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.63 2.372 . . . . 0.0 113.488 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.42 -2.96 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.852 1.661 . . . . 0.0 113.647 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.45 -47.66 83.17 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.761 1.224 . . . . 0.0 113.187 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.51 -27.01 46.71 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.807 1.671 . . . . 0.0 113.632 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.93 -45.32 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.948 0.795 . . . . 0.0 110.775 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -74.49 -30.11 61.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.152 0.581 . . . . 0.0 112.398 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -62.42 -44.2 97.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.481 1.112 . . . . 0.0 111.408 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.79 -17.0 64.66 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -112.95 3.06 16.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.523 1.929 . . . . 0.0 115.542 -177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 91.3 t -53.62 -40.37 80.02 Favored Pre-proline 0 N--CA 1.481 1.096 0 O-C-N 120.132 -1.605 . . . . 0.0 113.858 167.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.41 14.25 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.68 2.254 . . . . 0.0 114.065 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.1 mt -120.69 84.34 37.09 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.964 2.106 . . . . 0.0 109.308 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.45 -17.79 58.36 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.44 2.76 . . . . 0.0 115.297 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -105.77 5.54 30.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.423 2.289 . . . . 0.0 113.913 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -56.53 152.28 12.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.252 1.025 . . . . 0.0 113.251 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.57 35.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.654 1.597 . . . . 0.0 112.356 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.62 150.35 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.296 1.438 . . . . 0.0 109.584 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -139.21 142.3 37.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.479 1.112 . . . . 0.0 109.089 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.6 t -143.45 128.45 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.713 1.205 . . . . 0.0 109.063 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.45 155.03 29.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 36.54 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.058 2.543 . . . . 0.0 114.971 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.1 15.32 8.46 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.841 2.056 . . . . 0.0 113.171 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -139.43 145.1 38.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.616 1.566 . . . . 0.0 112.609 -171.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.25 141.09 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.429 1.892 . . . . 0.0 110.257 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.3 m -132.49 135.08 45.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 109.6 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.85 125.36 33.42 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.192 1.397 . . . . 0.0 109.564 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.9 m -134.86 131.21 37.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.888 1.275 . . . . 0.0 110.244 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.99 -174.47 45.32 Favored Glycine 0 CA--C 1.538 1.473 0 O-C-N 120.879 -1.138 . . . . 0.0 112.882 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -126.88 80.51 1.95 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.954 1.702 . . . . 0.0 113.726 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.74 153.87 90.01 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.763 1.625 . . . . 0.0 114.751 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -25.54 16.04 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 114.634 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.8 t -153.29 157.53 40.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.33 1.852 . . . . 0.0 110.71 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 p -59.64 -24.08 63.56 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.289 1.036 . . . . 0.0 113.41 169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.65 -44.07 87.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.546 1.138 . . . . 0.0 111.32 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -61.95 -39.68 92.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.232 0.613 . . . . 0.0 111.992 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -60.54 -43.34 97.31 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.183 0.901 . . . . 0.0 112.716 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.39 -43.51 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.368 0.667 . . . . 0.0 112.11 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.65 84.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.75 0.82 . . . . 0.0 112.195 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.3 -39.62 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.408 0.549 . . . . 0.0 110.836 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -64.33 -43.61 94.08 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.678 0.672 . . . . 0.0 111.737 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -67.59 -37.15 82.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.956 0.903 . . . . 0.0 112.136 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.84 83.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.809 0.444 . . . . 0.0 110.869 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.44 -37.56 87.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.931 0.492 . . . . 0.0 112.044 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.4 m -68.84 -36.64 78.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.652 0.781 . . . . 0.0 111.734 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 t -68.05 -38.69 82.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.185 0.994 . . . . 0.0 112.376 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 41.9 m -72.86 -40.02 66.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.093 0.957 . . . . 0.0 112.339 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -129.77 61.1 56.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.411 1.484 . . . . 0.0 113.906 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.63 -13.14 32.23 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.221 2.614 . . . . 0.0 113.154 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -98.9 3.17 47.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.818 2.047 . . . . 0.0 113.483 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -133.86 164.32 27.52 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.344 1.857 . . . . 0.0 111.691 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -76.65 150.78 36.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.529 0.732 . . . . 0.0 110.808 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.54 133.51 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.271 1.429 . . . . 0.0 109.92 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.75 84.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.891 1.676 . . . . 0.0 109.486 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.18 70.34 3.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.622 1.569 . . . . 0.0 111.48 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -68.3 -9.61 48.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.799 2.04 . . . . 0.0 114.251 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.4 pt -58.12 156.09 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.268 1.427 . . . . 0.0 112.861 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.2 173.7 11.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.782 1.233 . . . . 0.0 110.968 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.38 141.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.628 0.771 . . . . 0.0 109.094 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 14.9 t -56.41 151.1 13.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.477 1.111 . . . . 0.0 113.0 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -112.98 8.54 25.35 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.246 1.403 . . . . 0.0 114.793 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -150.32 140.14 21.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.963 1.305 . . . . 0.0 111.548 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -156.88 57.13 1.29 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.287 1.835 . . . . 0.0 111.984 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 154.27 75.12 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.225 2.617 . . . . 0.0 112.636 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.38 143.18 47.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.313 2.675 . . . . 0.0 112.203 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 159.73 178.07 33.4 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.893 1.235 . . . . 0.0 113.473 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.79 160.11 50.47 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.498 2.799 . . . . 0.0 112.109 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.21 115.2 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.426 2.75 . . . . 0.0 110.982 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.311 1.844 . . . . 0.0 112.137 -177.797 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.35 51.75 1.36 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.776 1.23 . . . . 0.0 112.602 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 t -151.71 135.77 16.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.108 1.763 . . . . 0.0 110.337 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.3 37.6 0.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.203 1.401 . . . . 0.0 112.211 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.86 123.66 22.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.071 1.348 . . . . 0.0 110.931 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -74.88 135.94 41.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.033 1.333 . . . . 0.0 111.846 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.1 mt -137.15 169.1 18.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.945 2.098 . . . . 0.0 112.369 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.96 151.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.544 2.738 . . . . 0.0 114.199 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.58 129.03 54.58 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.378 1.871 . . . . 0.0 111.643 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -154.06 154.93 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.565 1.146 . . . . 0.0 112.447 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -138.03 145.99 42.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.985 2.114 . . . . 0.0 110.787 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 tt -140.24 139.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.25 1.42 . . . . 0.0 109.153 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 t -146.8 143.49 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -105.02 148.12 27.09 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.657 1.583 . . . . 0.0 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.3 m -135.17 63.58 1.61 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.484 2.314 . . . . 0.0 111.407 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 -88.71 1.26 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.745 1.164 . . . . 0.0 113.058 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -122.53 34.15 5.23 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.063 1.745 . . . . 0.0 111.871 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.7 m -143.68 140.7 30.18 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.563 2.345 . . . . 0.0 108.239 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.24 143.97 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.381 1.073 . . . . 0.0 111.316 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.5 m -127.11 130.44 49.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.352 1.061 . . . . 0.0 111.562 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 122.75 47.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.21 2.204 . . . . 0.0 110.123 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.87 116.75 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.575 1.15 . . . . 0.0 109.313 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.77 -161.02 32.25 Favored Glycine 0 CA--C 1.525 0.719 0 O-C-N 120.502 -1.374 . . . . 0.0 114.727 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.14 142.21 24.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.073 2.149 . . . . 0.0 111.331 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -152.44 169.77 9.07 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.285 1.434 . . . . 0.0 112.749 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.26 -25.51 11.4 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.845 3.03 . . . . 0.0 114.179 174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -155.54 164.22 38.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.688 1.595 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -66.36 -26.35 67.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.615 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -29.94 69.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.457 0.703 . . . . 0.0 112.005 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.24 75.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.325 0.65 . . . . 0.0 112.606 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.9 -42.3 99.74 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.629 1.172 . . . . 0.0 111.371 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.74 82.71 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.745 0.818 . . . . 0.0 111.767 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.22 91.74 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.35 -39.4 89.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 111.754 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.21 -38.68 82.19 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.325 -0.86 . . . . 0.0 112.097 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -63.32 -40.94 98.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.442 1.097 . . . . 0.0 110.981 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -33.74 76.23 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.254 1.021 . . . . 0.0 112.978 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.52 -26.8 24.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.29 -27.73 66.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.806 1.642 . . . . 0.0 112.355 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.75 -29.26 25.5 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.918 2.199 . . . . 0.0 115.306 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.1 16.76 2.81 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.343 1.057 . . . . 0.0 113.523 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -56.28 133.39 52.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.86 0.864 . . . . 0.0 111.477 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.06 34.0 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.291 1.436 . . . . 0.0 111.216 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 103.21 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.578 2.852 . . . . 0.0 112.393 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.6 -9.94 6.82 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.607 2.051 . . . . 0.0 113.783 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.83 112.91 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 118.553 1.177 . . . . 0.0 110.795 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.98 158.46 36.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.866 1.667 . . . . 0.0 112.592 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -136.62 133.2 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.104 1.361 . . . . 0.0 109.807 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.8 139.48 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.191 1.797 . . . . 0.0 108.971 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -127.59 126.13 41.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 113.16 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -137.35 23.53 2.97 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.761 2.424 . . . . 0.0 111.684 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.6 144.98 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 120.768 -1.207 . . . . 0.0 111.22 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -116.2 161.66 18.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.17 1.788 . . . . 0.0 111.903 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -131.3 120.72 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.358 1.463 . . . . 0.0 111.765 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.42 129.75 4.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.608 1.963 . . . . 0.0 110.167 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.49 -3.23 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.085 3.19 . . . . 0.0 115.039 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.5 t -66.13 -19.25 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.714 2.006 . . . . 0.0 112.505 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.26 139.67 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 127.485 2.314 . . . . 0.0 109.824 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -144.98 146.83 32.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.429 1.892 . . . . 0.0 108.982 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.08 -179.82 6.0 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.68 174.64 1.31 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.682 2.393 . . . . 0.0 110.816 166.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.66 155.89 17.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.795 1.238 . . . . 0.0 112.056 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.75 0.26 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.122 1.369 . . . . 0.0 113.264 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.4 m -56.74 -40.11 75.14 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.105 -0.997 . . . . 0.0 111.699 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.1 m -83.28 -7.33 59.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.589 1.556 . . . . 0.0 114.167 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.84 -1.65 54.58 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.815 1.646 . . . . 0.0 114.32 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -45.58 -47.92 37.22 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.391 1.076 . . . . 0.0 113.132 169.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -24.22 54.63 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.125 1.884 . . . . 0.0 113.94 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.9 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.193 0.906 . . . . 0.0 110.813 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.94 -37.89 76.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.748 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.4 m -58.42 -41.35 84.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.64 -12.16 61.01 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 m -117.21 -5.46 11.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.622 1.969 . . . . 0.0 115.839 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.69 -40.82 80.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-N 121.867 2.121 . . . . 0.0 115.739 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.42 -8.32 23.08 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 CA-C-N 122.688 1.996 . . . . 0.0 114.373 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 24.8 mt -83.3 119.21 73.62 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.351 1.46 . . . . 0.0 110.934 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.87 -24.61 9.81 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.78 2.32 . . . . 0.0 115.39 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -113.47 8.5 17.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.402 1.881 . . . . 0.0 114.001 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -56.44 148.1 20.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.745 0.818 . . . . 0.0 112.934 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.32 166.72 39.01 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.532 1.063 . . . . 0.0 112.414 171.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.56 150.93 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.174 1.389 . . . . 0.0 110.3 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.57 145.51 47.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.365 1.066 . . . . 0.0 110.256 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.55 129.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.882 1.273 . . . . 0.0 108.672 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -159.61 158.92 32.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.329 0.652 . . . . 0.0 112.364 170.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 43.82 -89.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.556 2.342 . . . . 0.0 114.194 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.93 24.86 3.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.769 2.028 . . . . 0.0 111.727 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 20.2 m -135.74 142.3 44.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.803 1.641 . . . . 0.0 112.327 -171.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.14 129.32 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.544 1.938 . . . . 0.0 110.547 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 m -125.64 137.28 53.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.385 1.474 . . . . 0.0 110.666 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.2 125.53 31.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.354 1.462 . . . . 0.0 109.877 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 m -132.78 152.9 51.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.745 1.618 . . . . 0.0 110.416 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.05 -167.02 37.22 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 120.741 -1.224 . . . . 0.0 114.568 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 p -136.03 70.62 1.42 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.733 2.013 . . . . 0.0 112.861 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.19 153.14 95.47 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.6 1.56 . . . . 0.0 114.94 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.94 -27.87 20.29 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.608 2.872 . . . . 0.0 114.323 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.2 t -151.55 156.68 41.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.046 1.739 . . . . 0.0 111.139 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.1 m -58.33 -21.4 49.33 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.488 1.115 . . . . 0.0 113.409 167.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.44 -46.77 87.02 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.216 1.006 . . . . 0.0 111.614 170.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -59.77 -42.19 92.75 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.173 0.589 . . . . 0.0 111.791 170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -62.18 -44.59 96.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.835 0.743 . . . . 0.0 112.685 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.72 -42.15 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 111.82 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.63 -40.93 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.14 0.576 . . . . 0.0 111.059 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -64.87 -41.5 95.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.292 1.037 . . . . 0.0 111.846 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -69.23 -34.84 75.45 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.561 1.144 . . . . 0.0 112.521 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.94 83.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 117.929 0.331 . . . . 0.0 111.199 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.76 92.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.99 0.916 . . . . 0.0 112.513 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 t -74.4 -28.24 61.0 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.723 -0.611 . . . . 0.0 112.158 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -39.42 71.7 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.857 0.863 . . . . 0.0 112.81 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.1 t -79.58 -31.68 41.86 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -128.91 60.51 50.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.355 1.462 . . . . 0.0 114.029 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.58 -14.6 30.51 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.352 2.702 . . . . 0.0 114.859 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -95.72 -8.55 34.24 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.241 1.016 . . . . 0.0 113.453 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 98.7 mtp -106.43 160.77 15.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 112.507 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -67.35 142.85 56.65 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.466 0.706 . . . . 0.0 109.484 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.63 127.35 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 110.243 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.54 97.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.496 1.118 . . . . 0.0 110.767 -171.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -75.72 123.04 24.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.309 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -129.14 5.68 5.33 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.825 2.45 . . . . 0.0 111.6 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.0 mt -61.99 142.05 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.901 1.68 . . . . 0.0 110.529 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.02 -179.28 4.1 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.276 2.231 . . . . 0.0 110.261 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.0 t -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 120.948 -1.095 . . . . 0.0 111.179 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.0 t -55.55 158.51 3.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.432 1.893 . . . . 0.0 114.316 171.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.16 13.66 28.62 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.849 1.69 . . . . 0.0 113.305 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -143.14 -154.54 0.53 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.313 1.845 . . . . 0.0 110.29 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 45.56 56.45 15.4 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 126.286 1.834 . . . . 0.0 115.191 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.21 160.77 45.96 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.501 2.801 . . . . 0.0 112.617 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.36 159.39 53.54 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.389 2.726 . . . . 0.0 112.93 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.71 60.29 0.12 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.554 1.073 . . . . 0.0 113.568 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.4 157.73 58.82 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.534 2.823 . . . . 0.0 113.011 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.63 170.58 19.66 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.852 3.035 . . . . 0.0 112.655 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.942 1.697 . . . . 0.0 113.288 175.436 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 122.598 1.189 . . . . 0.0 113.924 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.43 163.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 129.728 3.211 . . . . 0.0 114.058 167.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.8 138.72 45.77 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.679 1.591 . . . . 0.0 112.331 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD21 ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -155.62 148.47 24.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.42 1.488 . . . . 0.0 110.507 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.6 p -151.38 159.51 44.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.195 1.474 . . . . 0.0 113.387 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.81 141.67 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.337 1.855 . . . . 0.0 108.781 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.6 p -143.36 146.66 33.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.573 0.749 . . . . 0.0 112.461 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -112.93 149.0 33.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.647 1.579 . . . . 0.0 111.833 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.5 m -136.3 58.2 1.75 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.336 2.254 . . . . 0.0 111.222 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.06 -86.92 1.18 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.572 1.082 . . . . 0.0 113.434 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -120.56 30.12 7.09 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.26 1.824 . . . . 0.0 112.245 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -142.34 137.76 30.75 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.184 2.193 . . . . 0.0 108.226 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.96 142.5 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.439 1.096 . . . . 0.0 111.282 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -127.35 130.46 49.49 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.923 1.289 . . . . 0.0 111.165 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.67 122.0 41.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.755 2.022 . . . . 0.0 110.524 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.3 mm -134.06 132.12 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.911 1.684 . . . . 0.0 109.722 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 165.19 -159.71 32.9 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.025 -1.672 . . . . 0.0 116.294 -172.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -158.37 145.1 17.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.94 2.496 . . . . 0.0 110.116 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HD21 ' A' ' 82' ' ' LEU . 16.1 m-85 -152.44 169.97 8.76 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.523 1.129 . . . . 0.0 113.002 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.79 -29.11 35.91 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.818 3.012 . . . . 0.0 113.664 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -152.76 162.87 40.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.36 1.552 . . . . 0.0 113.005 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.56 -27.34 69.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.425 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.08 70.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.434 0.694 . . . . 0.0 112.209 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -39.27 70.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.525 0.678 . . . . 0.0 111.864 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.9 -40.75 96.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.974 2.11 . . . . 0.0 112.385 170.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.48 -34.53 78.49 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.024 1.33 . . . . 0.0 112.366 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.27 80.0 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.233 -0.917 . . . . 0.0 112.436 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -65.26 -42.34 93.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.737 0.815 . . . . 0.0 111.288 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.6 ptp -74.82 -27.85 60.46 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -68.47 -40.0 81.17 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.41 -34.15 76.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.089 0.956 . . . . 0.0 112.795 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.66 -28.66 26.26 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -64.45 -28.93 70.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.864 1.266 . . . . 0.0 112.363 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -28.38 28.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.796 2.141 . . . . 0.0 115.393 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 tp -137.76 16.55 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.551 1.14 . . . . 0.0 113.274 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tt -58.59 137.13 57.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 111.403 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.46 147.17 32.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.738 1.615 . . . . 0.0 111.377 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.51 104.53 0.65 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.704 2.936 . . . . 0.0 112.283 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.58 -11.15 7.12 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.499 2.0 . . . . 0.0 113.727 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -69.32 113.08 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 118.358 1.079 . . . . 0.0 110.499 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -72.14 154.05 41.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.445 1.498 . . . . 0.0 112.371 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 t -137.09 131.02 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.285 1.434 . . . . 0.0 109.767 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.4 mt -129.55 141.84 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.186 1.794 . . . . 0.0 109.309 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.76 138.19 44.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.936 1.294 . . . . 0.0 113.043 -171.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.2 17.69 2.43 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.586 1.955 . . . . 0.0 112.672 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.39 124.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.946 -1.096 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -84.31 167.2 16.79 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.839 2.456 . . . . 0.0 113.102 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -133.11 125.04 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.193 1.397 . . . . 0.0 111.342 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -153.96 127.19 4.21 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.545 1.938 . . . . 0.0 110.742 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.34 -7.38 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.618 2.212 . . . . 0.0 114.723 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 p -70.3 -11.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.683 1.129 . . . . 0.0 113.742 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.89 147.34 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.323 1.849 . . . . 0.0 111.373 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -142.86 152.48 42.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.278 1.831 . . . . 0.0 110.687 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -145.32 177.9 8.48 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -175.79 0.26 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.02 2.528 . . . . 0.0 110.603 164.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -134.78 107.45 7.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.703 1.201 . . . . 0.0 111.743 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -69.01 -1.82 8.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 m -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 171.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.6 m -85.62 -12.09 52.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.179 1.792 . . . . 0.0 113.926 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -88.97 0.85 56.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.975 1.71 . . . . 0.0 114.125 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -45.54 -47.57 36.98 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 120.998 -1.063 . . . . 0.0 113.378 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.4 -22.76 38.86 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.364 2.043 . . . . 0.0 114.127 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -44.98 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.292 0.951 . . . . 0.0 110.474 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.73 -32.15 69.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.9 m -57.89 -42.01 83.74 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.084 0.856 . . . . 0.0 111.488 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.84 66.1 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.4 p -116.61 6.13 13.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.589 1.955 . . . . 0.0 116.165 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.2 t -52.28 -42.17 85.34 Favored Pre-proline 0 N--CA 1.482 1.172 0 O-C-N 120.185 -1.572 . . . . 0.0 113.58 167.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.86 12.49 1.95 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.672 2.248 . . . . 0.0 114.353 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 mt -113.96 97.74 45.81 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.264 1.826 . . . . 0.0 109.956 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.98 -23.48 21.79 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.906 2.404 . . . . 0.0 114.885 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.13 6.72 43.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.363 1.865 . . . . 0.0 113.653 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -52.42 152.1 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.959 1.304 . . . . 0.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.15 163.31 35.91 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.872 1.225 . . . . 0.0 111.769 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -140.75 149.6 42.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.269 1.028 . . . . 0.0 109.355 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 153.3 48.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.702 1.601 . . . . 0.0 110.868 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -143.52 133.73 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.101 1.36 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.12 146.09 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 112.484 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 51.36 -71.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 129.304 3.041 . . . . 0.0 117.997 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -144.95 21.0 1.61 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.37 1.868 . . . . 0.0 113.694 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -136.53 140.97 43.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.772 1.629 . . . . 0.0 111.139 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.23 131.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.829 2.052 . . . . 0.0 107.977 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.3 m -122.56 132.17 54.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.972 1.309 . . . . 0.0 110.128 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.64 123.77 36.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.312 1.445 . . . . 0.0 109.169 -173.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.0 t -135.23 152.34 51.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.687 1.195 . . . . 0.0 112.129 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 159.42 -178.41 35.56 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.78 -1.2 . . . . 0.0 114.046 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.3 p -120.7 84.65 2.26 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.598 2.359 . . . . 0.0 111.869 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.6 149.7 81.29 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.79 -30.36 27.34 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.558 2.838 . . . . 0.0 113.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t -152.21 164.5 37.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.64 1.176 . . . . 0.0 112.092 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -61.52 -21.61 64.39 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.616 1.166 . . . . 0.0 113.845 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -64.85 -40.28 94.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.222 1.009 . . . . 0.0 111.38 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -65.91 -39.95 91.03 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.015 -0.428 . . . . 0.0 111.958 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.74 -42.83 94.02 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.002 0.819 . . . . 0.0 112.585 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.78 -41.26 87.98 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 112.713 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.54 81.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.525 0.73 . . . . 0.0 112.424 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.33 -38.39 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.075 0.852 . . . . 0.0 110.553 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -61.45 -45.16 95.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.192 0.597 . . . . 0.0 111.293 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -61.94 -42.9 99.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.469 0.708 . . . . 0.0 112.204 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.03 92.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.663 0.385 . . . . 0.0 111.373 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.56 78.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.22 0.608 . . . . 0.0 112.371 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.8 m -67.85 -38.62 83.37 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.703 0.801 . . . . 0.0 111.734 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -35.95 74.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.66 -36.91 50.92 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.145 0.978 . . . . 0.0 112.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -135.74 64.27 56.24 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.615 1.566 . . . . 0.0 113.307 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.16 -3.92 14.5 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.449 2.766 . . . . 0.0 114.316 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.28 20.09 6.85 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.678 1.991 . . . . 0.0 113.062 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.3 mtt -135.7 163.5 30.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.775 1.63 . . . . 0.0 110.805 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -70.79 143.07 51.28 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.608 -0.683 . . . . 0.0 109.643 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 pt -137.41 86.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.72 1.608 . . . . 0.0 111.694 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.8 t -82.56 92.55 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.201 1.4 . . . . 0.0 110.687 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.76 68.92 4.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.599 1.56 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -68.03 -5.68 18.65 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.24 1.816 . . . . 0.0 114.542 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -42.21 137.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.832 2.053 . . . . 0.0 111.701 171.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 124.884 1.274 . . . . 0.0 110.955 172.601 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 CA--C 1.551 1.003 0 CA-C-O 122.048 0.928 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 m -41.23 164.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.872 3.269 . . . . 0.0 115.251 168.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.73 139.89 52.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.712 1.605 . . . . 0.0 112.381 166.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 tt -159.92 154.76 24.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.338 1.455 . . . . 0.0 111.784 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -139.42 150.31 45.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.556 1.942 . . . . 0.0 111.705 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -142.43 138.76 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.819 1.648 . . . . 0.0 108.885 171.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -145.88 142.73 29.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -107.0 148.99 28.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.125 1.77 . . . . 0.0 112.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.7 t -141.09 99.19 3.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.713 1.605 . . . . 0.0 110.943 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.77 -96.8 0.1 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.311 1.91 . . . . 0.0 113.619 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -120.58 34.95 5.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.15 1.78 . . . . 0.0 112.234 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -141.39 137.35 32.22 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.861 2.065 . . . . 0.0 108.89 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.83 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.256 1.022 . . . . 0.0 111.541 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.3 m -125.97 129.43 49.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.515 1.126 . . . . 0.0 111.165 -171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.468 ' CB ' HD11 ' A' ' 124' ' ' ILE . 7.6 mp -113.31 126.93 55.93 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.508 1.923 . . . . 0.0 110.1 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.1 mt -139.61 127.43 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.075 1.35 . . . . 0.0 109.257 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.48 -155.89 26.43 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.618 -1.301 . . . . 0.0 115.242 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.22 150.32 25.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.345 1.858 . . . . 0.0 112.289 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -152.34 170.12 8.52 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.323 1.849 . . . . 0.0 112.309 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.62 -31.8 32.3 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.382 3.388 . . . . 0.0 113.805 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.55 164.76 38.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 123.255 1.502 . . . . 0.0 112.813 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -60.57 -32.0 71.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.769 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 112.149 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -37.86 67.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.157 0.583 . . . . 0.0 111.992 172.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.648 ' HD2' HD13 ' A' ' 124' ' ' ILE . 5.4 ttpt -67.53 -34.81 77.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.69 1.196 . . . . 0.0 112.838 171.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.26 74.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.406 1.082 . . . . 0.0 111.632 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.32 80.71 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.623 -0.673 . . . . 0.0 112.809 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.66 -42.77 98.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.816 0.847 . . . . 0.0 111.458 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 28.8 ptm -73.39 -30.93 63.6 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.763 -0.586 . . . . 0.0 112.34 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.9 m -66.65 -40.34 88.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.086 0.954 . . . . 0.0 111.158 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.29 -31.91 72.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.313 1.045 . . . . 0.0 113.121 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.6 -25.34 21.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.58 -32.23 70.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.876 1.27 . . . . 0.0 112.246 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.14 -27.85 57.91 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.747 1.641 . . . . 0.0 115.117 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 14.41 6.08 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.502 1.521 . . . . 0.0 112.552 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.2 129.02 38.44 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.122 0.969 . . . . 0.0 111.383 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.83 41.42 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.555 1.542 . . . . 0.0 111.505 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.48 104.15 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.353 2.702 . . . . 0.0 112.97 -172.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.87 -9.09 9.83 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.78 2.133 . . . . 0.0 113.678 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.9 t -71.28 110.44 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 118.312 1.056 . . . . 0.0 111.799 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.23 156.42 39.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.381 1.873 . . . . 0.0 112.363 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.75 134.72 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.146 1.379 . . . . 0.0 109.623 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.84 140.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.253 1.821 . . . . 0.0 108.765 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.04 131.57 49.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.104 1.362 . . . . 0.0 112.163 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -140.35 24.95 2.27 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.279 2.231 . . . . 0.0 112.058 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 124' ' ' ILE . 1.3 mp -82.49 129.83 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.766 1.226 . . . . 0.0 111.022 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -92.84 169.63 10.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.178 1.391 . . . . 0.0 113.46 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.89 119.49 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.751 1.621 . . . . 0.0 110.694 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.25 126.24 5.07 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.596 2.358 . . . . 0.0 110.034 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.7 -4.2 14.19 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.321 2.681 . . . . 0.0 114.473 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.6 t -71.0 -13.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.398 1.879 . . . . 0.0 112.732 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.64 153.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.926 2.09 . . . . 0.0 110.555 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -146.71 143.84 29.01 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.32 1.848 . . . . 0.0 108.424 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 m -128.16 171.17 12.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.137 1.335 . . . . 0.0 114.476 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.61 176.01 4.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.131 1.772 . . . . 0.0 109.697 165.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -118.38 102.68 9.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.946 0.898 . . . . 0.0 112.295 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -69.77 -2.98 13.51 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.8 m -54.61 -33.89 61.15 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.901 -1.125 . . . . 0.0 112.492 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.6 m -96.32 1.8 52.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 113.676 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -91.44 -5.71 53.91 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.891 1.676 . . . . 0.0 113.455 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -45.91 -48.22 40.88 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.04 1.336 . . . . 0.0 113.006 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.56 -24.78 41.58 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.9 1.733 . . . . 0.0 113.862 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.35 -44.0 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.223 0.92 . . . . 0.0 110.407 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.23 -35.55 78.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.211 0.604 . . . . 0.0 112.214 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.9 m -59.71 -42.61 93.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.838 0.855 . . . . 0.0 111.554 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.23 -17.52 64.79 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 m -104.62 1.94 30.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.314 2.246 . . . . 0.0 114.884 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.31 -44.53 93.69 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-O 117.388 -1.291 . . . . 0.0 114.161 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.81 14.37 2.35 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.725 2.283 . . . . 0.0 114.193 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.3 93.78 23.84 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 109.761 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.53 -21.06 26.37 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.844 3.029 . . . . 0.0 116.657 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -107.4 13.0 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.079 1.752 . . . . 0.0 113.067 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.06 148.13 8.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 113.116 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.9 161.76 33.06 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 124.624 1.107 . . . . 0.0 111.58 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 tp -134.09 146.55 50.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.494 1.118 . . . . 0.0 109.114 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -135.73 151.6 50.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.986 0.915 . . . . 0.0 110.748 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -143.19 132.25 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.884 1.274 . . . . 0.0 109.05 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.23 155.08 28.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 167.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 41.39 -86.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.156 2.583 . . . . 0.0 114.991 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -140.64 29.54 1.93 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.907 1.23 . . . . 0.0 112.564 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.0 m -137.86 142.08 40.72 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.871 2.068 . . . . 0.0 110.67 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.64 142.91 31.27 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 125.527 1.531 . . . . 0.0 111.378 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 m -125.58 139.78 53.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.701 1.6 . . . . 0.0 110.163 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 mp -132.64 130.81 40.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.952 1.301 . . . . 0.0 110.405 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 27.4 m -138.05 151.08 47.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.654 1.182 . . . . 0.0 110.931 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.49 -174.4 39.71 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 120.542 -1.349 . . . . 0.0 115.883 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.2 p -128.11 80.07 1.94 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.879 2.472 . . . . 0.0 111.816 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.46 83.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -170.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.03 -29.12 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 113.976 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.2 t -150.25 155.9 40.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.622 1.969 . . . . 0.0 110.575 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.3 p -56.67 -24.7 50.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.326 1.45 . . . . 0.0 113.303 168.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.44 -45.92 92.25 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.317 . . . . 0.0 111.724 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.189 0.595 . . . . 0.0 112.172 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -63.25 -42.19 99.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.134 0.879 . . . . 0.0 112.444 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.18 -39.7 86.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.863 0.865 . . . . 0.0 112.153 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.44 93.77 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.977 -0.452 . . . . 0.0 112.162 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 72.9 t -67.91 -42.05 85.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 122.779 0.432 . . . . 0.0 111.094 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.711 0.687 . . . . 0.0 111.882 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -68.96 -39.82 79.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.053 0.941 . . . . 0.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.82 -43.18 99.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.572 0.349 . . . . 0.0 111.385 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.015 0.526 . . . . 0.0 112.195 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.4 m -64.97 -38.82 92.22 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.716 -0.615 . . . . 0.0 111.971 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.0 m -67.58 -36.09 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.401 0.68 . . . . 0.0 112.763 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 51.6 m -74.37 -38.2 63.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.354 1.062 . . . . 0.0 112.245 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.35 62.69 64.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.621 1.568 . . . . 0.0 113.536 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.0 -14.16 34.99 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.436 2.757 . . . . 0.0 114.1 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -95.16 5.88 50.58 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.208 1.803 . . . . 0.0 113.195 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.3 mtt -128.62 152.43 48.36 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.634 1.573 . . . . 0.0 111.824 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.92 146.64 45.96 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.216 0.606 . . . . 0.0 110.071 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.0 143.08 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.551 1.14 . . . . 0.0 109.693 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.59 93.38 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.783 1.233 . . . . 0.0 109.982 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -80.76 130.82 35.28 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.286 0.565 . . . . 0.0 111.488 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.92 3.89 3.78 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.731 2.412 . . . . 0.0 111.956 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.32 139.59 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.137 1.375 . . . . 0.0 109.748 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 111.356 173.57 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -42.54 165.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.936 2.894 . . . . 0.0 113.571 165.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.04 151.92 39.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 114.958 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mp -146.0 157.12 43.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 111.449 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 t -148.6 127.24 12.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.899 1.68 . . . . 0.0 110.0 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.0 139.42 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.686 1.594 . . . . 0.0 108.694 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -143.87 145.13 32.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.996 0.918 . . . . 0.0 112.522 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -109.81 149.11 30.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.649 1.579 . . . . 0.0 111.769 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -135.81 58.47 1.75 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.101 2.16 . . . . 0.0 111.443 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.75 -88.62 1.24 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.628 1.108 . . . . 0.0 113.231 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -119.46 30.41 7.11 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.703 1.601 . . . . 0.0 112.465 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -140.76 137.6 33.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.37 2.268 . . . . 0.0 108.021 167.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.1 142.31 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 0.0 111.312 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.2 m -127.85 128.8 45.86 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.645 1.178 . . . . 0.0 110.436 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.69 120.39 36.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.889 1.675 . . . . 0.0 109.266 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mm -119.14 144.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.375 1.87 . . . . 0.0 107.55 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.99 -153.87 23.0 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -162.22 143.64 10.68 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.204 2.201 . . . . 0.0 111.321 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -156.79 171.76 7.01 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.065 1.346 . . . . 0.0 113.004 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.18 -29.44 14.41 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.316 3.344 . . . . 0.0 113.645 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -156.34 166.48 33.3 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 123.392 1.568 . . . . 0.0 114.11 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.11 -32.16 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.721 1.608 . . . . 0.0 112.709 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.98 72.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.419 0.687 . . . . 0.0 111.903 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.44 67.54 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -39.38 94.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.218 1.407 . . . . 0.0 111.849 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.78 87.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 112.357 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.13 82.26 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.554 -0.716 . . . . 0.0 112.443 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.49 -39.79 81.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.157 0.983 . . . . 0.0 111.564 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -72.23 -33.58 67.67 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.226 -0.922 . . . . 0.0 112.341 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.6 m -63.5 -41.75 98.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.563 0.745 . . . . 0.0 111.149 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.82 78.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.144 0.978 . . . . 0.0 113.343 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.14 -43.52 61.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 111.836 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.65 -25.86 68.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 112.715 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.1 17.46 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.58 2.038 . . . . 0.0 114.409 172.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 7.24 3.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.479 1.112 . . . . 0.0 113.753 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.49 125.63 22.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.174 0.99 . . . . 0.0 110.815 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.4 148.97 40.15 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.022 1.329 . . . . 0.0 111.436 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.04 102.2 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.63 2.887 . . . . 0.0 112.443 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.86 -10.3 7.08 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.741 2.115 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.93 110.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.416 1.108 . . . . 0.0 110.734 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.49 152.48 45.33 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.515 1.526 . . . . 0.0 112.24 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.91 138.33 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.923 1.289 . . . . 0.0 111.993 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 87.1 mt -133.33 140.17 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.186 1.794 . . . . 0.0 108.781 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.31 134.31 41.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.26 1.424 . . . . 0.0 112.568 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -141.61 26.72 1.91 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.427 1.891 . . . . 0.0 113.16 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.76 130.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.596 -1.315 . . . . 0.0 111.154 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -82.4 160.66 22.72 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.028 1.731 . . . . 0.0 112.257 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.93 121.54 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 111.169 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.19 129.22 4.66 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.804 1.641 . . . . 0.0 110.656 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.07 -6.44 19.11 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.378 2.719 . . . . 0.0 114.823 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.84 -10.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.937 1.695 . . . . 0.0 112.603 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.1 144.49 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 128.595 2.758 . . . . 0.0 109.95 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -143.5 155.11 44.25 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.97 2.108 . . . . 0.0 109.548 -170.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -139.5 178.86 6.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.86 169.98 14.65 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.568 1.947 . . . . 0.0 110.177 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.26 158.93 15.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 112.52 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.26 2.32 11.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.559 1.544 . . . . 0.0 112.211 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 m -53.63 -32.39 51.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.163 1.385 . . . . 0.0 112.78 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.6 m -105.24 7.61 33.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.526 1.93 . . . . 0.0 113.674 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.61 56.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.482 1.513 . . . . 0.0 113.655 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -46.82 -48.81 50.42 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.71 1.204 . . . . 0.0 112.738 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 -24.87 38.73 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.888 1.725 . . . . 0.0 113.96 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.9 t -64.88 -45.29 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.329 0.968 . . . . 0.0 110.371 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -71.07 -31.3 67.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.744 0.818 . . . . 0.0 112.789 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.2 m -63.11 -42.58 99.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.907 0.776 . . . . 0.0 111.391 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.29 65.88 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.1 p -102.49 7.12 40.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.196 1.799 . . . . 0.0 115.364 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.7 t -48.62 -44.62 67.87 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.478 -1.389 . . . . 0.0 114.499 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.46 13.62 2.37 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.558 2.172 . . . . 0.0 114.226 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -113.95 92.8 27.03 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.146 1.779 . . . . 0.0 110.445 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.79 -22.78 23.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.454 2.769 . . . . 0.0 115.428 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -100.54 9.34 42.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.353 1.861 . . . . 0.0 113.342 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -52.56 149.31 6.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.023 0.916 . . . . 0.0 112.38 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 164.44 35.52 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.468 1.032 . . . . 0.0 111.772 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.53 146.84 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.68 1.192 . . . . 0.0 109.796 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -138.24 143.03 39.92 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.907 0.883 . . . . 0.0 110.002 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.76 131.96 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.904 0.882 . . . . 0.0 109.46 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.11 156.22 26.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 167.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 46.8 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 129.706 3.202 . . . . 0.0 117.813 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.89 22.98 1.1 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.468 2.307 . . . . 0.0 112.835 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.4 m -143.55 143.82 31.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.942 1.697 . . . . 0.0 112.148 -170.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.8 141.79 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 126.333 1.853 . . . . 0.0 110.53 167.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.3 m -131.17 137.57 49.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.884 1.674 . . . . 0.0 109.62 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.61 127.9 34.01 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.177 1.391 . . . . 0.0 109.23 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 91.1 m -130.69 152.18 50.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.644 1.577 . . . . 0.0 110.229 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.13 -174.66 39.45 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.753 -1.217 . . . . 0.0 114.385 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.5 p -128.17 74.91 1.58 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.105 2.162 . . . . 0.0 112.082 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.79 154.31 93.71 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 -26.36 19.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.624 2.883 . . . . 0.0 114.077 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.3 t -147.99 156.89 43.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.737 2.015 . . . . 0.0 110.423 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 52.3 p -54.0 -31.13 50.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.781 2.033 . . . . 0.0 112.577 168.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.32 -41.92 80.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 112.064 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.85 -43.35 96.42 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.098 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 169' ' ' SER . 12.4 ptmm? -66.91 -35.99 81.26 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.5 1.045 . . . . 0.0 112.272 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.25 -41.92 89.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.356 0.662 . . . . 0.0 112.449 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.48 91.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.735 0.814 . . . . 0.0 112.528 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.87 -42.9 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.375 0.534 . . . . 0.0 110.483 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -62.94 -41.5 99.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.88 1.272 . . . . 0.0 112.437 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -69.96 -37.65 75.86 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.215 1.006 . . . . 0.0 111.198 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.82 99.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.885 0.474 . . . . 0.0 111.385 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.46 88.16 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.58 0.627 . . . . 0.0 112.195 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.8 m -63.64 -39.91 95.53 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.745 -0.597 . . . . 0.0 112.049 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.2 m -67.63 -35.17 78.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 29.7 m -76.58 -38.62 54.6 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.051 0.94 . . . . 0.0 112.428 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -133.28 59.15 39.46 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.089 1.356 . . . . 0.0 113.428 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 -15.05 40.56 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.486 2.791 . . . . 0.0 113.85 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -92.16 0.81 57.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.839 1.655 . . . . 0.0 113.592 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 64.6 mtt -130.59 162.06 30.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.72 . . . . 0.0 112.307 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -70.72 147.34 49.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.16 131.15 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.45 1.5 . . . . 0.0 109.284 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.5 t -126.34 92.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 110.729 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.96 66.57 3.63 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.208 2.203 . . . . 0.0 113.723 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -67.24 -6.46 18.36 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.995 1.718 . . . . 0.0 114.573 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.81 142.1 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.33 1.852 . . . . 0.0 111.272 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 125.569 1.548 . . . . 0.0 110.594 171.588 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 121.553 0.692 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -43.5 157.04 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.536 2.734 . . . . 0.0 114.916 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.6 154.13 28.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.143 1.777 . . . . 0.0 113.628 166.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tp -154.73 152.02 29.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.821 1.648 . . . . 0.0 111.438 -171.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -149.99 131.38 14.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.209 1.404 . . . . 0.0 110.608 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 64.9 mt -135.71 142.86 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.375 1.47 . . . . 0.0 108.524 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.4 p -142.23 150.25 40.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.11 142.72 49.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.626 1.97 . . . . 0.0 110.255 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -141.37 66.19 1.37 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.745 . . . . 0.0 112.242 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.73 -81.18 1.27 Allowed Glycine 0 N--CA 1.477 1.37 0 O-C-N 121.223 -0.923 . . . . 0.0 114.708 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.98 32.71 5.05 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.388 173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.72 141.91 30.7 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.089 2.156 . . . . 0.0 108.967 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.68 142.82 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 111.211 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.6 m -130.2 125.24 34.45 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.982 1.313 . . . . 0.0 110.829 -171.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.71 128.48 55.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.032 1.733 . . . . 0.0 110.015 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.94 144.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.1 1.76 . . . . 0.0 108.443 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.29 -156.54 28.19 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.533 -1.354 . . . . 0.0 116.219 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -164.0 128.71 2.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.215 1.806 . . . . 0.0 112.29 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -143.51 168.02 14.03 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.707 1.603 . . . . 0.0 113.134 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -67.32 -31.81 34.27 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.095 3.197 . . . . 0.0 113.31 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.28 166.85 32.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 123.473 1.606 . . . . 0.0 113.573 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -60.82 -29.86 69.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.418 1.887 . . . . 0.0 113.489 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.27 -29.87 68.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.776 1.23 . . . . 0.0 112.199 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.72 83.16 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.63 -0.669 . . . . 0.0 111.204 173.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.129 1.372 . . . . 0.0 111.785 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.86 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.467 0.707 . . . . 0.0 112.581 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.61 76.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.29 -42.42 93.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.907 1.283 . . . . 0.0 111.543 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.7 ptm -73.11 -32.1 64.74 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.655 -0.653 . . . . 0.0 111.997 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -64.55 -38.55 91.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 111.056 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.25 -35.33 76.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.814 0.845 . . . . 0.0 112.968 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.92 -23.38 22.72 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.63 -29.62 68.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.909 1.284 . . . . 0.0 112.229 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.24 -27.14 52.0 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.813 1.673 . . . . 0.0 115.267 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 12.65 5.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.622 1.569 . . . . 0.0 112.459 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.42 125.46 23.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.729 0.811 . . . . 0.0 110.979 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.58 148.56 46.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.97 1.308 . . . . 0.0 111.079 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.31 102.49 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.496 2.798 . . . . 0.0 112.738 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.48 -8.96 8.28 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.684 2.088 . . . . 0.0 113.713 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.61 114.19 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.506 1.153 . . . . 0.0 111.006 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -69.99 153.63 42.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.783 1.633 . . . . 0.0 112.322 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.45 132.36 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.709 1.204 . . . . 0.0 110.006 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.0 148.59 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.998 1.719 . . . . 0.0 110.396 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.03 130.3 31.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.932 1.693 . . . . 0.0 111.823 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -140.75 28.92 1.93 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.603 2.361 . . . . 0.0 111.127 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.55 119.29 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.632 1.173 . . . . 0.0 109.927 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -73.85 165.51 24.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.388 1.875 . . . . 0.0 112.221 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.6 t -132.39 123.73 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.091 1.356 . . . . 0.0 111.021 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.62 120.78 2.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.468 1.907 . . . . 0.0 110.529 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.68 -6.39 18.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.655 2.237 . . . . 0.0 115.0 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.23 -12.9 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.007 0.923 . . . . 0.0 112.206 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.08 149.01 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.709 1.603 . . . . 0.0 110.52 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -145.21 145.74 31.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.288 1.835 . . . . 0.0 109.153 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -133.42 -179.61 5.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -68.01 -176.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 130.162 3.385 . . . . 0.0 110.866 170.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -123.95 95.11 4.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 112.795 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -73.18 2.31 7.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.9 m -56.46 -36.0 68.56 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.627 -1.296 . . . . 0.0 112.183 172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.8 m -89.5 -2.51 58.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.808 1.643 . . . . 0.0 113.762 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.52 -6.68 52.91 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.511 1.124 . . . . 0.0 113.294 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.72 -48.63 76.49 Favored Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 120.767 -1.208 . . . . 0.0 113.49 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.44 -28.43 32.48 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.584 2.189 . . . . 0.0 114.026 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.26 -46.23 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 0.855 . . . . 0.0 110.753 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.34 -30.57 63.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.578 0.751 . . . . 0.0 112.336 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.6 m -61.17 -44.54 97.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 111.305 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.65 -17.63 64.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 92.2 p -107.75 7.02 28.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 115.286 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -52.42 -47.4 93.31 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 167.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.07 12.46 1.23 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.807 2.338 . . . . 0.0 114.279 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 165' ' ' THR . 13.9 mt -110.59 96.55 28.36 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.746 2.019 . . . . 0.0 109.131 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 -19.54 28.36 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.978 2.452 . . . . 0.0 114.594 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -109.26 11.07 25.56 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.806 2.042 . . . . 0.0 113.843 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.92 155.04 1.91 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.899 1.28 . . . . 0.0 112.983 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.54 164.27 36.15 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.328 0.96 . . . . 0.0 112.196 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.08 145.45 49.37 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.517 1.127 . . . . 0.0 109.317 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -141.32 134.74 29.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.73 0.812 . . . . 0.0 109.924 173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.73 136.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.111 0.564 . . . . 0.0 109.997 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.98 150.45 25.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.787 0.435 . . . . 0.0 112.144 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 39.35 -101.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.569 1.948 . . . . 0.0 112.97 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -117.91 21.31 12.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.489 1.515 . . . . 0.0 112.99 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.2 m -135.61 137.23 41.7 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.086 1.754 . . . . 0.0 112.379 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.4 141.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 126.142 1.777 . . . . 0.0 111.682 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 88.0 m -131.42 136.98 48.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.933 1.693 . . . . 0.0 110.218 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -130.04 133.12 46.52 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.003 1.721 . . . . 0.0 109.471 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 31.7 m -138.88 148.32 43.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.915 1.286 . . . . 0.0 110.753 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.21 -172.0 37.36 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.523 -1.361 . . . . 0.0 114.885 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 148' ' ' ILE . 18.2 p -121.41 89.02 3.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.531 2.732 . . . . 0.0 111.998 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.02 53.94 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 120.695 -1.253 . . . . 0.0 113.73 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.27 -26.63 41.69 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.82 3.013 . . . . 0.0 114.226 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.5 t -147.94 157.04 43.32 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.55 1.94 . . . . 0.0 110.063 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 p -59.58 -20.87 58.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.094 0.958 . . . . 0.0 112.907 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.25 -47.55 83.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.756 1.223 . . . . 0.0 111.775 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -58.37 -42.2 86.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.187 0.595 . . . . 0.0 111.867 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -45.26 94.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.839 0.745 . . . . 0.0 112.203 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -66.21 -39.29 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.267 1.027 . . . . 0.0 111.983 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.75 89.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.703 0.801 . . . . 0.0 112.694 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.96 -38.64 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.702 -0.624 . . . . 0.0 110.914 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.668 0.787 . . . . 0.0 111.716 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -63.6 -40.09 96.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.584 0.754 . . . . 0.0 111.848 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.89 97.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.813 0.445 . . . . 0.0 111.376 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.64 -37.64 88.11 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.675 -0.64 . . . . 0.0 112.119 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.6 m -63.27 -41.29 99.01 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.623 -0.673 . . . . 0.0 111.751 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -65.82 -35.94 82.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.4 -36.91 52.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.077 0.951 . . . . 0.0 112.685 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -133.39 61.13 52.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.411 1.484 . . . . 0.0 113.635 -172.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.26 -9.58 25.65 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.687 2.925 . . . . 0.0 114.338 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -114.47 9.72 16.8 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.63 1.972 . . . . 0.0 113.601 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.6 mtm -126.17 161.13 28.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.437 1.895 . . . . 0.0 111.247 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -71.2 146.49 49.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.833 0.853 . . . . 0.0 110.036 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.6 pt -130.71 143.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.115 0.966 . . . . 0.0 111.381 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.0 t -135.68 121.87 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.596 1.158 . . . . 0.0 110.483 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -112.27 70.43 0.71 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.43 1.892 . . . . 0.0 111.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.1 -5.61 42.67 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.545 1.538 . . . . 0.0 114.336 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 68.8 mt -51.28 140.16 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.087 1.755 . . . . 0.0 111.257 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.727 1.611 . . . . 0.0 110.63 172.155 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.699 0.761 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -39.44 154.39 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 129.896 3.278 . . . . 0.0 117.179 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.12 135.42 39.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.676 1.591 . . . . 0.0 111.105 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD22 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -155.09 146.82 23.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.091 1.356 . . . . 0.0 110.817 -175.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -142.75 142.96 32.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.084 1.753 . . . . 0.0 110.809 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -142.6 136.66 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.989 1.316 . . . . 0.0 109.445 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -138.86 145.76 40.38 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.937 0.895 . . . . 0.0 112.02 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -108.53 150.49 27.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.011 1.324 . . . . 0.0 112.84 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.0 m -137.78 59.77 1.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.694 2.398 . . . . 0.0 111.99 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.03 -92.84 1.05 Allowed Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.018 1.294 . . . . 0.0 112.856 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -113.08 29.85 7.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.814 1.645 . . . . 0.0 112.327 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.32 140.49 30.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.466 2.307 . . . . 0.0 108.44 170.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.01 144.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.696 1.198 . . . . 0.0 111.131 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.7 m -129.56 128.13 42.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.384 1.074 . . . . 0.0 111.607 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.14 126.93 55.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.787 2.035 . . . . 0.0 110.525 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.5 mt -138.16 125.66 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.32 1.448 . . . . 0.0 109.137 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 172.65 -156.75 25.64 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 120.859 -1.151 . . . . 0.0 115.144 -171.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -159.45 146.27 16.69 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.882 2.073 . . . . 0.0 111.355 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -151.86 170.2 8.3 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.965 1.706 . . . . 0.0 111.586 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.31 -31.83 42.75 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.265 3.31 . . . . 0.0 113.537 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.47 165.65 35.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.617 1.675 . . . . 0.0 113.123 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.79 -25.77 68.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.728 2.011 . . . . 0.0 113.958 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.19 63.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.96 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -37.65 67.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.196 0.598 . . . . 0.0 111.836 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -26.54 60.52 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 172.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.5 75.65 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.439 -0.788 . . . . 0.0 112.301 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.0 85.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.914 -1.116 . . . . 0.0 112.282 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.76 -42.57 99.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -30.95 62.45 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.496 -0.752 . . . . 0.0 112.434 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.4 m -65.1 -38.44 90.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.81 1.244 . . . . 0.0 111.308 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.82 72.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.799 1.24 . . . . 0.0 113.182 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.29 -25.23 20.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.46 -30.99 70.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.978 1.311 . . . . 0.0 112.37 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.72 -27.15 55.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.601 1.572 . . . . 0.0 115.254 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 10.4 6.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.793 1.637 . . . . 0.0 112.453 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.59 130.45 46.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.451 1.101 . . . . 0.0 111.372 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.2 147.27 39.98 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.245 1.418 . . . . 0.0 111.108 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.88 102.92 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.593 2.862 . . . . 0.0 112.562 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.04 -10.28 7.43 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.838 2.161 . . . . 0.0 113.793 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.92 115.33 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.339 1.069 . . . . 0.0 110.896 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -73.81 155.02 39.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.009 1.724 . . . . 0.0 112.563 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -135.44 132.92 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.847 1.259 . . . . 0.0 109.851 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.2 mt -126.45 138.36 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.406 1.882 . . . . 0.0 108.855 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.63 132.43 37.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.745 1.218 . . . . 0.0 112.824 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -136.75 18.82 3.06 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.428 2.291 . . . . 0.0 112.315 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.82 132.89 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.689 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -94.49 169.82 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.65 1.58 . . . . 0.0 113.248 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.54 118.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.777 1.631 . . . . 0.0 110.774 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -149.3 123.06 4.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.107 2.163 . . . . 0.0 110.419 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.58 -5.06 15.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.023 2.482 . . . . 0.0 114.544 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.24 -13.28 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.209 1.804 . . . . 0.0 112.468 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.72 149.42 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.091 2.157 . . . . 0.0 109.71 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.38 152.58 48.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.038 2.135 . . . . 0.0 106.495 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.0 m -132.74 175.46 9.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.264 1.393 . . . . 0.0 114.256 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.98 158.18 33.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.692 1.597 . . . . 0.0 109.583 166.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.4 148.12 28.4 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.015 165.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.33 0.26 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.713 1.205 . . . . 0.0 113.052 171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -55.28 -37.86 67.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.205 1.002 . . . . 0.0 111.798 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -92.04 3.08 56.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.066 1.747 . . . . 0.0 113.848 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.72 -3.79 51.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.775 1.63 . . . . 0.0 113.687 172.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.07 -49.16 30.8 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.464 1.105 . . . . 0.0 112.39 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.59 -24.83 55.34 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.75 1.633 . . . . 0.0 113.692 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.6 t -66.2 -46.1 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.131 0.878 . . . . 0.0 110.687 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -73.87 -30.07 62.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.485 0.714 . . . . 0.0 112.57 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.8 m -66.77 -39.73 87.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.074 0.95 . . . . 0.0 111.541 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.17 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.8 p -101.13 7.88 43.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.364 1.866 . . . . 0.0 115.191 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.4 t -47.52 -44.97 56.7 Favored Pre-proline 0 N--CA 1.485 1.312 0 O-C-N 120.391 -1.443 . . . . 0.0 114.554 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.8 13.97 2.18 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.447 2.098 . . . . 0.0 114.089 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.39 91.97 35.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.171 1.788 . . . . 0.0 110.583 -171.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.07 -17.8 31.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.864 3.042 . . . . 0.0 115.879 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.97 16.08 16.16 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.743 2.417 . . . . 0.0 112.519 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -53.94 153.7 4.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.474 1.109 . . . . 0.0 112.74 168.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.17 161.28 33.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.135 1.35 . . . . 0.0 111.672 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tp -131.45 146.3 52.19 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.037 1.335 . . . . 0.0 109.235 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.75 147.62 42.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.126 0.97 . . . . 0.0 110.822 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.78 133.02 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.666 1.186 . . . . 0.0 109.744 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.24 152.8 24.66 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 167.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 42.15 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.585 3.154 . . . . 0.0 117.253 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -141.86 20.54 2.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.602 1.961 . . . . 0.0 113.022 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.6 m -138.3 140.97 39.81 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.029 1.332 . . . . 0.0 112.555 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.55 131.96 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.418 1.887 . . . . 0.0 111.084 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.6 m -123.94 137.74 54.58 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.679 1.592 . . . . 0.0 110.058 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.65 126.57 29.41 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.616 1.166 . . . . 0.0 110.663 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 98.8 m -132.07 150.86 52.05 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.344 1.457 . . . . 0.0 110.455 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.38 -175.13 39.68 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.79 -1.194 . . . . 0.0 114.183 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.0 p -130.13 81.02 1.99 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.208 1.803 . . . . 0.0 112.071 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.9 153.24 95.63 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.231 1.412 . . . . 0.0 114.293 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.99 -34.63 37.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.093 2.529 . . . . 0.0 113.168 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.7 m -144.47 156.02 43.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.65 1.98 . . . . 0.0 110.644 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 p -62.55 -22.86 66.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.222 1.009 . . . . 0.0 113.633 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -63.95 -42.87 97.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.617 1.167 . . . . 0.0 111.462 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -62.97 -40.9 99.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.451 0.569 . . . . 0.0 111.782 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.6 -46.82 87.82 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.474 0.579 . . . . 0.0 112.214 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.76 -37.66 85.05 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.371 0.668 . . . . 0.0 111.944 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.02 89.33 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.624 0.769 . . . . 0.0 112.573 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.03 -42.63 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.737 0.699 . . . . 0.0 110.655 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -42.07 99.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 112.316 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -72.65 -32.76 66.11 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.91 -47.2 78.6 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.22 93.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 t -72.38 -30.09 64.36 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.635 -0.666 . . . . 0.0 112.168 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.3 m -70.06 -38.98 75.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.138 0.975 . . . . 0.0 112.591 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 39.4 m -71.59 -39.33 70.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.684 1.194 . . . . 0.0 112.311 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -129.85 60.5 52.19 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.448 1.499 . . . . 0.0 113.732 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.39 -14.94 34.61 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.435 2.757 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.46 -1.85 58.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.7 1.6 . . . . 0.0 113.892 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -126.12 160.03 31.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 112.071 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -70.49 151.1 45.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.956 0.902 . . . . 0.0 110.406 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.87 135.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.027 0.931 . . . . 0.0 111.526 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 37.0 t -130.59 87.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.408 1.483 . . . . 0.0 109.825 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -72.97 130.89 41.37 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.902 . . . . 0.0 110.93 171.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -137.0 0.15 2.35 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.494 2.318 . . . . 0.0 111.929 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.15 142.7 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.259 1.823 . . . . 0.0 110.073 171.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 125.821 1.648 . . . . 0.0 110.557 172.383 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 121.857 0.837 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -37.38 161.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.353 3.061 . . . . 0.0 114.867 167.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.39 146.5 47.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.855 1.662 . . . . 0.0 114.077 167.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 tt -157.15 155.82 31.64 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.823 1.249 . . . . 0.0 112.195 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 t -139.26 140.01 37.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.93 2.092 . . . . 0.0 110.284 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.25 133.9 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.283 1.433 . . . . 0.0 108.864 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 t -143.29 142.25 31.28 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.251 0.62 . . . . 0.0 112.196 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.34 148.47 28.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.305 1.442 . . . . 0.0 110.897 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -143.7 66.04 1.3 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.541 1.536 . . . . 0.0 112.526 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -90.07 1.46 Allowed Glycine 0 N--CA 1.472 1.07 0 C-N-CA 124.308 0.956 . . . . 0.0 113.106 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -122.22 35.94 4.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.985 1.714 . . . . 0.0 111.729 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.4 m -145.0 145.73 31.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.93 2.492 . . . . 0.0 108.183 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 p -134.75 144.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.814 1.246 . . . . 0.0 110.987 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.4 m -128.78 132.78 47.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.422 1.089 . . . . 0.0 111.739 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 117.8 29.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.566 2.346 . . . . 0.0 109.637 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.37 120.33 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.604 1.162 . . . . 0.0 109.053 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.02 -154.02 17.18 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -170.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -153.27 145.92 24.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.515 2.326 . . . . 0.0 112.651 -170.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -155.94 171.43 7.32 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.641 1.576 . . . . 0.0 112.85 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.47 -30.61 23.35 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.327 3.351 . . . . 0.0 113.705 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -155.49 166.74 32.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.287 1.518 . . . . 0.0 113.16 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.62 -28.91 70.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.927 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.06 75.01 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.63 -37.73 67.93 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.365 0.666 . . . . 0.0 112.427 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -60.11 -45.88 91.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.631 1.172 . . . . 0.0 111.314 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.77 77.88 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.986 1.314 . . . . 0.0 111.956 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.48 92.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.14 -39.66 86.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 111.227 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 78.1 mmm -65.94 -41.55 91.18 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.548 0.739 . . . . 0.0 111.639 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.8 m -61.72 -40.48 95.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.343 1.057 . . . . 0.0 110.857 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.96 -31.44 72.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.686 1.194 . . . . 0.0 113.606 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -93.33 -22.39 18.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.7 -30.46 61.56 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.666 1.587 . . . . 0.0 112.367 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.83 -28.28 52.24 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.686 1.612 . . . . 0.0 114.986 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 9.54 6.44 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.81 1.644 . . . . 0.0 112.768 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.3 129.99 44.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.297 1.039 . . . . 0.0 111.109 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.51 149.11 40.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.201 1.401 . . . . 0.0 111.388 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.9 102.8 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.575 2.85 . . . . 0.0 112.582 -174.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -10.38 7.34 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.795 2.14 . . . . 0.0 113.662 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.34 114.78 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 118.358 1.079 . . . . 0.0 110.889 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -71.25 157.16 38.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.982 1.713 . . . . 0.0 112.734 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.97 140.21 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.557 1.143 . . . . 0.0 112.441 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.18 139.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.745 2.018 . . . . 0.0 108.391 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.31 134.81 34.75 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.87 29.88 1.87 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.179 2.592 . . . . 0.0 111.347 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.25 123.66 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.482 -1.386 . . . . 0.0 110.746 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -90.3 162.75 15.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.931 1.292 . . . . 0.0 112.551 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.7 117.98 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.046 1.339 . . . . 0.0 110.941 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.98 117.14 4.18 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.75 2.02 . . . . 0.0 109.878 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 -5.77 17.8 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.964 2.443 . . . . 0.0 114.953 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.66 -1.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.406 1.482 . . . . 0.0 113.527 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.35 142.48 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 128.899 2.879 . . . . 0.0 109.143 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -136.73 154.78 50.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.522 2.329 . . . . 0.0 108.802 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -136.05 177.28 7.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.746 1.157 . . . . 0.0 114.052 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -72.26 156.99 38.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.161 . . . . 0.0 108.271 167.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.42 152.93 37.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.847 -0.533 . . . . 0.0 111.311 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -122.72 3.07 9.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.463 1.505 . . . . 0.0 111.75 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.2 m -53.5 -37.54 62.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.526 1.13 . . . . 0.0 111.876 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.4 m -96.63 6.1 49.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 113.653 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.66 -6.28 59.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.159 1.384 . . . . 0.0 113.269 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.79 -50.12 44.92 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.026 1.33 . . . . 0.0 112.648 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.51 -24.28 56.63 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 113.738 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.97 -46.97 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.453 1.024 . . . . 0.0 110.649 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -74.32 -28.88 61.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 112.587 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 m -70.25 -41.17 73.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.809 1.244 . . . . 0.0 111.694 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.25 -28.64 68.88 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.312 -0.868 . . . . 0.0 112.649 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.7 p -90.52 0.1 57.46 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -45.6 -46.71 37.14 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 120.779 1.627 . . . . 0.0 115.159 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.51 13.67 1.34 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.727 2.285 . . . . 0.0 114.154 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.12 83.76 12.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.592 1.957 . . . . 0.0 110.188 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.09 -15.86 50.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.452 2.768 . . . . 0.0 115.075 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.89 1.93 27.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.778 2.431 . . . . 0.0 114.34 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -60.07 155.28 17.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.053 -1.029 . . . . 0.0 113.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.36 169.36 37.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.874 1.702 . . . . 0.0 112.995 167.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.19 147.79 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.433 1.893 . . . . 0.0 109.387 177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -136.91 140.26 42.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 109.904 168.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.41 134.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.999 0.92 . . . . 0.0 109.782 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.66 157.67 27.53 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.677 0.791 . . . . 0.0 112.701 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 44.59 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.837 2.455 . . . . 0.0 114.082 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -144.16 33.8 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 119.77 1.168 . . . . 0.0 112.463 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.8 m -133.27 139.14 46.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.75 2.02 . . . . 0.0 111.109 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.35 128.09 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.158 1.783 . . . . 0.0 111.401 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 84.9 m -122.77 134.65 54.42 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.886 1.674 . . . . 0.0 110.03 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.21 124.72 31.2 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.784 1.234 . . . . 0.0 110.174 -171.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.5 m -137.07 123.3 20.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.986 1.314 . . . . 0.0 110.947 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.47 48.28 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.948 1.261 . . . . 0.0 112.926 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.5 p -125.08 81.21 1.94 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 0.0 112.35 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.66 153.96 92.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.2 -31.05 30.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.2 2.6 . . . . 0.0 113.536 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 p -149.27 166.58 28.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.858 1.263 . . . . 0.0 112.804 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.5 p -64.05 -25.06 67.95 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 113.604 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -66.3 -42.16 88.72 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.482 -0.762 . . . . 0.0 111.09 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.32 -41.37 98.9 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.475 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -66.57 -40.54 89.01 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.631 1.105 . . . . 0.0 111.888 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.83 -43.99 97.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.647 1.179 . . . . 0.0 112.382 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.91 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.499 0.72 . . . . 0.0 112.185 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.57 -43.3 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 118.132 0.424 . . . . 0.0 111.243 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -70.02 -36.18 74.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.806 0.73 . . . . 0.0 112.663 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.29 -39.99 81.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.247 1.019 . . . . 0.0 111.571 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.87 95.82 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.08 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.46 87.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.139 0.575 . . . . 0.0 112.395 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.5 m -66.45 -38.1 86.61 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.716 -0.615 . . . . 0.0 111.594 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.8 t -65.27 -38.54 90.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.671 0.788 . . . . 0.0 112.616 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.0 m -73.31 -39.35 65.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.22 1.008 . . . . 0.0 112.764 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -131.96 61.41 57.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.549 1.54 . . . . 0.0 113.815 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.02 -10.95 26.82 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.664 2.909 . . . . 0.0 114.731 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -104.96 -0.93 26.43 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.082 1.753 . . . . 0.0 113.73 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -108.57 160.3 16.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.914 2.086 . . . . 0.0 111.711 -172.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -73.47 147.25 44.3 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.694 -0.628 . . . . 0.0 109.908 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.6 tt -135.04 142.17 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.7 0.8 . . . . 0.0 112.274 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.62 91.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.692 1.597 . . . . 0.0 110.194 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -83.18 74.07 10.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.298 1.839 . . . . 0.0 111.413 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -72.76 -11.54 60.65 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.989 1.315 . . . . 0.0 113.459 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.2 pt -52.04 144.21 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 127.106 2.162 . . . . 0.0 114.531 172.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.936 2.094 . . . . 0.0 111.088 178.811 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 CA--C 1.552 1.029 0 CA-C-O 122.054 0.93 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 t -35.91 162.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 131.114 3.766 . . . . 0.0 114.809 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 150.16 50.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.605 1.562 . . . . 0.0 114.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 tt -160.53 156.73 26.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 111.526 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.3 p -145.22 158.32 43.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 112.653 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -141.67 142.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 108.01 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -139.18 142.69 37.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.321 0.648 . . . . 0.0 111.936 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -112.9 148.28 35.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.777 1.631 . . . . 0.0 111.376 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -134.19 56.64 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.427 2.291 . . . . 0.0 110.438 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.3 -98.82 0.67 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 126.039 1.781 . . . . 0.0 112.365 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -96.38 18.4 14.0 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.406 1.482 . . . . 0.0 113.013 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -137.51 131.87 32.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.818 1.647 . . . . 0.0 108.81 167.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.26 137.8 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.545 1.138 . . . . 0.0 111.253 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -122.66 136.96 55.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.5 1.12 . . . . 0.0 112.6 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.86 121.98 39.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.944 2.098 . . . . 0.0 109.085 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 mt -135.27 133.04 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.02 1.328 . . . . 0.0 108.173 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.96 -146.88 12.28 Favored Glycine 0 N--CA 1.465 0.624 0 O-C-N 120.338 -1.476 . . . . 0.0 115.941 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -153.16 150.77 29.4 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.094 2.557 . . . . 0.0 111.842 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -157.7 170.07 9.56 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 126.026 1.73 . . . . 0.0 110.39 166.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -71.72 -29.96 15.1 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.392 3.395 . . . . 0.0 113.696 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -159.15 166.92 30.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.384 1.564 . . . . 0.0 113.554 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.56 -32.98 70.85 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.676 1.59 . . . . 0.0 112.836 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.97 73.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.818 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.6 60.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.452 0.701 . . . . 0.0 112.339 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.28 -42.03 96.63 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 111.817 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.35 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.684 1.194 . . . . 0.0 111.552 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.04 93.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.8 -39.6 80.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.677 0.791 . . . . 0.0 111.369 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm -65.14 -41.12 95.08 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.741 -0.599 . . . . 0.0 111.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.3 m -62.95 -39.8 95.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 0.0 110.897 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.45 75.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.965 0.906 . . . . 0.0 113.386 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.88 -24.1 21.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -73.04 -29.66 63.16 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.521 1.529 . . . . 0.0 112.337 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.05 52.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.817 1.675 . . . . 0.0 115.077 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 11.1 5.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.456 1.503 . . . . 0.0 112.76 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.75 135.46 56.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.225 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.42 150.27 37.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.814 1.646 . . . . 0.0 111.337 -176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.14 106.28 0.79 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.554 2.836 . . . . 0.0 112.523 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.84 -10.83 10.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.508 2.004 . . . . 0.0 113.75 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.48 118.27 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.345 1.058 . . . . 0.0 110.858 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -75.57 151.1 37.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 112.376 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -136.76 132.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.259 1.424 . . . . 0.0 109.454 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.7 mt -126.62 139.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.736 1.614 . . . . 0.0 109.451 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -132.57 128.16 36.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.43 1.492 . . . . 0.0 111.832 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -136.63 19.97 3.1 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.264 2.225 . . . . 0.0 112.147 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.1 mt -70.87 134.21 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 112.322 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -80.68 160.33 25.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.978 2.111 . . . . 0.0 112.721 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.5 t -131.62 119.16 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.161 1.384 . . . . 0.0 110.95 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.47 110.94 2.41 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.577 1.551 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.71 -6.07 16.98 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.987 2.458 . . . . 0.0 114.812 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.14 -16.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.938 0.895 . . . . 0.0 112.266 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 m -122.59 139.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.583 2.353 . . . . 0.0 110.203 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -128.37 155.54 44.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.273 1.829 . . . . 0.0 109.068 -170.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -139.08 179.79 6.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.09 176.22 2.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.451 1.9 . . . . 0.0 111.922 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -128.93 98.71 5.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 111.054 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.18 9.16 3.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.875 1.27 . . . . 0.0 113.022 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 67.4 m -51.93 -25.09 7.39 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.787 -1.195 . . . . 0.0 113.57 167.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 m -106.94 3.28 25.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.021 2.128 . . . . 0.0 113.818 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.09 -6.11 59.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.373 1.469 . . . . 0.0 113.657 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.21 -48.75 79.23 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.644 1.178 . . . . 0.0 113.2 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -23.6 44.27 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.792 1.661 . . . . 0.0 113.474 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.41 -46.34 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.925 0.784 . . . . 0.0 110.413 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -67.7 -35.47 78.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.999 0.52 . . . . 0.0 111.997 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.0 m -60.69 -44.52 96.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.074 0.949 . . . . 0.0 111.478 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.77 -26.56 67.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.268 0.627 . . . . 0.0 112.636 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.2 m -90.44 0.14 57.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.949 2.1 . . . . 0.0 115.576 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -52.89 -49.27 87.88 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-N 120.423 1.465 . . . . 0.0 114.001 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -84.26 18.39 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.009 2.473 . . . . 0.0 113.465 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mt -110.06 80.43 1.81 Allowed Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 127.014 2.126 . . . . 0.0 107.856 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.88 -21.39 50.48 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.035 2.49 . . . . 0.0 114.557 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -94.57 6.16 49.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.62 1.968 . . . . 0.0 113.509 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -54.81 153.77 5.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.731 1.213 . . . . 0.0 113.844 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.04 164.87 38.01 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.595 1.569 . . . . 0.0 110.768 167.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.46 164.16 30.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.693 -0.886 . . . . 0.0 112.976 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -138.02 152.52 48.94 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.458 1.503 . . . . 0.0 110.374 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 t -144.77 130.24 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.179 1.392 . . . . 0.0 108.682 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 143.75 20.68 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.083 -0.386 . . . . 0.0 112.014 167.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 42.39 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.124 2.17 . . . . 0.0 114.623 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -122.12 17.0 10.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.504 1.922 . . . . 0.0 113.364 -171.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 61.1 m -138.8 144.45 39.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.272 1.829 . . . . 0.0 112.485 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.66 132.56 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.229 2.212 . . . . 0.0 109.481 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 m -122.26 136.94 54.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 110.25 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mp -136.07 127.64 28.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.319 1.047 . . . . 0.0 110.093 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.0 m -136.14 151.85 50.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.616 1.566 . . . . 0.0 110.489 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.17 -176.41 42.09 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.261 -1.524 . . . . 0.0 113.907 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.2 m -132.78 112.71 12.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.928 1.291 . . . . 0.0 110.005 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.83 159.6 29.11 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.72 2.008 . . . . 0.0 113.67 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.47 -33.24 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.455 2.77 . . . . 0.0 113.143 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 55.2 m -144.68 155.41 43.57 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.491 1.916 . . . . 0.0 111.072 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 p -57.7 -27.6 63.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 113.088 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.42 -42.29 98.73 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.988 1.315 . . . . 0.0 111.624 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -62.56 -43.19 99.43 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.949 0.5 . . . . 0.0 111.912 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -62.72 -42.13 99.5 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.4 -41.19 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.263 1.425 . . . . 0.0 112.036 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.32 89.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.418 0.687 . . . . 0.0 112.054 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.41 -41.03 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 118.298 0.499 . . . . 0.0 111.115 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.14 -42.89 99.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.442 0.697 . . . . 0.0 111.967 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -66.17 -40.43 90.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.355 1.062 . . . . 0.0 111.569 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.36 97.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.002 0.521 . . . . 0.0 111.393 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.42 90.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.066 0.546 . . . . 0.0 111.974 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.0 m -63.43 -40.17 96.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.497 -0.752 . . . . 0.0 111.849 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.2 m -66.37 -35.81 81.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 35.7 m -77.52 -34.59 53.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.03 0.932 . . . . 0.0 112.668 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -126.87 59.64 36.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 0.0 113.553 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.85 -3.65 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.329 2.686 . . . . 0.0 114.834 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.84 20.22 4.6 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.708 2.003 . . . . 0.0 112.606 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.1 ttt -141.99 149.55 40.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.851 1.66 . . . . 0.0 109.976 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -70.42 141.34 52.13 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.146 -0.971 . . . . 0.0 111.142 -171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.65 138.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.545 1.538 . . . . 0.0 110.338 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.86 79.3 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.515 1.926 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -75.34 130.87 39.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.251 -0.906 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.36 5.35 3.76 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.389 2.276 . . . . 0.0 112.173 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 27.6 mt -56.6 143.45 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.835 1.654 . . . . 0.0 110.72 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 125.898 1.679 . . . . 0.0 111.44 176.59 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 122.004 0.907 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 t -36.92 158.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.0 2.92 . . . . 0.0 115.126 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.1 147.7 43.04 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.096 1.758 . . . . 0.0 114.285 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -155.99 153.54 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.976 1.71 . . . . 0.0 111.6 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -137.61 147.68 45.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.367 1.867 . . . . 0.0 111.158 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.46 138.47 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.344 1.857 . . . . 0.0 108.792 169.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 t -147.92 139.56 23.82 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.452 -0.78 . . . . 0.0 112.067 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -109.97 148.07 32.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.4 m -134.93 60.09 1.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.631 2.372 . . . . 0.0 110.948 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.36 -91.71 1.37 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.807 1.194 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -116.74 27.71 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.876 1.67 . . . . 0.0 112.8 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -140.29 131.7 26.84 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.264 1.826 . . . . 0.0 108.61 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.6 138.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 111.226 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -119.41 143.99 47.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.323 1.049 . . . . 0.0 112.252 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.51 110.76 14.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.671 2.388 . . . . 0.0 108.924 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.0 120.32 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.266 1.426 . . . . 0.0 108.679 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.77 -152.88 21.25 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.184 -0.947 . . . . 0.0 114.223 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.78 160.15 43.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.032 2.133 . . . . 0.0 111.895 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HD1' ' HG ' ' A' ' 132' ' ' SER . 9.0 m-85 -157.06 171.63 7.2 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 126.225 1.81 . . . . 0.0 112.227 171.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -65.32 -31.46 52.68 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.547 2.831 . . . . 0.0 114.09 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -157.23 168.6 26.93 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.126 1.441 . . . . 0.0 114.002 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.28 -29.06 70.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.568 1.547 . . . . 0.0 113.182 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.71 70.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.725 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.96 65.42 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -61.17 -40.96 95.83 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.172 -0.955 . . . . 0.0 111.817 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.2 78.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.144 0.978 . . . . 0.0 111.323 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.8 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.15 -46.14 82.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.721 0.691 . . . . 0.0 111.53 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.4 mmm -65.13 -39.88 93.68 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.671 0.788 . . . . 0.0 111.167 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.0 m -63.03 -41.5 99.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.062 0.945 . . . . 0.0 110.658 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.21 -29.28 68.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -92.37 -23.99 19.04 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.67 -32.09 73.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.695 1.598 . . . . 0.0 112.246 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.68 -29.4 49.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.841 1.686 . . . . 0.0 115.139 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.52 15.3 4.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.23 1.412 . . . . 0.0 112.524 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.82 127.21 31.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.68 0.792 . . . . 0.0 111.202 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.97 149.12 38.3 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.874 1.27 . . . . 0.0 111.155 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.29 103.7 0.81 Allowed 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.625 2.883 . . . . 0.0 112.602 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.64 -8.31 10.15 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.421 1.962 . . . . 0.0 113.596 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.88 112.1 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.425 1.113 . . . . 0.0 110.595 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.55 149.29 48.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.209 1.404 . . . . 0.0 111.728 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.4 t -135.51 127.72 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.007 1.323 . . . . 0.0 109.385 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.28 103.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.118 1.367 . . . . 0.0 109.036 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -85.22 123.4 30.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.271 1.028 . . . . 0.0 111.098 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.54 20.41 3.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.896 2.479 . . . . 0.0 111.03 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.27 122.85 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.154 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -80.9 168.73 18.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.204 1.802 . . . . 0.0 112.519 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.99 125.91 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 111.525 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.12 112.28 3.07 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.82 1.648 . . . . 0.0 110.305 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.62 -4.92 15.59 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.59 2.86 . . . . 0.0 114.607 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.05 -1.87 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.491 1.516 . . . . 0.0 113.477 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.77 154.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 128.257 2.623 . . . . 0.0 108.935 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.031 1.332 . . . . 0.0 108.116 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.414 ' HG ' ' HD1' ' A' ' 97' ' ' PHE . 1.2 m -141.71 171.25 14.32 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 178.5 7.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.013 2.125 . . . . 0.0 109.752 165.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.65 168.42 11.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.578 1.551 . . . . 0.0 113.769 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.37 13.78 8.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.131 2.172 . . . . 0.0 112.138 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -56.93 -30.4 63.96 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.697 -1.252 . . . . 0.0 113.384 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -102.86 1.65 34.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 0.0 113.663 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.73 -5.72 58.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.73 1.212 . . . . 0.0 113.787 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -48.78 -50.4 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 O-C-N 121.035 -1.04 . . . . 0.0 113.226 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 -24.55 41.21 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.495 2.13 . . . . 0.0 114.113 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.84 -45.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.569 1.077 . . . . 0.0 110.497 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.42 -33.53 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.223 0.609 . . . . 0.0 112.496 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.8 m -61.05 -43.12 99.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.126 0.875 . . . . 0.0 111.352 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.55 66.08 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.992 0.917 . . . . 0.0 113.448 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -106.45 7.68 31.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.573 1.949 . . . . 0.0 115.236 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.11 -44.97 88.59 Favored Pre-proline 0 N--CA 1.482 1.136 0 O-C-N 120.457 -1.402 . . . . 0.0 113.758 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.81 15.44 1.47 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.826 2.351 . . . . 0.0 113.942 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.478 ' CG2' ' H ' ' A' ' 165' ' ' THR . 13.6 mt -119.41 91.6 44.52 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 126.181 1.792 . . . . 0.0 110.63 -171.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.38 -20.88 31.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.963 2.442 . . . . 0.0 114.821 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.62 1.83 46.71 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.353 1.861 . . . . 0.0 113.819 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.3 149.7 9.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.667 1.187 . . . . 0.0 113.606 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.86 162.91 34.43 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.205 1.384 . . . . 0.0 111.772 167.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.5 tt -141.5 145.04 34.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.953 1.301 . . . . 0.0 108.949 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -140.28 149.75 43.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.981 1.312 . . . . 0.0 111.578 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.71 136.41 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.006 1.322 . . . . 0.0 110.82 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.55 152.84 18.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.536 1.134 . . . . 0.0 111.579 166.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 49.06 -69.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 129.798 3.239 . . . . 0.0 117.424 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.24 15.31 0.91 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.811 2.444 . . . . 0.0 113.658 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -139.66 155.9 47.13 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.136 -1.602 . . . . 0.0 114.276 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.33 110.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.603 1.961 . . . . 0.0 110.438 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.5 m -94.91 138.85 32.12 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.184 1.394 . . . . 0.0 110.708 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.09 124.72 35.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.641 1.576 . . . . 0.0 109.037 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.3 m -129.63 145.12 51.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.893 1.677 . . . . 0.0 110.447 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.7 -172.09 42.41 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 120.764 -1.21 . . . . 0.0 113.93 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.478 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 22.5 p -124.74 71.52 1.17 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.298 2.239 . . . . 0.0 112.908 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.2 149.27 97.17 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.1 -27.07 30.03 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.652 2.901 . . . . 0.0 114.15 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.2 t -148.38 156.87 43.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.465 1.906 . . . . 0.0 110.276 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 62.0 p -58.82 -20.93 54.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.086 0.954 . . . . 0.0 113.205 167.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.91 -47.33 81.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.81 1.244 . . . . 0.0 111.747 170.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -60.2 -40.1 88.85 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.268 0.627 . . . . 0.0 112.032 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.52 -46.27 90.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 0.0 112.256 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.91 -41.67 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.468 0.707 . . . . 0.0 112.092 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.91 95.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 112.407 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.72 -41.78 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.051 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.12 -45.22 93.02 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 111.872 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -69.13 -36.42 77.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.405 0.682 . . . . 0.0 111.351 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.33 86.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.047 0.539 . . . . 0.0 112.062 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.72 94.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.789 0.722 . . . . 0.0 111.907 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 85.7 m -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.688 -0.633 . . . . 0.0 111.933 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 73.7 m -66.68 -35.56 80.44 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.4 m -75.96 -36.92 59.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 112.728 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.01 59.5 45.59 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.305 1.442 . . . . 0.0 113.013 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.64 -5.16 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.175 . . . . 0.0 115.603 -171.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.5 14.79 8.22 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.141 1.777 . . . . 0.0 112.997 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.1 mtm -133.3 164.76 26.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.617 1.967 . . . . 0.0 110.207 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -76.96 152.75 35.13 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.348 -0.845 . . . . 0.0 111.741 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.99 136.93 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.099 1.36 . . . . 0.0 109.418 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.1 t -126.1 89.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.985 1.314 . . . . 0.0 109.618 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.95 65.57 1.44 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.674 2.39 . . . . 0.0 112.337 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -71.12 5.46 2.1 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.347 2.259 . . . . 0.0 114.387 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.1 mm -50.96 143.7 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.416 1.886 . . . . 0.0 111.301 171.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 125.879 1.672 . . . . 0.0 110.268 168.085 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 122.191 0.996 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.17 157.35 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 129.89 3.276 . . . . 0.0 114.981 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 tt -95.28 129.86 42.25 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.601 1.561 . . . . 0.0 110.777 167.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -153.79 140.98 19.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.235 1.014 . . . . 0.0 109.182 -175.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.429 ' N ' HD13 ' A' ' 82' ' ' LEU . 88.3 p -146.49 160.44 42.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 123.209 1.48 . . . . 0.0 113.371 172.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 tt -144.64 144.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.067 1.347 . . . . 0.0 109.715 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 t -142.58 141.16 31.94 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.011 0.524 . . . . 0.0 111.899 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -108.4 148.66 29.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.462 1.505 . . . . 0.0 112.141 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.3 m -137.18 60.29 1.65 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.037 2.135 . . . . 0.0 111.509 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.28 -89.06 1.38 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.545 1.069 . . . . 0.0 113.135 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -121.22 29.75 7.15 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.063 1.745 . . . . 0.0 112.099 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 96.6 m -141.02 136.29 31.95 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.998 2.119 . . . . 0.0 108.113 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.32 143.0 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.338 1.055 . . . . 0.0 111.418 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.0 m -126.78 126.11 42.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.216 1.006 . . . . 0.0 111.507 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.84 129.97 49.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.16 2.184 . . . . 0.0 110.379 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.26 144.07 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.077 1.351 . . . . 0.0 109.122 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 152.51 -147.77 17.86 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 119.964 -1.71 . . . . 0.0 115.466 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -154.41 143.56 21.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.326 2.65 . . . . 0.0 110.923 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -152.51 170.72 7.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.775 1.23 . . . . 0.0 112.426 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.71 -29.32 10.75 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.808 3.005 . . . . 0.0 114.287 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -159.57 172.08 18.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.356 1.55 . . . . 0.0 114.836 -171.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.41 -34.22 73.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.277 1.831 . . . . 0.0 112.985 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.66 71.16 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.074 0.55 . . . . 0.0 111.547 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.74 75.76 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.974 0.509 . . . . 0.0 112.274 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -63.19 -41.88 99.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.582 0.753 . . . . 0.0 111.804 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.62 84.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.388 0.675 . . . . 0.0 112.451 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.89 76.26 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.653 -0.654 . . . . 0.0 112.713 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.2 -40.58 90.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.652 1.181 . . . . 0.0 111.321 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -73.82 -32.46 63.71 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.746 -0.596 . . . . 0.0 112.109 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -65.48 -39.22 91.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.027 0.931 . . . . 0.0 110.98 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.15 79.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.978 0.911 . . . . 0.0 113.119 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.9 -24.83 24.7 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.92 -28.24 67.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.676 1.59 . . . . 0.0 112.203 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -53.7 -28.16 37.46 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.792 2.139 . . . . 0.0 115.388 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 146' ' ' VAL . 0.9 OUTLIER -135.32 15.15 3.48 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 113.598 174.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -55.9 127.38 30.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.93 0.892 . . . . 0.0 111.267 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.39 149.26 44.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.157 1.383 . . . . 0.0 111.176 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.87 102.76 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.529 2.819 . . . . 0.0 112.665 -174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.4 -8.7 8.36 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.742 2.115 . . . . 0.0 113.852 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.57 113.83 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.477 1.139 . . . . 0.0 111.055 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -73.68 153.14 40.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.906 1.682 . . . . 0.0 112.267 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.63 133.64 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.706 1.203 . . . . 0.0 109.846 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.0 mt -128.66 141.27 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.266 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -130.06 128.49 42.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.887 1.275 . . . . 0.0 112.766 -171.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.8 17.96 3.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.339 2.256 . . . . 0.0 112.73 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.81 130.77 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.811 1.244 . . . . 0.0 110.954 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -86.6 164.11 17.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.922 1.689 . . . . 0.0 112.373 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.85 120.79 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.118 1.367 . . . . 0.0 111.657 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.07 130.46 5.27 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.346 1.859 . . . . 0.0 110.156 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.27 -4.68 15.42 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.775 2.983 . . . . 0.0 114.691 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -15.14 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 126.002 1.721 . . . . 0.0 112.58 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.98 145.43 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 128.022 2.529 . . . . 0.0 110.491 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -141.68 150.85 42.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.282 1.833 . . . . 0.0 109.013 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -126.21 168.22 14.37 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.871 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -69.69 155.45 40.49 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.814 2.846 . . . . 0.0 108.586 167.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.35 88.19 7.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.379 1.072 . . . . 0.0 113.373 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -61.58 -8.65 4.62 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.717 -1.24 . . . . 0.0 113.55 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 m -49.17 -29.5 5.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.085 1.754 . . . . 0.0 112.506 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 m -108.97 2.33 21.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.63 2.372 . . . . 0.0 113.488 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.42 -2.96 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.852 1.661 . . . . 0.0 113.647 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.45 -47.66 83.17 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.761 1.224 . . . . 0.0 113.187 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.51 -27.01 46.71 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.807 1.671 . . . . 0.0 113.632 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.93 -45.32 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.948 0.795 . . . . 0.0 110.775 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -74.49 -30.11 61.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.152 0.581 . . . . 0.0 112.398 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -62.42 -44.2 97.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.481 1.112 . . . . 0.0 111.408 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.79 -17.0 64.66 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -112.95 3.06 16.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.523 1.929 . . . . 0.0 115.542 -177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 113' ' ' LEU . 91.3 t -53.62 -40.37 80.02 Favored Pre-proline 0 N--CA 1.481 1.096 0 O-C-N 120.132 -1.605 . . . . 0.0 113.858 167.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.41 14.25 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.68 2.254 . . . . 0.0 114.065 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.1 mt -120.69 84.34 37.09 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.964 2.106 . . . . 0.0 109.308 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.45 -17.79 58.36 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.44 2.76 . . . . 0.0 115.297 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -105.77 5.54 30.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.423 2.289 . . . . 0.0 113.913 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -56.53 152.28 12.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.252 1.025 . . . . 0.0 113.251 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.57 35.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.654 1.597 . . . . 0.0 112.356 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.62 150.35 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.296 1.438 . . . . 0.0 109.584 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -139.21 142.3 37.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.479 1.112 . . . . 0.0 109.089 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.6 t -143.45 128.45 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.713 1.205 . . . . 0.0 109.063 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.45 155.03 29.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 36.54 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.058 2.543 . . . . 0.0 114.971 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.1 15.32 8.46 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.841 2.056 . . . . 0.0 113.171 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -139.43 145.1 38.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.616 1.566 . . . . 0.0 112.609 -171.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.25 141.09 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.429 1.892 . . . . 0.0 110.257 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.3 m -132.49 135.08 45.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 109.6 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.85 125.36 33.42 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.192 1.397 . . . . 0.0 109.564 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.9 m -134.86 131.21 37.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.888 1.275 . . . . 0.0 110.244 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.99 -174.47 45.32 Favored Glycine 0 CA--C 1.538 1.473 0 O-C-N 120.879 -1.138 . . . . 0.0 112.882 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -126.88 80.51 1.95 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.954 1.702 . . . . 0.0 113.726 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.74 153.87 90.01 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.763 1.625 . . . . 0.0 114.751 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -25.54 16.04 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 114.634 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.8 t -153.29 157.53 40.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.33 1.852 . . . . 0.0 110.71 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 p -59.64 -24.08 63.56 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.289 1.036 . . . . 0.0 113.41 169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.65 -44.07 87.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.546 1.138 . . . . 0.0 111.32 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -61.95 -39.68 92.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.232 0.613 . . . . 0.0 111.992 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -60.54 -43.34 97.31 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.183 0.901 . . . . 0.0 112.716 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.39 -43.51 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.368 0.667 . . . . 0.0 112.11 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.65 84.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.75 0.82 . . . . 0.0 112.195 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.3 -39.62 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.408 0.549 . . . . 0.0 110.836 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -64.33 -43.61 94.08 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.678 0.672 . . . . 0.0 111.737 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -67.59 -37.15 82.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.956 0.903 . . . . 0.0 112.136 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.84 83.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.809 0.444 . . . . 0.0 110.869 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.44 -37.56 87.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.931 0.492 . . . . 0.0 112.044 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.4 m -68.84 -36.64 78.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.652 0.781 . . . . 0.0 111.734 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 t -68.05 -38.69 82.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.185 0.994 . . . . 0.0 112.376 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 41.9 m -72.86 -40.02 66.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.093 0.957 . . . . 0.0 112.339 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -129.77 61.1 56.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.411 1.484 . . . . 0.0 113.906 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.63 -13.14 32.23 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.221 2.614 . . . . 0.0 113.154 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -98.9 3.17 47.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.818 2.047 . . . . 0.0 113.483 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -133.86 164.32 27.52 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.344 1.857 . . . . 0.0 111.691 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -76.65 150.78 36.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.529 0.732 . . . . 0.0 110.808 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.54 133.51 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.271 1.429 . . . . 0.0 109.92 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.75 84.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.891 1.676 . . . . 0.0 109.486 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.18 70.34 3.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.622 1.569 . . . . 0.0 111.48 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -68.3 -9.61 48.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.799 2.04 . . . . 0.0 114.251 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.4 pt -58.12 156.09 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.268 1.427 . . . . 0.0 112.861 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 . . . . . 0 C--N 1.33 -0.254 0 C-N-CA 124.782 1.233 . . . . 0.0 110.968 168.619 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.887 0.851 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.96 151.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.544 2.738 . . . . 0.0 114.199 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.58 129.03 54.58 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.378 1.871 . . . . 0.0 111.643 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -154.06 154.93 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.565 1.146 . . . . 0.0 112.447 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -138.03 145.99 42.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.985 2.114 . . . . 0.0 110.787 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 tt -140.24 139.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.25 1.42 . . . . 0.0 109.153 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 t -146.8 143.49 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -105.02 148.12 27.09 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.657 1.583 . . . . 0.0 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.3 m -135.17 63.58 1.61 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.484 2.314 . . . . 0.0 111.407 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 -88.71 1.26 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.745 1.164 . . . . 0.0 113.058 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -122.53 34.15 5.23 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.063 1.745 . . . . 0.0 111.871 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.7 m -143.68 140.7 30.18 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.563 2.345 . . . . 0.0 108.239 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.24 143.97 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.381 1.073 . . . . 0.0 111.316 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.5 m -127.11 130.44 49.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.352 1.061 . . . . 0.0 111.562 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 122.75 47.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.21 2.204 . . . . 0.0 110.123 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.87 116.75 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.575 1.15 . . . . 0.0 109.313 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.77 -161.02 32.25 Favored Glycine 0 CA--C 1.525 0.719 0 O-C-N 120.502 -1.374 . . . . 0.0 114.727 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.14 142.21 24.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.073 2.149 . . . . 0.0 111.331 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -152.44 169.77 9.07 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.285 1.434 . . . . 0.0 112.749 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.26 -25.51 11.4 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.845 3.03 . . . . 0.0 114.179 174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -155.54 164.22 38.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.688 1.595 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -66.36 -26.35 67.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.615 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -29.94 69.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.457 0.703 . . . . 0.0 112.005 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.24 75.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.325 0.65 . . . . 0.0 112.606 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.9 -42.3 99.74 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.629 1.172 . . . . 0.0 111.371 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.74 82.71 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.745 0.818 . . . . 0.0 111.767 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.22 91.74 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.35 -39.4 89.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 111.754 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.21 -38.68 82.19 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.325 -0.86 . . . . 0.0 112.097 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -63.32 -40.94 98.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.442 1.097 . . . . 0.0 110.981 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -33.74 76.23 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.254 1.021 . . . . 0.0 112.978 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.52 -26.8 24.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.29 -27.73 66.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.806 1.642 . . . . 0.0 112.355 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.75 -29.26 25.5 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.918 2.199 . . . . 0.0 115.306 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.1 16.76 2.81 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.343 1.057 . . . . 0.0 113.523 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -56.28 133.39 52.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.86 0.864 . . . . 0.0 111.477 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.06 34.0 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.291 1.436 . . . . 0.0 111.216 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 103.21 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.578 2.852 . . . . 0.0 112.393 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.6 -9.94 6.82 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.607 2.051 . . . . 0.0 113.783 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.83 112.91 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 118.553 1.177 . . . . 0.0 110.795 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.98 158.46 36.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.866 1.667 . . . . 0.0 112.592 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -136.62 133.2 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.104 1.361 . . . . 0.0 109.807 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.8 139.48 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.191 1.797 . . . . 0.0 108.971 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -127.59 126.13 41.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 113.16 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -137.35 23.53 2.97 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.761 2.424 . . . . 0.0 111.684 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.6 144.98 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 120.768 -1.207 . . . . 0.0 111.22 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -116.2 161.66 18.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.17 1.788 . . . . 0.0 111.903 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -131.3 120.72 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.358 1.463 . . . . 0.0 111.765 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.42 129.75 4.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.608 1.963 . . . . 0.0 110.167 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.49 -3.23 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.085 3.19 . . . . 0.0 115.039 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.5 t -66.13 -19.25 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.714 2.006 . . . . 0.0 112.505 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.26 139.67 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 127.485 2.314 . . . . 0.0 109.824 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -144.98 146.83 32.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.429 1.892 . . . . 0.0 108.982 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.08 -179.82 6.0 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.68 174.64 1.31 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.682 2.393 . . . . 0.0 110.816 166.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.66 155.89 17.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.795 1.238 . . . . 0.0 112.056 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.75 0.26 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.122 1.369 . . . . 0.0 113.264 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.4 m -56.74 -40.11 75.14 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.105 -0.997 . . . . 0.0 111.699 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.1 m -83.28 -7.33 59.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.589 1.556 . . . . 0.0 114.167 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.84 -1.65 54.58 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.815 1.646 . . . . 0.0 114.32 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -45.58 -47.92 37.22 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.391 1.076 . . . . 0.0 113.132 169.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -24.22 54.63 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.125 1.884 . . . . 0.0 113.94 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.9 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.193 0.906 . . . . 0.0 110.813 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.94 -37.89 76.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.748 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.4 m -58.42 -41.35 84.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.64 -12.16 61.01 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 m -117.21 -5.46 11.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.622 1.969 . . . . 0.0 115.839 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.69 -40.82 80.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-N 121.867 2.121 . . . . 0.0 115.739 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.42 -8.32 23.08 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 CA-C-N 122.688 1.996 . . . . 0.0 114.373 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.419 ' CG2' ' H ' ' A' ' 165' ' ' THR . 24.8 mt -83.3 119.21 73.62 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.351 1.46 . . . . 0.0 110.934 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.87 -24.61 9.81 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.78 2.32 . . . . 0.0 115.39 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -113.47 8.5 17.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.402 1.881 . . . . 0.0 114.001 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -56.44 148.1 20.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.745 0.818 . . . . 0.0 112.934 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.32 166.72 39.01 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.532 1.063 . . . . 0.0 112.414 171.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.56 150.93 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.174 1.389 . . . . 0.0 110.3 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.57 145.51 47.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.365 1.066 . . . . 0.0 110.256 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.55 129.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.882 1.273 . . . . 0.0 108.672 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -159.61 158.92 32.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.329 0.652 . . . . 0.0 112.364 170.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 43.82 -89.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.556 2.342 . . . . 0.0 114.194 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.93 24.86 3.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.769 2.028 . . . . 0.0 111.727 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 20.2 m -135.74 142.3 44.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.803 1.641 . . . . 0.0 112.327 -171.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.14 129.32 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.544 1.938 . . . . 0.0 110.547 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 m -125.64 137.28 53.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.385 1.474 . . . . 0.0 110.666 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.2 125.53 31.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.354 1.462 . . . . 0.0 109.877 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 m -132.78 152.9 51.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.745 1.618 . . . . 0.0 110.416 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.05 -167.02 37.22 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 120.741 -1.224 . . . . 0.0 114.568 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.419 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 21.4 p -136.03 70.62 1.42 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.733 2.013 . . . . 0.0 112.861 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.19 153.14 95.47 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.6 1.56 . . . . 0.0 114.94 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.94 -27.87 20.29 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.608 2.872 . . . . 0.0 114.323 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.2 t -151.55 156.68 41.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.046 1.739 . . . . 0.0 111.139 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.1 m -58.33 -21.4 49.33 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.488 1.115 . . . . 0.0 113.409 167.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.44 -46.77 87.02 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.216 1.006 . . . . 0.0 111.614 170.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -59.77 -42.19 92.75 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.173 0.589 . . . . 0.0 111.791 170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -62.18 -44.59 96.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.835 0.743 . . . . 0.0 112.685 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.72 -42.15 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 111.82 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.63 -40.93 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.14 0.576 . . . . 0.0 111.059 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -64.87 -41.5 95.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.292 1.037 . . . . 0.0 111.846 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -69.23 -34.84 75.45 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.561 1.144 . . . . 0.0 112.521 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.94 83.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 117.929 0.331 . . . . 0.0 111.199 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.76 92.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.99 0.916 . . . . 0.0 112.513 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 t -74.4 -28.24 61.0 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.723 -0.611 . . . . 0.0 112.158 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -39.42 71.7 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.857 0.863 . . . . 0.0 112.81 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 183' ' ' TRP . 11.1 t -79.58 -31.68 41.86 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.646 ' CD2' HG23 ' A' ' 182' ' ' THR . 2.7 m-90 -128.91 60.51 50.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.355 1.462 . . . . 0.0 114.029 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.58 -14.6 30.51 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.352 2.702 . . . . 0.0 114.859 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -95.72 -8.55 34.24 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.241 1.016 . . . . 0.0 113.453 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 98.7 mtp -106.43 160.77 15.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 112.507 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -67.35 142.85 56.65 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.466 0.706 . . . . 0.0 109.484 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.63 127.35 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 110.243 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.54 97.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.496 1.118 . . . . 0.0 110.767 -171.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -75.72 123.04 24.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.309 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -129.14 5.68 5.33 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.825 2.45 . . . . 0.0 111.6 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.0 mt -61.99 142.05 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.901 1.68 . . . . 0.0 110.529 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 127.276 2.231 . . . . 0.0 110.261 178.4 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 42.11 54.73 4.05 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.772 2.029 . . . . 0.0 115.088 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 t -151.17 168.3 25.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.091 1.357 . . . . 0.0 112.575 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 150.26 31.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.994 1.718 . . . . 0.0 110.98 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.56 174.62 10.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.207 2.203 . . . . 0.0 110.789 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -139.05 45.94 1.97 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.894 1.278 . . . . 0.0 112.753 -171.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.52 169.07 1.87 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.21 1.804 . . . . 0.0 113.924 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.43 163.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 129.728 3.211 . . . . 0.0 114.058 167.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.8 138.72 45.77 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.679 1.591 . . . . 0.0 112.331 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD21 ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -155.62 148.47 24.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.42 1.488 . . . . 0.0 110.507 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.6 p -151.38 159.51 44.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.195 1.474 . . . . 0.0 113.387 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.81 141.67 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.337 1.855 . . . . 0.0 108.781 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.6 p -143.36 146.66 33.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.573 0.749 . . . . 0.0 112.461 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -112.93 149.0 33.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.647 1.579 . . . . 0.0 111.833 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.5 m -136.3 58.2 1.75 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.336 2.254 . . . . 0.0 111.222 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.06 -86.92 1.18 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.572 1.082 . . . . 0.0 113.434 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -120.56 30.12 7.09 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.26 1.824 . . . . 0.0 112.245 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -142.34 137.76 30.75 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.184 2.193 . . . . 0.0 108.226 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.96 142.5 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.439 1.096 . . . . 0.0 111.282 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -127.35 130.46 49.49 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.923 1.289 . . . . 0.0 111.165 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.67 122.0 41.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.755 2.022 . . . . 0.0 110.524 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.3 mm -134.06 132.12 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.911 1.684 . . . . 0.0 109.722 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 165.19 -159.71 32.9 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.025 -1.672 . . . . 0.0 116.294 -172.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -158.37 145.1 17.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.94 2.496 . . . . 0.0 110.116 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HD21 ' A' ' 82' ' ' LEU . 16.1 m-85 -152.44 169.97 8.76 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.523 1.129 . . . . 0.0 113.002 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.79 -29.11 35.91 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.818 3.012 . . . . 0.0 113.664 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -152.76 162.87 40.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.36 1.552 . . . . 0.0 113.005 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.56 -27.34 69.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.425 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.08 70.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.434 0.694 . . . . 0.0 112.209 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -39.27 70.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.525 0.678 . . . . 0.0 111.864 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.9 -40.75 96.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.974 2.11 . . . . 0.0 112.385 170.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.48 -34.53 78.49 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.024 1.33 . . . . 0.0 112.366 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.27 80.0 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.233 -0.917 . . . . 0.0 112.436 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -65.26 -42.34 93.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.737 0.815 . . . . 0.0 111.288 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.6 ptp -74.82 -27.85 60.46 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -68.47 -40.0 81.17 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.41 -34.15 76.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.089 0.956 . . . . 0.0 112.795 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.66 -28.66 26.26 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -64.45 -28.93 70.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.864 1.266 . . . . 0.0 112.363 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -28.38 28.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.796 2.141 . . . . 0.0 115.393 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 tp -137.76 16.55 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.551 1.14 . . . . 0.0 113.274 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tt -58.59 137.13 57.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 111.403 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.46 147.17 32.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.738 1.615 . . . . 0.0 111.377 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.51 104.53 0.65 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.704 2.936 . . . . 0.0 112.283 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.58 -11.15 7.12 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.499 2.0 . . . . 0.0 113.727 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -69.32 113.08 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 118.358 1.079 . . . . 0.0 110.499 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -72.14 154.05 41.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.445 1.498 . . . . 0.0 112.371 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 t -137.09 131.02 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.285 1.434 . . . . 0.0 109.767 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.4 mt -129.55 141.84 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.186 1.794 . . . . 0.0 109.309 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.76 138.19 44.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.936 1.294 . . . . 0.0 113.043 -171.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.2 17.69 2.43 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.586 1.955 . . . . 0.0 112.672 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.39 124.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.946 -1.096 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -84.31 167.2 16.79 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.839 2.456 . . . . 0.0 113.102 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -133.11 125.04 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.193 1.397 . . . . 0.0 111.342 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -153.96 127.19 4.21 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.545 1.938 . . . . 0.0 110.742 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.34 -7.38 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.618 2.212 . . . . 0.0 114.723 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 p -70.3 -11.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.683 1.129 . . . . 0.0 113.742 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.89 147.34 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.323 1.849 . . . . 0.0 111.373 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -142.86 152.48 42.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.278 1.831 . . . . 0.0 110.687 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -145.32 177.9 8.48 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -175.79 0.26 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.02 2.528 . . . . 0.0 110.603 164.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -134.78 107.45 7.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.703 1.201 . . . . 0.0 111.743 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -69.01 -1.82 8.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 m -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 171.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.6 m -85.62 -12.09 52.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.179 1.792 . . . . 0.0 113.926 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -88.97 0.85 56.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.975 1.71 . . . . 0.0 114.125 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -45.54 -47.57 36.98 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 120.998 -1.063 . . . . 0.0 113.378 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.4 -22.76 38.86 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.364 2.043 . . . . 0.0 114.127 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -44.98 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.292 0.951 . . . . 0.0 110.474 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.73 -32.15 69.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.9 m -57.89 -42.01 83.74 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.084 0.856 . . . . 0.0 111.488 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.84 66.1 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.4 p -116.61 6.13 13.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.589 1.955 . . . . 0.0 116.165 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.2 t -52.28 -42.17 85.34 Favored Pre-proline 0 N--CA 1.482 1.172 0 O-C-N 120.185 -1.572 . . . . 0.0 113.58 167.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.86 12.49 1.95 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.672 2.248 . . . . 0.0 114.353 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 mt -113.96 97.74 45.81 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.264 1.826 . . . . 0.0 109.956 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.98 -23.48 21.79 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.906 2.404 . . . . 0.0 114.885 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.13 6.72 43.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.363 1.865 . . . . 0.0 113.653 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -52.42 152.1 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.959 1.304 . . . . 0.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.15 163.31 35.91 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.872 1.225 . . . . 0.0 111.769 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -140.75 149.6 42.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.269 1.028 . . . . 0.0 109.355 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 153.3 48.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.702 1.601 . . . . 0.0 110.868 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -143.52 133.73 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.101 1.36 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.12 146.09 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 112.484 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 51.36 -71.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 129.304 3.041 . . . . 0.0 117.997 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -144.95 21.0 1.61 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.37 1.868 . . . . 0.0 113.694 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -136.53 140.97 43.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.772 1.629 . . . . 0.0 111.139 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.23 131.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.829 2.052 . . . . 0.0 107.977 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.3 m -122.56 132.17 54.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.972 1.309 . . . . 0.0 110.128 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.64 123.77 36.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.312 1.445 . . . . 0.0 109.169 -173.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.0 t -135.23 152.34 51.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.687 1.195 . . . . 0.0 112.129 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 159.42 -178.41 35.56 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.78 -1.2 . . . . 0.0 114.046 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.3 p -120.7 84.65 2.26 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.598 2.359 . . . . 0.0 111.869 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.6 149.7 81.29 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.79 -30.36 27.34 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.558 2.838 . . . . 0.0 113.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t -152.21 164.5 37.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.64 1.176 . . . . 0.0 112.092 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -61.52 -21.61 64.39 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.616 1.166 . . . . 0.0 113.845 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -64.85 -40.28 94.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.222 1.009 . . . . 0.0 111.38 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -65.91 -39.95 91.03 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.015 -0.428 . . . . 0.0 111.958 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.74 -42.83 94.02 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.002 0.819 . . . . 0.0 112.585 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.78 -41.26 87.98 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 112.713 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.54 81.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.525 0.73 . . . . 0.0 112.424 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.33 -38.39 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.075 0.852 . . . . 0.0 110.553 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -61.45 -45.16 95.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.192 0.597 . . . . 0.0 111.293 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -61.94 -42.9 99.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.469 0.708 . . . . 0.0 112.204 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.03 92.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.663 0.385 . . . . 0.0 111.373 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.56 78.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.22 0.608 . . . . 0.0 112.371 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.8 m -67.85 -38.62 83.37 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.703 0.801 . . . . 0.0 111.734 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -35.95 74.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.66 -36.91 50.92 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.145 0.978 . . . . 0.0 112.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -135.74 64.27 56.24 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.615 1.566 . . . . 0.0 113.307 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.16 -3.92 14.5 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.449 2.766 . . . . 0.0 114.316 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.28 20.09 6.85 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.678 1.991 . . . . 0.0 113.062 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.3 mtt -135.7 163.5 30.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.775 1.63 . . . . 0.0 110.805 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -70.79 143.07 51.28 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.608 -0.683 . . . . 0.0 109.643 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 pt -137.41 86.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.72 1.608 . . . . 0.0 111.694 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.8 t -82.56 92.55 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.201 1.4 . . . . 0.0 110.687 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.76 68.92 4.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.599 1.56 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -68.03 -5.68 18.65 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.24 1.816 . . . . 0.0 114.542 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -42.21 137.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.832 2.053 . . . . 0.0 111.701 171.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.6 161.58 33.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.884 1.274 . . . . 0.0 110.955 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.97 135.98 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.93 0.492 . . . . 0.0 109.712 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 53.7 m -55.07 135.9 48.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 112.694 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -167.69 31.22 0.18 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.228 0.918 . . . . 0.0 114.507 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -146.57 118.58 8.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.023 1.329 . . . . 0.0 110.857 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -155.74 57.77 1.64 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 112.327 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.94 154.15 73.55 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.294 2.662 . . . . 0.0 113.114 -174.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 95.47 0.86 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.144 3.229 . . . . 0.0 111.856 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.18 54.77 0.13 Allowed Glycine 0 CA--C 1.538 1.527 0 CA-C-O 118.484 -1.175 . . . . 0.0 114.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.53 156.16 67.24 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.18 2.587 . . . . 0.0 112.704 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.75 170.82 19.49 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.948 3.099 . . . . 0.0 112.716 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.014 2.526 . . . . 0.0 114.658 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.92 166.99 27.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.357 1.463 . . . . 0.0 111.979 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.0 m -133.78 142.56 47.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.034 1.733 . . . . 0.0 111.039 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.42 39.66 0.74 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 0.0 112.768 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.8 tp -74.86 121.32 21.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.889 1.276 . . . . 0.0 110.862 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 p -73.1 108.91 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.461 1.104 . . . . 0.0 113.659 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.53 177.51 4.82 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.914 2.086 . . . . 0.0 110.812 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 m -41.23 164.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.872 3.269 . . . . 0.0 115.251 168.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.73 139.89 52.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.712 1.605 . . . . 0.0 112.381 166.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 tt -159.92 154.76 24.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.338 1.455 . . . . 0.0 111.784 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -139.42 150.31 45.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.556 1.942 . . . . 0.0 111.705 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -142.43 138.76 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.819 1.648 . . . . 0.0 108.885 171.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -145.88 142.73 29.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -107.0 148.99 28.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.125 1.77 . . . . 0.0 112.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.7 t -141.09 99.19 3.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.713 1.605 . . . . 0.0 110.943 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.77 -96.8 0.1 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.311 1.91 . . . . 0.0 113.619 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -120.58 34.95 5.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.15 1.78 . . . . 0.0 112.234 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -141.39 137.35 32.22 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.861 2.065 . . . . 0.0 108.89 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.83 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.256 1.022 . . . . 0.0 111.541 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.3 m -125.97 129.43 49.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.515 1.126 . . . . 0.0 111.165 -171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.468 ' CB ' HD11 ' A' ' 124' ' ' ILE . 7.6 mp -113.31 126.93 55.93 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.508 1.923 . . . . 0.0 110.1 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.1 mt -139.61 127.43 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.075 1.35 . . . . 0.0 109.257 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.48 -155.89 26.43 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.618 -1.301 . . . . 0.0 115.242 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.22 150.32 25.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.345 1.858 . . . . 0.0 112.289 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -152.34 170.12 8.52 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.323 1.849 . . . . 0.0 112.309 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.62 -31.8 32.3 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.382 3.388 . . . . 0.0 113.805 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.55 164.76 38.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 123.255 1.502 . . . . 0.0 112.813 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -60.57 -32.0 71.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.769 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 112.149 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -37.86 67.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.157 0.583 . . . . 0.0 111.992 172.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.648 ' HD2' HD13 ' A' ' 124' ' ' ILE . 5.4 ttpt -67.53 -34.81 77.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.69 1.196 . . . . 0.0 112.838 171.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.26 74.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.406 1.082 . . . . 0.0 111.632 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.32 80.71 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.623 -0.673 . . . . 0.0 112.809 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.66 -42.77 98.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.816 0.847 . . . . 0.0 111.458 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 28.8 ptm -73.39 -30.93 63.6 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.763 -0.586 . . . . 0.0 112.34 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.9 m -66.65 -40.34 88.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.086 0.954 . . . . 0.0 111.158 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.29 -31.91 72.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.313 1.045 . . . . 0.0 113.121 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.6 -25.34 21.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.58 -32.23 70.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.876 1.27 . . . . 0.0 112.246 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.14 -27.85 57.91 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.747 1.641 . . . . 0.0 115.117 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 14.41 6.08 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.502 1.521 . . . . 0.0 112.552 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.2 129.02 38.44 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.122 0.969 . . . . 0.0 111.383 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.83 41.42 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.555 1.542 . . . . 0.0 111.505 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.48 104.15 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.353 2.702 . . . . 0.0 112.97 -172.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.87 -9.09 9.83 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.78 2.133 . . . . 0.0 113.678 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.9 t -71.28 110.44 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 118.312 1.056 . . . . 0.0 111.799 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.23 156.42 39.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.381 1.873 . . . . 0.0 112.363 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.75 134.72 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.146 1.379 . . . . 0.0 109.623 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.84 140.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.253 1.821 . . . . 0.0 108.765 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.04 131.57 49.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.104 1.362 . . . . 0.0 112.163 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -140.35 24.95 2.27 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.279 2.231 . . . . 0.0 112.058 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 124' ' ' ILE . 1.3 mp -82.49 129.83 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.766 1.226 . . . . 0.0 111.022 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -92.84 169.63 10.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.178 1.391 . . . . 0.0 113.46 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.89 119.49 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.751 1.621 . . . . 0.0 110.694 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.25 126.24 5.07 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.596 2.358 . . . . 0.0 110.034 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.7 -4.2 14.19 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.321 2.681 . . . . 0.0 114.473 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.6 t -71.0 -13.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.398 1.879 . . . . 0.0 112.732 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.64 153.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.926 2.09 . . . . 0.0 110.555 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -146.71 143.84 29.01 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.32 1.848 . . . . 0.0 108.424 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 m -128.16 171.17 12.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.137 1.335 . . . . 0.0 114.476 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.61 176.01 4.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.131 1.772 . . . . 0.0 109.697 165.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -118.38 102.68 9.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.946 0.898 . . . . 0.0 112.295 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -69.77 -2.98 13.51 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.8 m -54.61 -33.89 61.15 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.901 -1.125 . . . . 0.0 112.492 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.6 m -96.32 1.8 52.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 113.676 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -91.44 -5.71 53.91 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.891 1.676 . . . . 0.0 113.455 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -45.91 -48.22 40.88 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.04 1.336 . . . . 0.0 113.006 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.56 -24.78 41.58 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.9 1.733 . . . . 0.0 113.862 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.35 -44.0 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.223 0.92 . . . . 0.0 110.407 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.23 -35.55 78.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.211 0.604 . . . . 0.0 112.214 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.9 m -59.71 -42.61 93.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.838 0.855 . . . . 0.0 111.554 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.23 -17.52 64.79 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 m -104.62 1.94 30.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.314 2.246 . . . . 0.0 114.884 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.31 -44.53 93.69 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-O 117.388 -1.291 . . . . 0.0 114.161 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.81 14.37 2.35 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.725 2.283 . . . . 0.0 114.193 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.3 93.78 23.84 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 109.761 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.53 -21.06 26.37 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.844 3.029 . . . . 0.0 116.657 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -107.4 13.0 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.079 1.752 . . . . 0.0 113.067 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.06 148.13 8.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 113.116 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.9 161.76 33.06 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 124.624 1.107 . . . . 0.0 111.58 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 tp -134.09 146.55 50.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.494 1.118 . . . . 0.0 109.114 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -135.73 151.6 50.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.986 0.915 . . . . 0.0 110.748 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -143.19 132.25 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.884 1.274 . . . . 0.0 109.05 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.23 155.08 28.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 167.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 41.39 -86.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.156 2.583 . . . . 0.0 114.991 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -140.64 29.54 1.93 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.907 1.23 . . . . 0.0 112.564 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.0 m -137.86 142.08 40.72 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.871 2.068 . . . . 0.0 110.67 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.64 142.91 31.27 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 125.527 1.531 . . . . 0.0 111.378 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 m -125.58 139.78 53.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.701 1.6 . . . . 0.0 110.163 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 mp -132.64 130.81 40.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.952 1.301 . . . . 0.0 110.405 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 27.4 m -138.05 151.08 47.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.654 1.182 . . . . 0.0 110.931 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.49 -174.4 39.71 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 120.542 -1.349 . . . . 0.0 115.883 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.2 p -128.11 80.07 1.94 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.879 2.472 . . . . 0.0 111.816 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.46 83.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -170.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.03 -29.12 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 113.976 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.2 t -150.25 155.9 40.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.622 1.969 . . . . 0.0 110.575 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.3 p -56.67 -24.7 50.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.326 1.45 . . . . 0.0 113.303 168.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.44 -45.92 92.25 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.317 . . . . 0.0 111.724 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.189 0.595 . . . . 0.0 112.172 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -63.25 -42.19 99.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.134 0.879 . . . . 0.0 112.444 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.18 -39.7 86.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.863 0.865 . . . . 0.0 112.153 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.44 93.77 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.977 -0.452 . . . . 0.0 112.162 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 72.9 t -67.91 -42.05 85.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 122.779 0.432 . . . . 0.0 111.094 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.711 0.687 . . . . 0.0 111.882 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -68.96 -39.82 79.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.053 0.941 . . . . 0.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.82 -43.18 99.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.572 0.349 . . . . 0.0 111.385 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.015 0.526 . . . . 0.0 112.195 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.4 m -64.97 -38.82 92.22 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.716 -0.615 . . . . 0.0 111.971 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.0 m -67.58 -36.09 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.401 0.68 . . . . 0.0 112.763 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 51.6 m -74.37 -38.2 63.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.354 1.062 . . . . 0.0 112.245 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.35 62.69 64.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.621 1.568 . . . . 0.0 113.536 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.0 -14.16 34.99 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.436 2.757 . . . . 0.0 114.1 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -95.16 5.88 50.58 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.208 1.803 . . . . 0.0 113.195 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.3 mtt -128.62 152.43 48.36 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.634 1.573 . . . . 0.0 111.824 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.92 146.64 45.96 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.216 0.606 . . . . 0.0 110.071 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.0 143.08 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.551 1.14 . . . . 0.0 109.693 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.59 93.38 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.783 1.233 . . . . 0.0 109.982 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -80.76 130.82 35.28 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.286 0.565 . . . . 0.0 111.488 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.92 3.89 3.78 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.731 2.412 . . . . 0.0 111.956 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.32 139.59 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.137 1.375 . . . . 0.0 109.748 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -122.04 166.12 14.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 111.356 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.7 t -79.42 137.08 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.1 t -63.19 168.4 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.224 1.41 . . . . 0.0 113.188 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -155.43 -31.01 0.03 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.419 1.009 . . . . 0.0 115.078 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -150.34 119.18 6.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.798 1.239 . . . . 0.0 110.109 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -157.75 154.75 25.56 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.83 1.652 . . . . 0.0 111.472 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.5 162.56 42.01 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.313 2.675 . . . . 0.0 112.089 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.44 155.53 69.65 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.044 2.496 . . . . 0.0 112.343 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -96.34 177.7 33.73 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.554 1.073 . . . . 0.0 114.642 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 159.19 54.6 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.052 3.168 . . . . 0.0 112.192 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.23 114.87 3.76 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.542 2.828 . . . . 0.0 111.406 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.285 1.834 . . . . 0.0 111.934 -179.066 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.77 58.2 2.75 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.231 1.412 . . . . 0.0 113.002 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.3 m -63.13 155.46 27.94 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 113.667 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 48.36 42.74 18.64 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.207 1.803 . . . . 0.0 114.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.99 168.66 9.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.776 1.63 . . . . 0.0 113.218 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 t -140.54 102.74 4.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.047 0.939 . . . . 0.0 112.297 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.464 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 8.6 mp -118.83 174.8 6.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.099 2.559 . . . . 0.0 111.806 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -42.54 165.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.936 2.894 . . . . 0.0 113.571 165.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.04 151.92 39.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 114.958 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mp -146.0 157.12 43.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 111.449 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 t -148.6 127.24 12.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.899 1.68 . . . . 0.0 110.0 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.0 139.42 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.686 1.594 . . . . 0.0 108.694 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -143.87 145.13 32.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.996 0.918 . . . . 0.0 112.522 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -109.81 149.11 30.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.649 1.579 . . . . 0.0 111.769 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -135.81 58.47 1.75 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.101 2.16 . . . . 0.0 111.443 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.75 -88.62 1.24 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.628 1.108 . . . . 0.0 113.231 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -119.46 30.41 7.11 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.703 1.601 . . . . 0.0 112.465 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -140.76 137.6 33.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.37 2.268 . . . . 0.0 108.021 167.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.1 142.31 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 0.0 111.312 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.2 m -127.85 128.8 45.86 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.645 1.178 . . . . 0.0 110.436 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.69 120.39 36.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.889 1.675 . . . . 0.0 109.266 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mm -119.14 144.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.375 1.87 . . . . 0.0 107.55 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.99 -153.87 23.0 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -162.22 143.64 10.68 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.204 2.201 . . . . 0.0 111.321 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -156.79 171.76 7.01 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.065 1.346 . . . . 0.0 113.004 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.18 -29.44 14.41 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.316 3.344 . . . . 0.0 113.645 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -156.34 166.48 33.3 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 123.392 1.568 . . . . 0.0 114.11 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.11 -32.16 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.721 1.608 . . . . 0.0 112.709 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.98 72.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.419 0.687 . . . . 0.0 111.903 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.44 67.54 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -39.38 94.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.218 1.407 . . . . 0.0 111.849 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.78 87.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 112.357 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.13 82.26 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.554 -0.716 . . . . 0.0 112.443 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.49 -39.79 81.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.157 0.983 . . . . 0.0 111.564 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -72.23 -33.58 67.67 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.226 -0.922 . . . . 0.0 112.341 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.6 m -63.5 -41.75 98.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.563 0.745 . . . . 0.0 111.149 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.82 78.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.144 0.978 . . . . 0.0 113.343 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.14 -43.52 61.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 111.836 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.65 -25.86 68.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 112.715 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.1 17.46 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.58 2.038 . . . . 0.0 114.409 172.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 7.24 3.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.479 1.112 . . . . 0.0 113.753 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.49 125.63 22.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.174 0.99 . . . . 0.0 110.815 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.4 148.97 40.15 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.022 1.329 . . . . 0.0 111.436 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.04 102.2 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.63 2.887 . . . . 0.0 112.443 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.86 -10.3 7.08 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.741 2.115 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.93 110.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.416 1.108 . . . . 0.0 110.734 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.49 152.48 45.33 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.515 1.526 . . . . 0.0 112.24 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.91 138.33 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.923 1.289 . . . . 0.0 111.993 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 87.1 mt -133.33 140.17 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.186 1.794 . . . . 0.0 108.781 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.31 134.31 41.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.26 1.424 . . . . 0.0 112.568 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -141.61 26.72 1.91 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.427 1.891 . . . . 0.0 113.16 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.76 130.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.596 -1.315 . . . . 0.0 111.154 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -82.4 160.66 22.72 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.028 1.731 . . . . 0.0 112.257 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.93 121.54 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 111.169 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.19 129.22 4.66 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.804 1.641 . . . . 0.0 110.656 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.07 -6.44 19.11 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.378 2.719 . . . . 0.0 114.823 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.84 -10.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.937 1.695 . . . . 0.0 112.603 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.1 144.49 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 128.595 2.758 . . . . 0.0 109.95 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -143.5 155.11 44.25 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.97 2.108 . . . . 0.0 109.548 -170.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -139.5 178.86 6.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.86 169.98 14.65 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.568 1.947 . . . . 0.0 110.177 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.26 158.93 15.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 112.52 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.26 2.32 11.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.559 1.544 . . . . 0.0 112.211 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 m -53.63 -32.39 51.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.163 1.385 . . . . 0.0 112.78 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.6 m -105.24 7.61 33.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.526 1.93 . . . . 0.0 113.674 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.61 56.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.482 1.513 . . . . 0.0 113.655 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -46.82 -48.81 50.42 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.71 1.204 . . . . 0.0 112.738 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 -24.87 38.73 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.888 1.725 . . . . 0.0 113.96 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.9 t -64.88 -45.29 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.329 0.968 . . . . 0.0 110.371 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -71.07 -31.3 67.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.744 0.818 . . . . 0.0 112.789 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.2 m -63.11 -42.58 99.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.907 0.776 . . . . 0.0 111.391 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.29 65.88 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.1 p -102.49 7.12 40.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.196 1.799 . . . . 0.0 115.364 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.7 t -48.62 -44.62 67.87 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.478 -1.389 . . . . 0.0 114.499 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.46 13.62 2.37 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.558 2.172 . . . . 0.0 114.226 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -113.95 92.8 27.03 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.146 1.779 . . . . 0.0 110.445 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.79 -22.78 23.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.454 2.769 . . . . 0.0 115.428 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -100.54 9.34 42.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.353 1.861 . . . . 0.0 113.342 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -52.56 149.31 6.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.023 0.916 . . . . 0.0 112.38 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 164.44 35.52 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.468 1.032 . . . . 0.0 111.772 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.53 146.84 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.68 1.192 . . . . 0.0 109.796 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -138.24 143.03 39.92 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.907 0.883 . . . . 0.0 110.002 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.76 131.96 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.904 0.882 . . . . 0.0 109.46 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.11 156.22 26.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 167.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 99.0 mtt180 46.8 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 129.706 3.202 . . . . 0.0 117.813 174.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.89 22.98 1.1 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.468 2.307 . . . . 0.0 112.835 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.4 m -143.55 143.82 31.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.942 1.697 . . . . 0.0 112.148 -170.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.8 141.79 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 126.333 1.853 . . . . 0.0 110.53 167.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.3 m -131.17 137.57 49.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.884 1.674 . . . . 0.0 109.62 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.61 127.9 34.01 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.177 1.391 . . . . 0.0 109.23 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 91.1 m -130.69 152.18 50.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.644 1.577 . . . . 0.0 110.229 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.13 -174.66 39.45 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.753 -1.217 . . . . 0.0 114.385 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.5 p -128.17 74.91 1.58 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.105 2.162 . . . . 0.0 112.082 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.79 154.31 93.71 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 -26.36 19.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.624 2.883 . . . . 0.0 114.077 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.3 t -147.99 156.89 43.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.737 2.015 . . . . 0.0 110.423 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 52.3 p -54.0 -31.13 50.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.781 2.033 . . . . 0.0 112.577 168.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.32 -41.92 80.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 112.064 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.85 -43.35 96.42 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.098 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 169' ' ' SER . 12.4 ptmm? -66.91 -35.99 81.26 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.5 1.045 . . . . 0.0 112.272 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.25 -41.92 89.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.356 0.662 . . . . 0.0 112.449 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.48 91.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.735 0.814 . . . . 0.0 112.528 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.87 -42.9 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.375 0.534 . . . . 0.0 110.483 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -62.94 -41.5 99.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.88 1.272 . . . . 0.0 112.437 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -69.96 -37.65 75.86 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.215 1.006 . . . . 0.0 111.198 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.82 99.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.885 0.474 . . . . 0.0 111.385 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.46 88.16 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.58 0.627 . . . . 0.0 112.195 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.8 m -63.64 -39.91 95.53 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.745 -0.597 . . . . 0.0 112.049 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.2 m -67.63 -35.17 78.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 29.7 m -76.58 -38.62 54.6 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.051 0.94 . . . . 0.0 112.428 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -133.28 59.15 39.46 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.089 1.356 . . . . 0.0 113.428 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 -15.05 40.56 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.486 2.791 . . . . 0.0 113.85 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -92.16 0.81 57.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.839 1.655 . . . . 0.0 113.592 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 64.6 mtt -130.59 162.06 30.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.72 . . . . 0.0 112.307 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -70.72 147.34 49.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.16 131.15 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.45 1.5 . . . . 0.0 109.284 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.5 t -126.34 92.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 110.729 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.96 66.57 3.63 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.208 2.203 . . . . 0.0 113.723 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -67.24 -6.46 18.36 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.995 1.718 . . . . 0.0 114.573 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.81 142.1 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.33 1.852 . . . . 0.0 111.272 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -129.38 173.16 10.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.569 1.548 . . . . 0.0 110.594 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.45 143.59 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.582 0.753 . . . . 0.0 109.203 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 10.7 t -58.09 154.04 13.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.694 1.198 . . . . 0.0 113.353 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -169.66 38.87 0.2 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.587 1.089 . . . . 0.0 113.518 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -140.08 -162.32 1.33 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.769 1.627 . . . . 0.0 110.494 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.37 148.96 40.66 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.174 1.39 . . . . 0.0 113.513 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 160.6 48.99 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.467 2.778 . . . . 0.0 113.057 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.42 170.9 16.25 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.85 3.033 . . . . 0.0 112.782 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -164.73 -178.6 38.22 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.893 1.235 . . . . 0.0 113.545 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.86 158.54 57.46 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.763 2.975 . . . . 0.0 112.929 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.16 127.82 16.52 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.677 2.918 . . . . 0.0 111.059 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.312 1.845 . . . . 0.0 113.335 176.104 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.82 170.27 18.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.511 1.525 . . . . 0.0 111.864 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -117.29 165.37 13.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.577 1.551 . . . . 0.0 112.917 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.87 44.84 1.18 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.341 1.456 . . . . 0.0 111.855 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 109.68 1.55 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.519 1.528 . . . . 0.0 113.052 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 p -68.18 117.98 10.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.572 1.149 . . . . 0.0 111.311 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -146.18 174.06 11.66 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.252 2.621 . . . . 0.0 109.89 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -43.5 157.04 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.536 2.734 . . . . 0.0 114.916 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.6 154.13 28.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.143 1.777 . . . . 0.0 113.628 166.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tp -154.73 152.02 29.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.821 1.648 . . . . 0.0 111.438 -171.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -149.99 131.38 14.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.209 1.404 . . . . 0.0 110.608 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 64.9 mt -135.71 142.86 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.375 1.47 . . . . 0.0 108.524 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.4 p -142.23 150.25 40.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.11 142.72 49.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.626 1.97 . . . . 0.0 110.255 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -141.37 66.19 1.37 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.745 . . . . 0.0 112.242 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.73 -81.18 1.27 Allowed Glycine 0 N--CA 1.477 1.37 0 O-C-N 121.223 -0.923 . . . . 0.0 114.708 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.98 32.71 5.05 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.388 173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.72 141.91 30.7 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.089 2.156 . . . . 0.0 108.967 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.68 142.82 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 111.211 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.6 m -130.2 125.24 34.45 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.982 1.313 . . . . 0.0 110.829 -171.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.71 128.48 55.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.032 1.733 . . . . 0.0 110.015 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.94 144.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.1 1.76 . . . . 0.0 108.443 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.29 -156.54 28.19 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.533 -1.354 . . . . 0.0 116.219 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -164.0 128.71 2.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.215 1.806 . . . . 0.0 112.29 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -143.51 168.02 14.03 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.707 1.603 . . . . 0.0 113.134 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -67.32 -31.81 34.27 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.095 3.197 . . . . 0.0 113.31 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.28 166.85 32.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 123.473 1.606 . . . . 0.0 113.573 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -60.82 -29.86 69.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.418 1.887 . . . . 0.0 113.489 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.27 -29.87 68.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.776 1.23 . . . . 0.0 112.199 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.72 83.16 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.63 -0.669 . . . . 0.0 111.204 173.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.129 1.372 . . . . 0.0 111.785 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.86 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.467 0.707 . . . . 0.0 112.581 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.61 76.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.29 -42.42 93.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.907 1.283 . . . . 0.0 111.543 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.7 ptm -73.11 -32.1 64.74 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.655 -0.653 . . . . 0.0 111.997 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -64.55 -38.55 91.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 111.056 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.25 -35.33 76.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.814 0.845 . . . . 0.0 112.968 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.92 -23.38 22.72 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.63 -29.62 68.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.909 1.284 . . . . 0.0 112.229 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.24 -27.14 52.0 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.813 1.673 . . . . 0.0 115.267 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 12.65 5.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.622 1.569 . . . . 0.0 112.459 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.42 125.46 23.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.729 0.811 . . . . 0.0 110.979 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.58 148.56 46.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.97 1.308 . . . . 0.0 111.079 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.31 102.49 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.496 2.798 . . . . 0.0 112.738 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.48 -8.96 8.28 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.684 2.088 . . . . 0.0 113.713 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.61 114.19 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.506 1.153 . . . . 0.0 111.006 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -69.99 153.63 42.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.783 1.633 . . . . 0.0 112.322 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.45 132.36 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.709 1.204 . . . . 0.0 110.006 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.0 148.59 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.998 1.719 . . . . 0.0 110.396 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.03 130.3 31.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.932 1.693 . . . . 0.0 111.823 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -140.75 28.92 1.93 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.603 2.361 . . . . 0.0 111.127 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.55 119.29 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.632 1.173 . . . . 0.0 109.927 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -73.85 165.51 24.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.388 1.875 . . . . 0.0 112.221 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.6 t -132.39 123.73 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.091 1.356 . . . . 0.0 111.021 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.62 120.78 2.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.468 1.907 . . . . 0.0 110.529 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.68 -6.39 18.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.655 2.237 . . . . 0.0 115.0 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.23 -12.9 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.007 0.923 . . . . 0.0 112.206 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.08 149.01 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.709 1.603 . . . . 0.0 110.52 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -145.21 145.74 31.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.288 1.835 . . . . 0.0 109.153 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -133.42 -179.61 5.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -68.01 -176.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 130.162 3.385 . . . . 0.0 110.866 170.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -123.95 95.11 4.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 112.795 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -73.18 2.31 7.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.9 m -56.46 -36.0 68.56 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.627 -1.296 . . . . 0.0 112.183 172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.8 m -89.5 -2.51 58.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.808 1.643 . . . . 0.0 113.762 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.52 -6.68 52.91 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.511 1.124 . . . . 0.0 113.294 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.72 -48.63 76.49 Favored Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 120.767 -1.208 . . . . 0.0 113.49 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.44 -28.43 32.48 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.584 2.189 . . . . 0.0 114.026 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.26 -46.23 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 0.855 . . . . 0.0 110.753 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.34 -30.57 63.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.578 0.751 . . . . 0.0 112.336 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.6 m -61.17 -44.54 97.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 111.305 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.65 -17.63 64.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 92.2 p -107.75 7.02 28.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 115.286 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -52.42 -47.4 93.31 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 167.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.07 12.46 1.23 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.807 2.338 . . . . 0.0 114.279 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 165' ' ' THR . 13.9 mt -110.59 96.55 28.36 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.746 2.019 . . . . 0.0 109.131 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 -19.54 28.36 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.978 2.452 . . . . 0.0 114.594 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -109.26 11.07 25.56 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.806 2.042 . . . . 0.0 113.843 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.92 155.04 1.91 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.899 1.28 . . . . 0.0 112.983 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.54 164.27 36.15 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.328 0.96 . . . . 0.0 112.196 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.08 145.45 49.37 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.517 1.127 . . . . 0.0 109.317 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -141.32 134.74 29.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.73 0.812 . . . . 0.0 109.924 173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.73 136.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.111 0.564 . . . . 0.0 109.997 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.98 150.45 25.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.787 0.435 . . . . 0.0 112.144 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 39.35 -101.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.569 1.948 . . . . 0.0 112.97 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -117.91 21.31 12.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.489 1.515 . . . . 0.0 112.99 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.2 m -135.61 137.23 41.7 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.086 1.754 . . . . 0.0 112.379 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.4 141.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 126.142 1.777 . . . . 0.0 111.682 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 88.0 m -131.42 136.98 48.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.933 1.693 . . . . 0.0 110.218 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -130.04 133.12 46.52 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.003 1.721 . . . . 0.0 109.471 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 31.7 m -138.88 148.32 43.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.915 1.286 . . . . 0.0 110.753 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.21 -172.0 37.36 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.523 -1.361 . . . . 0.0 114.885 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 148' ' ' ILE . 18.2 p -121.41 89.02 3.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.531 2.732 . . . . 0.0 111.998 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.02 53.94 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 120.695 -1.253 . . . . 0.0 113.73 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.27 -26.63 41.69 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.82 3.013 . . . . 0.0 114.226 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.5 t -147.94 157.04 43.32 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.55 1.94 . . . . 0.0 110.063 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 p -59.58 -20.87 58.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.094 0.958 . . . . 0.0 112.907 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.25 -47.55 83.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.756 1.223 . . . . 0.0 111.775 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -58.37 -42.2 86.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.187 0.595 . . . . 0.0 111.867 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -45.26 94.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.839 0.745 . . . . 0.0 112.203 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -66.21 -39.29 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.267 1.027 . . . . 0.0 111.983 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.75 89.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.703 0.801 . . . . 0.0 112.694 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.96 -38.64 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.702 -0.624 . . . . 0.0 110.914 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.668 0.787 . . . . 0.0 111.716 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -63.6 -40.09 96.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.584 0.754 . . . . 0.0 111.848 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.89 97.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.813 0.445 . . . . 0.0 111.376 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.64 -37.64 88.11 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.675 -0.64 . . . . 0.0 112.119 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.6 m -63.27 -41.29 99.01 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.623 -0.673 . . . . 0.0 111.751 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -65.82 -35.94 82.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.4 -36.91 52.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.077 0.951 . . . . 0.0 112.685 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -133.39 61.13 52.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.411 1.484 . . . . 0.0 113.635 -172.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.26 -9.58 25.65 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.687 2.925 . . . . 0.0 114.338 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -114.47 9.72 16.8 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.63 1.972 . . . . 0.0 113.601 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.6 mtm -126.17 161.13 28.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.437 1.895 . . . . 0.0 111.247 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -71.2 146.49 49.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.833 0.853 . . . . 0.0 110.036 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.6 pt -130.71 143.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.115 0.966 . . . . 0.0 111.381 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.0 t -135.68 121.87 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.596 1.158 . . . . 0.0 110.483 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -112.27 70.43 0.71 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.43 1.892 . . . . 0.0 111.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.1 -5.61 42.67 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.545 1.538 . . . . 0.0 114.336 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 68.8 mt -51.28 140.16 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.087 1.755 . . . . 0.0 111.257 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -134.76 175.06 9.9 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.727 1.611 . . . . 0.0 110.63 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.7 t -77.78 141.11 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 111.183 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.0 m -54.25 149.25 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.048 . . . . 0.0 113.474 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.07 31.96 6.86 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.243 1.877 . . . . 0.0 113.896 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 53.28 48.94 20.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.549 1.94 . . . . 0.0 113.663 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -134.5 61.73 50.81 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.492 1.917 . . . . 0.0 113.006 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -68.06 162.44 39.99 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 123.538 2.825 . . . . 0.0 112.739 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -67.68 161.74 42.38 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.357 2.705 . . . . 0.0 112.996 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -176.05 -178.14 45.62 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.828 1.204 . . . . 0.0 113.686 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.68 159.23 54.26 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.751 2.967 . . . . 0.0 112.993 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.8 170.85 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.972 3.115 . . . . 0.0 112.654 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.916 1.686 . . . . 0.0 113.329 175.193 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.18 163.34 17.92 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.347 1.059 . . . . 0.0 113.327 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.2 t -151.38 150.99 31.12 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 111.039 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.87 53.71 0.77 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.186 1.794 . . . . 0.0 113.636 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.42 96.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.913 1.685 . . . . 0.0 111.197 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 t -58.73 119.29 6.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.25 1.82 . . . . 0.0 112.333 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pp -128.72 172.78 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.111 2.165 . . . . 0.0 111.708 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -39.44 154.39 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 129.896 3.278 . . . . 0.0 117.179 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.12 135.42 39.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.676 1.591 . . . . 0.0 111.105 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD22 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -155.09 146.82 23.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.091 1.356 . . . . 0.0 110.817 -175.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -142.75 142.96 32.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.084 1.753 . . . . 0.0 110.809 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -142.6 136.66 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.989 1.316 . . . . 0.0 109.445 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -138.86 145.76 40.38 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.937 0.895 . . . . 0.0 112.02 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -108.53 150.49 27.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.011 1.324 . . . . 0.0 112.84 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.0 m -137.78 59.77 1.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.694 2.398 . . . . 0.0 111.99 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.03 -92.84 1.05 Allowed Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.018 1.294 . . . . 0.0 112.856 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -113.08 29.85 7.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.814 1.645 . . . . 0.0 112.327 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.32 140.49 30.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.466 2.307 . . . . 0.0 108.44 170.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.01 144.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.696 1.198 . . . . 0.0 111.131 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.7 m -129.56 128.13 42.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.384 1.074 . . . . 0.0 111.607 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.14 126.93 55.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.787 2.035 . . . . 0.0 110.525 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.5 mt -138.16 125.66 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.32 1.448 . . . . 0.0 109.137 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 172.65 -156.75 25.64 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 120.859 -1.151 . . . . 0.0 115.144 -171.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -159.45 146.27 16.69 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.882 2.073 . . . . 0.0 111.355 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -151.86 170.2 8.3 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.965 1.706 . . . . 0.0 111.586 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.31 -31.83 42.75 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.265 3.31 . . . . 0.0 113.537 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.47 165.65 35.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.617 1.675 . . . . 0.0 113.123 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.79 -25.77 68.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.728 2.011 . . . . 0.0 113.958 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.19 63.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.96 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -37.65 67.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.196 0.598 . . . . 0.0 111.836 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -26.54 60.52 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 172.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.5 75.65 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.439 -0.788 . . . . 0.0 112.301 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.0 85.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.914 -1.116 . . . . 0.0 112.282 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.76 -42.57 99.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -30.95 62.45 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.496 -0.752 . . . . 0.0 112.434 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.4 m -65.1 -38.44 90.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.81 1.244 . . . . 0.0 111.308 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.82 72.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.799 1.24 . . . . 0.0 113.182 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.29 -25.23 20.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.46 -30.99 70.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.978 1.311 . . . . 0.0 112.37 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.72 -27.15 55.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.601 1.572 . . . . 0.0 115.254 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 10.4 6.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.793 1.637 . . . . 0.0 112.453 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.59 130.45 46.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.451 1.101 . . . . 0.0 111.372 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.2 147.27 39.98 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.245 1.418 . . . . 0.0 111.108 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.88 102.92 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.593 2.862 . . . . 0.0 112.562 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.04 -10.28 7.43 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.838 2.161 . . . . 0.0 113.793 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.92 115.33 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.339 1.069 . . . . 0.0 110.896 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -73.81 155.02 39.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.009 1.724 . . . . 0.0 112.563 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -135.44 132.92 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.847 1.259 . . . . 0.0 109.851 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.2 mt -126.45 138.36 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.406 1.882 . . . . 0.0 108.855 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.63 132.43 37.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.745 1.218 . . . . 0.0 112.824 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -136.75 18.82 3.06 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.428 2.291 . . . . 0.0 112.315 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.82 132.89 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.689 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -94.49 169.82 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.65 1.58 . . . . 0.0 113.248 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.54 118.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.777 1.631 . . . . 0.0 110.774 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -149.3 123.06 4.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.107 2.163 . . . . 0.0 110.419 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.58 -5.06 15.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.023 2.482 . . . . 0.0 114.544 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.24 -13.28 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.209 1.804 . . . . 0.0 112.468 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.72 149.42 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.091 2.157 . . . . 0.0 109.71 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.38 152.58 48.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.038 2.135 . . . . 0.0 106.495 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.0 m -132.74 175.46 9.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.264 1.393 . . . . 0.0 114.256 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.98 158.18 33.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.692 1.597 . . . . 0.0 109.583 166.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.4 148.12 28.4 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.015 165.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.33 0.26 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.713 1.205 . . . . 0.0 113.052 171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -55.28 -37.86 67.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.205 1.002 . . . . 0.0 111.798 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -92.04 3.08 56.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.066 1.747 . . . . 0.0 113.848 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.72 -3.79 51.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.775 1.63 . . . . 0.0 113.687 172.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.07 -49.16 30.8 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.464 1.105 . . . . 0.0 112.39 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.59 -24.83 55.34 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.75 1.633 . . . . 0.0 113.692 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.6 t -66.2 -46.1 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.131 0.878 . . . . 0.0 110.687 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -73.87 -30.07 62.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.485 0.714 . . . . 0.0 112.57 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.8 m -66.77 -39.73 87.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.074 0.95 . . . . 0.0 111.541 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.17 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.8 p -101.13 7.88 43.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.364 1.866 . . . . 0.0 115.191 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.4 t -47.52 -44.97 56.7 Favored Pre-proline 0 N--CA 1.485 1.312 0 O-C-N 120.391 -1.443 . . . . 0.0 114.554 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.8 13.97 2.18 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.447 2.098 . . . . 0.0 114.089 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.39 91.97 35.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.171 1.788 . . . . 0.0 110.583 -171.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.07 -17.8 31.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.864 3.042 . . . . 0.0 115.879 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.97 16.08 16.16 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.743 2.417 . . . . 0.0 112.519 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -53.94 153.7 4.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.474 1.109 . . . . 0.0 112.74 168.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.17 161.28 33.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.135 1.35 . . . . 0.0 111.672 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tp -131.45 146.3 52.19 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.037 1.335 . . . . 0.0 109.235 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.75 147.62 42.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.126 0.97 . . . . 0.0 110.822 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.78 133.02 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.666 1.186 . . . . 0.0 109.744 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.24 152.8 24.66 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 167.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 42.15 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.585 3.154 . . . . 0.0 117.253 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -141.86 20.54 2.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.602 1.961 . . . . 0.0 113.022 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.6 m -138.3 140.97 39.81 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.029 1.332 . . . . 0.0 112.555 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.55 131.96 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.418 1.887 . . . . 0.0 111.084 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.6 m -123.94 137.74 54.58 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.679 1.592 . . . . 0.0 110.058 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.65 126.57 29.41 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.616 1.166 . . . . 0.0 110.663 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 98.8 m -132.07 150.86 52.05 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.344 1.457 . . . . 0.0 110.455 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.38 -175.13 39.68 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.79 -1.194 . . . . 0.0 114.183 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.0 p -130.13 81.02 1.99 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.208 1.803 . . . . 0.0 112.071 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.9 153.24 95.63 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.231 1.412 . . . . 0.0 114.293 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.99 -34.63 37.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.093 2.529 . . . . 0.0 113.168 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.7 m -144.47 156.02 43.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.65 1.98 . . . . 0.0 110.644 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 p -62.55 -22.86 66.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.222 1.009 . . . . 0.0 113.633 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -63.95 -42.87 97.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.617 1.167 . . . . 0.0 111.462 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -62.97 -40.9 99.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.451 0.569 . . . . 0.0 111.782 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.6 -46.82 87.82 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.474 0.579 . . . . 0.0 112.214 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.76 -37.66 85.05 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.371 0.668 . . . . 0.0 111.944 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.02 89.33 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.624 0.769 . . . . 0.0 112.573 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.03 -42.63 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.737 0.699 . . . . 0.0 110.655 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -42.07 99.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 112.316 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -72.65 -32.76 66.11 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.91 -47.2 78.6 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.22 93.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 t -72.38 -30.09 64.36 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.635 -0.666 . . . . 0.0 112.168 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.3 m -70.06 -38.98 75.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.138 0.975 . . . . 0.0 112.591 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 39.4 m -71.59 -39.33 70.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.684 1.194 . . . . 0.0 112.311 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -129.85 60.5 52.19 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.448 1.499 . . . . 0.0 113.732 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.39 -14.94 34.61 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.435 2.757 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.46 -1.85 58.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.7 1.6 . . . . 0.0 113.892 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -126.12 160.03 31.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 112.071 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -70.49 151.1 45.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.956 0.902 . . . . 0.0 110.406 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.87 135.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.027 0.931 . . . . 0.0 111.526 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 37.0 t -130.59 87.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.408 1.483 . . . . 0.0 109.825 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -72.97 130.89 41.37 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.902 . . . . 0.0 110.93 171.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -137.0 0.15 2.35 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.494 2.318 . . . . 0.0 111.929 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.15 142.7 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.259 1.823 . . . . 0.0 110.073 171.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.67 173.55 8.92 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.821 1.648 . . . . 0.0 110.557 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.87 141.12 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.454 -0.779 . . . . 0.0 109.767 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.6 t -63.04 165.83 6.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 113.925 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 161.11 -3.8 0.08 OUTLIER Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.843 1.211 . . . . 0.0 115.494 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -152.36 160.4 43.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.671 1.989 . . . . 0.0 109.014 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 50.93 64.57 7.98 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.78 2.032 . . . . 0.0 114.53 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.14 161.04 31.67 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 123.464 2.776 . . . . 0.0 112.539 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.76 146.87 89.24 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.288 2.659 . . . . 0.0 113.375 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.73 -50.86 27.97 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 117.996 -1.447 . . . . 0.0 116.25 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.31 150.09 46.42 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 CA-C-N 120.898 2.349 . . . . 0.0 113.017 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 172.78 15.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.072 3.182 . . . . 0.0 112.831 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.293 0 C-N-CA 127.989 2.516 . . . . 0.0 114.63 178.701 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 CA-C-O 121.165 0.314 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.41 16.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.084 1.754 . . . . 0.0 111.202 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -131.28 159.57 37.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.223 1.409 . . . . 0.0 113.673 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.59 39.46 1.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.094 1.358 . . . . 0.0 112.718 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.09 131.85 35.24 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.445 1.498 . . . . 0.0 110.273 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -68.87 103.45 1.8 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.073 1.349 . . . . 0.0 113.315 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.07 176.08 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.742 2.017 . . . . 0.0 110.099 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -37.38 161.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.353 3.061 . . . . 0.0 114.867 167.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.39 146.5 47.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.855 1.662 . . . . 0.0 114.077 167.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 tt -157.15 155.82 31.64 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.823 1.249 . . . . 0.0 112.195 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 t -139.26 140.01 37.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.93 2.092 . . . . 0.0 110.284 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.25 133.9 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.283 1.433 . . . . 0.0 108.864 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 t -143.29 142.25 31.28 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.251 0.62 . . . . 0.0 112.196 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.34 148.47 28.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.305 1.442 . . . . 0.0 110.897 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -143.7 66.04 1.3 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.541 1.536 . . . . 0.0 112.526 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -90.07 1.46 Allowed Glycine 0 N--CA 1.472 1.07 0 C-N-CA 124.308 0.956 . . . . 0.0 113.106 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -122.22 35.94 4.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.985 1.714 . . . . 0.0 111.729 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.4 m -145.0 145.73 31.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.93 2.492 . . . . 0.0 108.183 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 p -134.75 144.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.814 1.246 . . . . 0.0 110.987 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.4 m -128.78 132.78 47.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.422 1.089 . . . . 0.0 111.739 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 117.8 29.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.566 2.346 . . . . 0.0 109.637 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.37 120.33 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.604 1.162 . . . . 0.0 109.053 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.02 -154.02 17.18 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -170.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -153.27 145.92 24.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.515 2.326 . . . . 0.0 112.651 -170.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -155.94 171.43 7.32 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.641 1.576 . . . . 0.0 112.85 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.47 -30.61 23.35 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.327 3.351 . . . . 0.0 113.705 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -155.49 166.74 32.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.287 1.518 . . . . 0.0 113.16 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.62 -28.91 70.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.927 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.06 75.01 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.63 -37.73 67.93 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.365 0.666 . . . . 0.0 112.427 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -60.11 -45.88 91.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.631 1.172 . . . . 0.0 111.314 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.77 77.88 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.986 1.314 . . . . 0.0 111.956 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.48 92.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.14 -39.66 86.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 111.227 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 78.1 mmm -65.94 -41.55 91.18 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.548 0.739 . . . . 0.0 111.639 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.8 m -61.72 -40.48 95.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.343 1.057 . . . . 0.0 110.857 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.96 -31.44 72.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.686 1.194 . . . . 0.0 113.606 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -93.33 -22.39 18.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.7 -30.46 61.56 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.666 1.587 . . . . 0.0 112.367 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.83 -28.28 52.24 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.686 1.612 . . . . 0.0 114.986 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 9.54 6.44 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.81 1.644 . . . . 0.0 112.768 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.3 129.99 44.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.297 1.039 . . . . 0.0 111.109 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.51 149.11 40.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.201 1.401 . . . . 0.0 111.388 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.9 102.8 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.575 2.85 . . . . 0.0 112.582 -174.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -10.38 7.34 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.795 2.14 . . . . 0.0 113.662 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.34 114.78 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 118.358 1.079 . . . . 0.0 110.889 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -71.25 157.16 38.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.982 1.713 . . . . 0.0 112.734 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.97 140.21 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.557 1.143 . . . . 0.0 112.441 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.18 139.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.745 2.018 . . . . 0.0 108.391 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.31 134.81 34.75 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.87 29.88 1.87 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.179 2.592 . . . . 0.0 111.347 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.25 123.66 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.482 -1.386 . . . . 0.0 110.746 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -90.3 162.75 15.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.931 1.292 . . . . 0.0 112.551 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.7 117.98 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.046 1.339 . . . . 0.0 110.941 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.98 117.14 4.18 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.75 2.02 . . . . 0.0 109.878 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 -5.77 17.8 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.964 2.443 . . . . 0.0 114.953 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.66 -1.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.406 1.482 . . . . 0.0 113.527 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.35 142.48 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 128.899 2.879 . . . . 0.0 109.143 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -136.73 154.78 50.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.522 2.329 . . . . 0.0 108.802 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -136.05 177.28 7.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.746 1.157 . . . . 0.0 114.052 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -72.26 156.99 38.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.161 . . . . 0.0 108.271 167.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.42 152.93 37.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.847 -0.533 . . . . 0.0 111.311 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -122.72 3.07 9.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.463 1.505 . . . . 0.0 111.75 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.2 m -53.5 -37.54 62.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.526 1.13 . . . . 0.0 111.876 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.4 m -96.63 6.1 49.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 113.653 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.66 -6.28 59.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.159 1.384 . . . . 0.0 113.269 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.79 -50.12 44.92 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.026 1.33 . . . . 0.0 112.648 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.51 -24.28 56.63 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 113.738 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.97 -46.97 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.453 1.024 . . . . 0.0 110.649 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -74.32 -28.88 61.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 112.587 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 m -70.25 -41.17 73.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.809 1.244 . . . . 0.0 111.694 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.25 -28.64 68.88 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.312 -0.868 . . . . 0.0 112.649 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.7 p -90.52 0.1 57.46 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -45.6 -46.71 37.14 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 120.779 1.627 . . . . 0.0 115.159 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.51 13.67 1.34 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.727 2.285 . . . . 0.0 114.154 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.12 83.76 12.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.592 1.957 . . . . 0.0 110.188 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.09 -15.86 50.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.452 2.768 . . . . 0.0 115.075 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.89 1.93 27.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.778 2.431 . . . . 0.0 114.34 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -60.07 155.28 17.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.053 -1.029 . . . . 0.0 113.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.36 169.36 37.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.874 1.702 . . . . 0.0 112.995 167.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.19 147.79 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.433 1.893 . . . . 0.0 109.387 177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -136.91 140.26 42.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 109.904 168.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.41 134.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.999 0.92 . . . . 0.0 109.782 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.66 157.67 27.53 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.677 0.791 . . . . 0.0 112.701 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 44.59 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.837 2.455 . . . . 0.0 114.082 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -144.16 33.8 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 119.77 1.168 . . . . 0.0 112.463 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.8 m -133.27 139.14 46.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.75 2.02 . . . . 0.0 111.109 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.35 128.09 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.158 1.783 . . . . 0.0 111.401 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 84.9 m -122.77 134.65 54.42 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.886 1.674 . . . . 0.0 110.03 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.21 124.72 31.2 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.784 1.234 . . . . 0.0 110.174 -171.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.5 m -137.07 123.3 20.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.986 1.314 . . . . 0.0 110.947 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.47 48.28 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.948 1.261 . . . . 0.0 112.926 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.5 p -125.08 81.21 1.94 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 0.0 112.35 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.66 153.96 92.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.2 -31.05 30.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.2 2.6 . . . . 0.0 113.536 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 p -149.27 166.58 28.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.858 1.263 . . . . 0.0 112.804 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.5 p -64.05 -25.06 67.95 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 113.604 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -66.3 -42.16 88.72 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.482 -0.762 . . . . 0.0 111.09 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.32 -41.37 98.9 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.475 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -66.57 -40.54 89.01 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.631 1.105 . . . . 0.0 111.888 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.83 -43.99 97.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.647 1.179 . . . . 0.0 112.382 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.91 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.499 0.72 . . . . 0.0 112.185 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.57 -43.3 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 118.132 0.424 . . . . 0.0 111.243 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -70.02 -36.18 74.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.806 0.73 . . . . 0.0 112.663 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.29 -39.99 81.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.247 1.019 . . . . 0.0 111.571 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.87 95.82 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.08 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.46 87.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.139 0.575 . . . . 0.0 112.395 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.5 m -66.45 -38.1 86.61 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.716 -0.615 . . . . 0.0 111.594 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.8 t -65.27 -38.54 90.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.671 0.788 . . . . 0.0 112.616 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.0 m -73.31 -39.35 65.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.22 1.008 . . . . 0.0 112.764 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -131.96 61.41 57.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.549 1.54 . . . . 0.0 113.815 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.02 -10.95 26.82 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.664 2.909 . . . . 0.0 114.731 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -104.96 -0.93 26.43 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.082 1.753 . . . . 0.0 113.73 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -108.57 160.3 16.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.914 2.086 . . . . 0.0 111.711 -172.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -73.47 147.25 44.3 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.694 -0.628 . . . . 0.0 109.908 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.6 tt -135.04 142.17 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.7 0.8 . . . . 0.0 112.274 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.62 91.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.692 1.597 . . . . 0.0 110.194 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -83.18 74.07 10.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.298 1.839 . . . . 0.0 111.413 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -72.76 -11.54 60.65 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.989 1.315 . . . . 0.0 113.459 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.2 pt -52.04 144.21 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 127.106 2.162 . . . . 0.0 114.531 172.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.35 170.28 16.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.936 2.094 . . . . 0.0 111.088 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.52 142.73 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 170.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.6 t -59.61 160.95 6.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.973 1.309 . . . . 0.0 113.13 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.1 -7.6 0.09 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.364 0.983 . . . . 0.0 115.379 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -142.87 140.0 31.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.406 1.882 . . . . 0.0 108.519 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 42.72 53.63 8.96 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.895 1.678 . . . . 0.0 114.592 -171.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -68.21 160.72 47.63 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.542 2.828 . . . . 0.0 112.61 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.88 162.73 41.02 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.362 2.708 . . . . 0.0 113.487 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.79 -176.5 49.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 125.102 1.334 . . . . 0.0 114.473 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.58 163.62 37.43 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.96 3.106 . . . . 0.0 112.781 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.75 62.17 7.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.984 3.789 . . . . 0.0 112.931 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.322 0 C-N-CA 127.005 2.122 . . . . 0.0 113.476 177.871 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.503 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.15 171.51 17.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.374 1.47 . . . . 0.0 112.076 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.4 p -132.71 166.55 21.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.897 2.079 . . . . 0.0 112.057 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 46.12 43.78 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.483 1.513 . . . . 0.0 113.228 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.07 115.0 1.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.827 2.051 . . . . 0.0 114.028 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 p -81.31 109.61 15.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.479 1.512 . . . . 0.0 112.709 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 3.8 mm? -134.52 171.19 14.66 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.701 2.8 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 t -35.91 162.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 131.114 3.766 . . . . 0.0 114.809 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 150.16 50.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.605 1.562 . . . . 0.0 114.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 tt -160.53 156.73 26.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 111.526 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.3 p -145.22 158.32 43.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 112.653 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -141.67 142.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 108.01 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -139.18 142.69 37.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.321 0.648 . . . . 0.0 111.936 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -112.9 148.28 35.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.777 1.631 . . . . 0.0 111.376 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -134.19 56.64 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.427 2.291 . . . . 0.0 110.438 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.3 -98.82 0.67 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 126.039 1.781 . . . . 0.0 112.365 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -96.38 18.4 14.0 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.406 1.482 . . . . 0.0 113.013 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -137.51 131.87 32.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.818 1.647 . . . . 0.0 108.81 167.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.26 137.8 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.545 1.138 . . . . 0.0 111.253 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -122.66 136.96 55.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.5 1.12 . . . . 0.0 112.6 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.86 121.98 39.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.944 2.098 . . . . 0.0 109.085 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 mt -135.27 133.04 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.02 1.328 . . . . 0.0 108.173 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.96 -146.88 12.28 Favored Glycine 0 N--CA 1.465 0.624 0 O-C-N 120.338 -1.476 . . . . 0.0 115.941 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -153.16 150.77 29.4 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.094 2.557 . . . . 0.0 111.842 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -157.7 170.07 9.56 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 126.026 1.73 . . . . 0.0 110.39 166.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -71.72 -29.96 15.1 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.392 3.395 . . . . 0.0 113.696 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -159.15 166.92 30.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.384 1.564 . . . . 0.0 113.554 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.56 -32.98 70.85 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.676 1.59 . . . . 0.0 112.836 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.97 73.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.818 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.6 60.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.452 0.701 . . . . 0.0 112.339 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.28 -42.03 96.63 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 111.817 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.35 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.684 1.194 . . . . 0.0 111.552 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.04 93.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.8 -39.6 80.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.677 0.791 . . . . 0.0 111.369 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm -65.14 -41.12 95.08 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.741 -0.599 . . . . 0.0 111.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.3 m -62.95 -39.8 95.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 0.0 110.897 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.45 75.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.965 0.906 . . . . 0.0 113.386 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.88 -24.1 21.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -73.04 -29.66 63.16 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.521 1.529 . . . . 0.0 112.337 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.05 52.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.817 1.675 . . . . 0.0 115.077 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 11.1 5.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.456 1.503 . . . . 0.0 112.76 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.75 135.46 56.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.225 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.42 150.27 37.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.814 1.646 . . . . 0.0 111.337 -176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.14 106.28 0.79 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.554 2.836 . . . . 0.0 112.523 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.84 -10.83 10.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.508 2.004 . . . . 0.0 113.75 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.48 118.27 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.345 1.058 . . . . 0.0 110.858 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -75.57 151.1 37.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 112.376 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -136.76 132.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.259 1.424 . . . . 0.0 109.454 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.7 mt -126.62 139.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.736 1.614 . . . . 0.0 109.451 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -132.57 128.16 36.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.43 1.492 . . . . 0.0 111.832 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -136.63 19.97 3.1 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.264 2.225 . . . . 0.0 112.147 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.1 mt -70.87 134.21 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 112.322 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -80.68 160.33 25.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.978 2.111 . . . . 0.0 112.721 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.5 t -131.62 119.16 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.161 1.384 . . . . 0.0 110.95 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.47 110.94 2.41 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.577 1.551 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.71 -6.07 16.98 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.987 2.458 . . . . 0.0 114.812 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.14 -16.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.938 0.895 . . . . 0.0 112.266 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 m -122.59 139.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.583 2.353 . . . . 0.0 110.203 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -128.37 155.54 44.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.273 1.829 . . . . 0.0 109.068 -170.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -139.08 179.79 6.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.09 176.22 2.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.451 1.9 . . . . 0.0 111.922 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -128.93 98.71 5.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 111.054 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.18 9.16 3.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.875 1.27 . . . . 0.0 113.022 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 67.4 m -51.93 -25.09 7.39 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.787 -1.195 . . . . 0.0 113.57 167.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 m -106.94 3.28 25.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.021 2.128 . . . . 0.0 113.818 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.09 -6.11 59.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.373 1.469 . . . . 0.0 113.657 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.21 -48.75 79.23 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.644 1.178 . . . . 0.0 113.2 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -23.6 44.27 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.792 1.661 . . . . 0.0 113.474 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.41 -46.34 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.925 0.784 . . . . 0.0 110.413 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -67.7 -35.47 78.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.999 0.52 . . . . 0.0 111.997 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.0 m -60.69 -44.52 96.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.074 0.949 . . . . 0.0 111.478 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.77 -26.56 67.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.268 0.627 . . . . 0.0 112.636 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.2 m -90.44 0.14 57.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.949 2.1 . . . . 0.0 115.576 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -52.89 -49.27 87.88 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-N 120.423 1.465 . . . . 0.0 114.001 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -84.26 18.39 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.009 2.473 . . . . 0.0 113.465 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mt -110.06 80.43 1.81 Allowed Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 127.014 2.126 . . . . 0.0 107.856 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.88 -21.39 50.48 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.035 2.49 . . . . 0.0 114.557 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -94.57 6.16 49.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.62 1.968 . . . . 0.0 113.509 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -54.81 153.77 5.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.731 1.213 . . . . 0.0 113.844 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.04 164.87 38.01 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.595 1.569 . . . . 0.0 110.768 167.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.46 164.16 30.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.693 -0.886 . . . . 0.0 112.976 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -138.02 152.52 48.94 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.458 1.503 . . . . 0.0 110.374 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 t -144.77 130.24 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.179 1.392 . . . . 0.0 108.682 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 143.75 20.68 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.083 -0.386 . . . . 0.0 112.014 167.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 94.2 mtm-85 42.39 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.124 2.17 . . . . 0.0 114.623 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -122.12 17.0 10.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.504 1.922 . . . . 0.0 113.364 -171.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 61.1 m -138.8 144.45 39.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.272 1.829 . . . . 0.0 112.485 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.66 132.56 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.229 2.212 . . . . 0.0 109.481 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 m -122.26 136.94 54.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 110.25 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mp -136.07 127.64 28.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.319 1.047 . . . . 0.0 110.093 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.0 m -136.14 151.85 50.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.616 1.566 . . . . 0.0 110.489 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.17 -176.41 42.09 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.261 -1.524 . . . . 0.0 113.907 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.2 m -132.78 112.71 12.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.928 1.291 . . . . 0.0 110.005 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.83 159.6 29.11 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.72 2.008 . . . . 0.0 113.67 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.47 -33.24 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.455 2.77 . . . . 0.0 113.143 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 55.2 m -144.68 155.41 43.57 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.491 1.916 . . . . 0.0 111.072 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 p -57.7 -27.6 63.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 113.088 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.42 -42.29 98.73 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.988 1.315 . . . . 0.0 111.624 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -62.56 -43.19 99.43 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.949 0.5 . . . . 0.0 111.912 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -62.72 -42.13 99.5 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.4 -41.19 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.263 1.425 . . . . 0.0 112.036 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.32 89.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.418 0.687 . . . . 0.0 112.054 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.41 -41.03 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 118.298 0.499 . . . . 0.0 111.115 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.14 -42.89 99.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.442 0.697 . . . . 0.0 111.967 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -66.17 -40.43 90.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.355 1.062 . . . . 0.0 111.569 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.36 97.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.002 0.521 . . . . 0.0 111.393 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.42 90.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.066 0.546 . . . . 0.0 111.974 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.0 m -63.43 -40.17 96.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.497 -0.752 . . . . 0.0 111.849 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.2 m -66.37 -35.81 81.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 35.7 m -77.52 -34.59 53.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.03 0.932 . . . . 0.0 112.668 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -126.87 59.64 36.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 0.0 113.553 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.85 -3.65 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.329 2.686 . . . . 0.0 114.834 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.84 20.22 4.6 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.708 2.003 . . . . 0.0 112.606 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.1 ttt -141.99 149.55 40.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.851 1.66 . . . . 0.0 109.976 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -70.42 141.34 52.13 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.146 -0.971 . . . . 0.0 111.142 -171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.65 138.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.545 1.538 . . . . 0.0 110.338 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.86 79.3 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.515 1.926 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -75.34 130.87 39.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.251 -0.906 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.36 5.35 3.76 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.389 2.276 . . . . 0.0 112.173 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 27.6 mt -56.6 143.45 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.835 1.654 . . . . 0.0 110.72 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -126.37 174.29 8.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.898 1.679 . . . . 0.0 111.44 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.09 142.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.539 1.136 . . . . 0.0 109.665 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 13.6 t -58.91 146.46 37.63 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.985 0.914 . . . . 0.0 113.429 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -153.64 12.77 0.57 Allowed Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.311 1.434 . . . . 0.0 114.4 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -145.5 21.03 1.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.729 1.612 . . . . 0.0 112.145 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.58 154.48 0.11 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 128.834 2.854 . . . . 0.0 114.574 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.41 163.79 35.18 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 122.971 2.447 . . . . 0.0 112.226 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.11 160.63 37.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.291 2.661 . . . . 0.0 112.702 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.63 64.49 0.55 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.88 1.229 . . . . 0.0 113.758 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.57 159.0 46.87 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.398 2.732 . . . . 0.0 112.299 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.55 165.9 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.486 2.791 . . . . 0.0 112.618 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.974 2.109 . . . . 0.0 112.068 -178.63 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.18 158.69 44.22 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.031 1.332 . . . . 0.0 111.831 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.9 t -157.98 177.24 11.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.524 1.53 . . . . 0.0 111.377 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.64 125.55 14.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.769 1.628 . . . . 0.0 109.849 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.76 169.03 18.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.661 1.584 . . . . 0.0 112.087 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -145.95 67.05 1.2 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.135 1.374 . . . . 0.0 112.191 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -82.62 167.34 18.37 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.902 1.681 . . . . 0.0 111.999 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 t -36.92 158.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.0 2.92 . . . . 0.0 115.126 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.1 147.7 43.04 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.096 1.758 . . . . 0.0 114.285 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -155.99 153.54 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.976 1.71 . . . . 0.0 111.6 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -137.61 147.68 45.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.367 1.867 . . . . 0.0 111.158 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.46 138.47 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.344 1.857 . . . . 0.0 108.792 169.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 t -147.92 139.56 23.82 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.452 -0.78 . . . . 0.0 112.067 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -109.97 148.07 32.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.4 m -134.93 60.09 1.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.631 2.372 . . . . 0.0 110.948 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.36 -91.71 1.37 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.807 1.194 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -116.74 27.71 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.876 1.67 . . . . 0.0 112.8 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -140.29 131.7 26.84 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.264 1.826 . . . . 0.0 108.61 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.6 138.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 111.226 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -119.41 143.99 47.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.323 1.049 . . . . 0.0 112.252 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.51 110.76 14.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.671 2.388 . . . . 0.0 108.924 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.0 120.32 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.266 1.426 . . . . 0.0 108.679 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.77 -152.88 21.25 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.184 -0.947 . . . . 0.0 114.223 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.78 160.15 43.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.032 2.133 . . . . 0.0 111.895 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HD1' ' HG ' ' A' ' 132' ' ' SER . 9.0 m-85 -157.06 171.63 7.2 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 126.225 1.81 . . . . 0.0 112.227 171.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -65.32 -31.46 52.68 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.547 2.831 . . . . 0.0 114.09 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -157.23 168.6 26.93 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.126 1.441 . . . . 0.0 114.002 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.28 -29.06 70.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.568 1.547 . . . . 0.0 113.182 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.71 70.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.725 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.96 65.42 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -61.17 -40.96 95.83 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.172 -0.955 . . . . 0.0 111.817 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.2 78.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.144 0.978 . . . . 0.0 111.323 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.8 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.15 -46.14 82.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.721 0.691 . . . . 0.0 111.53 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.4 mmm -65.13 -39.88 93.68 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.671 0.788 . . . . 0.0 111.167 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.0 m -63.03 -41.5 99.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.062 0.945 . . . . 0.0 110.658 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.21 -29.28 68.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -92.37 -23.99 19.04 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.67 -32.09 73.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.695 1.598 . . . . 0.0 112.246 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.68 -29.4 49.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.841 1.686 . . . . 0.0 115.139 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.52 15.3 4.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.23 1.412 . . . . 0.0 112.524 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.82 127.21 31.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.68 0.792 . . . . 0.0 111.202 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.97 149.12 38.3 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.874 1.27 . . . . 0.0 111.155 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.29 103.7 0.81 Allowed 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.625 2.883 . . . . 0.0 112.602 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.64 -8.31 10.15 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.421 1.962 . . . . 0.0 113.596 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.88 112.1 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.425 1.113 . . . . 0.0 110.595 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.55 149.29 48.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.209 1.404 . . . . 0.0 111.728 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.4 t -135.51 127.72 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.007 1.323 . . . . 0.0 109.385 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.28 103.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.118 1.367 . . . . 0.0 109.036 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -85.22 123.4 30.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.271 1.028 . . . . 0.0 111.098 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.54 20.41 3.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.896 2.479 . . . . 0.0 111.03 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.27 122.85 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.154 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -80.9 168.73 18.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.204 1.802 . . . . 0.0 112.519 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.99 125.91 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 111.525 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.12 112.28 3.07 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.82 1.648 . . . . 0.0 110.305 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.62 -4.92 15.59 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.59 2.86 . . . . 0.0 114.607 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.05 -1.87 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.491 1.516 . . . . 0.0 113.477 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.77 154.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 128.257 2.623 . . . . 0.0 108.935 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.031 1.332 . . . . 0.0 108.116 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.414 ' HG ' ' HD1' ' A' ' 97' ' ' PHE . 1.2 m -141.71 171.25 14.32 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 178.5 7.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.013 2.125 . . . . 0.0 109.752 165.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.65 168.42 11.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.578 1.551 . . . . 0.0 113.769 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.37 13.78 8.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.131 2.172 . . . . 0.0 112.138 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -56.93 -30.4 63.96 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.697 -1.252 . . . . 0.0 113.384 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -102.86 1.65 34.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 0.0 113.663 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.73 -5.72 58.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.73 1.212 . . . . 0.0 113.787 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -48.78 -50.4 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 O-C-N 121.035 -1.04 . . . . 0.0 113.226 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 -24.55 41.21 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.495 2.13 . . . . 0.0 114.113 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.84 -45.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.569 1.077 . . . . 0.0 110.497 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.42 -33.53 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.223 0.609 . . . . 0.0 112.496 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.8 m -61.05 -43.12 99.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.126 0.875 . . . . 0.0 111.352 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.55 66.08 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.992 0.917 . . . . 0.0 113.448 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -106.45 7.68 31.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.573 1.949 . . . . 0.0 115.236 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.11 -44.97 88.59 Favored Pre-proline 0 N--CA 1.482 1.136 0 O-C-N 120.457 -1.402 . . . . 0.0 113.758 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.81 15.44 1.47 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.826 2.351 . . . . 0.0 113.942 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.478 ' CG2' ' H ' ' A' ' 165' ' ' THR . 13.6 mt -119.41 91.6 44.52 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 126.181 1.792 . . . . 0.0 110.63 -171.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.38 -20.88 31.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.963 2.442 . . . . 0.0 114.821 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.62 1.83 46.71 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.353 1.861 . . . . 0.0 113.819 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.3 149.7 9.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.667 1.187 . . . . 0.0 113.606 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.86 162.91 34.43 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.205 1.384 . . . . 0.0 111.772 167.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.5 tt -141.5 145.04 34.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.953 1.301 . . . . 0.0 108.949 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -140.28 149.75 43.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.981 1.312 . . . . 0.0 111.578 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.71 136.41 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.006 1.322 . . . . 0.0 110.82 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.55 152.84 18.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.536 1.134 . . . . 0.0 111.579 166.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 49.06 -69.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 129.798 3.239 . . . . 0.0 117.424 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.24 15.31 0.91 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.811 2.444 . . . . 0.0 113.658 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -139.66 155.9 47.13 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.136 -1.602 . . . . 0.0 114.276 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.33 110.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.603 1.961 . . . . 0.0 110.438 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.5 m -94.91 138.85 32.12 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.184 1.394 . . . . 0.0 110.708 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.09 124.72 35.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.641 1.576 . . . . 0.0 109.037 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.3 m -129.63 145.12 51.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.893 1.677 . . . . 0.0 110.447 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.7 -172.09 42.41 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 120.764 -1.21 . . . . 0.0 113.93 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.478 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 22.5 p -124.74 71.52 1.17 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.298 2.239 . . . . 0.0 112.908 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.2 149.27 97.17 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.1 -27.07 30.03 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.652 2.901 . . . . 0.0 114.15 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.2 t -148.38 156.87 43.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.465 1.906 . . . . 0.0 110.276 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 62.0 p -58.82 -20.93 54.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.086 0.954 . . . . 0.0 113.205 167.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.91 -47.33 81.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.81 1.244 . . . . 0.0 111.747 170.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -60.2 -40.1 88.85 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.268 0.627 . . . . 0.0 112.032 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.52 -46.27 90.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 0.0 112.256 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.91 -41.67 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.468 0.707 . . . . 0.0 112.092 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.91 95.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 112.407 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.72 -41.78 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.051 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.12 -45.22 93.02 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 111.872 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -69.13 -36.42 77.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.405 0.682 . . . . 0.0 111.351 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.33 86.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.047 0.539 . . . . 0.0 112.062 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.72 94.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.789 0.722 . . . . 0.0 111.907 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 85.7 m -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.688 -0.633 . . . . 0.0 111.933 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 73.7 m -66.68 -35.56 80.44 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.4 m -75.96 -36.92 59.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 112.728 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.01 59.5 45.59 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.305 1.442 . . . . 0.0 113.013 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.64 -5.16 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.175 . . . . 0.0 115.603 -171.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.5 14.79 8.22 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.141 1.777 . . . . 0.0 112.997 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.1 mtm -133.3 164.76 26.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.617 1.967 . . . . 0.0 110.207 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -76.96 152.75 35.13 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.348 -0.845 . . . . 0.0 111.741 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.99 136.93 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.099 1.36 . . . . 0.0 109.418 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.1 t -126.1 89.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.985 1.314 . . . . 0.0 109.618 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.95 65.57 1.44 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.674 2.39 . . . . 0.0 112.337 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -71.12 5.46 2.1 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.347 2.259 . . . . 0.0 114.387 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.1 mm -50.96 143.7 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.416 1.886 . . . . 0.0 111.301 171.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -128.56 173.33 10.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.879 1.672 . . . . 0.0 110.268 168.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.9 t -87.26 144.12 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.882 0.873 . . . . 0.0 109.455 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 13.5 t -55.18 149.89 11.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.443 1.497 . . . . 0.0 113.996 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -177.62 42.76 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.464 1.506 . . . . 0.0 112.45 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -137.63 122.89 19.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.617 1.567 . . . . 0.0 110.499 -171.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.79 154.22 86.13 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.818 1.247 . . . . 0.0 113.107 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.63 160.57 47.5 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 123.155 2.57 . . . . 0.0 111.915 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.04 143.45 72.18 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.021 2.481 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 173.09 60.14 0.05 OUTLIER Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.566 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.15 157.75 58.17 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.424 2.749 . . . . 0.0 113.033 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.9 170.53 19.47 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.836 3.024 . . . . 0.0 112.61 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.613 1.965 . . . . 0.0 111.929 -179.93 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.65 166.64 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 127.284 2.233 . . . . 0.0 115.528 -172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 m -74.3 120.95 20.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.618 1.167 . . . . 0.0 111.09 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.18 58.2 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.726 0.811 . . . . 0.0 112.45 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.49 136.67 22.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.982 1.313 . . . . 0.0 109.977 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 t -86.66 116.5 24.81 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 112.549 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.92 171.91 7.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.479 2.312 . . . . 0.0 110.603 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.17 157.35 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 129.89 3.276 . . . . 0.0 114.981 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 tt -95.28 129.86 42.25 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.601 1.561 . . . . 0.0 110.777 167.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -153.79 140.98 19.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.235 1.014 . . . . 0.0 109.182 -175.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.429 ' N ' HD13 ' A' ' 82' ' ' LEU . 88.3 p -146.49 160.44 42.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 123.209 1.48 . . . . 0.0 113.371 172.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 tt -144.64 144.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.067 1.347 . . . . 0.0 109.715 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 t -142.58 141.16 31.94 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.011 0.524 . . . . 0.0 111.899 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -108.4 148.66 29.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.462 1.505 . . . . 0.0 112.141 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.3 m -137.18 60.29 1.65 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.037 2.135 . . . . 0.0 111.509 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.28 -89.06 1.38 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.545 1.069 . . . . 0.0 113.135 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -121.22 29.75 7.15 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.063 1.745 . . . . 0.0 112.099 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 96.6 m -141.02 136.29 31.95 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.998 2.119 . . . . 0.0 108.113 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.32 143.0 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.338 1.055 . . . . 0.0 111.418 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.0 m -126.78 126.11 42.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.216 1.006 . . . . 0.0 111.507 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.84 129.97 49.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.16 2.184 . . . . 0.0 110.379 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.26 144.07 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.077 1.351 . . . . 0.0 109.122 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 152.51 -147.77 17.86 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 119.964 -1.71 . . . . 0.0 115.466 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -154.41 143.56 21.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.326 2.65 . . . . 0.0 110.923 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -152.51 170.72 7.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.775 1.23 . . . . 0.0 112.426 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.71 -29.32 10.75 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.808 3.005 . . . . 0.0 114.287 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -159.57 172.08 18.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.356 1.55 . . . . 0.0 114.836 -171.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.41 -34.22 73.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.277 1.831 . . . . 0.0 112.985 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.66 71.16 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.074 0.55 . . . . 0.0 111.547 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.74 75.76 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.974 0.509 . . . . 0.0 112.274 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -63.19 -41.88 99.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.582 0.753 . . . . 0.0 111.804 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.62 84.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.388 0.675 . . . . 0.0 112.451 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.89 76.26 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.653 -0.654 . . . . 0.0 112.713 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.2 -40.58 90.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.652 1.181 . . . . 0.0 111.321 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -73.82 -32.46 63.71 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.746 -0.596 . . . . 0.0 112.109 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -65.48 -39.22 91.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.027 0.931 . . . . 0.0 110.98 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.15 79.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.978 0.911 . . . . 0.0 113.119 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.9 -24.83 24.7 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.92 -28.24 67.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.676 1.59 . . . . 0.0 112.203 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -53.7 -28.16 37.46 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.792 2.139 . . . . 0.0 115.388 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 146' ' ' VAL . 0.9 OUTLIER -135.32 15.15 3.48 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 113.598 174.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -55.9 127.38 30.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.93 0.892 . . . . 0.0 111.267 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.39 149.26 44.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.157 1.383 . . . . 0.0 111.176 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.87 102.76 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.529 2.819 . . . . 0.0 112.665 -174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.4 -8.7 8.36 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.742 2.115 . . . . 0.0 113.852 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.57 113.83 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.477 1.139 . . . . 0.0 111.055 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -73.68 153.14 40.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.906 1.682 . . . . 0.0 112.267 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.63 133.64 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.706 1.203 . . . . 0.0 109.846 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.0 mt -128.66 141.27 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.266 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -130.06 128.49 42.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.887 1.275 . . . . 0.0 112.766 -171.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.8 17.96 3.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.339 2.256 . . . . 0.0 112.73 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.81 130.77 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.811 1.244 . . . . 0.0 110.954 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -86.6 164.11 17.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.922 1.689 . . . . 0.0 112.373 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.85 120.79 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.118 1.367 . . . . 0.0 111.657 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.07 130.46 5.27 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.346 1.859 . . . . 0.0 110.156 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.27 -4.68 15.42 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.775 2.983 . . . . 0.0 114.691 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -15.14 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 126.002 1.721 . . . . 0.0 112.58 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.98 145.43 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 128.022 2.529 . . . . 0.0 110.491 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -141.68 150.85 42.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.282 1.833 . . . . 0.0 109.013 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -126.21 168.22 14.37 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.871 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -69.69 155.45 40.49 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.814 2.846 . . . . 0.0 108.586 167.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.35 88.19 7.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.379 1.072 . . . . 0.0 113.373 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -61.58 -8.65 4.62 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.717 -1.24 . . . . 0.0 113.55 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 m -49.17 -29.5 5.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.085 1.754 . . . . 0.0 112.506 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 m -108.97 2.33 21.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.63 2.372 . . . . 0.0 113.488 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.42 -2.96 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.852 1.661 . . . . 0.0 113.647 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.45 -47.66 83.17 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.761 1.224 . . . . 0.0 113.187 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.51 -27.01 46.71 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.807 1.671 . . . . 0.0 113.632 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.93 -45.32 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.948 0.795 . . . . 0.0 110.775 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -74.49 -30.11 61.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.152 0.581 . . . . 0.0 112.398 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -62.42 -44.2 97.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.481 1.112 . . . . 0.0 111.408 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.79 -17.0 64.66 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -112.95 3.06 16.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.523 1.929 . . . . 0.0 115.542 -177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 113' ' ' LEU . 91.3 t -53.62 -40.37 80.02 Favored Pre-proline 0 N--CA 1.481 1.096 0 O-C-N 120.132 -1.605 . . . . 0.0 113.858 167.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.41 14.25 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.68 2.254 . . . . 0.0 114.065 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.1 mt -120.69 84.34 37.09 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.964 2.106 . . . . 0.0 109.308 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.45 -17.79 58.36 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.44 2.76 . . . . 0.0 115.297 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -105.77 5.54 30.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.423 2.289 . . . . 0.0 113.913 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -56.53 152.28 12.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.252 1.025 . . . . 0.0 113.251 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.57 35.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.654 1.597 . . . . 0.0 112.356 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.62 150.35 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.296 1.438 . . . . 0.0 109.584 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -139.21 142.3 37.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.479 1.112 . . . . 0.0 109.089 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.6 t -143.45 128.45 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.713 1.205 . . . . 0.0 109.063 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.45 155.03 29.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 36.54 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.058 2.543 . . . . 0.0 114.971 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.1 15.32 8.46 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.841 2.056 . . . . 0.0 113.171 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -139.43 145.1 38.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.616 1.566 . . . . 0.0 112.609 -171.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.25 141.09 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.429 1.892 . . . . 0.0 110.257 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.3 m -132.49 135.08 45.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 109.6 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.85 125.36 33.42 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.192 1.397 . . . . 0.0 109.564 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.9 m -134.86 131.21 37.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.888 1.275 . . . . 0.0 110.244 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.99 -174.47 45.32 Favored Glycine 0 CA--C 1.538 1.473 0 O-C-N 120.879 -1.138 . . . . 0.0 112.882 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -126.88 80.51 1.95 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.954 1.702 . . . . 0.0 113.726 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.74 153.87 90.01 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.763 1.625 . . . . 0.0 114.751 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -25.54 16.04 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 114.634 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.8 t -153.29 157.53 40.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.33 1.852 . . . . 0.0 110.71 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 p -59.64 -24.08 63.56 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.289 1.036 . . . . 0.0 113.41 169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.65 -44.07 87.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.546 1.138 . . . . 0.0 111.32 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -61.95 -39.68 92.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.232 0.613 . . . . 0.0 111.992 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -60.54 -43.34 97.31 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.183 0.901 . . . . 0.0 112.716 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.39 -43.51 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.368 0.667 . . . . 0.0 112.11 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.65 84.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.75 0.82 . . . . 0.0 112.195 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.3 -39.62 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.408 0.549 . . . . 0.0 110.836 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -64.33 -43.61 94.08 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.678 0.672 . . . . 0.0 111.737 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -67.59 -37.15 82.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.956 0.903 . . . . 0.0 112.136 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.84 83.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.809 0.444 . . . . 0.0 110.869 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.44 -37.56 87.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.931 0.492 . . . . 0.0 112.044 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.4 m -68.84 -36.64 78.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.652 0.781 . . . . 0.0 111.734 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 t -68.05 -38.69 82.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.185 0.994 . . . . 0.0 112.376 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 41.9 m -72.86 -40.02 66.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.093 0.957 . . . . 0.0 112.339 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -129.77 61.1 56.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.411 1.484 . . . . 0.0 113.906 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.63 -13.14 32.23 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.221 2.614 . . . . 0.0 113.154 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -98.9 3.17 47.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.818 2.047 . . . . 0.0 113.483 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -133.86 164.32 27.52 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.344 1.857 . . . . 0.0 111.691 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -76.65 150.78 36.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.529 0.732 . . . . 0.0 110.808 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.54 133.51 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.271 1.429 . . . . 0.0 109.92 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.75 84.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.891 1.676 . . . . 0.0 109.486 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.18 70.34 3.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.622 1.569 . . . . 0.0 111.48 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -68.3 -9.61 48.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.799 2.04 . . . . 0.0 114.251 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.4 pt -58.12 156.09 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.268 1.427 . . . . 0.0 112.861 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.2 173.7 11.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.782 1.233 . . . . 0.0 110.968 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.38 141.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.628 0.771 . . . . 0.0 109.094 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 14.9 t -56.41 151.1 13.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.477 1.111 . . . . 0.0 113.0 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -112.98 8.54 25.35 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.246 1.403 . . . . 0.0 114.793 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -150.32 140.14 21.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.963 1.305 . . . . 0.0 111.548 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -156.88 57.13 1.29 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.287 1.835 . . . . 0.0 111.984 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 154.27 75.12 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.225 2.617 . . . . 0.0 112.636 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.38 143.18 47.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.313 2.675 . . . . 0.0 112.203 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 159.73 178.07 33.4 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.893 1.235 . . . . 0.0 113.473 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.79 160.11 50.47 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.498 2.799 . . . . 0.0 112.109 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.21 115.2 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.426 2.75 . . . . 0.0 110.982 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.311 1.844 . . . . 0.0 112.137 -177.797 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.35 51.75 1.36 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.776 1.23 . . . . 0.0 112.602 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 t -151.71 135.77 16.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.108 1.763 . . . . 0.0 110.337 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.3 37.6 0.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.203 1.401 . . . . 0.0 112.211 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.86 123.66 22.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.071 1.348 . . . . 0.0 110.931 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -74.88 135.94 41.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.033 1.333 . . . . 0.0 111.846 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.1 mt -137.15 169.1 18.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.945 2.098 . . . . 0.0 112.369 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.96 151.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.544 2.738 . . . . 0.0 114.199 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.58 129.03 54.58 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.378 1.871 . . . . 0.0 111.643 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -154.06 154.93 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.565 1.146 . . . . 0.0 112.447 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -138.03 145.99 42.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.985 2.114 . . . . 0.0 110.787 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 tt -140.24 139.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.25 1.42 . . . . 0.0 109.153 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 t -146.8 143.49 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -105.02 148.12 27.09 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.657 1.583 . . . . 0.0 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.3 m -135.17 63.58 1.61 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.484 2.314 . . . . 0.0 111.407 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 -88.71 1.26 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.745 1.164 . . . . 0.0 113.058 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -122.53 34.15 5.23 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.063 1.745 . . . . 0.0 111.871 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.7 m -143.68 140.7 30.18 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.563 2.345 . . . . 0.0 108.239 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.24 143.97 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.381 1.073 . . . . 0.0 111.316 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.5 m -127.11 130.44 49.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.352 1.061 . . . . 0.0 111.562 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 122.75 47.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.21 2.204 . . . . 0.0 110.123 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.87 116.75 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.575 1.15 . . . . 0.0 109.313 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.77 -161.02 32.25 Favored Glycine 0 CA--C 1.525 0.719 0 O-C-N 120.502 -1.374 . . . . 0.0 114.727 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.14 142.21 24.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.073 2.149 . . . . 0.0 111.331 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -152.44 169.77 9.07 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.285 1.434 . . . . 0.0 112.749 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.26 -25.51 11.4 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.845 3.03 . . . . 0.0 114.179 174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -155.54 164.22 38.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.688 1.595 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -66.36 -26.35 67.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.615 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -29.94 69.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.457 0.703 . . . . 0.0 112.005 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.24 75.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.325 0.65 . . . . 0.0 112.606 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.9 -42.3 99.74 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.629 1.172 . . . . 0.0 111.371 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.74 82.71 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.745 0.818 . . . . 0.0 111.767 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.22 91.74 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.35 -39.4 89.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 111.754 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.21 -38.68 82.19 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.325 -0.86 . . . . 0.0 112.097 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -63.32 -40.94 98.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.442 1.097 . . . . 0.0 110.981 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -33.74 76.23 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.254 1.021 . . . . 0.0 112.978 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.52 -26.8 24.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.29 -27.73 66.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.806 1.642 . . . . 0.0 112.355 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.75 -29.26 25.5 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.918 2.199 . . . . 0.0 115.306 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.1 16.76 2.81 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.343 1.057 . . . . 0.0 113.523 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -56.28 133.39 52.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.86 0.864 . . . . 0.0 111.477 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.06 34.0 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.291 1.436 . . . . 0.0 111.216 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 103.21 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.578 2.852 . . . . 0.0 112.393 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.6 -9.94 6.82 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.607 2.051 . . . . 0.0 113.783 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.83 112.91 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 118.553 1.177 . . . . 0.0 110.795 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.98 158.46 36.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.866 1.667 . . . . 0.0 112.592 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -136.62 133.2 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.104 1.361 . . . . 0.0 109.807 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.8 139.48 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.191 1.797 . . . . 0.0 108.971 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -127.59 126.13 41.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 113.16 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -137.35 23.53 2.97 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.761 2.424 . . . . 0.0 111.684 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.6 144.98 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 120.768 -1.207 . . . . 0.0 111.22 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -116.2 161.66 18.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.17 1.788 . . . . 0.0 111.903 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -131.3 120.72 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.358 1.463 . . . . 0.0 111.765 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.42 129.75 4.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.608 1.963 . . . . 0.0 110.167 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.49 -3.23 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.085 3.19 . . . . 0.0 115.039 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.5 t -66.13 -19.25 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.714 2.006 . . . . 0.0 112.505 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.26 139.67 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 127.485 2.314 . . . . 0.0 109.824 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -144.98 146.83 32.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.429 1.892 . . . . 0.0 108.982 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.08 -179.82 6.0 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.68 174.64 1.31 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.682 2.393 . . . . 0.0 110.816 166.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.66 155.89 17.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.795 1.238 . . . . 0.0 112.056 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.75 0.26 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.122 1.369 . . . . 0.0 113.264 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.4 m -56.74 -40.11 75.14 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.105 -0.997 . . . . 0.0 111.699 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.1 m -83.28 -7.33 59.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.589 1.556 . . . . 0.0 114.167 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.84 -1.65 54.58 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.815 1.646 . . . . 0.0 114.32 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -45.58 -47.92 37.22 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.391 1.076 . . . . 0.0 113.132 169.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -24.22 54.63 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.125 1.884 . . . . 0.0 113.94 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.9 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.193 0.906 . . . . 0.0 110.813 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.94 -37.89 76.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.748 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.4 m -58.42 -41.35 84.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.64 -12.16 61.01 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 m -117.21 -5.46 11.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.622 1.969 . . . . 0.0 115.839 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.69 -40.82 80.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-N 121.867 2.121 . . . . 0.0 115.739 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.42 -8.32 23.08 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 CA-C-N 122.688 1.996 . . . . 0.0 114.373 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.419 ' CG2' ' H ' ' A' ' 165' ' ' THR . 24.8 mt -83.3 119.21 73.62 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.351 1.46 . . . . 0.0 110.934 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.87 -24.61 9.81 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.78 2.32 . . . . 0.0 115.39 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -113.47 8.5 17.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.402 1.881 . . . . 0.0 114.001 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -56.44 148.1 20.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.745 0.818 . . . . 0.0 112.934 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.32 166.72 39.01 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.532 1.063 . . . . 0.0 112.414 171.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.56 150.93 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.174 1.389 . . . . 0.0 110.3 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.57 145.51 47.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.365 1.066 . . . . 0.0 110.256 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.55 129.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.882 1.273 . . . . 0.0 108.672 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -159.61 158.92 32.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.329 0.652 . . . . 0.0 112.364 170.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 43.82 -89.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.556 2.342 . . . . 0.0 114.194 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.93 24.86 3.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.769 2.028 . . . . 0.0 111.727 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 20.2 m -135.74 142.3 44.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.803 1.641 . . . . 0.0 112.327 -171.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.14 129.32 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.544 1.938 . . . . 0.0 110.547 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 m -125.64 137.28 53.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.385 1.474 . . . . 0.0 110.666 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.2 125.53 31.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.354 1.462 . . . . 0.0 109.877 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 m -132.78 152.9 51.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.745 1.618 . . . . 0.0 110.416 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.05 -167.02 37.22 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 120.741 -1.224 . . . . 0.0 114.568 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.419 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 21.4 p -136.03 70.62 1.42 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.733 2.013 . . . . 0.0 112.861 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.19 153.14 95.47 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.6 1.56 . . . . 0.0 114.94 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.94 -27.87 20.29 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.608 2.872 . . . . 0.0 114.323 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.2 t -151.55 156.68 41.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.046 1.739 . . . . 0.0 111.139 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.1 m -58.33 -21.4 49.33 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.488 1.115 . . . . 0.0 113.409 167.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.44 -46.77 87.02 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.216 1.006 . . . . 0.0 111.614 170.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -59.77 -42.19 92.75 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.173 0.589 . . . . 0.0 111.791 170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -62.18 -44.59 96.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.835 0.743 . . . . 0.0 112.685 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.72 -42.15 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 111.82 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.63 -40.93 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.14 0.576 . . . . 0.0 111.059 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -64.87 -41.5 95.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.292 1.037 . . . . 0.0 111.846 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -69.23 -34.84 75.45 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.561 1.144 . . . . 0.0 112.521 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.94 83.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 117.929 0.331 . . . . 0.0 111.199 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.76 92.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.99 0.916 . . . . 0.0 112.513 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 t -74.4 -28.24 61.0 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.723 -0.611 . . . . 0.0 112.158 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -39.42 71.7 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.857 0.863 . . . . 0.0 112.81 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 183' ' ' TRP . 11.1 t -79.58 -31.68 41.86 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.646 ' CD2' HG23 ' A' ' 182' ' ' THR . 2.7 m-90 -128.91 60.51 50.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.355 1.462 . . . . 0.0 114.029 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.58 -14.6 30.51 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.352 2.702 . . . . 0.0 114.859 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -95.72 -8.55 34.24 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.241 1.016 . . . . 0.0 113.453 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 98.7 mtp -106.43 160.77 15.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 112.507 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -67.35 142.85 56.65 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.466 0.706 . . . . 0.0 109.484 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.63 127.35 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 110.243 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.54 97.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.496 1.118 . . . . 0.0 110.767 -171.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -75.72 123.04 24.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.309 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -129.14 5.68 5.33 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.825 2.45 . . . . 0.0 111.6 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.0 mt -61.99 142.05 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.901 1.68 . . . . 0.0 110.529 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.02 -179.28 4.1 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.276 2.231 . . . . 0.0 110.261 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.0 t -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 120.948 -1.095 . . . . 0.0 111.179 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.0 t -55.55 158.51 3.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.432 1.893 . . . . 0.0 114.316 171.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.16 13.66 28.62 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.849 1.69 . . . . 0.0 113.305 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -143.14 -154.54 0.53 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.313 1.845 . . . . 0.0 110.29 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 45.56 56.45 15.4 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 126.286 1.834 . . . . 0.0 115.191 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.21 160.77 45.96 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.501 2.801 . . . . 0.0 112.617 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.36 159.39 53.54 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.389 2.726 . . . . 0.0 112.93 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.71 60.29 0.12 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.554 1.073 . . . . 0.0 113.568 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.4 157.73 58.82 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.534 2.823 . . . . 0.0 113.011 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.63 170.58 19.66 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.852 3.035 . . . . 0.0 112.655 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.942 1.697 . . . . 0.0 113.288 175.436 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 122.598 1.189 . . . . 0.0 113.924 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.43 163.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 129.728 3.211 . . . . 0.0 114.058 167.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.8 138.72 45.77 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.679 1.591 . . . . 0.0 112.331 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD21 ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -155.62 148.47 24.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.42 1.488 . . . . 0.0 110.507 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.6 p -151.38 159.51 44.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.195 1.474 . . . . 0.0 113.387 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.81 141.67 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.337 1.855 . . . . 0.0 108.781 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.6 p -143.36 146.66 33.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.573 0.749 . . . . 0.0 112.461 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -112.93 149.0 33.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.647 1.579 . . . . 0.0 111.833 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.5 m -136.3 58.2 1.75 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.336 2.254 . . . . 0.0 111.222 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.06 -86.92 1.18 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.572 1.082 . . . . 0.0 113.434 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -120.56 30.12 7.09 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.26 1.824 . . . . 0.0 112.245 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -142.34 137.76 30.75 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.184 2.193 . . . . 0.0 108.226 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.96 142.5 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.439 1.096 . . . . 0.0 111.282 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -127.35 130.46 49.49 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.923 1.289 . . . . 0.0 111.165 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.67 122.0 41.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.755 2.022 . . . . 0.0 110.524 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.3 mm -134.06 132.12 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.911 1.684 . . . . 0.0 109.722 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 165.19 -159.71 32.9 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.025 -1.672 . . . . 0.0 116.294 -172.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -158.37 145.1 17.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.94 2.496 . . . . 0.0 110.116 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HD21 ' A' ' 82' ' ' LEU . 16.1 m-85 -152.44 169.97 8.76 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.523 1.129 . . . . 0.0 113.002 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.79 -29.11 35.91 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.818 3.012 . . . . 0.0 113.664 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -152.76 162.87 40.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.36 1.552 . . . . 0.0 113.005 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.56 -27.34 69.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.425 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.08 70.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.434 0.694 . . . . 0.0 112.209 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -39.27 70.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.525 0.678 . . . . 0.0 111.864 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.9 -40.75 96.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.974 2.11 . . . . 0.0 112.385 170.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.48 -34.53 78.49 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.024 1.33 . . . . 0.0 112.366 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.27 80.0 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.233 -0.917 . . . . 0.0 112.436 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -65.26 -42.34 93.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.737 0.815 . . . . 0.0 111.288 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.6 ptp -74.82 -27.85 60.46 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -68.47 -40.0 81.17 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.41 -34.15 76.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.089 0.956 . . . . 0.0 112.795 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.66 -28.66 26.26 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -64.45 -28.93 70.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.864 1.266 . . . . 0.0 112.363 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -28.38 28.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.796 2.141 . . . . 0.0 115.393 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 tp -137.76 16.55 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.551 1.14 . . . . 0.0 113.274 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tt -58.59 137.13 57.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 111.403 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.46 147.17 32.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.738 1.615 . . . . 0.0 111.377 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.51 104.53 0.65 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.704 2.936 . . . . 0.0 112.283 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.58 -11.15 7.12 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.499 2.0 . . . . 0.0 113.727 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -69.32 113.08 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 118.358 1.079 . . . . 0.0 110.499 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -72.14 154.05 41.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.445 1.498 . . . . 0.0 112.371 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 t -137.09 131.02 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.285 1.434 . . . . 0.0 109.767 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.4 mt -129.55 141.84 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.186 1.794 . . . . 0.0 109.309 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.76 138.19 44.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.936 1.294 . . . . 0.0 113.043 -171.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.2 17.69 2.43 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.586 1.955 . . . . 0.0 112.672 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.39 124.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.946 -1.096 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -84.31 167.2 16.79 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.839 2.456 . . . . 0.0 113.102 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -133.11 125.04 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.193 1.397 . . . . 0.0 111.342 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -153.96 127.19 4.21 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.545 1.938 . . . . 0.0 110.742 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.34 -7.38 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.618 2.212 . . . . 0.0 114.723 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 p -70.3 -11.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.683 1.129 . . . . 0.0 113.742 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.89 147.34 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.323 1.849 . . . . 0.0 111.373 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -142.86 152.48 42.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.278 1.831 . . . . 0.0 110.687 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -145.32 177.9 8.48 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -175.79 0.26 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.02 2.528 . . . . 0.0 110.603 164.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -134.78 107.45 7.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.703 1.201 . . . . 0.0 111.743 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -69.01 -1.82 8.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 m -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 171.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.6 m -85.62 -12.09 52.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.179 1.792 . . . . 0.0 113.926 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -88.97 0.85 56.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.975 1.71 . . . . 0.0 114.125 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -45.54 -47.57 36.98 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 120.998 -1.063 . . . . 0.0 113.378 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.4 -22.76 38.86 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.364 2.043 . . . . 0.0 114.127 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -44.98 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.292 0.951 . . . . 0.0 110.474 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.73 -32.15 69.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.9 m -57.89 -42.01 83.74 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.084 0.856 . . . . 0.0 111.488 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.84 66.1 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.4 p -116.61 6.13 13.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.589 1.955 . . . . 0.0 116.165 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.2 t -52.28 -42.17 85.34 Favored Pre-proline 0 N--CA 1.482 1.172 0 O-C-N 120.185 -1.572 . . . . 0.0 113.58 167.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.86 12.49 1.95 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.672 2.248 . . . . 0.0 114.353 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 mt -113.96 97.74 45.81 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.264 1.826 . . . . 0.0 109.956 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.98 -23.48 21.79 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.906 2.404 . . . . 0.0 114.885 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.13 6.72 43.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.363 1.865 . . . . 0.0 113.653 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -52.42 152.1 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.959 1.304 . . . . 0.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.15 163.31 35.91 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.872 1.225 . . . . 0.0 111.769 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -140.75 149.6 42.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.269 1.028 . . . . 0.0 109.355 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 153.3 48.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.702 1.601 . . . . 0.0 110.868 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -143.52 133.73 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.101 1.36 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.12 146.09 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 112.484 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 51.36 -71.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 129.304 3.041 . . . . 0.0 117.997 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -144.95 21.0 1.61 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.37 1.868 . . . . 0.0 113.694 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -136.53 140.97 43.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.772 1.629 . . . . 0.0 111.139 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.23 131.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.829 2.052 . . . . 0.0 107.977 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.3 m -122.56 132.17 54.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.972 1.309 . . . . 0.0 110.128 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.64 123.77 36.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.312 1.445 . . . . 0.0 109.169 -173.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.0 t -135.23 152.34 51.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.687 1.195 . . . . 0.0 112.129 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 159.42 -178.41 35.56 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.78 -1.2 . . . . 0.0 114.046 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.3 p -120.7 84.65 2.26 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.598 2.359 . . . . 0.0 111.869 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.6 149.7 81.29 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.79 -30.36 27.34 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.558 2.838 . . . . 0.0 113.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t -152.21 164.5 37.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.64 1.176 . . . . 0.0 112.092 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -61.52 -21.61 64.39 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.616 1.166 . . . . 0.0 113.845 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -64.85 -40.28 94.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.222 1.009 . . . . 0.0 111.38 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -65.91 -39.95 91.03 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.015 -0.428 . . . . 0.0 111.958 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.74 -42.83 94.02 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.002 0.819 . . . . 0.0 112.585 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.78 -41.26 87.98 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 112.713 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.54 81.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.525 0.73 . . . . 0.0 112.424 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.33 -38.39 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.075 0.852 . . . . 0.0 110.553 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -61.45 -45.16 95.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.192 0.597 . . . . 0.0 111.293 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -61.94 -42.9 99.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.469 0.708 . . . . 0.0 112.204 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.03 92.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.663 0.385 . . . . 0.0 111.373 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.56 78.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.22 0.608 . . . . 0.0 112.371 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.8 m -67.85 -38.62 83.37 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.703 0.801 . . . . 0.0 111.734 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -35.95 74.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.66 -36.91 50.92 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.145 0.978 . . . . 0.0 112.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -135.74 64.27 56.24 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.615 1.566 . . . . 0.0 113.307 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.16 -3.92 14.5 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.449 2.766 . . . . 0.0 114.316 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.28 20.09 6.85 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.678 1.991 . . . . 0.0 113.062 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.3 mtt -135.7 163.5 30.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.775 1.63 . . . . 0.0 110.805 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -70.79 143.07 51.28 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.608 -0.683 . . . . 0.0 109.643 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 pt -137.41 86.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.72 1.608 . . . . 0.0 111.694 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.8 t -82.56 92.55 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.201 1.4 . . . . 0.0 110.687 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.76 68.92 4.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.599 1.56 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -68.03 -5.68 18.65 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.24 1.816 . . . . 0.0 114.542 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -42.21 137.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.832 2.053 . . . . 0.0 111.701 171.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 124.884 1.274 . . . . 0.0 110.955 172.601 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 CA--C 1.551 1.003 0 CA-C-O 122.048 0.928 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 m -41.23 164.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.872 3.269 . . . . 0.0 115.251 168.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.73 139.89 52.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.712 1.605 . . . . 0.0 112.381 166.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 tt -159.92 154.76 24.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.338 1.455 . . . . 0.0 111.784 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -139.42 150.31 45.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.556 1.942 . . . . 0.0 111.705 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -142.43 138.76 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.819 1.648 . . . . 0.0 108.885 171.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -145.88 142.73 29.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -107.0 148.99 28.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.125 1.77 . . . . 0.0 112.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.7 t -141.09 99.19 3.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.713 1.605 . . . . 0.0 110.943 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.77 -96.8 0.1 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.311 1.91 . . . . 0.0 113.619 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -120.58 34.95 5.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.15 1.78 . . . . 0.0 112.234 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -141.39 137.35 32.22 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.861 2.065 . . . . 0.0 108.89 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.83 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.256 1.022 . . . . 0.0 111.541 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.3 m -125.97 129.43 49.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.515 1.126 . . . . 0.0 111.165 -171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.468 ' CB ' HD11 ' A' ' 124' ' ' ILE . 7.6 mp -113.31 126.93 55.93 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.508 1.923 . . . . 0.0 110.1 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.1 mt -139.61 127.43 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.075 1.35 . . . . 0.0 109.257 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.48 -155.89 26.43 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.618 -1.301 . . . . 0.0 115.242 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.22 150.32 25.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.345 1.858 . . . . 0.0 112.289 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -152.34 170.12 8.52 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.323 1.849 . . . . 0.0 112.309 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.62 -31.8 32.3 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.382 3.388 . . . . 0.0 113.805 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.55 164.76 38.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 123.255 1.502 . . . . 0.0 112.813 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -60.57 -32.0 71.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.769 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 112.149 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -37.86 67.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.157 0.583 . . . . 0.0 111.992 172.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.648 ' HD2' HD13 ' A' ' 124' ' ' ILE . 5.4 ttpt -67.53 -34.81 77.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.69 1.196 . . . . 0.0 112.838 171.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.26 74.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.406 1.082 . . . . 0.0 111.632 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.32 80.71 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.623 -0.673 . . . . 0.0 112.809 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.66 -42.77 98.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.816 0.847 . . . . 0.0 111.458 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 28.8 ptm -73.39 -30.93 63.6 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.763 -0.586 . . . . 0.0 112.34 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.9 m -66.65 -40.34 88.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.086 0.954 . . . . 0.0 111.158 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.29 -31.91 72.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.313 1.045 . . . . 0.0 113.121 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.6 -25.34 21.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.58 -32.23 70.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.876 1.27 . . . . 0.0 112.246 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.14 -27.85 57.91 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.747 1.641 . . . . 0.0 115.117 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 14.41 6.08 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.502 1.521 . . . . 0.0 112.552 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.2 129.02 38.44 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.122 0.969 . . . . 0.0 111.383 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.83 41.42 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.555 1.542 . . . . 0.0 111.505 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.48 104.15 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.353 2.702 . . . . 0.0 112.97 -172.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.87 -9.09 9.83 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.78 2.133 . . . . 0.0 113.678 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.9 t -71.28 110.44 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 118.312 1.056 . . . . 0.0 111.799 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.23 156.42 39.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.381 1.873 . . . . 0.0 112.363 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.75 134.72 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.146 1.379 . . . . 0.0 109.623 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.84 140.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.253 1.821 . . . . 0.0 108.765 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.04 131.57 49.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.104 1.362 . . . . 0.0 112.163 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -140.35 24.95 2.27 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.279 2.231 . . . . 0.0 112.058 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 124' ' ' ILE . 1.3 mp -82.49 129.83 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.766 1.226 . . . . 0.0 111.022 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -92.84 169.63 10.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.178 1.391 . . . . 0.0 113.46 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.89 119.49 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.751 1.621 . . . . 0.0 110.694 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.25 126.24 5.07 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.596 2.358 . . . . 0.0 110.034 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.7 -4.2 14.19 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.321 2.681 . . . . 0.0 114.473 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.6 t -71.0 -13.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.398 1.879 . . . . 0.0 112.732 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.64 153.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.926 2.09 . . . . 0.0 110.555 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -146.71 143.84 29.01 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.32 1.848 . . . . 0.0 108.424 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 m -128.16 171.17 12.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.137 1.335 . . . . 0.0 114.476 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.61 176.01 4.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.131 1.772 . . . . 0.0 109.697 165.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -118.38 102.68 9.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.946 0.898 . . . . 0.0 112.295 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -69.77 -2.98 13.51 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.8 m -54.61 -33.89 61.15 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.901 -1.125 . . . . 0.0 112.492 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.6 m -96.32 1.8 52.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 113.676 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -91.44 -5.71 53.91 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.891 1.676 . . . . 0.0 113.455 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -45.91 -48.22 40.88 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.04 1.336 . . . . 0.0 113.006 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.56 -24.78 41.58 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.9 1.733 . . . . 0.0 113.862 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.35 -44.0 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.223 0.92 . . . . 0.0 110.407 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.23 -35.55 78.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.211 0.604 . . . . 0.0 112.214 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.9 m -59.71 -42.61 93.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.838 0.855 . . . . 0.0 111.554 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.23 -17.52 64.79 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 m -104.62 1.94 30.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.314 2.246 . . . . 0.0 114.884 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.31 -44.53 93.69 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-O 117.388 -1.291 . . . . 0.0 114.161 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.81 14.37 2.35 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.725 2.283 . . . . 0.0 114.193 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.3 93.78 23.84 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 109.761 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.53 -21.06 26.37 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.844 3.029 . . . . 0.0 116.657 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -107.4 13.0 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.079 1.752 . . . . 0.0 113.067 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.06 148.13 8.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 113.116 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.9 161.76 33.06 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 124.624 1.107 . . . . 0.0 111.58 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 tp -134.09 146.55 50.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.494 1.118 . . . . 0.0 109.114 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -135.73 151.6 50.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.986 0.915 . . . . 0.0 110.748 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -143.19 132.25 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.884 1.274 . . . . 0.0 109.05 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.23 155.08 28.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 167.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 41.39 -86.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.156 2.583 . . . . 0.0 114.991 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -140.64 29.54 1.93 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.907 1.23 . . . . 0.0 112.564 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.0 m -137.86 142.08 40.72 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.871 2.068 . . . . 0.0 110.67 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.64 142.91 31.27 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 125.527 1.531 . . . . 0.0 111.378 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 m -125.58 139.78 53.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.701 1.6 . . . . 0.0 110.163 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 mp -132.64 130.81 40.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.952 1.301 . . . . 0.0 110.405 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 27.4 m -138.05 151.08 47.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.654 1.182 . . . . 0.0 110.931 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.49 -174.4 39.71 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 120.542 -1.349 . . . . 0.0 115.883 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.2 p -128.11 80.07 1.94 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.879 2.472 . . . . 0.0 111.816 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.46 83.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -170.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.03 -29.12 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 113.976 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.2 t -150.25 155.9 40.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.622 1.969 . . . . 0.0 110.575 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.3 p -56.67 -24.7 50.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.326 1.45 . . . . 0.0 113.303 168.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.44 -45.92 92.25 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.317 . . . . 0.0 111.724 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.189 0.595 . . . . 0.0 112.172 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -63.25 -42.19 99.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.134 0.879 . . . . 0.0 112.444 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.18 -39.7 86.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.863 0.865 . . . . 0.0 112.153 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.44 93.77 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.977 -0.452 . . . . 0.0 112.162 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 72.9 t -67.91 -42.05 85.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 122.779 0.432 . . . . 0.0 111.094 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.711 0.687 . . . . 0.0 111.882 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -68.96 -39.82 79.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.053 0.941 . . . . 0.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.82 -43.18 99.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.572 0.349 . . . . 0.0 111.385 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.015 0.526 . . . . 0.0 112.195 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.4 m -64.97 -38.82 92.22 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.716 -0.615 . . . . 0.0 111.971 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.0 m -67.58 -36.09 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.401 0.68 . . . . 0.0 112.763 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 51.6 m -74.37 -38.2 63.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.354 1.062 . . . . 0.0 112.245 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.35 62.69 64.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.621 1.568 . . . . 0.0 113.536 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.0 -14.16 34.99 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.436 2.757 . . . . 0.0 114.1 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -95.16 5.88 50.58 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.208 1.803 . . . . 0.0 113.195 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.3 mtt -128.62 152.43 48.36 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.634 1.573 . . . . 0.0 111.824 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.92 146.64 45.96 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.216 0.606 . . . . 0.0 110.071 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.0 143.08 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.551 1.14 . . . . 0.0 109.693 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.59 93.38 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.783 1.233 . . . . 0.0 109.982 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -80.76 130.82 35.28 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.286 0.565 . . . . 0.0 111.488 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.92 3.89 3.78 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.731 2.412 . . . . 0.0 111.956 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.32 139.59 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.137 1.375 . . . . 0.0 109.748 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 111.356 173.57 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -42.54 165.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.936 2.894 . . . . 0.0 113.571 165.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.04 151.92 39.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 114.958 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mp -146.0 157.12 43.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 111.449 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 t -148.6 127.24 12.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.899 1.68 . . . . 0.0 110.0 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.0 139.42 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.686 1.594 . . . . 0.0 108.694 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -143.87 145.13 32.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.996 0.918 . . . . 0.0 112.522 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -109.81 149.11 30.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.649 1.579 . . . . 0.0 111.769 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -135.81 58.47 1.75 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.101 2.16 . . . . 0.0 111.443 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.75 -88.62 1.24 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.628 1.108 . . . . 0.0 113.231 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -119.46 30.41 7.11 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.703 1.601 . . . . 0.0 112.465 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -140.76 137.6 33.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.37 2.268 . . . . 0.0 108.021 167.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.1 142.31 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 0.0 111.312 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.2 m -127.85 128.8 45.86 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.645 1.178 . . . . 0.0 110.436 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.69 120.39 36.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.889 1.675 . . . . 0.0 109.266 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mm -119.14 144.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.375 1.87 . . . . 0.0 107.55 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.99 -153.87 23.0 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -162.22 143.64 10.68 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.204 2.201 . . . . 0.0 111.321 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -156.79 171.76 7.01 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.065 1.346 . . . . 0.0 113.004 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.18 -29.44 14.41 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.316 3.344 . . . . 0.0 113.645 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -156.34 166.48 33.3 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 123.392 1.568 . . . . 0.0 114.11 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.11 -32.16 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.721 1.608 . . . . 0.0 112.709 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.98 72.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.419 0.687 . . . . 0.0 111.903 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.44 67.54 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -39.38 94.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.218 1.407 . . . . 0.0 111.849 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.78 87.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 112.357 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.13 82.26 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.554 -0.716 . . . . 0.0 112.443 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.49 -39.79 81.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.157 0.983 . . . . 0.0 111.564 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -72.23 -33.58 67.67 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.226 -0.922 . . . . 0.0 112.341 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.6 m -63.5 -41.75 98.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.563 0.745 . . . . 0.0 111.149 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.82 78.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.144 0.978 . . . . 0.0 113.343 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.14 -43.52 61.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 111.836 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.65 -25.86 68.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 112.715 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.1 17.46 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.58 2.038 . . . . 0.0 114.409 172.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 7.24 3.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.479 1.112 . . . . 0.0 113.753 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.49 125.63 22.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.174 0.99 . . . . 0.0 110.815 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.4 148.97 40.15 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.022 1.329 . . . . 0.0 111.436 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.04 102.2 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.63 2.887 . . . . 0.0 112.443 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.86 -10.3 7.08 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.741 2.115 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.93 110.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.416 1.108 . . . . 0.0 110.734 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.49 152.48 45.33 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.515 1.526 . . . . 0.0 112.24 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.91 138.33 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.923 1.289 . . . . 0.0 111.993 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 87.1 mt -133.33 140.17 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.186 1.794 . . . . 0.0 108.781 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.31 134.31 41.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.26 1.424 . . . . 0.0 112.568 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -141.61 26.72 1.91 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.427 1.891 . . . . 0.0 113.16 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.76 130.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.596 -1.315 . . . . 0.0 111.154 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -82.4 160.66 22.72 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.028 1.731 . . . . 0.0 112.257 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.93 121.54 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 111.169 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.19 129.22 4.66 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.804 1.641 . . . . 0.0 110.656 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.07 -6.44 19.11 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.378 2.719 . . . . 0.0 114.823 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.84 -10.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.937 1.695 . . . . 0.0 112.603 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.1 144.49 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 128.595 2.758 . . . . 0.0 109.95 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -143.5 155.11 44.25 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.97 2.108 . . . . 0.0 109.548 -170.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -139.5 178.86 6.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.86 169.98 14.65 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.568 1.947 . . . . 0.0 110.177 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.26 158.93 15.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 112.52 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.26 2.32 11.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.559 1.544 . . . . 0.0 112.211 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 m -53.63 -32.39 51.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.163 1.385 . . . . 0.0 112.78 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.6 m -105.24 7.61 33.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.526 1.93 . . . . 0.0 113.674 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.61 56.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.482 1.513 . . . . 0.0 113.655 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -46.82 -48.81 50.42 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.71 1.204 . . . . 0.0 112.738 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 -24.87 38.73 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.888 1.725 . . . . 0.0 113.96 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.9 t -64.88 -45.29 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.329 0.968 . . . . 0.0 110.371 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -71.07 -31.3 67.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.744 0.818 . . . . 0.0 112.789 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.2 m -63.11 -42.58 99.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.907 0.776 . . . . 0.0 111.391 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.29 65.88 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.1 p -102.49 7.12 40.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.196 1.799 . . . . 0.0 115.364 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.7 t -48.62 -44.62 67.87 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.478 -1.389 . . . . 0.0 114.499 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.46 13.62 2.37 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.558 2.172 . . . . 0.0 114.226 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -113.95 92.8 27.03 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.146 1.779 . . . . 0.0 110.445 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.79 -22.78 23.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.454 2.769 . . . . 0.0 115.428 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -100.54 9.34 42.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.353 1.861 . . . . 0.0 113.342 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -52.56 149.31 6.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.023 0.916 . . . . 0.0 112.38 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 164.44 35.52 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.468 1.032 . . . . 0.0 111.772 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.53 146.84 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.68 1.192 . . . . 0.0 109.796 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -138.24 143.03 39.92 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.907 0.883 . . . . 0.0 110.002 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.76 131.96 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.904 0.882 . . . . 0.0 109.46 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.11 156.22 26.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 167.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 46.8 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 129.706 3.202 . . . . 0.0 117.813 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.89 22.98 1.1 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.468 2.307 . . . . 0.0 112.835 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.4 m -143.55 143.82 31.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.942 1.697 . . . . 0.0 112.148 -170.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.8 141.79 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 126.333 1.853 . . . . 0.0 110.53 167.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.3 m -131.17 137.57 49.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.884 1.674 . . . . 0.0 109.62 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.61 127.9 34.01 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.177 1.391 . . . . 0.0 109.23 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 91.1 m -130.69 152.18 50.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.644 1.577 . . . . 0.0 110.229 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.13 -174.66 39.45 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.753 -1.217 . . . . 0.0 114.385 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.5 p -128.17 74.91 1.58 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.105 2.162 . . . . 0.0 112.082 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.79 154.31 93.71 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 -26.36 19.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.624 2.883 . . . . 0.0 114.077 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.3 t -147.99 156.89 43.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.737 2.015 . . . . 0.0 110.423 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 52.3 p -54.0 -31.13 50.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.781 2.033 . . . . 0.0 112.577 168.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.32 -41.92 80.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 112.064 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.85 -43.35 96.42 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.098 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 169' ' ' SER . 12.4 ptmm? -66.91 -35.99 81.26 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.5 1.045 . . . . 0.0 112.272 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.25 -41.92 89.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.356 0.662 . . . . 0.0 112.449 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.48 91.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.735 0.814 . . . . 0.0 112.528 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.87 -42.9 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.375 0.534 . . . . 0.0 110.483 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -62.94 -41.5 99.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.88 1.272 . . . . 0.0 112.437 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -69.96 -37.65 75.86 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.215 1.006 . . . . 0.0 111.198 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.82 99.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.885 0.474 . . . . 0.0 111.385 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.46 88.16 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.58 0.627 . . . . 0.0 112.195 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.8 m -63.64 -39.91 95.53 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.745 -0.597 . . . . 0.0 112.049 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.2 m -67.63 -35.17 78.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 29.7 m -76.58 -38.62 54.6 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.051 0.94 . . . . 0.0 112.428 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -133.28 59.15 39.46 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.089 1.356 . . . . 0.0 113.428 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 -15.05 40.56 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.486 2.791 . . . . 0.0 113.85 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -92.16 0.81 57.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.839 1.655 . . . . 0.0 113.592 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 64.6 mtt -130.59 162.06 30.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.72 . . . . 0.0 112.307 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -70.72 147.34 49.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.16 131.15 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.45 1.5 . . . . 0.0 109.284 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.5 t -126.34 92.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 110.729 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.96 66.57 3.63 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.208 2.203 . . . . 0.0 113.723 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -67.24 -6.46 18.36 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.995 1.718 . . . . 0.0 114.573 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.81 142.1 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.33 1.852 . . . . 0.0 111.272 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 125.569 1.548 . . . . 0.0 110.594 171.588 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 121.553 0.692 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -43.5 157.04 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.536 2.734 . . . . 0.0 114.916 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.6 154.13 28.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.143 1.777 . . . . 0.0 113.628 166.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tp -154.73 152.02 29.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.821 1.648 . . . . 0.0 111.438 -171.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -149.99 131.38 14.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.209 1.404 . . . . 0.0 110.608 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 64.9 mt -135.71 142.86 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.375 1.47 . . . . 0.0 108.524 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.4 p -142.23 150.25 40.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.11 142.72 49.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.626 1.97 . . . . 0.0 110.255 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -141.37 66.19 1.37 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.745 . . . . 0.0 112.242 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.73 -81.18 1.27 Allowed Glycine 0 N--CA 1.477 1.37 0 O-C-N 121.223 -0.923 . . . . 0.0 114.708 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.98 32.71 5.05 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.388 173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.72 141.91 30.7 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.089 2.156 . . . . 0.0 108.967 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.68 142.82 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 111.211 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.6 m -130.2 125.24 34.45 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.982 1.313 . . . . 0.0 110.829 -171.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.71 128.48 55.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.032 1.733 . . . . 0.0 110.015 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.94 144.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.1 1.76 . . . . 0.0 108.443 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.29 -156.54 28.19 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.533 -1.354 . . . . 0.0 116.219 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -164.0 128.71 2.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.215 1.806 . . . . 0.0 112.29 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -143.51 168.02 14.03 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.707 1.603 . . . . 0.0 113.134 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -67.32 -31.81 34.27 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.095 3.197 . . . . 0.0 113.31 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.28 166.85 32.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 123.473 1.606 . . . . 0.0 113.573 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -60.82 -29.86 69.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.418 1.887 . . . . 0.0 113.489 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.27 -29.87 68.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.776 1.23 . . . . 0.0 112.199 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.72 83.16 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.63 -0.669 . . . . 0.0 111.204 173.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.129 1.372 . . . . 0.0 111.785 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.86 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.467 0.707 . . . . 0.0 112.581 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.61 76.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.29 -42.42 93.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.907 1.283 . . . . 0.0 111.543 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.7 ptm -73.11 -32.1 64.74 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.655 -0.653 . . . . 0.0 111.997 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -64.55 -38.55 91.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 111.056 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.25 -35.33 76.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.814 0.845 . . . . 0.0 112.968 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.92 -23.38 22.72 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.63 -29.62 68.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.909 1.284 . . . . 0.0 112.229 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.24 -27.14 52.0 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.813 1.673 . . . . 0.0 115.267 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 12.65 5.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.622 1.569 . . . . 0.0 112.459 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.42 125.46 23.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.729 0.811 . . . . 0.0 110.979 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.58 148.56 46.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.97 1.308 . . . . 0.0 111.079 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.31 102.49 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.496 2.798 . . . . 0.0 112.738 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.48 -8.96 8.28 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.684 2.088 . . . . 0.0 113.713 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.61 114.19 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.506 1.153 . . . . 0.0 111.006 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -69.99 153.63 42.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.783 1.633 . . . . 0.0 112.322 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.45 132.36 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.709 1.204 . . . . 0.0 110.006 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.0 148.59 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.998 1.719 . . . . 0.0 110.396 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.03 130.3 31.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.932 1.693 . . . . 0.0 111.823 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -140.75 28.92 1.93 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.603 2.361 . . . . 0.0 111.127 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.55 119.29 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.632 1.173 . . . . 0.0 109.927 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -73.85 165.51 24.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.388 1.875 . . . . 0.0 112.221 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.6 t -132.39 123.73 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.091 1.356 . . . . 0.0 111.021 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.62 120.78 2.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.468 1.907 . . . . 0.0 110.529 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.68 -6.39 18.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.655 2.237 . . . . 0.0 115.0 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.23 -12.9 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.007 0.923 . . . . 0.0 112.206 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.08 149.01 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.709 1.603 . . . . 0.0 110.52 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -145.21 145.74 31.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.288 1.835 . . . . 0.0 109.153 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -133.42 -179.61 5.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -68.01 -176.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 130.162 3.385 . . . . 0.0 110.866 170.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -123.95 95.11 4.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 112.795 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -73.18 2.31 7.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.9 m -56.46 -36.0 68.56 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.627 -1.296 . . . . 0.0 112.183 172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.8 m -89.5 -2.51 58.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.808 1.643 . . . . 0.0 113.762 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.52 -6.68 52.91 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.511 1.124 . . . . 0.0 113.294 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.72 -48.63 76.49 Favored Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 120.767 -1.208 . . . . 0.0 113.49 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.44 -28.43 32.48 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.584 2.189 . . . . 0.0 114.026 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.26 -46.23 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 0.855 . . . . 0.0 110.753 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.34 -30.57 63.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.578 0.751 . . . . 0.0 112.336 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.6 m -61.17 -44.54 97.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 111.305 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.65 -17.63 64.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 92.2 p -107.75 7.02 28.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 115.286 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -52.42 -47.4 93.31 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 167.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.07 12.46 1.23 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.807 2.338 . . . . 0.0 114.279 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 165' ' ' THR . 13.9 mt -110.59 96.55 28.36 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.746 2.019 . . . . 0.0 109.131 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 -19.54 28.36 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.978 2.452 . . . . 0.0 114.594 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -109.26 11.07 25.56 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.806 2.042 . . . . 0.0 113.843 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.92 155.04 1.91 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.899 1.28 . . . . 0.0 112.983 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.54 164.27 36.15 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.328 0.96 . . . . 0.0 112.196 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.08 145.45 49.37 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.517 1.127 . . . . 0.0 109.317 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -141.32 134.74 29.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.73 0.812 . . . . 0.0 109.924 173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.73 136.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.111 0.564 . . . . 0.0 109.997 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.98 150.45 25.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.787 0.435 . . . . 0.0 112.144 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 39.35 -101.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.569 1.948 . . . . 0.0 112.97 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -117.91 21.31 12.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.489 1.515 . . . . 0.0 112.99 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.2 m -135.61 137.23 41.7 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.086 1.754 . . . . 0.0 112.379 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.4 141.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 126.142 1.777 . . . . 0.0 111.682 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 88.0 m -131.42 136.98 48.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.933 1.693 . . . . 0.0 110.218 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -130.04 133.12 46.52 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.003 1.721 . . . . 0.0 109.471 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 31.7 m -138.88 148.32 43.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.915 1.286 . . . . 0.0 110.753 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.21 -172.0 37.36 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.523 -1.361 . . . . 0.0 114.885 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 148' ' ' ILE . 18.2 p -121.41 89.02 3.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.531 2.732 . . . . 0.0 111.998 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.02 53.94 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 120.695 -1.253 . . . . 0.0 113.73 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.27 -26.63 41.69 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.82 3.013 . . . . 0.0 114.226 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.5 t -147.94 157.04 43.32 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.55 1.94 . . . . 0.0 110.063 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 p -59.58 -20.87 58.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.094 0.958 . . . . 0.0 112.907 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.25 -47.55 83.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.756 1.223 . . . . 0.0 111.775 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -58.37 -42.2 86.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.187 0.595 . . . . 0.0 111.867 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -45.26 94.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.839 0.745 . . . . 0.0 112.203 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -66.21 -39.29 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.267 1.027 . . . . 0.0 111.983 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.75 89.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.703 0.801 . . . . 0.0 112.694 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.96 -38.64 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.702 -0.624 . . . . 0.0 110.914 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.668 0.787 . . . . 0.0 111.716 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -63.6 -40.09 96.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.584 0.754 . . . . 0.0 111.848 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.89 97.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.813 0.445 . . . . 0.0 111.376 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.64 -37.64 88.11 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.675 -0.64 . . . . 0.0 112.119 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.6 m -63.27 -41.29 99.01 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.623 -0.673 . . . . 0.0 111.751 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -65.82 -35.94 82.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.4 -36.91 52.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.077 0.951 . . . . 0.0 112.685 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -133.39 61.13 52.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.411 1.484 . . . . 0.0 113.635 -172.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.26 -9.58 25.65 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.687 2.925 . . . . 0.0 114.338 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -114.47 9.72 16.8 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.63 1.972 . . . . 0.0 113.601 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.6 mtm -126.17 161.13 28.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.437 1.895 . . . . 0.0 111.247 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -71.2 146.49 49.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.833 0.853 . . . . 0.0 110.036 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.6 pt -130.71 143.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.115 0.966 . . . . 0.0 111.381 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.0 t -135.68 121.87 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.596 1.158 . . . . 0.0 110.483 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -112.27 70.43 0.71 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.43 1.892 . . . . 0.0 111.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.1 -5.61 42.67 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.545 1.538 . . . . 0.0 114.336 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 68.8 mt -51.28 140.16 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.087 1.755 . . . . 0.0 111.257 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.727 1.611 . . . . 0.0 110.63 172.155 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.699 0.761 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -39.44 154.39 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 129.896 3.278 . . . . 0.0 117.179 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.12 135.42 39.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.676 1.591 . . . . 0.0 111.105 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD22 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -155.09 146.82 23.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.091 1.356 . . . . 0.0 110.817 -175.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -142.75 142.96 32.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.084 1.753 . . . . 0.0 110.809 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -142.6 136.66 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.989 1.316 . . . . 0.0 109.445 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -138.86 145.76 40.38 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.937 0.895 . . . . 0.0 112.02 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -108.53 150.49 27.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.011 1.324 . . . . 0.0 112.84 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.0 m -137.78 59.77 1.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.694 2.398 . . . . 0.0 111.99 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.03 -92.84 1.05 Allowed Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.018 1.294 . . . . 0.0 112.856 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -113.08 29.85 7.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.814 1.645 . . . . 0.0 112.327 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.32 140.49 30.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.466 2.307 . . . . 0.0 108.44 170.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.01 144.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.696 1.198 . . . . 0.0 111.131 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.7 m -129.56 128.13 42.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.384 1.074 . . . . 0.0 111.607 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.14 126.93 55.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.787 2.035 . . . . 0.0 110.525 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.5 mt -138.16 125.66 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.32 1.448 . . . . 0.0 109.137 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 172.65 -156.75 25.64 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 120.859 -1.151 . . . . 0.0 115.144 -171.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -159.45 146.27 16.69 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.882 2.073 . . . . 0.0 111.355 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -151.86 170.2 8.3 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.965 1.706 . . . . 0.0 111.586 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.31 -31.83 42.75 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.265 3.31 . . . . 0.0 113.537 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.47 165.65 35.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.617 1.675 . . . . 0.0 113.123 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.79 -25.77 68.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.728 2.011 . . . . 0.0 113.958 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.19 63.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.96 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -37.65 67.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.196 0.598 . . . . 0.0 111.836 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -26.54 60.52 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 172.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.5 75.65 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.439 -0.788 . . . . 0.0 112.301 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.0 85.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.914 -1.116 . . . . 0.0 112.282 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.76 -42.57 99.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -30.95 62.45 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.496 -0.752 . . . . 0.0 112.434 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.4 m -65.1 -38.44 90.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.81 1.244 . . . . 0.0 111.308 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.82 72.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.799 1.24 . . . . 0.0 113.182 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.29 -25.23 20.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.46 -30.99 70.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.978 1.311 . . . . 0.0 112.37 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.72 -27.15 55.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.601 1.572 . . . . 0.0 115.254 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 10.4 6.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.793 1.637 . . . . 0.0 112.453 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.59 130.45 46.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.451 1.101 . . . . 0.0 111.372 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.2 147.27 39.98 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.245 1.418 . . . . 0.0 111.108 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.88 102.92 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.593 2.862 . . . . 0.0 112.562 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.04 -10.28 7.43 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.838 2.161 . . . . 0.0 113.793 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.92 115.33 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.339 1.069 . . . . 0.0 110.896 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -73.81 155.02 39.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.009 1.724 . . . . 0.0 112.563 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -135.44 132.92 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.847 1.259 . . . . 0.0 109.851 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.2 mt -126.45 138.36 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.406 1.882 . . . . 0.0 108.855 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.63 132.43 37.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.745 1.218 . . . . 0.0 112.824 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -136.75 18.82 3.06 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.428 2.291 . . . . 0.0 112.315 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.82 132.89 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.689 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -94.49 169.82 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.65 1.58 . . . . 0.0 113.248 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.54 118.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.777 1.631 . . . . 0.0 110.774 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -149.3 123.06 4.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.107 2.163 . . . . 0.0 110.419 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.58 -5.06 15.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.023 2.482 . . . . 0.0 114.544 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.24 -13.28 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.209 1.804 . . . . 0.0 112.468 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.72 149.42 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.091 2.157 . . . . 0.0 109.71 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.38 152.58 48.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.038 2.135 . . . . 0.0 106.495 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.0 m -132.74 175.46 9.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.264 1.393 . . . . 0.0 114.256 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.98 158.18 33.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.692 1.597 . . . . 0.0 109.583 166.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.4 148.12 28.4 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.015 165.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.33 0.26 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.713 1.205 . . . . 0.0 113.052 171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -55.28 -37.86 67.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.205 1.002 . . . . 0.0 111.798 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -92.04 3.08 56.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.066 1.747 . . . . 0.0 113.848 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.72 -3.79 51.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.775 1.63 . . . . 0.0 113.687 172.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.07 -49.16 30.8 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.464 1.105 . . . . 0.0 112.39 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.59 -24.83 55.34 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.75 1.633 . . . . 0.0 113.692 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.6 t -66.2 -46.1 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.131 0.878 . . . . 0.0 110.687 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -73.87 -30.07 62.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.485 0.714 . . . . 0.0 112.57 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.8 m -66.77 -39.73 87.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.074 0.95 . . . . 0.0 111.541 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.17 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.8 p -101.13 7.88 43.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.364 1.866 . . . . 0.0 115.191 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.4 t -47.52 -44.97 56.7 Favored Pre-proline 0 N--CA 1.485 1.312 0 O-C-N 120.391 -1.443 . . . . 0.0 114.554 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.8 13.97 2.18 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.447 2.098 . . . . 0.0 114.089 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.39 91.97 35.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.171 1.788 . . . . 0.0 110.583 -171.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.07 -17.8 31.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.864 3.042 . . . . 0.0 115.879 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.97 16.08 16.16 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.743 2.417 . . . . 0.0 112.519 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -53.94 153.7 4.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.474 1.109 . . . . 0.0 112.74 168.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.17 161.28 33.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.135 1.35 . . . . 0.0 111.672 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tp -131.45 146.3 52.19 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.037 1.335 . . . . 0.0 109.235 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.75 147.62 42.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.126 0.97 . . . . 0.0 110.822 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.78 133.02 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.666 1.186 . . . . 0.0 109.744 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.24 152.8 24.66 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 167.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 42.15 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.585 3.154 . . . . 0.0 117.253 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -141.86 20.54 2.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.602 1.961 . . . . 0.0 113.022 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.6 m -138.3 140.97 39.81 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.029 1.332 . . . . 0.0 112.555 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.55 131.96 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.418 1.887 . . . . 0.0 111.084 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.6 m -123.94 137.74 54.58 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.679 1.592 . . . . 0.0 110.058 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.65 126.57 29.41 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.616 1.166 . . . . 0.0 110.663 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 98.8 m -132.07 150.86 52.05 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.344 1.457 . . . . 0.0 110.455 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.38 -175.13 39.68 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.79 -1.194 . . . . 0.0 114.183 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.0 p -130.13 81.02 1.99 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.208 1.803 . . . . 0.0 112.071 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.9 153.24 95.63 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.231 1.412 . . . . 0.0 114.293 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.99 -34.63 37.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.093 2.529 . . . . 0.0 113.168 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.7 m -144.47 156.02 43.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.65 1.98 . . . . 0.0 110.644 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 p -62.55 -22.86 66.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.222 1.009 . . . . 0.0 113.633 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -63.95 -42.87 97.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.617 1.167 . . . . 0.0 111.462 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -62.97 -40.9 99.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.451 0.569 . . . . 0.0 111.782 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.6 -46.82 87.82 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.474 0.579 . . . . 0.0 112.214 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.76 -37.66 85.05 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.371 0.668 . . . . 0.0 111.944 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.02 89.33 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.624 0.769 . . . . 0.0 112.573 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.03 -42.63 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.737 0.699 . . . . 0.0 110.655 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -42.07 99.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 112.316 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -72.65 -32.76 66.11 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.91 -47.2 78.6 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.22 93.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 t -72.38 -30.09 64.36 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.635 -0.666 . . . . 0.0 112.168 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.3 m -70.06 -38.98 75.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.138 0.975 . . . . 0.0 112.591 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 39.4 m -71.59 -39.33 70.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.684 1.194 . . . . 0.0 112.311 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -129.85 60.5 52.19 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.448 1.499 . . . . 0.0 113.732 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.39 -14.94 34.61 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.435 2.757 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.46 -1.85 58.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.7 1.6 . . . . 0.0 113.892 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -126.12 160.03 31.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 112.071 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -70.49 151.1 45.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.956 0.902 . . . . 0.0 110.406 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.87 135.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.027 0.931 . . . . 0.0 111.526 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 37.0 t -130.59 87.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.408 1.483 . . . . 0.0 109.825 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -72.97 130.89 41.37 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.902 . . . . 0.0 110.93 171.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -137.0 0.15 2.35 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.494 2.318 . . . . 0.0 111.929 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.15 142.7 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.259 1.823 . . . . 0.0 110.073 171.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 125.821 1.648 . . . . 0.0 110.557 172.383 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 121.857 0.837 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -37.38 161.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.353 3.061 . . . . 0.0 114.867 167.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.39 146.5 47.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.855 1.662 . . . . 0.0 114.077 167.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 tt -157.15 155.82 31.64 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.823 1.249 . . . . 0.0 112.195 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 t -139.26 140.01 37.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.93 2.092 . . . . 0.0 110.284 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.25 133.9 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.283 1.433 . . . . 0.0 108.864 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 t -143.29 142.25 31.28 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.251 0.62 . . . . 0.0 112.196 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.34 148.47 28.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.305 1.442 . . . . 0.0 110.897 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -143.7 66.04 1.3 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.541 1.536 . . . . 0.0 112.526 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -90.07 1.46 Allowed Glycine 0 N--CA 1.472 1.07 0 C-N-CA 124.308 0.956 . . . . 0.0 113.106 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -122.22 35.94 4.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.985 1.714 . . . . 0.0 111.729 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.4 m -145.0 145.73 31.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.93 2.492 . . . . 0.0 108.183 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 p -134.75 144.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.814 1.246 . . . . 0.0 110.987 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.4 m -128.78 132.78 47.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.422 1.089 . . . . 0.0 111.739 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 117.8 29.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.566 2.346 . . . . 0.0 109.637 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.37 120.33 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.604 1.162 . . . . 0.0 109.053 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.02 -154.02 17.18 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -170.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -153.27 145.92 24.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.515 2.326 . . . . 0.0 112.651 -170.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -155.94 171.43 7.32 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.641 1.576 . . . . 0.0 112.85 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.47 -30.61 23.35 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.327 3.351 . . . . 0.0 113.705 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -155.49 166.74 32.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.287 1.518 . . . . 0.0 113.16 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.62 -28.91 70.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.927 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.06 75.01 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.63 -37.73 67.93 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.365 0.666 . . . . 0.0 112.427 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -60.11 -45.88 91.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.631 1.172 . . . . 0.0 111.314 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.77 77.88 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.986 1.314 . . . . 0.0 111.956 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.48 92.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.14 -39.66 86.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 111.227 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 78.1 mmm -65.94 -41.55 91.18 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.548 0.739 . . . . 0.0 111.639 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.8 m -61.72 -40.48 95.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.343 1.057 . . . . 0.0 110.857 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.96 -31.44 72.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.686 1.194 . . . . 0.0 113.606 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -93.33 -22.39 18.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.7 -30.46 61.56 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.666 1.587 . . . . 0.0 112.367 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.83 -28.28 52.24 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.686 1.612 . . . . 0.0 114.986 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 9.54 6.44 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.81 1.644 . . . . 0.0 112.768 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.3 129.99 44.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.297 1.039 . . . . 0.0 111.109 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.51 149.11 40.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.201 1.401 . . . . 0.0 111.388 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.9 102.8 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.575 2.85 . . . . 0.0 112.582 -174.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -10.38 7.34 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.795 2.14 . . . . 0.0 113.662 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.34 114.78 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 118.358 1.079 . . . . 0.0 110.889 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -71.25 157.16 38.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.982 1.713 . . . . 0.0 112.734 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.97 140.21 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.557 1.143 . . . . 0.0 112.441 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.18 139.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.745 2.018 . . . . 0.0 108.391 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.31 134.81 34.75 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.87 29.88 1.87 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.179 2.592 . . . . 0.0 111.347 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.25 123.66 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.482 -1.386 . . . . 0.0 110.746 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -90.3 162.75 15.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.931 1.292 . . . . 0.0 112.551 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.7 117.98 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.046 1.339 . . . . 0.0 110.941 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.98 117.14 4.18 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.75 2.02 . . . . 0.0 109.878 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 -5.77 17.8 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.964 2.443 . . . . 0.0 114.953 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.66 -1.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.406 1.482 . . . . 0.0 113.527 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.35 142.48 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 128.899 2.879 . . . . 0.0 109.143 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -136.73 154.78 50.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.522 2.329 . . . . 0.0 108.802 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -136.05 177.28 7.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.746 1.157 . . . . 0.0 114.052 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -72.26 156.99 38.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.161 . . . . 0.0 108.271 167.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.42 152.93 37.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.847 -0.533 . . . . 0.0 111.311 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -122.72 3.07 9.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.463 1.505 . . . . 0.0 111.75 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.2 m -53.5 -37.54 62.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.526 1.13 . . . . 0.0 111.876 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.4 m -96.63 6.1 49.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 113.653 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.66 -6.28 59.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.159 1.384 . . . . 0.0 113.269 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.79 -50.12 44.92 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.026 1.33 . . . . 0.0 112.648 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.51 -24.28 56.63 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 113.738 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.97 -46.97 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.453 1.024 . . . . 0.0 110.649 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -74.32 -28.88 61.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 112.587 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 m -70.25 -41.17 73.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.809 1.244 . . . . 0.0 111.694 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.25 -28.64 68.88 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.312 -0.868 . . . . 0.0 112.649 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.7 p -90.52 0.1 57.46 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -45.6 -46.71 37.14 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 120.779 1.627 . . . . 0.0 115.159 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.51 13.67 1.34 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.727 2.285 . . . . 0.0 114.154 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.12 83.76 12.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.592 1.957 . . . . 0.0 110.188 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.09 -15.86 50.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.452 2.768 . . . . 0.0 115.075 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.89 1.93 27.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.778 2.431 . . . . 0.0 114.34 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -60.07 155.28 17.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.053 -1.029 . . . . 0.0 113.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.36 169.36 37.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.874 1.702 . . . . 0.0 112.995 167.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.19 147.79 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.433 1.893 . . . . 0.0 109.387 177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -136.91 140.26 42.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 109.904 168.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.41 134.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.999 0.92 . . . . 0.0 109.782 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.66 157.67 27.53 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.677 0.791 . . . . 0.0 112.701 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 44.59 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.837 2.455 . . . . 0.0 114.082 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -144.16 33.8 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 119.77 1.168 . . . . 0.0 112.463 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.8 m -133.27 139.14 46.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.75 2.02 . . . . 0.0 111.109 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.35 128.09 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.158 1.783 . . . . 0.0 111.401 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 84.9 m -122.77 134.65 54.42 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.886 1.674 . . . . 0.0 110.03 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.21 124.72 31.2 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.784 1.234 . . . . 0.0 110.174 -171.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.5 m -137.07 123.3 20.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.986 1.314 . . . . 0.0 110.947 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.47 48.28 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.948 1.261 . . . . 0.0 112.926 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.5 p -125.08 81.21 1.94 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 0.0 112.35 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.66 153.96 92.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.2 -31.05 30.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.2 2.6 . . . . 0.0 113.536 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 p -149.27 166.58 28.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.858 1.263 . . . . 0.0 112.804 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.5 p -64.05 -25.06 67.95 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 113.604 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -66.3 -42.16 88.72 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.482 -0.762 . . . . 0.0 111.09 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.32 -41.37 98.9 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.475 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -66.57 -40.54 89.01 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.631 1.105 . . . . 0.0 111.888 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.83 -43.99 97.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.647 1.179 . . . . 0.0 112.382 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.91 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.499 0.72 . . . . 0.0 112.185 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.57 -43.3 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 118.132 0.424 . . . . 0.0 111.243 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -70.02 -36.18 74.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.806 0.73 . . . . 0.0 112.663 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.29 -39.99 81.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.247 1.019 . . . . 0.0 111.571 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.87 95.82 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.08 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.46 87.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.139 0.575 . . . . 0.0 112.395 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.5 m -66.45 -38.1 86.61 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.716 -0.615 . . . . 0.0 111.594 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.8 t -65.27 -38.54 90.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.671 0.788 . . . . 0.0 112.616 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.0 m -73.31 -39.35 65.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.22 1.008 . . . . 0.0 112.764 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -131.96 61.41 57.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.549 1.54 . . . . 0.0 113.815 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.02 -10.95 26.82 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.664 2.909 . . . . 0.0 114.731 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -104.96 -0.93 26.43 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.082 1.753 . . . . 0.0 113.73 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -108.57 160.3 16.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.914 2.086 . . . . 0.0 111.711 -172.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -73.47 147.25 44.3 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.694 -0.628 . . . . 0.0 109.908 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.6 tt -135.04 142.17 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.7 0.8 . . . . 0.0 112.274 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.62 91.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.692 1.597 . . . . 0.0 110.194 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -83.18 74.07 10.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.298 1.839 . . . . 0.0 111.413 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -72.76 -11.54 60.65 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.989 1.315 . . . . 0.0 113.459 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.2 pt -52.04 144.21 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 127.106 2.162 . . . . 0.0 114.531 172.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.936 2.094 . . . . 0.0 111.088 178.811 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 CA--C 1.552 1.029 0 CA-C-O 122.054 0.93 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 t -35.91 162.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 131.114 3.766 . . . . 0.0 114.809 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 150.16 50.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.605 1.562 . . . . 0.0 114.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 tt -160.53 156.73 26.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 111.526 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.3 p -145.22 158.32 43.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 112.653 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -141.67 142.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 108.01 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -139.18 142.69 37.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.321 0.648 . . . . 0.0 111.936 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -112.9 148.28 35.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.777 1.631 . . . . 0.0 111.376 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -134.19 56.64 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.427 2.291 . . . . 0.0 110.438 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.3 -98.82 0.67 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 126.039 1.781 . . . . 0.0 112.365 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -96.38 18.4 14.0 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.406 1.482 . . . . 0.0 113.013 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -137.51 131.87 32.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.818 1.647 . . . . 0.0 108.81 167.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.26 137.8 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.545 1.138 . . . . 0.0 111.253 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -122.66 136.96 55.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.5 1.12 . . . . 0.0 112.6 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.86 121.98 39.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.944 2.098 . . . . 0.0 109.085 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 mt -135.27 133.04 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.02 1.328 . . . . 0.0 108.173 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.96 -146.88 12.28 Favored Glycine 0 N--CA 1.465 0.624 0 O-C-N 120.338 -1.476 . . . . 0.0 115.941 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -153.16 150.77 29.4 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.094 2.557 . . . . 0.0 111.842 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -157.7 170.07 9.56 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 126.026 1.73 . . . . 0.0 110.39 166.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -71.72 -29.96 15.1 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.392 3.395 . . . . 0.0 113.696 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -159.15 166.92 30.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.384 1.564 . . . . 0.0 113.554 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.56 -32.98 70.85 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.676 1.59 . . . . 0.0 112.836 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.97 73.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.818 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.6 60.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.452 0.701 . . . . 0.0 112.339 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.28 -42.03 96.63 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 111.817 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.35 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.684 1.194 . . . . 0.0 111.552 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.04 93.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.8 -39.6 80.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.677 0.791 . . . . 0.0 111.369 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm -65.14 -41.12 95.08 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.741 -0.599 . . . . 0.0 111.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.3 m -62.95 -39.8 95.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 0.0 110.897 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.45 75.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.965 0.906 . . . . 0.0 113.386 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.88 -24.1 21.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -73.04 -29.66 63.16 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.521 1.529 . . . . 0.0 112.337 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.05 52.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.817 1.675 . . . . 0.0 115.077 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 11.1 5.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.456 1.503 . . . . 0.0 112.76 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.75 135.46 56.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.225 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.42 150.27 37.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.814 1.646 . . . . 0.0 111.337 -176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.14 106.28 0.79 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.554 2.836 . . . . 0.0 112.523 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.84 -10.83 10.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.508 2.004 . . . . 0.0 113.75 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.48 118.27 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.345 1.058 . . . . 0.0 110.858 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -75.57 151.1 37.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 112.376 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -136.76 132.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.259 1.424 . . . . 0.0 109.454 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.7 mt -126.62 139.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.736 1.614 . . . . 0.0 109.451 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -132.57 128.16 36.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.43 1.492 . . . . 0.0 111.832 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -136.63 19.97 3.1 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.264 2.225 . . . . 0.0 112.147 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.1 mt -70.87 134.21 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 112.322 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -80.68 160.33 25.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.978 2.111 . . . . 0.0 112.721 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.5 t -131.62 119.16 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.161 1.384 . . . . 0.0 110.95 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.47 110.94 2.41 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.577 1.551 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.71 -6.07 16.98 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.987 2.458 . . . . 0.0 114.812 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.14 -16.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.938 0.895 . . . . 0.0 112.266 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 m -122.59 139.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.583 2.353 . . . . 0.0 110.203 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -128.37 155.54 44.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.273 1.829 . . . . 0.0 109.068 -170.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -139.08 179.79 6.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.09 176.22 2.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.451 1.9 . . . . 0.0 111.922 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -128.93 98.71 5.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 111.054 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.18 9.16 3.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.875 1.27 . . . . 0.0 113.022 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 67.4 m -51.93 -25.09 7.39 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.787 -1.195 . . . . 0.0 113.57 167.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 m -106.94 3.28 25.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.021 2.128 . . . . 0.0 113.818 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.09 -6.11 59.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.373 1.469 . . . . 0.0 113.657 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.21 -48.75 79.23 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.644 1.178 . . . . 0.0 113.2 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -23.6 44.27 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.792 1.661 . . . . 0.0 113.474 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.41 -46.34 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.925 0.784 . . . . 0.0 110.413 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -67.7 -35.47 78.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.999 0.52 . . . . 0.0 111.997 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.0 m -60.69 -44.52 96.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.074 0.949 . . . . 0.0 111.478 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.77 -26.56 67.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.268 0.627 . . . . 0.0 112.636 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.2 m -90.44 0.14 57.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.949 2.1 . . . . 0.0 115.576 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -52.89 -49.27 87.88 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-N 120.423 1.465 . . . . 0.0 114.001 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -84.26 18.39 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.009 2.473 . . . . 0.0 113.465 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mt -110.06 80.43 1.81 Allowed Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 127.014 2.126 . . . . 0.0 107.856 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.88 -21.39 50.48 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.035 2.49 . . . . 0.0 114.557 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -94.57 6.16 49.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.62 1.968 . . . . 0.0 113.509 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -54.81 153.77 5.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.731 1.213 . . . . 0.0 113.844 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.04 164.87 38.01 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.595 1.569 . . . . 0.0 110.768 167.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.46 164.16 30.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.693 -0.886 . . . . 0.0 112.976 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -138.02 152.52 48.94 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.458 1.503 . . . . 0.0 110.374 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 t -144.77 130.24 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.179 1.392 . . . . 0.0 108.682 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 143.75 20.68 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.083 -0.386 . . . . 0.0 112.014 167.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 42.39 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.124 2.17 . . . . 0.0 114.623 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -122.12 17.0 10.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.504 1.922 . . . . 0.0 113.364 -171.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 61.1 m -138.8 144.45 39.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.272 1.829 . . . . 0.0 112.485 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.66 132.56 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.229 2.212 . . . . 0.0 109.481 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 m -122.26 136.94 54.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 110.25 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mp -136.07 127.64 28.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.319 1.047 . . . . 0.0 110.093 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.0 m -136.14 151.85 50.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.616 1.566 . . . . 0.0 110.489 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.17 -176.41 42.09 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.261 -1.524 . . . . 0.0 113.907 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.2 m -132.78 112.71 12.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.928 1.291 . . . . 0.0 110.005 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.83 159.6 29.11 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.72 2.008 . . . . 0.0 113.67 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.47 -33.24 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.455 2.77 . . . . 0.0 113.143 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 55.2 m -144.68 155.41 43.57 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.491 1.916 . . . . 0.0 111.072 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 p -57.7 -27.6 63.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 113.088 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.42 -42.29 98.73 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.988 1.315 . . . . 0.0 111.624 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -62.56 -43.19 99.43 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.949 0.5 . . . . 0.0 111.912 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -62.72 -42.13 99.5 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.4 -41.19 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.263 1.425 . . . . 0.0 112.036 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.32 89.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.418 0.687 . . . . 0.0 112.054 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.41 -41.03 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 118.298 0.499 . . . . 0.0 111.115 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.14 -42.89 99.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.442 0.697 . . . . 0.0 111.967 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -66.17 -40.43 90.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.355 1.062 . . . . 0.0 111.569 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.36 97.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.002 0.521 . . . . 0.0 111.393 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.42 90.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.066 0.546 . . . . 0.0 111.974 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.0 m -63.43 -40.17 96.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.497 -0.752 . . . . 0.0 111.849 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.2 m -66.37 -35.81 81.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 35.7 m -77.52 -34.59 53.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.03 0.932 . . . . 0.0 112.668 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -126.87 59.64 36.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 0.0 113.553 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.85 -3.65 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.329 2.686 . . . . 0.0 114.834 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.84 20.22 4.6 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.708 2.003 . . . . 0.0 112.606 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.1 ttt -141.99 149.55 40.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.851 1.66 . . . . 0.0 109.976 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -70.42 141.34 52.13 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.146 -0.971 . . . . 0.0 111.142 -171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.65 138.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.545 1.538 . . . . 0.0 110.338 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.86 79.3 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.515 1.926 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -75.34 130.87 39.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.251 -0.906 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.36 5.35 3.76 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.389 2.276 . . . . 0.0 112.173 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 27.6 mt -56.6 143.45 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.835 1.654 . . . . 0.0 110.72 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 125.898 1.679 . . . . 0.0 111.44 176.59 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 CA--C 1.548 0.876 0 CA-C-O 122.004 0.907 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 t -36.92 158.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.0 2.92 . . . . 0.0 115.126 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.1 147.7 43.04 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.096 1.758 . . . . 0.0 114.285 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -155.99 153.54 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.976 1.71 . . . . 0.0 111.6 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -137.61 147.68 45.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.367 1.867 . . . . 0.0 111.158 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.46 138.47 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.344 1.857 . . . . 0.0 108.792 169.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 t -147.92 139.56 23.82 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.452 -0.78 . . . . 0.0 112.067 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -109.97 148.07 32.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.4 m -134.93 60.09 1.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.631 2.372 . . . . 0.0 110.948 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.36 -91.71 1.37 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.807 1.194 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -116.74 27.71 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.876 1.67 . . . . 0.0 112.8 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -140.29 131.7 26.84 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.264 1.826 . . . . 0.0 108.61 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.6 138.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 111.226 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -119.41 143.99 47.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.323 1.049 . . . . 0.0 112.252 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.51 110.76 14.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.671 2.388 . . . . 0.0 108.924 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.0 120.32 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.266 1.426 . . . . 0.0 108.679 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.77 -152.88 21.25 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.184 -0.947 . . . . 0.0 114.223 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.78 160.15 43.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.032 2.133 . . . . 0.0 111.895 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HD1' ' HG ' ' A' ' 132' ' ' SER . 9.0 m-85 -157.06 171.63 7.2 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 126.225 1.81 . . . . 0.0 112.227 171.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -65.32 -31.46 52.68 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.547 2.831 . . . . 0.0 114.09 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -157.23 168.6 26.93 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.126 1.441 . . . . 0.0 114.002 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.28 -29.06 70.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.568 1.547 . . . . 0.0 113.182 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.71 70.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.725 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.96 65.42 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -61.17 -40.96 95.83 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.172 -0.955 . . . . 0.0 111.817 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.2 78.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.144 0.978 . . . . 0.0 111.323 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.8 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.15 -46.14 82.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.721 0.691 . . . . 0.0 111.53 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.4 mmm -65.13 -39.88 93.68 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.671 0.788 . . . . 0.0 111.167 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.0 m -63.03 -41.5 99.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.062 0.945 . . . . 0.0 110.658 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.21 -29.28 68.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -92.37 -23.99 19.04 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.67 -32.09 73.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.695 1.598 . . . . 0.0 112.246 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.68 -29.4 49.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.841 1.686 . . . . 0.0 115.139 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.52 15.3 4.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.23 1.412 . . . . 0.0 112.524 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.82 127.21 31.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.68 0.792 . . . . 0.0 111.202 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.97 149.12 38.3 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.874 1.27 . . . . 0.0 111.155 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.29 103.7 0.81 Allowed 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.625 2.883 . . . . 0.0 112.602 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.64 -8.31 10.15 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.421 1.962 . . . . 0.0 113.596 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.88 112.1 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.425 1.113 . . . . 0.0 110.595 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.55 149.29 48.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.209 1.404 . . . . 0.0 111.728 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.4 t -135.51 127.72 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.007 1.323 . . . . 0.0 109.385 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.28 103.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.118 1.367 . . . . 0.0 109.036 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -85.22 123.4 30.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.271 1.028 . . . . 0.0 111.098 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.54 20.41 3.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.896 2.479 . . . . 0.0 111.03 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.27 122.85 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.154 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -80.9 168.73 18.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.204 1.802 . . . . 0.0 112.519 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.99 125.91 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 111.525 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.12 112.28 3.07 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.82 1.648 . . . . 0.0 110.305 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.62 -4.92 15.59 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.59 2.86 . . . . 0.0 114.607 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.05 -1.87 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.491 1.516 . . . . 0.0 113.477 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.77 154.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 128.257 2.623 . . . . 0.0 108.935 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.031 1.332 . . . . 0.0 108.116 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.414 ' HG ' ' HD1' ' A' ' 97' ' ' PHE . 1.2 m -141.71 171.25 14.32 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 178.5 7.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.013 2.125 . . . . 0.0 109.752 165.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.65 168.42 11.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.578 1.551 . . . . 0.0 113.769 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.37 13.78 8.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.131 2.172 . . . . 0.0 112.138 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -56.93 -30.4 63.96 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.697 -1.252 . . . . 0.0 113.384 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -102.86 1.65 34.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 0.0 113.663 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.73 -5.72 58.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.73 1.212 . . . . 0.0 113.787 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -48.78 -50.4 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 O-C-N 121.035 -1.04 . . . . 0.0 113.226 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 -24.55 41.21 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.495 2.13 . . . . 0.0 114.113 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.84 -45.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.569 1.077 . . . . 0.0 110.497 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.42 -33.53 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.223 0.609 . . . . 0.0 112.496 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.8 m -61.05 -43.12 99.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.126 0.875 . . . . 0.0 111.352 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.55 66.08 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.992 0.917 . . . . 0.0 113.448 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -106.45 7.68 31.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.573 1.949 . . . . 0.0 115.236 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.11 -44.97 88.59 Favored Pre-proline 0 N--CA 1.482 1.136 0 O-C-N 120.457 -1.402 . . . . 0.0 113.758 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.81 15.44 1.47 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.826 2.351 . . . . 0.0 113.942 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.478 ' CG2' ' H ' ' A' ' 165' ' ' THR . 13.6 mt -119.41 91.6 44.52 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 126.181 1.792 . . . . 0.0 110.63 -171.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.38 -20.88 31.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.963 2.442 . . . . 0.0 114.821 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.62 1.83 46.71 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.353 1.861 . . . . 0.0 113.819 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.3 149.7 9.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.667 1.187 . . . . 0.0 113.606 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.86 162.91 34.43 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.205 1.384 . . . . 0.0 111.772 167.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.5 tt -141.5 145.04 34.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.953 1.301 . . . . 0.0 108.949 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -140.28 149.75 43.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.981 1.312 . . . . 0.0 111.578 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.71 136.41 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.006 1.322 . . . . 0.0 110.82 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.55 152.84 18.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.536 1.134 . . . . 0.0 111.579 166.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 49.06 -69.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 129.798 3.239 . . . . 0.0 117.424 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.24 15.31 0.91 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.811 2.444 . . . . 0.0 113.658 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -139.66 155.9 47.13 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.136 -1.602 . . . . 0.0 114.276 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.33 110.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.603 1.961 . . . . 0.0 110.438 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.5 m -94.91 138.85 32.12 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.184 1.394 . . . . 0.0 110.708 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.09 124.72 35.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.641 1.576 . . . . 0.0 109.037 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.3 m -129.63 145.12 51.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.893 1.677 . . . . 0.0 110.447 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.7 -172.09 42.41 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 120.764 -1.21 . . . . 0.0 113.93 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.478 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 22.5 p -124.74 71.52 1.17 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.298 2.239 . . . . 0.0 112.908 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.2 149.27 97.17 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.1 -27.07 30.03 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.652 2.901 . . . . 0.0 114.15 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.2 t -148.38 156.87 43.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.465 1.906 . . . . 0.0 110.276 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 62.0 p -58.82 -20.93 54.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.086 0.954 . . . . 0.0 113.205 167.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.91 -47.33 81.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.81 1.244 . . . . 0.0 111.747 170.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -60.2 -40.1 88.85 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.268 0.627 . . . . 0.0 112.032 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.52 -46.27 90.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 0.0 112.256 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.91 -41.67 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.468 0.707 . . . . 0.0 112.092 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.91 95.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 112.407 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.72 -41.78 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.051 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.12 -45.22 93.02 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 111.872 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -69.13 -36.42 77.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.405 0.682 . . . . 0.0 111.351 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.33 86.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.047 0.539 . . . . 0.0 112.062 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.72 94.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.789 0.722 . . . . 0.0 111.907 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 85.7 m -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.688 -0.633 . . . . 0.0 111.933 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 73.7 m -66.68 -35.56 80.44 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.4 m -75.96 -36.92 59.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 112.728 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.01 59.5 45.59 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.305 1.442 . . . . 0.0 113.013 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.64 -5.16 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.175 . . . . 0.0 115.603 -171.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.5 14.79 8.22 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.141 1.777 . . . . 0.0 112.997 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.1 mtm -133.3 164.76 26.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.617 1.967 . . . . 0.0 110.207 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -76.96 152.75 35.13 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.348 -0.845 . . . . 0.0 111.741 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.99 136.93 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.099 1.36 . . . . 0.0 109.418 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.1 t -126.1 89.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.985 1.314 . . . . 0.0 109.618 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -74.95 65.57 1.44 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.674 2.39 . . . . 0.0 112.337 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -71.12 5.46 2.1 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.347 2.259 . . . . 0.0 114.387 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.1 mm -50.96 143.7 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.416 1.886 . . . . 0.0 111.301 171.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 125.879 1.672 . . . . 0.0 110.268 168.085 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 122.191 0.996 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.17 157.35 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 129.89 3.276 . . . . 0.0 114.981 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 tt -95.28 129.86 42.25 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.601 1.561 . . . . 0.0 110.777 167.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -153.79 140.98 19.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.235 1.014 . . . . 0.0 109.182 -175.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.429 ' N ' HD13 ' A' ' 82' ' ' LEU . 88.3 p -146.49 160.44 42.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 123.209 1.48 . . . . 0.0 113.371 172.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 tt -144.64 144.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.067 1.347 . . . . 0.0 109.715 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 t -142.58 141.16 31.94 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.011 0.524 . . . . 0.0 111.899 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -108.4 148.66 29.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.462 1.505 . . . . 0.0 112.141 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.3 m -137.18 60.29 1.65 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.037 2.135 . . . . 0.0 111.509 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.28 -89.06 1.38 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.545 1.069 . . . . 0.0 113.135 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -121.22 29.75 7.15 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.063 1.745 . . . . 0.0 112.099 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 96.6 m -141.02 136.29 31.95 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.998 2.119 . . . . 0.0 108.113 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.32 143.0 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.338 1.055 . . . . 0.0 111.418 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.0 m -126.78 126.11 42.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.216 1.006 . . . . 0.0 111.507 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.84 129.97 49.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.16 2.184 . . . . 0.0 110.379 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.26 144.07 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.077 1.351 . . . . 0.0 109.122 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 152.51 -147.77 17.86 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 119.964 -1.71 . . . . 0.0 115.466 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -154.41 143.56 21.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.326 2.65 . . . . 0.0 110.923 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -152.51 170.72 7.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.775 1.23 . . . . 0.0 112.426 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.71 -29.32 10.75 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.808 3.005 . . . . 0.0 114.287 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -159.57 172.08 18.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.356 1.55 . . . . 0.0 114.836 -171.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.41 -34.22 73.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.277 1.831 . . . . 0.0 112.985 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.66 71.16 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.074 0.55 . . . . 0.0 111.547 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.74 75.76 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.974 0.509 . . . . 0.0 112.274 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -63.19 -41.88 99.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.582 0.753 . . . . 0.0 111.804 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.62 84.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.388 0.675 . . . . 0.0 112.451 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.89 76.26 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.653 -0.654 . . . . 0.0 112.713 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.2 -40.58 90.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.652 1.181 . . . . 0.0 111.321 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -73.82 -32.46 63.71 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.746 -0.596 . . . . 0.0 112.109 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -65.48 -39.22 91.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.027 0.931 . . . . 0.0 110.98 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.15 79.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.978 0.911 . . . . 0.0 113.119 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.9 -24.83 24.7 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.92 -28.24 67.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.676 1.59 . . . . 0.0 112.203 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -53.7 -28.16 37.46 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.792 2.139 . . . . 0.0 115.388 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 146' ' ' VAL . 0.9 OUTLIER -135.32 15.15 3.48 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 113.598 174.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -55.9 127.38 30.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.93 0.892 . . . . 0.0 111.267 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.39 149.26 44.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.157 1.383 . . . . 0.0 111.176 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.87 102.76 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.529 2.819 . . . . 0.0 112.665 -174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.4 -8.7 8.36 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.742 2.115 . . . . 0.0 113.852 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.57 113.83 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.477 1.139 . . . . 0.0 111.055 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -73.68 153.14 40.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.906 1.682 . . . . 0.0 112.267 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.63 133.64 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.706 1.203 . . . . 0.0 109.846 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.0 mt -128.66 141.27 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.266 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -130.06 128.49 42.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.887 1.275 . . . . 0.0 112.766 -171.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.8 17.96 3.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.339 2.256 . . . . 0.0 112.73 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.81 130.77 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.811 1.244 . . . . 0.0 110.954 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -86.6 164.11 17.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.922 1.689 . . . . 0.0 112.373 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.85 120.79 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.118 1.367 . . . . 0.0 111.657 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.07 130.46 5.27 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.346 1.859 . . . . 0.0 110.156 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.27 -4.68 15.42 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.775 2.983 . . . . 0.0 114.691 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -15.14 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 126.002 1.721 . . . . 0.0 112.58 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.98 145.43 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 128.022 2.529 . . . . 0.0 110.491 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -141.68 150.85 42.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.282 1.833 . . . . 0.0 109.013 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -126.21 168.22 14.37 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.871 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -69.69 155.45 40.49 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.814 2.846 . . . . 0.0 108.586 167.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.35 88.19 7.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.379 1.072 . . . . 0.0 113.373 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -61.58 -8.65 4.62 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.717 -1.24 . . . . 0.0 113.55 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 m -49.17 -29.5 5.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.085 1.754 . . . . 0.0 112.506 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 m -108.97 2.33 21.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.63 2.372 . . . . 0.0 113.488 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.42 -2.96 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.852 1.661 . . . . 0.0 113.647 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.45 -47.66 83.17 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.761 1.224 . . . . 0.0 113.187 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.51 -27.01 46.71 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.807 1.671 . . . . 0.0 113.632 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.93 -45.32 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.948 0.795 . . . . 0.0 110.775 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -74.49 -30.11 61.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.152 0.581 . . . . 0.0 112.398 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -62.42 -44.2 97.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.481 1.112 . . . . 0.0 111.408 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.79 -17.0 64.66 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -112.95 3.06 16.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.523 1.929 . . . . 0.0 115.542 -177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 113' ' ' LEU . 91.3 t -53.62 -40.37 80.02 Favored Pre-proline 0 N--CA 1.481 1.096 0 O-C-N 120.132 -1.605 . . . . 0.0 113.858 167.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.41 14.25 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.68 2.254 . . . . 0.0 114.065 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.1 mt -120.69 84.34 37.09 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.964 2.106 . . . . 0.0 109.308 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.45 -17.79 58.36 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.44 2.76 . . . . 0.0 115.297 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -105.77 5.54 30.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.423 2.289 . . . . 0.0 113.913 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -56.53 152.28 12.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.252 1.025 . . . . 0.0 113.251 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.57 35.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.654 1.597 . . . . 0.0 112.356 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.62 150.35 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.296 1.438 . . . . 0.0 109.584 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -139.21 142.3 37.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.479 1.112 . . . . 0.0 109.089 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.6 t -143.45 128.45 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.713 1.205 . . . . 0.0 109.063 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.45 155.03 29.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 36.54 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.058 2.543 . . . . 0.0 114.971 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.1 15.32 8.46 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.841 2.056 . . . . 0.0 113.171 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -139.43 145.1 38.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.616 1.566 . . . . 0.0 112.609 -171.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.25 141.09 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.429 1.892 . . . . 0.0 110.257 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.3 m -132.49 135.08 45.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 109.6 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.85 125.36 33.42 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.192 1.397 . . . . 0.0 109.564 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.9 m -134.86 131.21 37.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.888 1.275 . . . . 0.0 110.244 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.99 -174.47 45.32 Favored Glycine 0 CA--C 1.538 1.473 0 O-C-N 120.879 -1.138 . . . . 0.0 112.882 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -126.88 80.51 1.95 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.954 1.702 . . . . 0.0 113.726 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.74 153.87 90.01 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.763 1.625 . . . . 0.0 114.751 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -25.54 16.04 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 114.634 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.8 t -153.29 157.53 40.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.33 1.852 . . . . 0.0 110.71 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 p -59.64 -24.08 63.56 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.289 1.036 . . . . 0.0 113.41 169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.65 -44.07 87.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.546 1.138 . . . . 0.0 111.32 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -61.95 -39.68 92.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.232 0.613 . . . . 0.0 111.992 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -60.54 -43.34 97.31 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.183 0.901 . . . . 0.0 112.716 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.39 -43.51 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.368 0.667 . . . . 0.0 112.11 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.65 84.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.75 0.82 . . . . 0.0 112.195 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.3 -39.62 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.408 0.549 . . . . 0.0 110.836 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -64.33 -43.61 94.08 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.678 0.672 . . . . 0.0 111.737 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -67.59 -37.15 82.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.956 0.903 . . . . 0.0 112.136 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.84 83.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.809 0.444 . . . . 0.0 110.869 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.44 -37.56 87.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.931 0.492 . . . . 0.0 112.044 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.4 m -68.84 -36.64 78.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.652 0.781 . . . . 0.0 111.734 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 t -68.05 -38.69 82.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.185 0.994 . . . . 0.0 112.376 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 41.9 m -72.86 -40.02 66.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.093 0.957 . . . . 0.0 112.339 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -129.77 61.1 56.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.411 1.484 . . . . 0.0 113.906 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.63 -13.14 32.23 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.221 2.614 . . . . 0.0 113.154 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -98.9 3.17 47.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.818 2.047 . . . . 0.0 113.483 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -133.86 164.32 27.52 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.344 1.857 . . . . 0.0 111.691 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -76.65 150.78 36.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.529 0.732 . . . . 0.0 110.808 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.54 133.51 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.271 1.429 . . . . 0.0 109.92 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.75 84.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.891 1.676 . . . . 0.0 109.486 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.18 70.34 3.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.622 1.569 . . . . 0.0 111.48 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -68.3 -9.61 48.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.799 2.04 . . . . 0.0 114.251 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.4 pt -58.12 156.09 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.268 1.427 . . . . 0.0 112.861 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 . . . . . 0 C--N 1.33 -0.254 0 C-N-CA 124.782 1.233 . . . . 0.0 110.968 168.619 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.887 0.851 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.96 151.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.544 2.738 . . . . 0.0 114.199 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.58 129.03 54.58 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.378 1.871 . . . . 0.0 111.643 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -154.06 154.93 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.565 1.146 . . . . 0.0 112.447 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -138.03 145.99 42.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.985 2.114 . . . . 0.0 110.787 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 tt -140.24 139.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.25 1.42 . . . . 0.0 109.153 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 t -146.8 143.49 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -105.02 148.12 27.09 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.657 1.583 . . . . 0.0 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.3 m -135.17 63.58 1.61 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.484 2.314 . . . . 0.0 111.407 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 -88.71 1.26 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.745 1.164 . . . . 0.0 113.058 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -122.53 34.15 5.23 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.063 1.745 . . . . 0.0 111.871 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.7 m -143.68 140.7 30.18 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.563 2.345 . . . . 0.0 108.239 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.24 143.97 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.381 1.073 . . . . 0.0 111.316 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.5 m -127.11 130.44 49.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.352 1.061 . . . . 0.0 111.562 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 122.75 47.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.21 2.204 . . . . 0.0 110.123 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.87 116.75 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.575 1.15 . . . . 0.0 109.313 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.77 -161.02 32.25 Favored Glycine 0 CA--C 1.525 0.719 0 O-C-N 120.502 -1.374 . . . . 0.0 114.727 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.14 142.21 24.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.073 2.149 . . . . 0.0 111.331 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -152.44 169.77 9.07 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.285 1.434 . . . . 0.0 112.749 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.26 -25.51 11.4 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.845 3.03 . . . . 0.0 114.179 174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -155.54 164.22 38.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.688 1.595 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -66.36 -26.35 67.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.615 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -29.94 69.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.457 0.703 . . . . 0.0 112.005 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.24 75.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.325 0.65 . . . . 0.0 112.606 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.9 -42.3 99.74 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.629 1.172 . . . . 0.0 111.371 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.74 82.71 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.745 0.818 . . . . 0.0 111.767 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.22 91.74 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.35 -39.4 89.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 111.754 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.21 -38.68 82.19 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.325 -0.86 . . . . 0.0 112.097 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -63.32 -40.94 98.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.442 1.097 . . . . 0.0 110.981 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -33.74 76.23 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.254 1.021 . . . . 0.0 112.978 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.52 -26.8 24.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.29 -27.73 66.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.806 1.642 . . . . 0.0 112.355 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.75 -29.26 25.5 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.918 2.199 . . . . 0.0 115.306 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.1 16.76 2.81 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.343 1.057 . . . . 0.0 113.523 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -56.28 133.39 52.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.86 0.864 . . . . 0.0 111.477 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.06 34.0 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.291 1.436 . . . . 0.0 111.216 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 103.21 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.578 2.852 . . . . 0.0 112.393 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.6 -9.94 6.82 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.607 2.051 . . . . 0.0 113.783 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.83 112.91 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 118.553 1.177 . . . . 0.0 110.795 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.98 158.46 36.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.866 1.667 . . . . 0.0 112.592 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -136.62 133.2 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.104 1.361 . . . . 0.0 109.807 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.8 139.48 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.191 1.797 . . . . 0.0 108.971 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -127.59 126.13 41.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 113.16 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -137.35 23.53 2.97 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.761 2.424 . . . . 0.0 111.684 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.6 144.98 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 120.768 -1.207 . . . . 0.0 111.22 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -116.2 161.66 18.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.17 1.788 . . . . 0.0 111.903 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -131.3 120.72 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.358 1.463 . . . . 0.0 111.765 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.42 129.75 4.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.608 1.963 . . . . 0.0 110.167 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.49 -3.23 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.085 3.19 . . . . 0.0 115.039 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.5 t -66.13 -19.25 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.714 2.006 . . . . 0.0 112.505 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.26 139.67 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 127.485 2.314 . . . . 0.0 109.824 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -144.98 146.83 32.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.429 1.892 . . . . 0.0 108.982 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.08 -179.82 6.0 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.68 174.64 1.31 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.682 2.393 . . . . 0.0 110.816 166.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.66 155.89 17.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.795 1.238 . . . . 0.0 112.056 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.75 0.26 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.122 1.369 . . . . 0.0 113.264 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.4 m -56.74 -40.11 75.14 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.105 -0.997 . . . . 0.0 111.699 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.1 m -83.28 -7.33 59.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.589 1.556 . . . . 0.0 114.167 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.84 -1.65 54.58 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.815 1.646 . . . . 0.0 114.32 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -45.58 -47.92 37.22 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.391 1.076 . . . . 0.0 113.132 169.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -24.22 54.63 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.125 1.884 . . . . 0.0 113.94 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.9 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.193 0.906 . . . . 0.0 110.813 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.94 -37.89 76.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.748 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.4 m -58.42 -41.35 84.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.64 -12.16 61.01 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 m -117.21 -5.46 11.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.622 1.969 . . . . 0.0 115.839 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.69 -40.82 80.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-N 121.867 2.121 . . . . 0.0 115.739 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.42 -8.32 23.08 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 CA-C-N 122.688 1.996 . . . . 0.0 114.373 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.419 ' CG2' ' H ' ' A' ' 165' ' ' THR . 24.8 mt -83.3 119.21 73.62 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.351 1.46 . . . . 0.0 110.934 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.87 -24.61 9.81 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.78 2.32 . . . . 0.0 115.39 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -113.47 8.5 17.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.402 1.881 . . . . 0.0 114.001 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -56.44 148.1 20.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.745 0.818 . . . . 0.0 112.934 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.32 166.72 39.01 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.532 1.063 . . . . 0.0 112.414 171.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.56 150.93 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.174 1.389 . . . . 0.0 110.3 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.57 145.51 47.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.365 1.066 . . . . 0.0 110.256 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.55 129.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.882 1.273 . . . . 0.0 108.672 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -159.61 158.92 32.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.329 0.652 . . . . 0.0 112.364 170.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 43.82 -89.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.556 2.342 . . . . 0.0 114.194 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.93 24.86 3.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.769 2.028 . . . . 0.0 111.727 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 20.2 m -135.74 142.3 44.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.803 1.641 . . . . 0.0 112.327 -171.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.14 129.32 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.544 1.938 . . . . 0.0 110.547 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 m -125.64 137.28 53.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.385 1.474 . . . . 0.0 110.666 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.2 125.53 31.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.354 1.462 . . . . 0.0 109.877 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 m -132.78 152.9 51.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.745 1.618 . . . . 0.0 110.416 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.05 -167.02 37.22 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 120.741 -1.224 . . . . 0.0 114.568 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.419 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 21.4 p -136.03 70.62 1.42 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.733 2.013 . . . . 0.0 112.861 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.19 153.14 95.47 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.6 1.56 . . . . 0.0 114.94 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.94 -27.87 20.29 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.608 2.872 . . . . 0.0 114.323 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.2 t -151.55 156.68 41.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.046 1.739 . . . . 0.0 111.139 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.1 m -58.33 -21.4 49.33 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.488 1.115 . . . . 0.0 113.409 167.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.44 -46.77 87.02 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.216 1.006 . . . . 0.0 111.614 170.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -59.77 -42.19 92.75 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.173 0.589 . . . . 0.0 111.791 170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -62.18 -44.59 96.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.835 0.743 . . . . 0.0 112.685 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.72 -42.15 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 111.82 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.63 -40.93 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.14 0.576 . . . . 0.0 111.059 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -64.87 -41.5 95.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.292 1.037 . . . . 0.0 111.846 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -69.23 -34.84 75.45 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.561 1.144 . . . . 0.0 112.521 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.94 83.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 117.929 0.331 . . . . 0.0 111.199 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.76 92.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.99 0.916 . . . . 0.0 112.513 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 t -74.4 -28.24 61.0 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.723 -0.611 . . . . 0.0 112.158 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -39.42 71.7 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.857 0.863 . . . . 0.0 112.81 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 183' ' ' TRP . 11.1 t -79.58 -31.68 41.86 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.646 ' CD2' HG23 ' A' ' 182' ' ' THR . 2.7 m-90 -128.91 60.51 50.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.355 1.462 . . . . 0.0 114.029 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.58 -14.6 30.51 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.352 2.702 . . . . 0.0 114.859 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -95.72 -8.55 34.24 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.241 1.016 . . . . 0.0 113.453 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 98.7 mtp -106.43 160.77 15.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 112.507 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -67.35 142.85 56.65 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.466 0.706 . . . . 0.0 109.484 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.63 127.35 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 110.243 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.54 97.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.496 1.118 . . . . 0.0 110.767 -171.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -75.72 123.04 24.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.309 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -129.14 5.68 5.33 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.825 2.45 . . . . 0.0 111.6 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.0 mt -61.99 142.05 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.901 1.68 . . . . 0.0 110.529 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 127.276 2.231 . . . . 0.0 110.261 178.4 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 42.11 54.73 4.05 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.772 2.029 . . . . 0.0 115.088 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 t -151.17 168.3 25.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.091 1.357 . . . . 0.0 112.575 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.52 150.26 31.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.994 1.718 . . . . 0.0 110.98 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.4 mt -136.56 174.62 10.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.207 2.203 . . . . 0.0 110.789 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -139.05 45.94 1.97 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.894 1.278 . . . . 0.0 112.753 -171.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.52 169.07 1.87 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.21 1.804 . . . . 0.0 113.924 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.43 163.94 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 129.728 3.211 . . . . 0.0 114.058 167.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 pp -109.8 138.72 45.77 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.679 1.591 . . . . 0.0 112.331 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD21 ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -155.62 148.47 24.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.42 1.488 . . . . 0.0 110.507 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.6 p -151.38 159.51 44.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.195 1.474 . . . . 0.0 113.387 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.81 141.67 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.337 1.855 . . . . 0.0 108.781 174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.6 p -143.36 146.66 33.7 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.573 0.749 . . . . 0.0 112.461 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -112.93 149.0 33.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.647 1.579 . . . . 0.0 111.833 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.5 m -136.3 58.2 1.75 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.336 2.254 . . . . 0.0 111.222 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.06 -86.92 1.18 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.572 1.082 . . . . 0.0 113.434 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -120.56 30.12 7.09 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.26 1.824 . . . . 0.0 112.245 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.4 m -142.34 137.76 30.75 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.184 2.193 . . . . 0.0 108.226 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.96 142.5 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.439 1.096 . . . . 0.0 111.282 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -127.35 130.46 49.49 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.923 1.289 . . . . 0.0 111.165 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.67 122.0 41.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.755 2.022 . . . . 0.0 110.524 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.3 mm -134.06 132.12 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.911 1.684 . . . . 0.0 109.722 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 165.19 -159.71 32.9 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.025 -1.672 . . . . 0.0 116.294 -172.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -158.37 145.1 17.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.94 2.496 . . . . 0.0 110.116 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HD21 ' A' ' 82' ' ' LEU . 16.1 m-85 -152.44 169.97 8.76 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.523 1.129 . . . . 0.0 113.002 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -67.79 -29.11 35.91 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.818 3.012 . . . . 0.0 113.664 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -152.76 162.87 40.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.36 1.552 . . . . 0.0 113.005 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.56 -27.34 69.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 113.802 -1.545 . . . . 0.0 112.425 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.08 70.81 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.434 0.694 . . . . 0.0 112.209 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -39.27 70.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.525 0.678 . . . . 0.0 111.864 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.9 -40.75 96.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.974 2.11 . . . . 0.0 112.385 170.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.48 -34.53 78.49 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.024 1.33 . . . . 0.0 112.366 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.27 80.0 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.233 -0.917 . . . . 0.0 112.436 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -65.26 -42.34 93.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.737 0.815 . . . . 0.0 111.288 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.6 ptp -74.82 -27.85 60.46 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -68.47 -40.0 81.17 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.41 -34.15 76.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.089 0.956 . . . . 0.0 112.795 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.66 -28.66 26.26 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -64.45 -28.93 70.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.864 1.266 . . . . 0.0 112.363 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.51 -28.38 28.76 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.796 2.141 . . . . 0.0 115.393 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 tp -137.76 16.55 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.551 1.14 . . . . 0.0 113.274 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 tt -58.59 137.13 57.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 111.403 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.46 147.17 32.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.738 1.615 . . . . 0.0 111.377 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.51 104.53 0.65 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.704 2.936 . . . . 0.0 112.283 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.58 -11.15 7.12 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.499 2.0 . . . . 0.0 113.727 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -69.32 113.08 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 118.358 1.079 . . . . 0.0 110.499 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -72.14 154.05 41.3 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.445 1.498 . . . . 0.0 112.371 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 t -137.09 131.02 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.285 1.434 . . . . 0.0 109.767 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.4 mt -129.55 141.84 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.186 1.794 . . . . 0.0 109.309 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.76 138.19 44.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.936 1.294 . . . . 0.0 113.043 -171.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -140.2 17.69 2.43 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.586 1.955 . . . . 0.0 112.672 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.39 124.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.946 -1.096 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -84.31 167.2 16.79 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.839 2.456 . . . . 0.0 113.102 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -133.11 125.04 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.193 1.397 . . . . 0.0 111.342 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -153.96 127.19 4.21 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 126.545 1.938 . . . . 0.0 110.742 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.34 -7.38 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.618 2.212 . . . . 0.0 114.723 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 p -70.3 -11.9 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.683 1.129 . . . . 0.0 113.742 172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.89 147.34 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.323 1.849 . . . . 0.0 111.373 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -142.86 152.48 42.18 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.278 1.831 . . . . 0.0 110.687 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -145.32 177.9 8.48 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -175.79 0.26 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.02 2.528 . . . . 0.0 110.603 164.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -134.78 107.45 7.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.703 1.201 . . . . 0.0 111.743 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -69.01 -1.82 8.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 m -54.36 -33.7 59.65 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 171.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.6 m -85.62 -12.09 52.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.179 1.792 . . . . 0.0 113.926 173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -88.97 0.85 56.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.975 1.71 . . . . 0.0 114.125 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -45.54 -47.57 36.98 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 120.998 -1.063 . . . . 0.0 113.378 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.4 -22.76 38.86 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.364 2.043 . . . . 0.0 114.127 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -44.98 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.292 0.951 . . . . 0.0 110.474 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.73 -32.15 69.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.9 m -57.89 -42.01 83.74 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.084 0.856 . . . . 0.0 111.488 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.47 -19.84 66.1 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.4 p -116.61 6.13 13.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.589 1.955 . . . . 0.0 116.165 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.2 t -52.28 -42.17 85.34 Favored Pre-proline 0 N--CA 1.482 1.172 0 O-C-N 120.185 -1.572 . . . . 0.0 113.58 167.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.86 12.49 1.95 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.672 2.248 . . . . 0.0 114.353 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 mt -113.96 97.74 45.81 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.264 1.826 . . . . 0.0 109.956 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.98 -23.48 21.79 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.906 2.404 . . . . 0.0 114.885 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.13 6.72 43.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.363 1.865 . . . . 0.0 113.653 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -52.42 152.1 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.959 1.304 . . . . 0.0 113.396 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.15 163.31 35.91 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.872 1.225 . . . . 0.0 111.769 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -140.75 149.6 42.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.269 1.028 . . . . 0.0 109.355 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 153.3 48.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.702 1.601 . . . . 0.0 110.868 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -143.52 133.73 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.101 1.36 . . . . 0.0 109.834 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -157.12 146.09 19.99 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.302 0.641 . . . . 0.0 112.484 166.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 51.36 -71.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 129.304 3.041 . . . . 0.0 117.997 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -144.95 21.0 1.61 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.37 1.868 . . . . 0.0 113.694 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 53.6 m -136.53 140.97 43.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.772 1.629 . . . . 0.0 111.139 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.23 131.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.829 2.052 . . . . 0.0 107.977 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.3 m -122.56 132.17 54.18 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.972 1.309 . . . . 0.0 110.128 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.64 123.77 36.38 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.312 1.445 . . . . 0.0 109.169 -173.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.0 t -135.23 152.34 51.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.687 1.195 . . . . 0.0 112.129 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 159.42 -178.41 35.56 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.78 -1.2 . . . . 0.0 114.046 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.3 p -120.7 84.65 2.26 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.598 2.359 . . . . 0.0 111.869 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.6 149.7 81.29 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.79 -30.36 27.34 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.558 2.838 . . . . 0.0 113.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t -152.21 164.5 37.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.64 1.176 . . . . 0.0 112.092 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -61.52 -21.61 64.39 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.616 1.166 . . . . 0.0 113.845 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -64.85 -40.28 94.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.222 1.009 . . . . 0.0 111.38 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -65.91 -39.95 91.03 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.015 -0.428 . . . . 0.0 111.958 170.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.74 -42.83 94.02 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.002 0.819 . . . . 0.0 112.585 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.78 -41.26 87.98 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 112.713 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.54 81.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.525 0.73 . . . . 0.0 112.424 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 91.9 t -67.33 -38.39 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.075 0.852 . . . . 0.0 110.553 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -61.45 -45.16 95.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.192 0.597 . . . . 0.0 111.293 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -61.94 -42.9 99.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.469 0.708 . . . . 0.0 112.204 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.03 92.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.663 0.385 . . . . 0.0 111.373 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.56 78.86 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.22 0.608 . . . . 0.0 112.371 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.8 m -67.85 -38.62 83.37 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.703 0.801 . . . . 0.0 111.734 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -35.95 74.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.256 0.622 . . . . 0.0 112.348 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.66 -36.91 50.92 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.145 0.978 . . . . 0.0 112.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -135.74 64.27 56.24 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.615 1.566 . . . . 0.0 113.307 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.16 -3.92 14.5 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.449 2.766 . . . . 0.0 114.316 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -127.28 20.09 6.85 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.678 1.991 . . . . 0.0 113.062 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.3 mtt -135.7 163.5 30.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.775 1.63 . . . . 0.0 110.805 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -70.79 143.07 51.28 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.608 -0.683 . . . . 0.0 109.643 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 pt -137.41 86.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.72 1.608 . . . . 0.0 111.694 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.8 t -82.56 92.55 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.201 1.4 . . . . 0.0 110.687 -176.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -78.76 68.92 4.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.599 1.56 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -68.03 -5.68 18.65 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.24 1.816 . . . . 0.0 114.542 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.7 mm -42.21 137.67 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.832 2.053 . . . . 0.0 111.701 171.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.6 161.58 33.51 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.884 1.274 . . . . 0.0 110.955 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 22.6 t -82.97 135.98 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.93 0.492 . . . . 0.0 109.712 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 53.7 m -55.07 135.9 48.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 112.694 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -167.69 31.22 0.18 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.228 0.918 . . . . 0.0 114.507 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -146.57 118.58 8.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.023 1.329 . . . . 0.0 110.857 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -155.74 57.77 1.64 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 112.327 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.94 154.15 73.55 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.294 2.662 . . . . 0.0 113.114 -174.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.38 95.47 0.86 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.144 3.229 . . . . 0.0 111.856 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.18 54.77 0.13 Allowed Glycine 0 CA--C 1.538 1.527 0 CA-C-O 118.484 -1.175 . . . . 0.0 114.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.53 156.16 67.24 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.18 2.587 . . . . 0.0 112.704 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.75 170.82 19.49 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.948 3.099 . . . . 0.0 112.716 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.014 2.526 . . . . 0.0 114.658 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.92 166.99 27.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.357 1.463 . . . . 0.0 111.979 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.0 m -133.78 142.56 47.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.034 1.733 . . . . 0.0 111.039 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.42 39.66 0.74 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.911 1.284 . . . . 0.0 112.768 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.8 tp -74.86 121.32 21.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.889 1.276 . . . . 0.0 110.862 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.2 p -73.1 108.91 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.461 1.104 . . . . 0.0 113.659 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.53 177.51 4.82 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.914 2.086 . . . . 0.0 110.812 170.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 m -41.23 164.31 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.872 3.269 . . . . 0.0 115.251 168.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.73 139.89 52.44 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.712 1.605 . . . . 0.0 112.381 166.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.7 tt -159.92 154.76 24.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.338 1.455 . . . . 0.0 111.784 -176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.4 m -139.42 150.31 45.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.556 1.942 . . . . 0.0 111.705 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -142.43 138.76 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.819 1.648 . . . . 0.0 108.885 171.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -145.88 142.73 29.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -107.0 148.99 28.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.125 1.77 . . . . 0.0 112.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.7 t -141.09 99.19 3.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.713 1.605 . . . . 0.0 110.943 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.77 -96.8 0.1 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.311 1.91 . . . . 0.0 113.619 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -120.58 34.95 5.03 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.15 1.78 . . . . 0.0 112.234 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -141.39 137.35 32.22 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.861 2.065 . . . . 0.0 108.89 169.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.83 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.256 1.022 . . . . 0.0 111.541 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.3 m -125.97 129.43 49.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.515 1.126 . . . . 0.0 111.165 -171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.468 ' CB ' HD11 ' A' ' 124' ' ' ILE . 7.6 mp -113.31 126.93 55.93 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.508 1.923 . . . . 0.0 110.1 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.1 mt -139.61 127.43 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.075 1.35 . . . . 0.0 109.257 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.48 -155.89 26.43 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 120.618 -1.301 . . . . 0.0 115.242 -171.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.22 150.32 25.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.345 1.858 . . . . 0.0 112.289 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -152.34 170.12 8.52 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.323 1.849 . . . . 0.0 112.309 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.62 -31.8 32.3 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.382 3.388 . . . . 0.0 113.805 169.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -155.55 164.76 38.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 123.255 1.502 . . . . 0.0 112.813 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -60.57 -32.0 71.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.769 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.48 69.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.97 0.908 . . . . 0.0 112.149 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -37.86 67.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.157 0.583 . . . . 0.0 111.992 172.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.648 ' HD2' HD13 ' A' ' 124' ' ' ILE . 5.4 ttpt -67.53 -34.81 77.86 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.69 1.196 . . . . 0.0 112.838 171.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.17 -35.26 74.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.406 1.082 . . . . 0.0 111.632 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.32 80.71 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.623 -0.673 . . . . 0.0 112.809 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.66 -42.77 98.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.816 0.847 . . . . 0.0 111.458 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 28.8 ptm -73.39 -30.93 63.6 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.763 -0.586 . . . . 0.0 112.34 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.9 m -66.65 -40.34 88.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.086 0.954 . . . . 0.0 111.158 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.29 -31.91 72.57 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.313 1.045 . . . . 0.0 113.121 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.6 -25.34 21.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.58 -32.23 70.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.876 1.27 . . . . 0.0 112.246 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -57.14 -27.85 57.91 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.747 1.641 . . . . 0.0 115.117 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 14.41 6.08 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.502 1.521 . . . . 0.0 112.552 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.2 129.02 38.44 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.122 0.969 . . . . 0.0 111.383 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.33 152.83 41.42 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.555 1.542 . . . . 0.0 111.505 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.48 104.15 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.353 2.702 . . . . 0.0 112.97 -172.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.87 -9.09 9.83 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.78 2.133 . . . . 0.0 113.678 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.9 t -71.28 110.44 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 118.312 1.056 . . . . 0.0 111.799 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.23 156.42 39.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.381 1.873 . . . . 0.0 112.363 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.75 134.72 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.146 1.379 . . . . 0.0 109.623 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.84 140.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.253 1.821 . . . . 0.0 108.765 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -128.04 131.57 49.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.104 1.362 . . . . 0.0 112.163 -170.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -140.35 24.95 2.27 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 127.279 2.231 . . . . 0.0 112.058 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 124' ' ' ILE . 1.3 mp -82.49 129.83 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.766 1.226 . . . . 0.0 111.022 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -92.84 169.63 10.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.178 1.391 . . . . 0.0 113.46 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.89 119.49 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.751 1.621 . . . . 0.0 110.694 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -150.25 126.24 5.07 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 127.596 2.358 . . . . 0.0 110.034 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.7 -4.2 14.19 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.321 2.681 . . . . 0.0 114.473 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.6 t -71.0 -13.54 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.398 1.879 . . . . 0.0 112.732 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.64 153.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 126.926 2.09 . . . . 0.0 110.555 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -146.71 143.84 29.01 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.32 1.848 . . . . 0.0 108.424 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 m -128.16 171.17 12.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.137 1.335 . . . . 0.0 114.476 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.61 176.01 4.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.131 1.772 . . . . 0.0 109.697 165.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -118.38 102.68 9.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.946 0.898 . . . . 0.0 112.295 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -69.77 -2.98 13.51 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.8 m -54.61 -33.89 61.15 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.901 -1.125 . . . . 0.0 112.492 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.6 m -96.32 1.8 52.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.337 1.855 . . . . 0.0 113.676 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -91.44 -5.71 53.91 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.891 1.676 . . . . 0.0 113.455 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -45.91 -48.22 40.88 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.04 1.336 . . . . 0.0 113.006 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.56 -24.78 41.58 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.9 1.733 . . . . 0.0 113.862 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.2 t -66.35 -44.0 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.223 0.92 . . . . 0.0 110.407 174.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.23 -35.55 78.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.211 0.604 . . . . 0.0 112.214 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.9 m -59.71 -42.61 93.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.838 0.855 . . . . 0.0 111.554 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.23 -17.52 64.79 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 m -104.62 1.94 30.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.314 2.246 . . . . 0.0 114.884 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.0 t -52.31 -44.53 93.69 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-O 117.388 -1.291 . . . . 0.0 114.161 173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.81 14.37 2.35 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.725 2.283 . . . . 0.0 114.193 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 mt -112.3 93.78 23.84 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 109.761 -171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.53 -21.06 26.37 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.844 3.029 . . . . 0.0 116.657 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -107.4 13.0 27.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.079 1.752 . . . . 0.0 113.067 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.06 148.13 8.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 113.116 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.9 161.76 33.06 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 124.624 1.107 . . . . 0.0 111.58 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 tp -134.09 146.55 50.4 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.494 1.118 . . . . 0.0 109.114 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -135.73 151.6 50.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.986 0.915 . . . . 0.0 110.748 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 44.8 t -143.19 132.25 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.884 1.274 . . . . 0.0 109.05 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.23 155.08 28.33 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 167.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 41.39 -86.36 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.156 2.583 . . . . 0.0 114.991 -174.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -140.64 29.54 1.93 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.907 1.23 . . . . 0.0 112.564 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 54.0 m -137.86 142.08 40.72 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.871 2.068 . . . . 0.0 110.67 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.3 m -118.64 142.91 31.27 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 125.527 1.531 . . . . 0.0 111.378 170.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 m -125.58 139.78 53.3 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.701 1.6 . . . . 0.0 110.163 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 mp -132.64 130.81 40.65 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.952 1.301 . . . . 0.0 110.405 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 27.4 m -138.05 151.08 47.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.654 1.182 . . . . 0.0 110.931 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.49 -174.4 39.71 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 120.542 -1.349 . . . . 0.0 115.883 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.2 p -128.11 80.07 1.94 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.879 2.472 . . . . 0.0 111.816 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.68 155.46 83.31 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -170.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.03 -29.12 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.452 2.768 . . . . 0.0 113.976 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.2 t -150.25 155.9 40.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.622 1.969 . . . . 0.0 110.575 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.3 p -56.67 -24.7 50.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.326 1.45 . . . . 0.0 113.303 168.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.44 -45.92 92.25 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.317 . . . . 0.0 111.724 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.189 0.595 . . . . 0.0 112.172 170.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -63.25 -42.19 99.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.134 0.879 . . . . 0.0 112.444 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.18 -39.7 86.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.863 0.865 . . . . 0.0 112.153 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.44 93.77 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.977 -0.452 . . . . 0.0 112.162 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 72.9 t -67.91 -42.05 85.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 122.779 0.432 . . . . 0.0 111.094 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -68.4 -38.18 81.04 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.711 0.687 . . . . 0.0 111.882 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -68.96 -39.82 79.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.053 0.941 . . . . 0.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.82 -43.18 99.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.572 0.349 . . . . 0.0 111.385 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.015 0.526 . . . . 0.0 112.195 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.4 m -64.97 -38.82 92.22 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.716 -0.615 . . . . 0.0 111.971 173.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.0 m -67.58 -36.09 80.24 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.401 0.68 . . . . 0.0 112.763 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 51.6 m -74.37 -38.2 63.24 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.354 1.062 . . . . 0.0 112.245 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.35 62.69 64.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.621 1.568 . . . . 0.0 113.536 -171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.0 -14.16 34.99 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.436 2.757 . . . . 0.0 114.1 -175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -95.16 5.88 50.58 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.208 1.803 . . . . 0.0 113.195 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.3 mtt -128.62 152.43 48.36 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.634 1.573 . . . . 0.0 111.824 -171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -72.92 146.64 45.96 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.216 0.606 . . . . 0.0 110.071 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 pp -126.0 143.08 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.551 1.14 . . . . 0.0 109.693 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 31.9 t -135.59 93.38 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.783 1.233 . . . . 0.0 109.982 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -80.76 130.82 35.28 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.286 0.565 . . . . 0.0 111.488 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.92 3.89 3.78 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.731 2.412 . . . . 0.0 111.956 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.32 139.59 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.137 1.375 . . . . 0.0 109.748 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -122.04 166.12 14.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 111.356 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.7 t -79.42 137.08 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.1 t -63.19 168.4 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.224 1.41 . . . . 0.0 113.188 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -155.43 -31.01 0.03 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.419 1.009 . . . . 0.0 115.078 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -150.34 119.18 6.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.798 1.239 . . . . 0.0 110.109 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -157.75 154.75 25.56 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.83 1.652 . . . . 0.0 111.472 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.5 162.56 42.01 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.313 2.675 . . . . 0.0 112.089 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.44 155.53 69.65 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.044 2.496 . . . . 0.0 112.343 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -96.34 177.7 33.73 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.554 1.073 . . . . 0.0 114.642 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.45 159.19 54.6 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.052 3.168 . . . . 0.0 112.192 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.23 114.87 3.76 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.542 2.828 . . . . 0.0 111.406 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.285 1.834 . . . . 0.0 111.934 -179.066 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.779 -0.529 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.77 58.2 2.75 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.231 1.412 . . . . 0.0 113.002 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.3 m -63.13 155.46 27.94 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 113.667 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 48.36 42.74 18.64 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.207 1.803 . . . . 0.0 114.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 tp -66.99 168.66 9.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.776 1.63 . . . . 0.0 113.218 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 t -140.54 102.74 4.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.047 0.939 . . . . 0.0 112.297 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.464 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 8.6 mp -118.83 174.8 6.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 128.099 2.559 . . . . 0.0 111.806 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 m -42.54 165.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.936 2.894 . . . . 0.0 113.571 165.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.04 151.92 39.23 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.411 1.484 . . . . 0.0 114.958 167.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.8 mp -146.0 157.12 43.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 111.449 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.2 t -148.6 127.24 12.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.899 1.68 . . . . 0.0 110.0 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.0 139.42 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.686 1.594 . . . . 0.0 108.694 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -143.87 145.13 32.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.996 0.918 . . . . 0.0 112.522 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -109.81 149.11 30.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.649 1.579 . . . . 0.0 111.769 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.9 m -135.81 58.47 1.75 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.101 2.16 . . . . 0.0 111.443 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.75 -88.62 1.24 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.628 1.108 . . . . 0.0 113.231 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -119.46 30.41 7.11 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.703 1.601 . . . . 0.0 112.465 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -140.76 137.6 33.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.37 2.268 . . . . 0.0 108.021 167.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.1 142.31 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.515 1.126 . . . . 0.0 111.312 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.2 m -127.85 128.8 45.86 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.645 1.178 . . . . 0.0 110.436 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.69 120.39 36.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.889 1.675 . . . . 0.0 109.266 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mm -119.14 144.43 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.375 1.87 . . . . 0.0 107.55 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.99 -153.87 23.0 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 117.083 1.593 . . . . 0.0 117.083 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -162.22 143.64 10.68 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.204 2.201 . . . . 0.0 111.321 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -156.79 171.76 7.01 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.065 1.346 . . . . 0.0 113.004 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.18 -29.44 14.41 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.316 3.344 . . . . 0.0 113.645 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -156.34 166.48 33.3 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 123.392 1.568 . . . . 0.0 114.11 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.11 -32.16 70.73 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.721 1.608 . . . . 0.0 112.709 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.98 72.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.419 0.687 . . . . 0.0 111.903 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.53 -39.44 67.54 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -39.38 94.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.218 1.407 . . . . 0.0 111.849 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.78 87.35 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 112.357 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.27 -39.13 82.26 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.554 -0.716 . . . . 0.0 112.443 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.49 -39.79 81.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.157 0.983 . . . . 0.0 111.564 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -72.23 -33.58 67.67 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.226 -0.922 . . . . 0.0 112.341 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.6 m -63.5 -41.75 98.54 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.563 0.745 . . . . 0.0 111.149 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.82 78.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.144 0.978 . . . . 0.0 113.343 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.14 -43.52 61.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 111.836 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.65 -25.86 68.13 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.84 1.656 . . . . 0.0 112.715 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.1 17.46 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.58 2.038 . . . . 0.0 114.409 172.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.86 7.24 3.21 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.479 1.112 . . . . 0.0 113.753 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 tt -56.49 125.63 22.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.174 0.99 . . . . 0.0 110.815 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.4 148.97 40.15 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.022 1.329 . . . . 0.0 111.436 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.04 102.2 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.63 2.887 . . . . 0.0 112.443 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.86 -10.3 7.08 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.741 2.115 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.93 110.04 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.416 1.108 . . . . 0.0 110.734 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.49 152.48 45.33 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.515 1.526 . . . . 0.0 112.24 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.91 138.33 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.923 1.289 . . . . 0.0 111.993 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 87.1 mt -133.33 140.17 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.186 1.794 . . . . 0.0 108.781 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -134.31 134.31 41.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.26 1.424 . . . . 0.0 112.568 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -141.61 26.72 1.91 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.427 1.891 . . . . 0.0 113.16 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.76 130.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.596 -1.315 . . . . 0.0 111.154 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -82.4 160.66 22.72 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.028 1.731 . . . . 0.0 112.257 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.93 121.54 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 111.169 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.19 129.22 4.66 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.804 1.641 . . . . 0.0 110.656 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.07 -6.44 19.11 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.378 2.719 . . . . 0.0 114.823 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.84 -10.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.937 1.695 . . . . 0.0 112.603 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.1 144.49 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 128.595 2.758 . . . . 0.0 109.95 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -143.5 155.11 44.25 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.97 2.108 . . . . 0.0 109.548 -170.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -139.5 178.86 6.91 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.86 169.98 14.65 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.568 1.947 . . . . 0.0 110.177 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.26 158.93 15.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 112.52 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.26 2.32 11.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.559 1.544 . . . . 0.0 112.211 167.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 m -53.63 -32.39 51.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.163 1.385 . . . . 0.0 112.78 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.6 m -105.24 7.61 33.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.526 1.93 . . . . 0.0 113.674 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.61 56.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.482 1.513 . . . . 0.0 113.655 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -46.82 -48.81 50.42 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.71 1.204 . . . . 0.0 112.738 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 -24.87 38.73 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.888 1.725 . . . . 0.0 113.96 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.9 t -64.88 -45.29 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.329 0.968 . . . . 0.0 110.371 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -71.07 -31.3 67.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.744 0.818 . . . . 0.0 112.789 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.2 m -63.11 -42.58 99.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.907 0.776 . . . . 0.0 111.391 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.29 65.88 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.1 p -102.49 7.12 40.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.196 1.799 . . . . 0.0 115.364 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.7 t -48.62 -44.62 67.87 Favored Pre-proline 0 N--CA 1.485 1.28 0 O-C-N 120.478 -1.389 . . . . 0.0 114.499 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.46 13.62 2.37 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.558 2.172 . . . . 0.0 114.226 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.1 mt -113.95 92.8 27.03 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.146 1.779 . . . . 0.0 110.445 -171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.79 -22.78 23.26 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.454 2.769 . . . . 0.0 115.428 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -100.54 9.34 42.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.353 1.861 . . . . 0.0 113.342 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -52.56 149.31 6.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 122.023 0.916 . . . . 0.0 112.38 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.27 164.44 35.52 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.468 1.032 . . . . 0.0 111.772 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.53 146.84 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.68 1.192 . . . . 0.0 109.796 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -138.24 143.03 39.92 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.907 0.883 . . . . 0.0 110.002 169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.76 131.96 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.904 0.882 . . . . 0.0 109.46 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.11 156.22 26.44 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 167.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 99.0 mtt180 46.8 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 129.706 3.202 . . . . 0.0 117.813 174.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.89 22.98 1.1 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.468 2.307 . . . . 0.0 112.835 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.4 m -143.55 143.82 31.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.942 1.697 . . . . 0.0 112.148 -170.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -118.8 141.79 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 126.333 1.853 . . . . 0.0 110.53 167.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.3 m -131.17 137.57 49.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.884 1.674 . . . . 0.0 109.62 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.61 127.9 34.01 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.177 1.391 . . . . 0.0 109.23 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 91.1 m -130.69 152.18 50.32 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.644 1.577 . . . . 0.0 110.229 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.13 -174.66 39.45 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.753 -1.217 . . . . 0.0 114.385 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.5 p -128.17 74.91 1.58 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.105 2.162 . . . . 0.0 112.082 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.79 154.31 93.71 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 -26.36 19.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.624 2.883 . . . . 0.0 114.077 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.3 t -147.99 156.89 43.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.737 2.015 . . . . 0.0 110.423 177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 172' ' ' LYS . 52.3 p -54.0 -31.13 50.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.781 2.033 . . . . 0.0 112.577 168.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.32 -41.92 80.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.679 1.192 . . . . 0.0 112.064 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.85 -43.35 96.42 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.098 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 169' ' ' SER . 12.4 ptmm? -66.91 -35.99 81.26 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 119.5 1.045 . . . . 0.0 112.272 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.25 -41.92 89.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.356 0.662 . . . . 0.0 112.449 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.48 91.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.735 0.814 . . . . 0.0 112.528 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.87 -42.9 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.375 0.534 . . . . 0.0 110.483 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -62.94 -41.5 99.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.88 1.272 . . . . 0.0 112.437 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -69.96 -37.65 75.86 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.215 1.006 . . . . 0.0 111.198 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.82 99.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 122.885 0.474 . . . . 0.0 111.385 173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.46 88.16 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.58 0.627 . . . . 0.0 112.195 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.8 m -63.64 -39.91 95.53 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.745 -0.597 . . . . 0.0 112.049 172.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.2 m -67.63 -35.17 78.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 29.7 m -76.58 -38.62 54.6 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.051 0.94 . . . . 0.0 112.428 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -133.28 59.15 39.46 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.089 1.356 . . . . 0.0 113.428 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.69 -15.05 40.56 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.486 2.791 . . . . 0.0 113.85 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -92.16 0.81 57.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.839 1.655 . . . . 0.0 113.592 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 64.6 mtt -130.59 162.06 30.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.72 . . . . 0.0 112.307 -173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -70.72 147.34 49.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.16 131.15 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.45 1.5 . . . . 0.0 109.284 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.5 t -126.34 92.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.823 1.249 . . . . 0.0 110.729 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.96 66.57 3.63 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.208 2.203 . . . . 0.0 113.723 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -67.24 -6.46 18.36 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.995 1.718 . . . . 0.0 114.573 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 8.6 mt -53.81 142.1 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.33 1.852 . . . . 0.0 111.272 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -129.38 173.16 10.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.569 1.548 . . . . 0.0 110.594 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 24.8 t -82.45 143.59 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.582 0.753 . . . . 0.0 109.203 172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 10.7 t -58.09 154.04 13.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.694 1.198 . . . . 0.0 113.353 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -169.66 38.87 0.2 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.587 1.089 . . . . 0.0 113.518 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -140.08 -162.32 1.33 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.769 1.627 . . . . 0.0 110.494 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -56.37 148.96 40.66 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.174 1.39 . . . . 0.0 113.513 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 160.6 48.99 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.467 2.778 . . . . 0.0 113.057 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.42 170.9 16.25 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.85 3.033 . . . . 0.0 112.782 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -164.73 -178.6 38.22 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.893 1.235 . . . . 0.0 113.545 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.86 158.54 57.46 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.763 2.975 . . . . 0.0 112.929 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.16 127.82 16.52 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.677 2.918 . . . . 0.0 111.059 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.359 0 C-N-CA 126.312 1.845 . . . . 0.0 113.335 176.104 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.82 170.27 18.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.511 1.525 . . . . 0.0 111.864 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.6 m -117.29 165.37 13.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.577 1.551 . . . . 0.0 112.917 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.87 44.84 1.18 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.341 1.456 . . . . 0.0 111.855 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 109.68 1.55 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.519 1.528 . . . . 0.0 113.052 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 p -68.18 117.98 10.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.572 1.149 . . . . 0.0 111.311 168.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -146.18 174.06 11.66 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 128.252 2.621 . . . . 0.0 109.89 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -43.5 157.04 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 128.536 2.734 . . . . 0.0 114.916 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.6 154.13 28.88 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.143 1.777 . . . . 0.0 113.628 166.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tp -154.73 152.02 29.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.821 1.648 . . . . 0.0 111.438 -171.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.1 t -149.99 131.38 14.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.209 1.404 . . . . 0.0 110.608 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 64.9 mt -135.71 142.86 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.375 1.47 . . . . 0.0 108.524 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.4 p -142.23 150.25 40.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.11 142.72 49.58 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.626 1.97 . . . . 0.0 110.255 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -141.37 66.19 1.37 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.745 . . . . 0.0 112.242 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.73 -81.18 1.27 Allowed Glycine 0 N--CA 1.477 1.37 0 O-C-N 121.223 -0.923 . . . . 0.0 114.708 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -126.98 32.71 5.05 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.388 173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.72 141.91 30.7 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 127.089 2.156 . . . . 0.0 108.967 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.68 142.82 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.737 1.215 . . . . 0.0 111.211 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.6 m -130.2 125.24 34.45 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.982 1.313 . . . . 0.0 110.829 -171.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.71 128.48 55.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.032 1.733 . . . . 0.0 110.015 -174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.9 mt -134.94 144.16 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.1 1.76 . . . . 0.0 108.443 -176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.29 -156.54 28.19 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.533 -1.354 . . . . 0.0 116.219 -174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -164.0 128.71 2.8 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.215 1.806 . . . . 0.0 112.29 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -143.51 168.02 14.03 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.707 1.603 . . . . 0.0 113.134 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -67.32 -31.81 34.27 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.095 3.197 . . . . 0.0 113.31 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -155.28 166.85 32.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 123.473 1.606 . . . . 0.0 113.573 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -60.82 -29.86 69.73 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.418 1.887 . . . . 0.0 113.489 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.27 -29.87 68.76 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.776 1.23 . . . . 0.0 112.199 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.72 83.16 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.63 -0.669 . . . . 0.0 111.204 173.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.129 1.372 . . . . 0.0 111.785 171.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.29 -37.86 88.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.467 0.707 . . . . 0.0 112.581 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.61 76.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.406 -0.809 . . . . 0.0 112.473 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.7 tp -65.29 -42.42 93.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.907 1.283 . . . . 0.0 111.543 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.7 ptm -73.11 -32.1 64.74 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.655 -0.653 . . . . 0.0 111.997 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -64.55 -38.55 91.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 111.056 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.25 -35.33 76.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.814 0.845 . . . . 0.0 112.968 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.92 -23.38 22.72 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.63 -29.62 68.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.909 1.284 . . . . 0.0 112.229 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.24 -27.14 52.0 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.813 1.673 . . . . 0.0 115.267 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.49 12.65 5.45 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.622 1.569 . . . . 0.0 112.459 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.42 125.46 23.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.729 0.811 . . . . 0.0 110.979 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.58 148.56 46.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.97 1.308 . . . . 0.0 111.079 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.31 102.49 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.496 2.798 . . . . 0.0 112.738 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.48 -8.96 8.28 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.684 2.088 . . . . 0.0 113.713 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.61 114.19 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.506 1.153 . . . . 0.0 111.006 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -69.99 153.63 42.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.783 1.633 . . . . 0.0 112.322 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.45 132.36 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.709 1.204 . . . . 0.0 110.006 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.0 148.59 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.998 1.719 . . . . 0.0 110.396 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -137.03 130.3 31.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.932 1.693 . . . . 0.0 111.823 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -140.75 28.92 1.93 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.603 2.361 . . . . 0.0 111.127 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.55 119.29 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.632 1.173 . . . . 0.0 109.927 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -73.85 165.51 24.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.388 1.875 . . . . 0.0 112.221 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.6 t -132.39 123.73 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.091 1.356 . . . . 0.0 111.021 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -153.62 120.78 2.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.468 1.907 . . . . 0.0 110.529 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.68 -6.39 18.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.655 2.237 . . . . 0.0 115.0 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.23 -12.9 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.007 0.923 . . . . 0.0 112.206 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.2 m -109.08 149.01 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.709 1.603 . . . . 0.0 110.52 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -145.21 145.74 31.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.288 1.835 . . . . 0.0 109.153 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -133.42 -179.61 5.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -170.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.803 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -68.01 -176.52 0.7 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 130.162 3.385 . . . . 0.0 110.866 170.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -123.95 95.11 4.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 112.795 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -73.18 2.31 7.53 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.9 m -56.46 -36.0 68.56 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.627 -1.296 . . . . 0.0 112.183 172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.8 m -89.5 -2.51 58.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.808 1.643 . . . . 0.0 113.762 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.52 -6.68 52.91 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.511 1.124 . . . . 0.0 113.294 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.72 -48.63 76.49 Favored Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 120.767 -1.208 . . . . 0.0 113.49 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.44 -28.43 32.48 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.584 2.189 . . . . 0.0 114.026 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.26 -46.23 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 0.855 . . . . 0.0 110.753 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.34 -30.57 63.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.578 0.751 . . . . 0.0 112.336 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.6 m -61.17 -44.54 97.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 111.305 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.65 -17.63 64.13 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 92.2 p -107.75 7.02 28.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.673 1.989 . . . . 0.0 115.286 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 92.8 t -52.42 -47.4 93.31 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 167.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.07 12.46 1.23 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 122.807 2.338 . . . . 0.0 114.279 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 165' ' ' THR . 13.9 mt -110.59 96.55 28.36 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.746 2.019 . . . . 0.0 109.131 -176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 -19.54 28.36 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.978 2.452 . . . . 0.0 114.594 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -109.26 11.07 25.56 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.806 2.042 . . . . 0.0 113.843 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.92 155.04 1.91 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.899 1.28 . . . . 0.0 112.983 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.54 164.27 36.15 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-O 122.328 0.96 . . . . 0.0 112.196 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tp -134.08 145.45 49.37 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.517 1.127 . . . . 0.0 109.317 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -141.32 134.74 29.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.73 0.812 . . . . 0.0 109.924 173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.7 t -141.73 136.29 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.111 0.564 . . . . 0.0 109.997 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.98 150.45 25.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.787 0.435 . . . . 0.0 112.144 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 39.35 -101.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.569 1.948 . . . . 0.0 112.97 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -117.91 21.31 12.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.489 1.515 . . . . 0.0 112.99 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 29.2 m -135.61 137.23 41.7 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.086 1.754 . . . . 0.0 112.379 -175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 m -118.4 141.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 126.142 1.777 . . . . 0.0 111.682 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 88.0 m -131.42 136.98 48.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.933 1.693 . . . . 0.0 110.218 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -130.04 133.12 46.52 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.003 1.721 . . . . 0.0 109.471 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 31.7 m -138.88 148.32 43.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.915 1.286 . . . . 0.0 110.753 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.21 -172.0 37.36 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.523 -1.361 . . . . 0.0 114.885 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 148' ' ' ILE . 18.2 p -121.41 89.02 3.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.531 2.732 . . . . 0.0 111.998 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.02 53.94 Favored Pre-proline 0 CA--C 1.549 0.91 0 O-C-N 120.695 -1.253 . . . . 0.0 113.73 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.27 -26.63 41.69 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.82 3.013 . . . . 0.0 114.226 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.5 t -147.94 157.04 43.32 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.55 1.94 . . . . 0.0 110.063 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 p -59.58 -20.87 58.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.094 0.958 . . . . 0.0 112.907 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.25 -47.55 83.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.756 1.223 . . . . 0.0 111.775 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -58.37 -42.2 86.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.187 0.595 . . . . 0.0 111.867 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.56 -45.26 94.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.839 0.745 . . . . 0.0 112.203 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -66.21 -39.29 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.267 1.027 . . . . 0.0 111.983 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.75 89.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.703 0.801 . . . . 0.0 112.694 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 75.2 t -67.96 -38.64 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.702 -0.624 . . . . 0.0 110.914 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.46 -45.43 94.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.668 0.787 . . . . 0.0 111.716 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -63.6 -40.09 96.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.584 0.754 . . . . 0.0 111.848 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.89 97.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.813 0.445 . . . . 0.0 111.376 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.64 -37.64 88.11 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.675 -0.64 . . . . 0.0 112.119 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 30.6 m -63.27 -41.29 99.01 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.623 -0.673 . . . . 0.0 111.751 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.5 m -65.82 -35.94 82.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 25.1 m -77.4 -36.91 52.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.077 0.951 . . . . 0.0 112.685 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -133.39 61.13 52.48 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.411 1.484 . . . . 0.0 113.635 -172.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.26 -9.58 25.65 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.687 2.925 . . . . 0.0 114.338 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -114.47 9.72 16.8 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.63 1.972 . . . . 0.0 113.601 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.6 mtm -126.17 161.13 28.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.437 1.895 . . . . 0.0 111.247 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -71.2 146.49 49.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.833 0.853 . . . . 0.0 110.036 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.6 pt -130.71 143.44 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.115 0.966 . . . . 0.0 111.381 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.0 t -135.68 121.87 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.596 1.158 . . . . 0.0 110.483 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -112.27 70.43 0.71 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.43 1.892 . . . . 0.0 111.157 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.1 -5.61 42.67 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.545 1.538 . . . . 0.0 114.336 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 68.8 mt -51.28 140.16 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.087 1.755 . . . . 0.0 111.257 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -134.76 175.06 9.9 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.727 1.611 . . . . 0.0 110.63 172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.7 t -77.78 141.11 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.793 0.837 . . . . 0.0 111.183 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.0 m -54.25 149.25 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.048 . . . . 0.0 113.474 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.07 31.96 6.86 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.243 1.877 . . . . 0.0 113.896 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 53.28 48.94 20.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.549 1.94 . . . . 0.0 113.663 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -134.5 61.73 50.81 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 126.492 1.917 . . . . 0.0 113.006 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -68.06 162.44 39.99 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 123.538 2.825 . . . . 0.0 112.739 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -67.68 161.74 42.38 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.357 2.705 . . . . 0.0 112.996 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -176.05 -178.14 45.62 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.828 1.204 . . . . 0.0 113.686 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.68 159.23 54.26 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.751 2.967 . . . . 0.0 112.993 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.8 170.85 19.09 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.972 3.115 . . . . 0.0 112.654 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.916 1.686 . . . . 0.0 113.329 175.193 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.18 163.34 17.92 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.347 1.059 . . . . 0.0 113.327 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.2 t -151.38 150.99 31.12 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 111.039 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.87 53.71 0.77 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.186 1.794 . . . . 0.0 113.636 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.42 96.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.913 1.685 . . . . 0.0 111.197 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 t -58.73 119.29 6.85 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.25 1.82 . . . . 0.0 112.333 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pp -128.72 172.78 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.111 2.165 . . . . 0.0 111.708 176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -39.44 154.39 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 129.896 3.278 . . . . 0.0 117.179 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.12 135.42 39.82 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.676 1.591 . . . . 0.0 111.105 167.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD22 ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -155.09 146.82 23.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.091 1.356 . . . . 0.0 110.817 -175.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -142.75 142.96 32.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.084 1.753 . . . . 0.0 110.809 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -142.6 136.66 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.989 1.316 . . . . 0.0 109.445 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -138.86 145.76 40.38 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.937 0.895 . . . . 0.0 112.02 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -108.53 150.49 27.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.011 1.324 . . . . 0.0 112.84 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.0 m -137.78 59.77 1.65 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.694 2.398 . . . . 0.0 111.99 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.03 -92.84 1.05 Allowed Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.018 1.294 . . . . 0.0 112.856 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -113.08 29.85 7.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.814 1.645 . . . . 0.0 112.327 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.4 m -143.32 140.49 30.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.466 2.307 . . . . 0.0 108.44 170.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 p -132.01 144.57 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.696 1.198 . . . . 0.0 111.131 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.7 m -129.56 128.13 42.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.384 1.074 . . . . 0.0 111.607 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.14 126.93 55.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.787 2.035 . . . . 0.0 110.525 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.5 mt -138.16 125.66 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.32 1.448 . . . . 0.0 109.137 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' HD22 ' A' ' 82' ' ' LEU . . . 172.65 -156.75 25.64 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 120.859 -1.151 . . . . 0.0 115.144 -171.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -159.45 146.27 16.69 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.882 2.073 . . . . 0.0 111.355 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -151.86 170.2 8.3 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.965 1.706 . . . . 0.0 111.586 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.31 -31.83 42.75 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.265 3.31 . . . . 0.0 113.537 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -156.47 165.65 35.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 123.617 1.675 . . . . 0.0 113.123 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.79 -25.77 68.06 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.728 2.011 . . . . 0.0 113.958 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.19 63.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.96 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.84 -37.65 67.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.196 0.598 . . . . 0.0 111.836 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -26.54 60.52 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 172.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.5 75.65 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.439 -0.788 . . . . 0.0 112.301 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.36 -39.0 85.68 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.914 -1.116 . . . . 0.0 112.282 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.76 -42.57 99.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -30.95 62.45 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.496 -0.752 . . . . 0.0 112.434 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.4 m -65.1 -38.44 90.71 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.81 1.244 . . . . 0.0 111.308 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.82 72.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.799 1.24 . . . . 0.0 113.182 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.29 -25.23 20.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -67.46 -30.99 70.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.978 1.311 . . . . 0.0 112.37 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.72 -27.15 55.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.601 1.572 . . . . 0.0 115.254 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 10.4 6.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.793 1.637 . . . . 0.0 112.453 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.59 130.45 46.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.451 1.101 . . . . 0.0 111.372 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.2 147.27 39.98 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.245 1.418 . . . . 0.0 111.108 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.88 102.92 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.593 2.862 . . . . 0.0 112.562 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.04 -10.28 7.43 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.838 2.161 . . . . 0.0 113.793 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.92 115.33 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.339 1.069 . . . . 0.0 110.896 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -73.81 155.02 39.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.009 1.724 . . . . 0.0 112.563 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -135.44 132.92 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.847 1.259 . . . . 0.0 109.851 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 91.2 mt -126.45 138.36 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.406 1.882 . . . . 0.0 108.855 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -135.63 132.43 37.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.745 1.218 . . . . 0.0 112.824 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -136.75 18.82 3.06 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 127.428 2.291 . . . . 0.0 112.315 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.82 132.89 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 120.859 -1.151 . . . . 0.0 111.689 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -94.49 169.82 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.65 1.58 . . . . 0.0 113.248 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.54 118.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.777 1.631 . . . . 0.0 110.774 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -149.3 123.06 4.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.107 2.163 . . . . 0.0 110.419 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.58 -5.06 15.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.023 2.482 . . . . 0.0 114.544 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.5 t -72.24 -13.28 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.209 1.804 . . . . 0.0 112.468 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.72 149.42 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.091 2.157 . . . . 0.0 109.71 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.38 152.58 48.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.038 2.135 . . . . 0.0 106.495 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.0 m -132.74 175.46 9.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.264 1.393 . . . . 0.0 114.256 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.98 158.18 33.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.692 1.597 . . . . 0.0 109.583 166.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.4 148.12 28.4 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.015 165.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.33 0.26 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.713 1.205 . . . . 0.0 113.052 171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -55.28 -37.86 67.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.205 1.002 . . . . 0.0 111.798 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.9 m -92.04 3.08 56.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.066 1.747 . . . . 0.0 113.848 172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.72 -3.79 51.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.775 1.63 . . . . 0.0 113.687 172.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -45.07 -49.16 30.8 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.464 1.105 . . . . 0.0 112.39 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.59 -24.83 55.34 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.75 1.633 . . . . 0.0 113.692 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.6 t -66.2 -46.1 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.131 0.878 . . . . 0.0 110.687 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -73.87 -30.07 62.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.485 0.714 . . . . 0.0 112.57 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.8 m -66.77 -39.73 87.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.074 0.95 . . . . 0.0 111.541 173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.17 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.8 p -101.13 7.88 43.02 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.364 1.866 . . . . 0.0 115.191 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.4 t -47.52 -44.97 56.7 Favored Pre-proline 0 N--CA 1.485 1.312 0 O-C-N 120.391 -1.443 . . . . 0.0 114.554 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.8 13.97 2.18 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.447 2.098 . . . . 0.0 114.089 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.0 mt -116.39 91.97 35.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.171 1.788 . . . . 0.0 110.583 -171.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.07 -17.8 31.42 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.864 3.042 . . . . 0.0 115.879 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.97 16.08 16.16 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.743 2.417 . . . . 0.0 112.519 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -53.94 153.7 4.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.474 1.109 . . . . 0.0 112.74 168.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.17 161.28 33.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.135 1.35 . . . . 0.0 111.672 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tp -131.45 146.3 52.19 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.037 1.335 . . . . 0.0 109.235 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.75 147.62 42.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.126 0.97 . . . . 0.0 110.822 172.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.78 133.02 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.666 1.186 . . . . 0.0 109.744 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.24 152.8 24.66 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 167.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 42.15 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 129.585 3.154 . . . . 0.0 117.253 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -141.86 20.54 2.14 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.602 1.961 . . . . 0.0 113.022 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.6 m -138.3 140.97 39.81 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.029 1.332 . . . . 0.0 112.555 -171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.6 m -116.55 131.96 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.418 1.887 . . . . 0.0 111.084 169.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.6 m -123.94 137.74 54.58 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.679 1.592 . . . . 0.0 110.058 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 mp -134.65 126.57 29.41 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.616 1.166 . . . . 0.0 110.663 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 98.8 m -132.07 150.86 52.05 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.344 1.457 . . . . 0.0 110.455 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.38 -175.13 39.68 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.79 -1.194 . . . . 0.0 114.183 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 19.0 p -130.13 81.02 1.99 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.208 1.803 . . . . 0.0 112.071 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -69.9 153.24 95.63 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.231 1.412 . . . . 0.0 114.293 -170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.99 -34.63 37.65 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.093 2.529 . . . . 0.0 113.168 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.7 m -144.47 156.02 43.99 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.65 1.98 . . . . 0.0 110.644 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 p -62.55 -22.86 66.65 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.222 1.009 . . . . 0.0 113.633 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -63.95 -42.87 97.19 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.617 1.167 . . . . 0.0 111.462 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -62.97 -40.9 99.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.451 0.569 . . . . 0.0 111.782 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.6 -46.82 87.82 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.474 0.579 . . . . 0.0 112.214 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.76 -37.66 85.05 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.371 0.668 . . . . 0.0 111.944 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.11 -38.02 89.33 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.624 0.769 . . . . 0.0 112.573 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.03 -42.63 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.737 0.699 . . . . 0.0 110.655 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -42.07 99.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 112.316 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -72.65 -32.76 66.11 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.43 1.092 . . . . 0.0 111.903 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.91 -47.2 78.6 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 119.6 -0.238 . . . . 0.0 111.003 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.36 -39.22 93.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 t -72.38 -30.09 64.36 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.635 -0.666 . . . . 0.0 112.168 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 45.3 m -70.06 -38.98 75.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.138 0.975 . . . . 0.0 112.591 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 39.4 m -71.59 -39.33 70.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.684 1.194 . . . . 0.0 112.311 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -129.85 60.5 52.19 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.448 1.499 . . . . 0.0 113.732 -172.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.39 -14.94 34.61 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.435 2.757 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.46 -1.85 58.27 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.7 1.6 . . . . 0.0 113.892 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -126.12 160.03 31.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.034 1.734 . . . . 0.0 112.071 -176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -70.49 151.1 45.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.956 0.902 . . . . 0.0 110.406 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.87 135.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.027 0.931 . . . . 0.0 111.526 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 37.0 t -130.59 87.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.408 1.483 . . . . 0.0 109.825 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -72.97 130.89 41.37 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.902 . . . . 0.0 110.93 171.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -137.0 0.15 2.35 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.494 2.318 . . . . 0.0 111.929 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.15 142.7 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.259 1.823 . . . . 0.0 110.073 171.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.67 173.55 8.92 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.821 1.648 . . . . 0.0 110.557 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.87 141.12 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 121.454 -0.779 . . . . 0.0 109.767 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.6 t -63.04 165.83 6.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 113.925 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 161.11 -3.8 0.08 OUTLIER Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.843 1.211 . . . . 0.0 115.494 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -152.36 160.4 43.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.671 1.989 . . . . 0.0 109.014 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 50.93 64.57 7.98 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.78 2.032 . . . . 0.0 114.53 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.14 161.04 31.67 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 123.464 2.776 . . . . 0.0 112.539 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.76 146.87 89.24 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.288 2.659 . . . . 0.0 113.375 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.73 -50.86 27.97 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 117.996 -1.447 . . . . 0.0 116.25 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.31 150.09 46.42 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 CA-C-N 120.898 2.349 . . . . 0.0 113.017 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 172.78 15.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.072 3.182 . . . . 0.0 112.831 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.293 0 C-N-CA 127.989 2.516 . . . . 0.0 114.63 178.701 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 CA-C-O 121.165 0.314 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.44 171.41 16.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.084 1.754 . . . . 0.0 111.202 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -131.28 159.57 37.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.223 1.409 . . . . 0.0 113.673 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.59 39.46 1.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.094 1.358 . . . . 0.0 112.718 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.09 131.85 35.24 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.445 1.498 . . . . 0.0 110.273 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.8 p -68.87 103.45 1.8 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.073 1.349 . . . . 0.0 113.315 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.07 176.08 5.28 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.742 2.017 . . . . 0.0 110.099 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -37.38 161.03 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.353 3.061 . . . . 0.0 114.867 167.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.39 146.5 47.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.855 1.662 . . . . 0.0 114.077 167.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 tt -157.15 155.82 31.64 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.823 1.249 . . . . 0.0 112.195 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.0 t -139.26 140.01 37.55 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.93 2.092 . . . . 0.0 110.284 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.25 133.9 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.283 1.433 . . . . 0.0 108.864 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 t -143.29 142.25 31.28 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.251 0.62 . . . . 0.0 112.196 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -106.34 148.47 28.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.305 1.442 . . . . 0.0 110.897 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -143.7 66.04 1.3 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.541 1.536 . . . . 0.0 112.526 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -90.07 1.46 Allowed Glycine 0 N--CA 1.472 1.07 0 C-N-CA 124.308 0.956 . . . . 0.0 113.106 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -122.22 35.94 4.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.985 1.714 . . . . 0.0 111.729 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 95.4 m -145.0 145.73 31.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.93 2.492 . . . . 0.0 108.183 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 p -134.75 144.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.814 1.246 . . . . 0.0 110.987 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.4 m -128.78 132.78 47.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.422 1.089 . . . . 0.0 111.739 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 117.8 29.47 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.566 2.346 . . . . 0.0 109.637 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.37 120.33 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.604 1.162 . . . . 0.0 109.053 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.02 -154.02 17.18 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 116.575 1.39 . . . . 0.0 116.575 -170.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -153.27 145.92 24.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.515 2.326 . . . . 0.0 112.651 -170.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -155.94 171.43 7.32 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.641 1.576 . . . . 0.0 112.85 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -69.47 -30.61 23.35 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.327 3.351 . . . . 0.0 113.705 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -155.49 166.74 32.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.287 1.518 . . . . 0.0 113.16 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.62 -28.91 70.24 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.056 -1.429 . . . . 0.0 112.927 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.06 75.01 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.63 -37.73 67.93 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.365 0.666 . . . . 0.0 112.427 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -60.11 -45.88 91.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.631 1.172 . . . . 0.0 111.314 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.77 77.88 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.986 1.314 . . . . 0.0 111.956 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.48 92.95 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.14 -39.66 86.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.843 0.857 . . . . 0.0 111.227 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 78.1 mmm -65.94 -41.55 91.18 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.548 0.739 . . . . 0.0 111.639 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.8 m -61.72 -40.48 95.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.343 1.057 . . . . 0.0 110.857 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.96 -31.44 72.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.686 1.194 . . . . 0.0 113.606 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -93.33 -22.39 18.99 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.7 -30.46 61.56 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.666 1.587 . . . . 0.0 112.367 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.83 -28.28 52.24 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.686 1.612 . . . . 0.0 114.986 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.77 9.54 6.44 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.81 1.644 . . . . 0.0 112.768 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.3 129.99 44.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.297 1.039 . . . . 0.0 111.109 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.51 149.11 40.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.201 1.401 . . . . 0.0 111.388 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.9 102.8 0.55 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.575 2.85 . . . . 0.0 112.582 -174.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.22 -10.38 7.34 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.795 2.14 . . . . 0.0 113.662 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.34 114.78 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 118.358 1.079 . . . . 0.0 110.889 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -71.25 157.16 38.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.982 1.713 . . . . 0.0 112.734 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.8 p -133.97 140.21 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.557 1.143 . . . . 0.0 112.441 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.18 139.33 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.745 2.018 . . . . 0.0 108.391 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.31 134.81 34.75 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -140.87 29.88 1.87 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.179 2.592 . . . . 0.0 111.347 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.25 123.66 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 120.482 -1.386 . . . . 0.0 110.746 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -90.3 162.75 15.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.931 1.292 . . . . 0.0 112.551 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.8 t -133.7 117.98 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.046 1.339 . . . . 0.0 110.941 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.98 117.14 4.18 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.75 2.02 . . . . 0.0 109.878 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 -5.77 17.8 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.964 2.443 . . . . 0.0 114.953 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.66 -1.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.406 1.482 . . . . 0.0 113.527 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.35 142.48 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 128.899 2.879 . . . . 0.0 109.143 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -136.73 154.78 50.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.522 2.329 . . . . 0.0 108.802 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -136.05 177.28 7.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.746 1.157 . . . . 0.0 114.052 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -72.26 156.99 38.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.161 . . . . 0.0 108.271 167.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.42 152.93 37.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.847 -0.533 . . . . 0.0 111.311 167.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -122.72 3.07 9.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.463 1.505 . . . . 0.0 111.75 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.2 m -53.5 -37.54 62.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.526 1.13 . . . . 0.0 111.876 170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.4 m -96.63 6.1 49.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 113.653 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.66 -6.28 59.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.159 1.384 . . . . 0.0 113.269 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.79 -50.12 44.92 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.026 1.33 . . . . 0.0 112.648 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.51 -24.28 56.63 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.769 1.646 . . . . 0.0 113.738 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.97 -46.97 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.453 1.024 . . . . 0.0 110.649 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -74.32 -28.88 61.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 112.587 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 m -70.25 -41.17 73.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.809 1.244 . . . . 0.0 111.694 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.25 -28.64 68.88 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.312 -0.868 . . . . 0.0 112.649 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.7 p -90.52 0.1 57.46 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.0 t -45.6 -46.71 37.14 Favored Pre-proline 0 N--CA 1.487 1.423 0 CA-C-N 120.779 1.627 . . . . 0.0 115.159 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.51 13.67 1.34 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.727 2.285 . . . . 0.0 114.154 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.12 83.76 12.91 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.592 1.957 . . . . 0.0 110.188 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.09 -15.86 50.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.452 2.768 . . . . 0.0 115.075 -173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.89 1.93 27.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.778 2.431 . . . . 0.0 114.34 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -60.07 155.28 17.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.053 -1.029 . . . . 0.0 113.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.36 169.36 37.65 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.874 1.702 . . . . 0.0 112.995 167.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.19 147.79 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.433 1.893 . . . . 0.0 109.387 177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -136.91 140.26 42.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 109.904 168.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.41 134.05 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.999 0.92 . . . . 0.0 109.782 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.66 157.67 27.53 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.677 0.791 . . . . 0.0 112.701 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 44.59 -86.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.837 2.455 . . . . 0.0 114.082 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -144.16 33.8 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 119.77 1.168 . . . . 0.0 112.463 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 35.8 m -133.27 139.14 46.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.75 2.02 . . . . 0.0 111.109 -171.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.35 128.09 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.158 1.783 . . . . 0.0 111.401 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 84.9 m -122.77 134.65 54.42 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.886 1.674 . . . . 0.0 110.03 -173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -131.21 124.72 31.2 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.784 1.234 . . . . 0.0 110.174 -171.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.5 m -137.07 123.3 20.53 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.986 1.314 . . . . 0.0 110.947 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -179.04 -178.47 48.28 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.948 1.261 . . . . 0.0 112.926 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.5 p -125.08 81.21 1.94 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 0.0 112.35 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.66 153.96 92.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.2 -31.05 30.15 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.2 2.6 . . . . 0.0 113.536 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 p -149.27 166.58 28.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.858 1.263 . . . . 0.0 112.804 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.5 p -64.05 -25.06 67.95 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.288 1.035 . . . . 0.0 113.604 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -66.3 -42.16 88.72 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.482 -0.762 . . . . 0.0 111.09 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -63.32 -41.37 98.9 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.475 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -66.57 -40.54 89.01 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.631 1.105 . . . . 0.0 111.888 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.83 -43.99 97.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.647 1.179 . . . . 0.0 112.382 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.91 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.499 0.72 . . . . 0.0 112.185 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.57 -43.3 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 118.132 0.424 . . . . 0.0 111.243 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -70.02 -36.18 74.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.806 0.73 . . . . 0.0 112.663 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.29 -39.99 81.9 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.247 1.019 . . . . 0.0 111.571 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.87 95.82 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.08 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.46 87.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.139 0.575 . . . . 0.0 112.395 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.5 m -66.45 -38.1 86.61 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.716 -0.615 . . . . 0.0 111.594 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.8 t -65.27 -38.54 90.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.671 0.788 . . . . 0.0 112.616 173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.0 m -73.31 -39.35 65.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.22 1.008 . . . . 0.0 112.764 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -131.96 61.41 57.83 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.549 1.54 . . . . 0.0 113.815 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.02 -10.95 26.82 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.664 2.909 . . . . 0.0 114.731 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -104.96 -0.93 26.43 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.082 1.753 . . . . 0.0 113.73 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -108.57 160.3 16.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.914 2.086 . . . . 0.0 111.711 -172.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -73.47 147.25 44.3 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.694 -0.628 . . . . 0.0 109.908 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.6 tt -135.04 142.17 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.7 0.8 . . . . 0.0 112.274 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 34.0 t -131.62 91.86 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.692 1.597 . . . . 0.0 110.194 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -83.18 74.07 10.04 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.298 1.839 . . . . 0.0 111.413 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -72.76 -11.54 60.65 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.989 1.315 . . . . 0.0 113.459 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.2 pt -52.04 144.21 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 127.106 2.162 . . . . 0.0 114.531 172.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.35 170.28 16.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.936 2.094 . . . . 0.0 111.088 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.52 142.73 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 170.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.6 t -59.61 160.95 6.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.973 1.309 . . . . 0.0 113.13 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 162.1 -7.6 0.09 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.364 0.983 . . . . 0.0 115.379 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -142.87 140.0 31.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.406 1.882 . . . . 0.0 108.519 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 42.72 53.63 8.96 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.895 1.678 . . . . 0.0 114.592 -171.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -68.21 160.72 47.63 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.542 2.828 . . . . 0.0 112.61 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.88 162.73 41.02 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.362 2.708 . . . . 0.0 113.487 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.79 -176.5 49.35 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 125.102 1.334 . . . . 0.0 114.473 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.58 163.62 37.43 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.96 3.106 . . . . 0.0 112.781 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -76.75 62.17 7.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.984 3.789 . . . . 0.0 112.931 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.322 0 C-N-CA 127.005 2.122 . . . . 0.0 113.476 177.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.503 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.15 171.51 17.27 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.374 1.47 . . . . 0.0 112.076 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.4 p -132.71 166.55 21.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.897 2.079 . . . . 0.0 112.057 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 46.12 43.78 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.483 1.513 . . . . 0.0 113.228 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.07 115.0 1.33 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.827 2.051 . . . . 0.0 114.028 -171.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 p -81.31 109.61 15.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.479 1.512 . . . . 0.0 112.709 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 3.8 mm? -134.52 171.19 14.66 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.701 2.8 . . . . 0.0 109.173 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 t -35.91 162.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 131.114 3.766 . . . . 0.0 114.809 165.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 150.16 50.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.605 1.562 . . . . 0.0 114.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.7 tt -160.53 156.73 26.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 111.526 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 93.3 p -145.22 158.32 43.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 112.653 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.9 mt -141.67 142.35 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.131 1.372 . . . . 0.0 108.01 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m -139.18 142.69 37.94 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.321 0.648 . . . . 0.0 111.936 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -112.9 148.28 35.3 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.777 1.631 . . . . 0.0 111.376 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -134.19 56.64 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.427 2.291 . . . . 0.0 110.438 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.3 -98.82 0.67 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 126.039 1.781 . . . . 0.0 112.365 -174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -96.38 18.4 14.0 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.406 1.482 . . . . 0.0 113.013 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.1 m -137.51 131.87 32.43 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.818 1.647 . . . . 0.0 108.81 167.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.26 137.8 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.545 1.138 . . . . 0.0 111.253 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -122.66 136.96 55.03 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.5 1.12 . . . . 0.0 112.6 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.86 121.98 39.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.944 2.098 . . . . 0.0 109.085 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 mt -135.27 133.04 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.02 1.328 . . . . 0.0 108.173 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.96 -146.88 12.28 Favored Glycine 0 N--CA 1.465 0.624 0 O-C-N 120.338 -1.476 . . . . 0.0 115.941 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -153.16 150.77 29.4 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.094 2.557 . . . . 0.0 111.842 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -157.7 170.07 9.56 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 126.026 1.73 . . . . 0.0 110.39 166.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -71.72 -29.96 15.1 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.392 3.395 . . . . 0.0 113.696 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -159.15 166.92 30.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.384 1.564 . . . . 0.0 113.554 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.56 -32.98 70.85 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.676 1.59 . . . . 0.0 112.836 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.65 -31.97 73.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.818 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.58 -35.6 60.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.452 0.701 . . . . 0.0 112.339 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.28 -42.03 96.63 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.017 1.327 . . . . 0.0 111.817 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.35 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.684 1.194 . . . . 0.0 111.552 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.04 93.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.8 -39.6 80.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.677 0.791 . . . . 0.0 111.369 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm -65.14 -41.12 95.08 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.741 -0.599 . . . . 0.0 111.832 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.3 m -62.95 -39.8 95.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.207 1.003 . . . . 0.0 110.897 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.45 75.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.965 0.906 . . . . 0.0 113.386 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.88 -24.1 21.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -73.04 -29.66 63.16 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.521 1.529 . . . . 0.0 112.337 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.05 52.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.817 1.675 . . . . 0.0 115.077 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 11.1 5.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.456 1.503 . . . . 0.0 112.76 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.75 135.46 56.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.786 0.834 . . . . 0.0 111.225 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.42 150.27 37.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.814 1.646 . . . . 0.0 111.337 -176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.14 106.28 0.79 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.554 2.836 . . . . 0.0 112.523 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.84 -10.83 10.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.508 2.004 . . . . 0.0 113.75 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.48 118.27 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.345 1.058 . . . . 0.0 110.858 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -75.57 151.1 37.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 112.376 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -136.76 132.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.259 1.424 . . . . 0.0 109.454 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.7 mt -126.62 139.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.736 1.614 . . . . 0.0 109.451 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -132.57 128.16 36.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.43 1.492 . . . . 0.0 111.832 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -136.63 19.97 3.1 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.264 2.225 . . . . 0.0 112.147 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 84.1 mt -70.87 134.21 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.739 1.215 . . . . 0.0 112.322 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -80.68 160.33 25.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.978 2.111 . . . . 0.0 112.721 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.5 t -131.62 119.16 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.161 1.384 . . . . 0.0 110.95 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.47 110.94 2.41 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.577 1.551 . . . . 0.0 110.961 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.71 -6.07 16.98 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.987 2.458 . . . . 0.0 114.812 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.14 -16.47 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.938 0.895 . . . . 0.0 112.266 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.2 m -122.59 139.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.583 2.353 . . . . 0.0 110.203 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -128.37 155.54 44.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.273 1.829 . . . . 0.0 109.068 -170.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -139.08 179.79 6.3 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.09 176.22 2.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.451 1.9 . . . . 0.0 111.922 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -128.93 98.71 5.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 111.054 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.18 9.16 3.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.875 1.27 . . . . 0.0 113.022 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 67.4 m -51.93 -25.09 7.39 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.787 -1.195 . . . . 0.0 113.57 167.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.0 m -106.94 3.28 25.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.021 2.128 . . . . 0.0 113.818 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -84.09 -6.11 59.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.373 1.469 . . . . 0.0 113.657 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.21 -48.75 79.23 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.644 1.178 . . . . 0.0 113.2 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -23.6 44.27 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.792 1.661 . . . . 0.0 113.474 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.41 -46.34 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.925 0.784 . . . . 0.0 110.413 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -67.7 -35.47 78.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.999 0.52 . . . . 0.0 111.997 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.0 m -60.69 -44.52 96.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.074 0.949 . . . . 0.0 111.478 173.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.77 -26.56 67.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.268 0.627 . . . . 0.0 112.636 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.2 m -90.44 0.14 57.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.949 2.1 . . . . 0.0 115.576 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -52.89 -49.27 87.88 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-N 120.423 1.465 . . . . 0.0 114.001 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -84.26 18.39 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.009 2.473 . . . . 0.0 113.465 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mt -110.06 80.43 1.81 Allowed Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 127.014 2.126 . . . . 0.0 107.856 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.88 -21.39 50.48 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.035 2.49 . . . . 0.0 114.557 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -94.57 6.16 49.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.62 1.968 . . . . 0.0 113.509 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -54.81 153.77 5.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.731 1.213 . . . . 0.0 113.844 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.04 164.87 38.01 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.595 1.569 . . . . 0.0 110.768 167.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.8 pp -142.46 164.16 30.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.693 -0.886 . . . . 0.0 112.976 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -138.02 152.52 48.94 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.458 1.503 . . . . 0.0 110.374 173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 t -144.77 130.24 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.179 1.392 . . . . 0.0 108.682 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 143.75 20.68 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.083 -0.386 . . . . 0.0 112.014 167.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 94.2 mtm-85 42.39 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.124 2.17 . . . . 0.0 114.623 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -122.12 17.0 10.79 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.504 1.922 . . . . 0.0 113.364 -171.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 61.1 m -138.8 144.45 39.35 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.272 1.829 . . . . 0.0 112.485 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.66 132.56 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.229 2.212 . . . . 0.0 109.481 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 m -122.26 136.94 54.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.661 1.584 . . . . 0.0 110.25 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.6 mp -136.07 127.64 28.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.319 1.047 . . . . 0.0 110.093 -175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 25.0 m -136.14 151.85 50.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.616 1.566 . . . . 0.0 110.489 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.17 -176.41 42.09 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.261 -1.524 . . . . 0.0 113.907 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.2 m -132.78 112.71 12.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.928 1.291 . . . . 0.0 110.005 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.83 159.6 29.11 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.72 2.008 . . . . 0.0 113.67 -170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.47 -33.24 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.455 2.77 . . . . 0.0 113.143 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 55.2 m -144.68 155.41 43.57 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.491 1.916 . . . . 0.0 111.072 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 p -57.7 -27.6 63.07 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.223 1.409 . . . . 0.0 113.088 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -63.42 -42.29 98.73 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.988 1.315 . . . . 0.0 111.624 173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -62.56 -43.19 99.43 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.949 0.5 . . . . 0.0 111.912 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -62.72 -42.13 99.5 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.4 -41.19 85.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.263 1.425 . . . . 0.0 112.036 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.32 89.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.418 0.687 . . . . 0.0 112.054 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.41 -41.03 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 118.298 0.499 . . . . 0.0 111.115 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -63.14 -42.89 99.56 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.442 0.697 . . . . 0.0 111.967 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -66.17 -40.43 90.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.355 1.062 . . . . 0.0 111.569 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.36 97.73 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.002 0.521 . . . . 0.0 111.393 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.42 90.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.066 0.546 . . . . 0.0 111.974 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.0 m -63.43 -40.17 96.44 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.497 -0.752 . . . . 0.0 111.849 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.2 m -66.37 -35.81 81.28 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 35.7 m -77.52 -34.59 53.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.03 0.932 . . . . 0.0 112.668 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -126.87 59.64 36.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.075 1.75 . . . . 0.0 113.553 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.85 -3.65 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.329 2.686 . . . . 0.0 114.834 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.84 20.22 4.6 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.708 2.003 . . . . 0.0 112.606 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.1 ttt -141.99 149.55 40.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.851 1.66 . . . . 0.0 109.976 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -70.42 141.34 52.13 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.146 -0.971 . . . . 0.0 111.142 -171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.65 138.37 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.545 1.538 . . . . 0.0 110.338 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.86 79.3 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.515 1.926 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -75.34 130.87 39.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.251 -0.906 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.36 5.35 3.76 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.389 2.276 . . . . 0.0 112.173 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 27.6 mt -56.6 143.45 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.835 1.654 . . . . 0.0 110.72 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -126.37 174.29 8.7 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.898 1.679 . . . . 0.0 111.44 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.09 142.88 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.539 1.136 . . . . 0.0 109.665 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 13.6 t -58.91 146.46 37.63 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.985 0.914 . . . . 0.0 113.429 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -153.64 12.77 0.57 Allowed Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.311 1.434 . . . . 0.0 114.4 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -145.5 21.03 1.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.729 1.612 . . . . 0.0 112.145 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 62.58 154.48 0.11 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 128.834 2.854 . . . . 0.0 114.574 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.41 163.79 35.18 Favored 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 122.971 2.447 . . . . 0.0 112.226 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.11 160.63 37.19 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.291 2.661 . . . . 0.0 112.702 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.63 64.49 0.55 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.88 1.229 . . . . 0.0 113.758 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.57 159.0 46.87 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.398 2.732 . . . . 0.0 112.299 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.55 165.9 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.486 2.791 . . . . 0.0 112.618 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.974 2.109 . . . . 0.0 112.068 -178.63 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.18 158.69 44.22 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.031 1.332 . . . . 0.0 111.831 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.9 t -157.98 177.24 11.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.524 1.53 . . . . 0.0 111.377 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.64 125.55 14.39 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.769 1.628 . . . . 0.0 109.849 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.76 169.03 18.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.661 1.584 . . . . 0.0 112.087 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -145.95 67.05 1.2 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.135 1.374 . . . . 0.0 112.191 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -82.62 167.34 18.37 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.902 1.681 . . . . 0.0 111.999 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 t -36.92 158.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.0 2.92 . . . . 0.0 115.126 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.1 147.7 43.04 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.096 1.758 . . . . 0.0 114.285 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -155.99 153.54 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.976 1.71 . . . . 0.0 111.6 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.7 m -137.61 147.68 45.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.367 1.867 . . . . 0.0 111.158 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.46 138.47 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.344 1.857 . . . . 0.0 108.792 169.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 t -147.92 139.56 23.82 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.452 -0.78 . . . . 0.0 112.067 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -109.97 148.07 32.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.459 1.504 . . . . 0.0 112.095 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.4 m -134.93 60.09 1.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.631 2.372 . . . . 0.0 110.948 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.36 -91.71 1.37 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.807 1.194 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -116.74 27.71 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.876 1.67 . . . . 0.0 112.8 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -140.29 131.7 26.84 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.264 1.826 . . . . 0.0 108.61 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.6 138.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.457 1.103 . . . . 0.0 111.226 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -119.41 143.99 47.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.323 1.049 . . . . 0.0 112.252 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.51 110.76 14.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.671 2.388 . . . . 0.0 108.924 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.0 120.32 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.266 1.426 . . . . 0.0 108.679 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.77 -152.88 21.25 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.184 -0.947 . . . . 0.0 114.223 -170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.78 160.15 43.11 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.032 2.133 . . . . 0.0 111.895 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HD1' ' HG ' ' A' ' 132' ' ' SER . 9.0 m-85 -157.06 171.63 7.2 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 126.225 1.81 . . . . 0.0 112.227 171.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -65.32 -31.46 52.68 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.547 2.831 . . . . 0.0 114.09 169.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -157.23 168.6 26.93 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.126 1.441 . . . . 0.0 114.002 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.28 -29.06 70.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.568 1.547 . . . . 0.0 113.182 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.64 -29.71 70.72 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.725 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.96 65.42 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -61.17 -40.96 95.83 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.172 -0.955 . . . . 0.0 111.817 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.02 -36.2 78.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.144 0.978 . . . . 0.0 111.323 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.8 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.15 -46.14 82.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.721 0.691 . . . . 0.0 111.53 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.4 mmm -65.13 -39.88 93.68 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.671 0.788 . . . . 0.0 111.167 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.0 m -63.03 -41.5 99.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.062 0.945 . . . . 0.0 110.658 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.21 -29.28 68.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -92.37 -23.99 19.04 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.67 -32.09 73.18 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.695 1.598 . . . . 0.0 112.246 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.68 -29.4 49.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.841 1.686 . . . . 0.0 115.139 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.52 15.3 4.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.23 1.412 . . . . 0.0 112.524 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.82 127.21 31.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.68 0.792 . . . . 0.0 111.202 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.97 149.12 38.3 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.874 1.27 . . . . 0.0 111.155 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.29 103.7 0.81 Allowed 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 123.625 2.883 . . . . 0.0 112.602 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 121.64 -8.31 10.15 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.421 1.962 . . . . 0.0 113.596 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.88 112.1 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.425 1.113 . . . . 0.0 110.595 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.55 149.29 48.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.209 1.404 . . . . 0.0 111.728 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.4 t -135.51 127.72 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.007 1.323 . . . . 0.0 109.385 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.28 103.35 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.118 1.367 . . . . 0.0 109.036 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -85.22 123.4 30.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.271 1.028 . . . . 0.0 111.098 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -134.54 20.41 3.62 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.896 2.479 . . . . 0.0 111.03 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.27 122.85 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 120.92 -1.113 . . . . 0.0 110.154 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -80.9 168.73 18.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.204 1.802 . . . . 0.0 112.519 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.99 125.91 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.746 1.218 . . . . 0.0 111.525 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.12 112.28 3.07 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.82 1.648 . . . . 0.0 110.305 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.62 -4.92 15.59 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.59 2.86 . . . . 0.0 114.607 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.05 -1.87 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.491 1.516 . . . . 0.0 113.477 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.77 154.98 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 128.257 2.623 . . . . 0.0 108.935 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.031 1.332 . . . . 0.0 108.116 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.414 ' HG ' ' HD1' ' A' ' 97' ' ' PHE . 1.2 m -141.71 171.25 14.32 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.59 178.5 7.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.013 2.125 . . . . 0.0 109.752 165.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.65 168.42 11.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.578 1.551 . . . . 0.0 113.769 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.37 13.78 8.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.131 2.172 . . . . 0.0 112.138 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -56.93 -30.4 63.96 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.697 -1.252 . . . . 0.0 113.384 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.1 m -102.86 1.65 34.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.245 1.818 . . . . 0.0 113.663 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.73 -5.72 58.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.73 1.212 . . . . 0.0 113.787 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -48.78 -50.4 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 O-C-N 121.035 -1.04 . . . . 0.0 113.226 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.67 -24.55 41.21 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.495 2.13 . . . . 0.0 114.113 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.84 -45.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.569 1.077 . . . . 0.0 110.497 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.42 -33.53 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.223 0.609 . . . . 0.0 112.496 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 59.8 m -61.05 -43.12 99.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.126 0.875 . . . . 0.0 111.352 171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.55 66.08 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.992 0.917 . . . . 0.0 113.448 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -106.45 7.68 31.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.573 1.949 . . . . 0.0 115.236 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.11 -44.97 88.59 Favored Pre-proline 0 N--CA 1.482 1.136 0 O-C-N 120.457 -1.402 . . . . 0.0 113.758 167.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.81 15.44 1.47 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.826 2.351 . . . . 0.0 113.942 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.478 ' CG2' ' H ' ' A' ' 165' ' ' THR . 13.6 mt -119.41 91.6 44.52 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 126.181 1.792 . . . . 0.0 110.63 -171.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.38 -20.88 31.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.963 2.442 . . . . 0.0 114.821 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -98.62 1.83 46.71 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.353 1.861 . . . . 0.0 113.819 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -54.3 149.7 9.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.667 1.187 . . . . 0.0 113.606 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.86 162.91 34.43 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.205 1.384 . . . . 0.0 111.772 167.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.5 tt -141.5 145.04 34.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.953 1.301 . . . . 0.0 108.949 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -140.28 149.75 43.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.981 1.312 . . . . 0.0 111.578 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.71 136.41 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.006 1.322 . . . . 0.0 110.82 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -161.55 152.84 18.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.536 1.134 . . . . 0.0 111.579 166.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 49.06 -69.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 129.798 3.239 . . . . 0.0 117.424 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -149.24 15.31 0.91 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 127.811 2.444 . . . . 0.0 113.658 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -139.66 155.9 47.13 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 120.136 -1.602 . . . . 0.0 114.276 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.33 110.76 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.603 1.961 . . . . 0.0 110.438 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.5 m -94.91 138.85 32.12 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.184 1.394 . . . . 0.0 110.708 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.09 124.72 35.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.641 1.576 . . . . 0.0 109.037 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.3 m -129.63 145.12 51.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.893 1.677 . . . . 0.0 110.447 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.7 -172.09 42.41 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 120.764 -1.21 . . . . 0.0 113.93 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.478 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 22.5 p -124.74 71.52 1.17 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.298 2.239 . . . . 0.0 112.908 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.2 149.27 97.17 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -171.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.1 -27.07 30.03 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.652 2.901 . . . . 0.0 114.15 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 37.2 t -148.38 156.87 43.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.465 1.906 . . . . 0.0 110.276 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 62.0 p -58.82 -20.93 54.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.086 0.954 . . . . 0.0 113.205 167.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.91 -47.33 81.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.81 1.244 . . . . 0.0 111.747 170.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -60.2 -40.1 88.85 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.268 0.627 . . . . 0.0 112.032 170.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.52 -46.27 90.76 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.043 0.838 . . . . 0.0 112.256 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.91 -41.67 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.468 0.707 . . . . 0.0 112.092 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.91 95.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 112.407 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.72 -41.78 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.295 0.638 . . . . 0.0 111.051 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.12 -45.22 93.02 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 111.872 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -69.13 -36.42 77.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.405 0.682 . . . . 0.0 111.351 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.33 86.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.047 0.539 . . . . 0.0 112.062 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.72 94.82 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.789 0.722 . . . . 0.0 111.907 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 85.7 m -63.37 -39.0 93.34 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.688 -0.633 . . . . 0.0 111.933 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 73.7 m -66.68 -35.56 80.44 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.4 m -75.96 -36.92 59.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.214 1.006 . . . . 0.0 112.728 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.01 59.5 45.59 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.305 1.442 . . . . 0.0 113.013 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.64 -5.16 16.47 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.175 . . . . 0.0 115.603 -171.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.5 14.79 8.22 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.141 1.777 . . . . 0.0 112.997 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.1 mtm -133.3 164.76 26.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.617 1.967 . . . . 0.0 110.207 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -76.96 152.75 35.13 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.348 -0.845 . . . . 0.0 111.741 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.99 136.93 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.099 1.36 . . . . 0.0 109.418 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.1 t -126.1 89.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.985 1.314 . . . . 0.0 109.618 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -74.95 65.57 1.44 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.674 2.39 . . . . 0.0 112.337 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -71.12 5.46 2.1 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.347 2.259 . . . . 0.0 114.387 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.1 mm -50.96 143.7 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.416 1.886 . . . . 0.0 111.301 171.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -128.56 173.33 10.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.879 1.672 . . . . 0.0 110.268 168.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.9 t -87.26 144.12 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.882 0.873 . . . . 0.0 109.455 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 13.5 t -55.18 149.89 11.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.443 1.497 . . . . 0.0 113.996 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -177.62 42.76 0.09 OUTLIER Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.464 1.506 . . . . 0.0 112.45 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -137.63 122.89 19.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.617 1.567 . . . . 0.0 110.499 -171.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.79 154.22 86.13 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.818 1.247 . . . . 0.0 113.107 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.63 160.57 47.5 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 123.155 2.57 . . . . 0.0 111.915 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.04 143.45 72.18 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.021 2.481 . . . . 0.0 112.282 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 173.09 60.14 0.05 OUTLIER Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.693 -1.059 . . . . 0.0 113.566 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -66.15 157.75 58.17 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.424 2.749 . . . . 0.0 113.033 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.9 170.53 19.47 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.836 3.024 . . . . 0.0 112.61 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.613 1.965 . . . . 0.0 111.929 -179.93 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.65 166.64 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 127.284 2.233 . . . . 0.0 115.528 -172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 m -74.3 120.95 20.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.618 1.167 . . . . 0.0 111.09 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.18 58.2 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.726 0.811 . . . . 0.0 112.45 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.49 136.67 22.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.982 1.313 . . . . 0.0 109.977 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 t -86.66 116.5 24.81 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 112.549 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.92 171.91 7.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.479 2.312 . . . . 0.0 110.603 175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.17 157.35 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 129.89 3.276 . . . . 0.0 114.981 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 tt -95.28 129.86 42.25 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.601 1.561 . . . . 0.0 110.777 167.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 83' ' ' SER . 0.7 OUTLIER -153.79 140.98 19.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.235 1.014 . . . . 0.0 109.182 -175.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.429 ' N ' HD13 ' A' ' 82' ' ' LEU . 88.3 p -146.49 160.44 42.1 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 123.209 1.48 . . . . 0.0 113.371 172.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 tt -144.64 144.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.067 1.347 . . . . 0.0 109.715 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 t -142.58 141.16 31.94 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.011 0.524 . . . . 0.0 111.899 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -108.4 148.66 29.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.462 1.505 . . . . 0.0 112.141 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.3 m -137.18 60.29 1.65 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.037 2.135 . . . . 0.0 111.509 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.28 -89.06 1.38 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.545 1.069 . . . . 0.0 113.135 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -121.22 29.75 7.15 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.063 1.745 . . . . 0.0 112.099 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 96.6 m -141.02 136.29 31.95 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.998 2.119 . . . . 0.0 108.113 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.32 143.0 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.338 1.055 . . . . 0.0 111.418 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.0 m -126.78 126.11 42.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.216 1.006 . . . . 0.0 111.507 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.84 129.97 49.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.16 2.184 . . . . 0.0 110.379 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.4 mt -137.26 144.07 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.077 1.351 . . . . 0.0 109.122 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 152.51 -147.77 17.86 Favored Glycine 0 C--N 1.338 0.681 0 O-C-N 119.964 -1.71 . . . . 0.0 115.466 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -154.41 143.56 21.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.326 2.65 . . . . 0.0 110.923 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -152.51 170.72 7.62 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.775 1.23 . . . . 0.0 112.426 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.71 -29.32 10.75 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.808 3.005 . . . . 0.0 114.287 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -159.57 172.08 18.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.356 1.55 . . . . 0.0 114.836 -171.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.41 -34.22 73.64 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.277 1.831 . . . . 0.0 112.985 172.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.2 -30.66 71.16 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.074 0.55 . . . . 0.0 111.547 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.74 75.76 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.974 0.509 . . . . 0.0 112.274 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -63.19 -41.88 99.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.582 0.753 . . . . 0.0 111.804 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.62 84.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.388 0.675 . . . . 0.0 112.451 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.64 -40.89 76.26 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.653 -0.654 . . . . 0.0 112.713 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp -66.2 -40.58 90.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.652 1.181 . . . . 0.0 111.321 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.5 ptm -73.82 -32.46 63.71 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.746 -0.596 . . . . 0.0 112.109 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.0 m -65.48 -39.22 91.66 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.027 0.931 . . . . 0.0 110.98 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.15 79.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.978 0.911 . . . . 0.0 113.119 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.9 -24.83 24.7 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.92 -28.24 67.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.676 1.59 . . . . 0.0 112.203 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -53.7 -28.16 37.46 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 126.792 2.139 . . . . 0.0 115.388 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.407 HD23 HG21 ' A' ' 146' ' ' VAL . 0.9 OUTLIER -135.32 15.15 3.48 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.337 1.055 . . . . 0.0 113.598 174.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.7 tt -55.9 127.38 30.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.93 0.892 . . . . 0.0 111.267 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.39 149.26 44.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.157 1.383 . . . . 0.0 111.176 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.87 102.76 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.529 2.819 . . . . 0.0 112.665 -174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 124.4 -8.7 8.36 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.742 2.115 . . . . 0.0 113.852 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.57 113.83 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.477 1.139 . . . . 0.0 111.055 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -73.68 153.14 40.23 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.906 1.682 . . . . 0.0 112.267 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.63 133.64 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.706 1.203 . . . . 0.0 109.846 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.0 mt -128.66 141.27 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.266 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -130.06 128.49 42.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.887 1.275 . . . . 0.0 112.766 -171.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.8 17.96 3.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.339 2.256 . . . . 0.0 112.73 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.81 130.77 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.811 1.244 . . . . 0.0 110.954 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -86.6 164.11 17.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.922 1.689 . . . . 0.0 112.373 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.85 120.79 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.118 1.367 . . . . 0.0 111.657 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.07 130.46 5.27 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.346 1.859 . . . . 0.0 110.156 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.27 -4.68 15.42 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.775 2.983 . . . . 0.0 114.691 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.4 t -67.3 -15.14 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 126.002 1.721 . . . . 0.0 112.58 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.98 145.43 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 128.022 2.529 . . . . 0.0 110.491 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -141.68 150.85 42.42 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.282 1.833 . . . . 0.0 109.013 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -126.21 168.22 14.37 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.871 HD12 ' H ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -69.69 155.45 40.49 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.814 2.846 . . . . 0.0 108.586 167.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.35 88.19 7.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.379 1.072 . . . . 0.0 113.373 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -61.58 -8.65 4.62 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.717 -1.24 . . . . 0.0 113.55 167.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 m -49.17 -29.5 5.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.085 1.754 . . . . 0.0 112.506 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.2 m -108.97 2.33 21.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.63 2.372 . . . . 0.0 113.488 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.42 -2.96 51.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.852 1.661 . . . . 0.0 113.647 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.45 -47.66 83.17 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.761 1.224 . . . . 0.0 113.187 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.51 -27.01 46.71 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.807 1.671 . . . . 0.0 113.632 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.93 -45.32 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 118.948 0.795 . . . . 0.0 110.775 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -74.49 -30.11 61.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.152 0.581 . . . . 0.0 112.398 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -62.42 -44.2 97.0 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.481 1.112 . . . . 0.0 111.408 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.79 -17.0 64.66 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -112.95 3.06 16.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.523 1.929 . . . . 0.0 115.542 -177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.407 HG21 HD23 ' A' ' 113' ' ' LEU . 91.3 t -53.62 -40.37 80.02 Favored Pre-proline 0 N--CA 1.481 1.096 0 O-C-N 120.132 -1.605 . . . . 0.0 113.858 167.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.41 14.25 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.68 2.254 . . . . 0.0 114.065 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.1 mt -120.69 84.34 37.09 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.964 2.106 . . . . 0.0 109.308 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.45 -17.79 58.36 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.44 2.76 . . . . 0.0 115.297 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -105.77 5.54 30.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.423 2.289 . . . . 0.0 113.913 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -56.53 152.28 12.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.252 1.025 . . . . 0.0 113.251 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.57 35.04 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.654 1.597 . . . . 0.0 112.356 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.62 150.35 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.296 1.438 . . . . 0.0 109.584 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -139.21 142.3 37.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.479 1.112 . . . . 0.0 109.089 168.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.6 t -143.45 128.45 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.713 1.205 . . . . 0.0 109.063 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.45 155.03 29.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 36.54 -89.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.058 2.543 . . . . 0.0 114.971 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -125.1 15.32 8.46 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.841 2.056 . . . . 0.0 113.171 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 32.2 m -139.43 145.1 38.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.616 1.566 . . . . 0.0 112.609 -171.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.25 141.09 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 126.429 1.892 . . . . 0.0 110.257 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.3 m -132.49 135.08 45.78 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.04 1.736 . . . . 0.0 109.6 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.85 125.36 33.42 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.192 1.397 . . . . 0.0 109.564 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.9 m -134.86 131.21 37.11 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.888 1.275 . . . . 0.0 110.244 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.99 -174.47 45.32 Favored Glycine 0 CA--C 1.538 1.473 0 O-C-N 120.879 -1.138 . . . . 0.0 112.882 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -126.88 80.51 1.95 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.954 1.702 . . . . 0.0 113.726 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.74 153.87 90.01 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 125.763 1.625 . . . . 0.0 114.751 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -25.54 16.04 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.607 2.871 . . . . 0.0 114.634 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.8 t -153.29 157.53 40.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.33 1.852 . . . . 0.0 110.71 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 54.5 p -59.64 -24.08 63.56 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.289 1.036 . . . . 0.0 113.41 169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -65.65 -44.07 87.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.546 1.138 . . . . 0.0 111.32 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -61.95 -39.68 92.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.232 0.613 . . . . 0.0 111.992 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -60.54 -43.34 97.31 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.183 0.901 . . . . 0.0 112.716 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.39 -43.51 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.368 0.667 . . . . 0.0 112.11 175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.65 84.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.75 0.82 . . . . 0.0 112.195 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.3 -39.62 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.408 0.549 . . . . 0.0 110.836 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -64.33 -43.61 94.08 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.678 0.672 . . . . 0.0 111.737 175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -67.59 -37.15 82.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.956 0.903 . . . . 0.0 112.136 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.84 83.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.809 0.444 . . . . 0.0 110.869 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.44 -37.56 87.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.931 0.492 . . . . 0.0 112.044 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.4 m -68.84 -36.64 78.43 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.652 0.781 . . . . 0.0 111.734 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 t -68.05 -38.69 82.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.185 0.994 . . . . 0.0 112.376 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 41.9 m -72.86 -40.02 66.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.093 0.957 . . . . 0.0 112.339 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -129.77 61.1 56.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.411 1.484 . . . . 0.0 113.906 -171.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.63 -13.14 32.23 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.221 2.614 . . . . 0.0 113.154 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -98.9 3.17 47.13 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.818 2.047 . . . . 0.0 113.483 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -133.86 164.32 27.52 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.344 1.857 . . . . 0.0 111.691 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -76.65 150.78 36.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.529 0.732 . . . . 0.0 110.808 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.54 133.51 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.271 1.429 . . . . 0.0 109.92 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.75 84.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.891 1.676 . . . . 0.0 109.486 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.18 70.34 3.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.622 1.569 . . . . 0.0 111.48 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -68.3 -9.61 48.92 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.799 2.04 . . . . 0.0 114.251 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.4 pt -58.12 156.09 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.268 1.427 . . . . 0.0 112.861 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.2 173.7 11.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.782 1.233 . . . . 0.0 110.968 168.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.38 141.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.628 0.771 . . . . 0.0 109.094 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 14.9 t -56.41 151.1 13.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.477 1.111 . . . . 0.0 113.0 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -112.98 8.54 25.35 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.246 1.403 . . . . 0.0 114.793 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -150.32 140.14 21.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.963 1.305 . . . . 0.0 111.548 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -156.88 57.13 1.29 Allowed Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.287 1.835 . . . . 0.0 111.984 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 154.27 75.12 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.225 2.617 . . . . 0.0 112.636 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.38 143.18 47.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.313 2.675 . . . . 0.0 112.203 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 159.73 178.07 33.4 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.893 1.235 . . . . 0.0 113.473 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.79 160.11 50.47 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.498 2.799 . . . . 0.0 112.109 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.21 115.2 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.426 2.75 . . . . 0.0 110.982 175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 126.311 1.844 . . . . 0.0 112.137 -177.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.35 51.75 1.36 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.776 1.23 . . . . 0.0 112.602 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.9 t -151.71 135.77 16.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.108 1.763 . . . . 0.0 110.337 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.3 37.6 0.39 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.203 1.401 . . . . 0.0 112.211 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.86 123.66 22.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.071 1.348 . . . . 0.0 110.931 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -74.88 135.94 41.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.033 1.333 . . . . 0.0 111.846 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.1 mt -137.15 169.1 18.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.945 2.098 . . . . 0.0 112.369 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.96 151.29 0.32 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.544 2.738 . . . . 0.0 114.199 173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.58 129.03 54.58 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.378 1.871 . . . . 0.0 111.643 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.9 tt -154.06 154.93 34.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.565 1.146 . . . . 0.0 112.447 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -138.03 145.99 42.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.985 2.114 . . . . 0.0 110.787 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 tt -140.24 139.08 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.25 1.42 . . . . 0.0 109.153 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 t -146.8 143.49 28.67 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -105.02 148.12 27.09 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.657 1.583 . . . . 0.0 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.3 m -135.17 63.58 1.61 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.484 2.314 . . . . 0.0 111.407 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.95 -88.71 1.26 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.745 1.164 . . . . 0.0 113.058 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -122.53 34.15 5.23 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.063 1.745 . . . . 0.0 111.871 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.7 m -143.68 140.7 30.18 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.563 2.345 . . . . 0.0 108.239 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.24 143.97 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.381 1.073 . . . . 0.0 111.316 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 56.5 m -127.11 130.44 49.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.352 1.061 . . . . 0.0 111.562 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 122.75 47.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.21 2.204 . . . . 0.0 110.123 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.87 116.75 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.575 1.15 . . . . 0.0 109.313 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.77 -161.02 32.25 Favored Glycine 0 CA--C 1.525 0.719 0 O-C-N 120.502 -1.374 . . . . 0.0 114.727 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.14 142.21 24.0 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.073 2.149 . . . . 0.0 111.331 -170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -152.44 169.77 9.07 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.285 1.434 . . . . 0.0 112.749 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.26 -25.51 11.4 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.845 3.03 . . . . 0.0 114.179 174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -155.54 164.22 38.95 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.688 1.595 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -66.36 -26.35 67.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.615 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -29.94 69.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.457 0.703 . . . . 0.0 112.005 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 -40.24 75.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.325 0.65 . . . . 0.0 112.606 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.9 -42.3 99.74 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.629 1.172 . . . . 0.0 111.371 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.74 82.71 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.745 0.818 . . . . 0.0 111.767 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.22 91.74 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.35 -39.4 89.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.586 1.154 . . . . 0.0 111.754 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.21 -38.68 82.19 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.325 -0.86 . . . . 0.0 112.097 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.1 m -63.32 -40.94 98.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.442 1.097 . . . . 0.0 110.981 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.46 -33.74 76.23 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.254 1.021 . . . . 0.0 112.978 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 pp -86.52 -26.8 24.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.29 -27.73 66.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.806 1.642 . . . . 0.0 112.355 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.75 -29.26 25.5 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.918 2.199 . . . . 0.0 115.306 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.1 16.76 2.81 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.343 1.057 . . . . 0.0 113.523 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -56.28 133.39 52.6 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.86 0.864 . . . . 0.0 111.477 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.25 146.06 34.0 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.291 1.436 . . . . 0.0 111.216 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 103.21 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.578 2.852 . . . . 0.0 112.393 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.6 -9.94 6.82 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.607 2.051 . . . . 0.0 113.783 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.83 112.91 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 118.553 1.177 . . . . 0.0 110.795 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.98 158.46 36.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.866 1.667 . . . . 0.0 112.592 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -136.62 133.2 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.104 1.361 . . . . 0.0 109.807 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.8 139.48 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.191 1.797 . . . . 0.0 108.971 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -127.59 126.13 41.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 113.16 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -137.35 23.53 2.97 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.761 2.424 . . . . 0.0 111.684 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.0 mm -66.6 144.98 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 120.768 -1.207 . . . . 0.0 111.22 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -116.2 161.66 18.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.17 1.788 . . . . 0.0 111.903 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -131.3 120.72 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.358 1.463 . . . . 0.0 111.765 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.42 129.75 4.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.608 1.963 . . . . 0.0 110.167 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.49 -3.23 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.085 3.19 . . . . 0.0 115.039 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.5 t -66.13 -19.25 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.714 2.006 . . . . 0.0 112.505 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.26 139.67 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 127.485 2.314 . . . . 0.0 109.824 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -144.98 146.83 32.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.429 1.892 . . . . 0.0 108.982 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.08 -179.82 6.0 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.68 174.64 1.31 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.682 2.393 . . . . 0.0 110.816 166.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.66 155.89 17.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.795 1.238 . . . . 0.0 112.056 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -112.75 0.26 15.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.122 1.369 . . . . 0.0 113.264 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.4 m -56.74 -40.11 75.14 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.105 -0.997 . . . . 0.0 111.699 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.1 m -83.28 -7.33 59.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.589 1.556 . . . . 0.0 114.167 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.84 -1.65 54.58 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.815 1.646 . . . . 0.0 114.32 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -45.58 -47.92 37.22 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.391 1.076 . . . . 0.0 113.132 169.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -24.22 54.63 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.125 1.884 . . . . 0.0 113.94 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.9 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.193 0.906 . . . . 0.0 110.813 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -69.94 -37.89 76.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.195 -0.431 . . . . 0.0 111.748 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.4 m -58.42 -41.35 84.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.418 1.087 . . . . 0.0 111.479 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.64 -12.16 61.01 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 m -117.21 -5.46 11.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.622 1.969 . . . . 0.0 115.839 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.69 -40.82 80.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-N 121.867 2.121 . . . . 0.0 115.739 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.42 -8.32 23.08 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 CA-C-N 122.688 1.996 . . . . 0.0 114.373 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.419 ' CG2' ' H ' ' A' ' 165' ' ' THR . 24.8 mt -83.3 119.21 73.62 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.351 1.46 . . . . 0.0 110.934 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.87 -24.61 9.81 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.78 2.32 . . . . 0.0 115.39 -173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -113.47 8.5 17.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.402 1.881 . . . . 0.0 114.001 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -56.44 148.1 20.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.745 0.818 . . . . 0.0 112.934 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.32 166.72 39.01 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.532 1.063 . . . . 0.0 112.414 171.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.56 150.93 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.174 1.389 . . . . 0.0 110.3 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.57 145.51 47.03 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.365 1.066 . . . . 0.0 110.256 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.55 129.77 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.882 1.273 . . . . 0.0 108.672 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -159.61 158.92 32.49 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.329 0.652 . . . . 0.0 112.364 170.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 43.82 -89.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.556 2.342 . . . . 0.0 114.194 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.93 24.86 3.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.769 2.028 . . . . 0.0 111.727 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 20.2 m -135.74 142.3 44.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.803 1.641 . . . . 0.0 112.327 -171.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.8 m -121.14 129.32 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.544 1.938 . . . . 0.0 110.547 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 m -125.64 137.28 53.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.385 1.474 . . . . 0.0 110.666 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.2 125.53 31.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.354 1.462 . . . . 0.0 109.877 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.0 m -132.78 152.9 51.68 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.745 1.618 . . . . 0.0 110.416 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 163.05 -167.02 37.22 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 120.741 -1.224 . . . . 0.0 114.568 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.419 ' H ' ' CG2' ' A' ' 148' ' ' ILE . 21.4 p -136.03 70.62 1.42 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.733 2.013 . . . . 0.0 112.861 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.19 153.14 95.47 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.6 1.56 . . . . 0.0 114.94 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.94 -27.87 20.29 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.608 2.872 . . . . 0.0 114.323 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 38.2 t -151.55 156.68 41.0 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.046 1.739 . . . . 0.0 111.139 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.1 m -58.33 -21.4 49.33 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.488 1.115 . . . . 0.0 113.409 167.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.44 -46.77 87.02 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.216 1.006 . . . . 0.0 111.614 170.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -59.77 -42.19 92.75 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.173 0.589 . . . . 0.0 111.791 170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -62.18 -44.59 96.25 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.835 0.743 . . . . 0.0 112.685 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.72 -42.15 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.834 0.854 . . . . 0.0 111.82 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.63 -40.93 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.14 0.576 . . . . 0.0 111.059 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -64.87 -41.5 95.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.292 1.037 . . . . 0.0 111.846 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -69.23 -34.84 75.45 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.561 1.144 . . . . 0.0 112.521 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.94 -44.94 83.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 117.929 0.331 . . . . 0.0 111.199 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.76 92.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.99 0.916 . . . . 0.0 112.513 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 t -74.4 -28.24 61.0 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.723 -0.611 . . . . 0.0 112.158 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -39.42 71.7 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.857 0.863 . . . . 0.0 112.81 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 183' ' ' TRP . 11.1 t -79.58 -31.68 41.86 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.646 ' CD2' HG23 ' A' ' 182' ' ' THR . 2.7 m-90 -128.91 60.51 50.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.355 1.462 . . . . 0.0 114.029 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.58 -14.6 30.51 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.352 2.702 . . . . 0.0 114.859 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -95.72 -8.55 34.24 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.241 1.016 . . . . 0.0 113.453 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 98.7 mtp -106.43 160.77 15.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 112.507 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -67.35 142.85 56.65 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.466 0.706 . . . . 0.0 109.484 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.63 127.35 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 110.243 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.54 97.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.496 1.118 . . . . 0.0 110.767 -171.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -75.72 123.04 24.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.309 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -129.14 5.68 5.33 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.825 2.45 . . . . 0.0 111.6 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.0 mt -61.99 142.05 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.901 1.68 . . . . 0.0 110.529 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -122.02 -179.28 4.1 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.276 2.231 . . . . 0.0 110.261 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.0 t -84.06 147.99 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 120.948 -1.095 . . . . 0.0 111.179 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.0 t -55.55 158.51 3.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.432 1.893 . . . . 0.0 114.316 171.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -111.16 13.66 28.62 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.849 1.69 . . . . 0.0 113.305 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -143.14 -154.54 0.53 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.313 1.845 . . . . 0.0 110.29 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 45.56 56.45 15.4 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 126.286 1.834 . . . . 0.0 115.191 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.21 160.77 45.96 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.501 2.801 . . . . 0.0 112.617 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.36 159.39 53.54 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.389 2.726 . . . . 0.0 112.93 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -174.71 60.29 0.12 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.554 1.073 . . . . 0.0 113.568 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.4 157.73 58.82 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.534 2.823 . . . . 0.0 113.011 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.63 170.58 19.66 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.852 3.035 . . . . 0.0 112.655 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.942 1.697 . . . . 0.0 113.288 175.436 . . . . . . . . 0 0 . 1 stop_ save_